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Abstract 
Background 
Many patients are referred from primary care with suspected heart failure and are found to 
have preserved systolic function.  These patients may be labelled as having normal ejection 
fraction or diastolic heart failure, the diagnosis of which is both controversial and difficult.  
Previous work has identified a large proportion of these patients to have an alternative, pre-
existing diagnosis.  This thesis prospectively assesses the prevalence of undiagnosed 
ischaemic heart disease and respiratory disease in this patient group and assess diastolic 
function using multiple methods.  The central hypothesis being tested was that first third 
fractional filling, a radionuclide ventriculogram (RNVG) parameter previously used to 
assess diastolic function at rest, would identify diastolic dysfunction more accurately under 
stress conditions. 
Methods 
Patients were recruited from an open access echocardiography service. Echocardiography, 
including tissue Doppler assessment, was carried out independently by 2 experienced 
observers.  Confounding diagnoses including coronary artery disease and respiratory 
disease were actively sought by myocardial perfusion imaging and spirometry.  N-terminal 
proBNP was measured.  List mode radionuclide ventriculography was performed at rest 
supine and during upright bicycle exercise with simultaneous measurement of VO2 max. 
Validation of the reliability and reproducibility of first third fractional filling, peak filling 
rate, time to peak filling and other radionuclide parameters of systolic and diastolic 
function was undertaken.  This demonstrated that it was possible to measure both first third 
fractional filling and peak filling rate with the short acquisition times necessary for 
assessment during stress.  Time to peak filling was poorly reproducible under these 
conditions. 
A normal range for first third fractional filling at rest and during exercise was established.  
Due to a strong inverse relationship between heart rate and first third fractional filling, a 
continuous reference range was constructed using an exponential model.  This unique 
approach enables the calculation of the lower limit of normal at any heart rate.  A more 
conventional mean ± 2 standard deviations was used for the other RNVG parameters. 
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Results 
Eighty three patients were recruited and completed an extensive multi-modality assessment 
of systolic and diastolic function.  As with previous work in this field, the patients were 
predominantly female (82%) and elderly (mean age 66.7).  Mild left ventricular systolic 
dysfunction as determined by RNVG was missed by echocardiography in one third of 
patients.  Systolic dysfunction more significant than this was not observed.  N-terminal 
proBNP was elevated in 21 of 82 patients where it was available with no significant 
difference in left ventricular ejection fraction between those with normal and elevated 
levels.  Myocardial perfusion scanning was normal in 46 of 83 patients and showed 
significant ischaemia in 20 of 83.  Spirometry was normal in 58 of 82 patients, with mild 
airflow obstruction in 20 patients and moderate obstruction in 4.  In only one patient were 
no alternative diagnoses present. 
There was poor correlation between indices of diastolic function at rest including first third 
fractional filling, echocardiographic parameters and NT-proBNP.  The assessment of 
diastolic function using stress radionuclide ventriculography did not improve the 
correlation between measured indices.  On stress, however, low first third fractional filling 
predicted exercise intolerance as an inability to reach anaerobic threshold. 
Conclusions 
Alternative diagnoses to diastolic dysfunction are present almost universally in patients 
with suspected normal ejection fraction heart failure.  This is true even where these 
diagnoses are not previously established.  This thesis underlines the need to fully assess 
this patient group to allow appropriate targeting of therapy.  It is also clear that 
echocardiography alone is potentially misleading and it is suggested that it is better placed 
within a tiered assessment process. 
The assessment of diastolic function using stress radionuclide ventriculography, although 
an appealing concept, does not improve diagnostic accuracy within this patient group.  The 
marked heterogeneity of this patient group is likely to have played a role in this and it may 
be of interest to reassess stress radionuclide ventriculography in a more acute heart failure 
population. 
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1. Introduction 
1.1 Diastolic Dysfunction 
Diastolic dysfunction is an area of cardiology that has become of increasing interest over 
the last two decades.  It has progressed from a subject confined to academic research 
studies to a disease entity in its own right to which a substantial disease burden has been 
attributed, with drug trials and endpoint data beginning to emerge, enabling rational 
treatment strategies to be devised.  It is an area which has created much controversy, from 
the technicalities of how to define it and best measure it, to whether diastolic dysfunction is 
a genuine clinical entity in its own right, or whether it is something which is dependent on 
the presence of other structural heart disease and should not be diagnosed in the absence of 
this. 
Part of this debate is fuelled by the limitations inherent in the methods used to assess 
diastolic function, particularly non-invasively.  It has been argued that since many of the 
parameters in use are non-specific, being affected by factors other than those inherent to 
the left ventricle, and are more commonly found with increasing age, what is often being 
measured is in fact part of the normal aging process.  Where this normal aging process 
ends and pathology begins has been difficult to define, particularly because many of the 
“abnormalities” which can be measured are not infrequently found where there is no 
clinical evidence of heart failure.  Similarly, measurements can be normal or ambiguous 
even in the presence of what is thought to be heart failure. 
Another fundamental problem when dealing with diastolic dysfunction is one of definitions 
and terminology.  There are two main terms in use to describe the syndrome, these being 
‘diastolic dysfunction’ and ‘heart failure with preserved systolic function’.  Although the 
terms are superficially similar and often used synonymously, in fact they imply very 
different things.  The importance of this distinction will be explored further. 
1.1.1 The Concept of Diastolic Dysfunction 
With the development of echocardiography and angiocardiography, both radionuclide and 
x-ray contrast, allowing visualisation of the failing heart and quantification of systolic 
function, a subset of patients emerged who did not have systolic impairment, valvular 
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dysfunction or pulmonary hypertension/cor pulmonale, yet had been regarded as having 
heart failure.  Although alternative non-cardiac diagnoses will account for a proportion of 
these, a subset of patients remain in whom the clinical syndrome of heart failure exists but 
systolic and valvular function are preserved.  Attention therefore turned to the part of the 
cardiac cycle which had received relatively little attention, namely diastole. 
The concept underlying diastolic dysfunction is that due to an abnormality either of 
structure or function of the left ventricle there is impairment of left ventricular filling.  This 
reduction in filling will lead to a decrease in stroke volume and cardiac output unless left 
ventricular filling pressures are increased to compensate.  This increase in left atrial and 
intra-pulmonary pressures, as measured by pulmonary capillary wedge pressure, mirrors 
the process which follows a rise in left ventricular diastolic pressures due to systolic 
dysfunction with all its consequences in terms of clinical signs and symptoms.  In effect 
two separate but related pathologies come together to form a single common pathway 
responsible for the clinical syndrome seen. 
Although the concept itself is attractive with a clear flow of logic from a putative structural 
or functional problem to its sequelae and the resulting clinical syndrome, the process of 
demonstrating the underlying problem or its haemodynamic consequences reliably has 
been far from easy. 
1.1.2 Diastolic Dysfunction versus Heart Failure with a Normal 
Ejection Fraction 
Defining what is mean by diastolic heart failure is fairly fundamental, but surprisingly 
something which is confused by two different terms which, although used interchangeably, 
differ fundamentally in terms of what pathology is covered by the definition and where this 
pathology is located. 
Heart failure with preserved systolic function is a looser term which lacks precision and 
specificity, although it is simpler to apply in routine clinical practice, indeed being used in 
a major clinical trial, CHARM-Preserved(1).  The term refers to the clinical syndrome of 
heart failure where left ventricular systolic function has been assessed as preserved, i.e. at a 
sufficient level where it should not be expected to account for heart failure.  However, this 
does not automatically mean that there is an abnormality of diastolic function to account 
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for the clinical findings.  The syndrome encompassed by this term can very likely include 
signs and symptoms which, although clinically taken for heart failure, are not cardiac in 
origin at all.  If a clinical syndrome is to be attributed to cardiac causes, it is surely 
imperative that an abnormality of cardiac structure or function can be demonstrated.  A 
patient with dyspnoea and ankle oedema could easily be interpreted as having heart failure 
but, as these are non-specific and, in the case of dyspnoea, subjective findings, to make 
such a decision without actually demonstrating abnormal cardiac function intuitively seems 
wrong. 
More recently, terminology has evolved further.  Heart failure with a normal ejection 
fraction (HFNEF) has become the term of choice for this condition(2).  This takes into 
account the observation that abnormalities of left ventricular longitudinal systolic function 
may be demonstrable before the ejection fraction becomes abnormal(3, 4). 
Diastolic dysfunction on the other hand, specifically implies that there is a measurable 
abnormality in diastolic function which is responsible for the signs and symptoms 
observed.  If one is to be more specific still, it implies that the abnormality is intrinsic to 
the ventricle rather than a reflection of some factor external to the ventricle.  It is here that 
much of the problem in diagnosing diastolic heart failure arises – the difficulty in 
differentiating intrinsic and extrinsic factors using measurements which can be affected by 
either or both simultaneously. 
Whilst such a distinction may appear to be unnecessary pedantry, it is of major 
significance both in routine clinical practice where medication must be prescribed 
appropriately for cardiac dysfunction, rather than inappropriately for non-cardiac disorders, 
and in the context of clinical trials.  Where the entry criteria for a trial are sufficiently loose 
to allow inclusion of patients with non-cardiac disease, the magnitude of any treatment 
effect from the drug under study is at risk of being diluted.  This can be further 
compounded if the drug in question has pleiotropic effects.  Such a potential limitation can 
be seen in CHARM-Preserved(1) where diastolic function is not itself measured, instead 
the distinction is made on the basis of impaired or ‘preserved’ systolic function with an 
ejection fraction cut point of 40%. 
The necessity of measuring diastolic function has itself been questioned.  Zile et al put 
forth this point of view in 2001(5).   In a group of 63 patients who met Framingham 
criteria for heart failure but with normal left ventricular systolic function on a 
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contemporaneous echocardiogram, 58 had elevated left ventricular end diastolic pressure at 
cardiac catheterisation.  Using a combination of E/A ratio, isovolumetric relaxation time 
and mitral deceleration time, all patients could be demonstrated to have abnormal diastolic 
function by at least one of these criteria.  However, these measures in isolation performed 
poorly – the best correlation was with deceleration time which was abnormal in 64%.  E/A 
ratio performed less well at 48% abnormal, even although the criterion for abnormality was 
set at <1.0, with only 38% having diastolic dysfunction by IVRT criteria.  One critical 
factor with this group of patients is that they were required to have left ventricular 
hypertrophy, a condition one would expect to result in impaired diastolic function.  In a 
less rigorously defined group, such as is seen in routine practice, the percentage of patients 
with diastolic dysfunction validated on invasive study could be expected to be significantly 
less.  Perhaps the argument here should not be that we should not measure diastolic 
function at all, but rather we should endeavour to use methods other than standard 
transmitral Doppler which has been repeatedly shown to be unreliable(6). 
1.2 Defining Diastole - The Components of Diastolic 
Function 
To understand what processes and pathologies can lead to diastolic dysfunction it is 
important to first understand the complex processes which combine to produce diastole. 
When regarded from a flow mechanics viewpoint, diastole begins with a phase of 
isovolumetric relaxation following the closure of the aortic valve as left ventricular 
pressure falls below aortic pressure.  At this point the mitral valve is also closed.  As left 
ventricular pressure continues to fall, it decreases below left atrial pressure allowing the 
mitral valve to open, marking the end of isovolumetric relaxation and the beginning of 
passive ventricular filling.  As ventricular filling progresses, left ventricular pressure will 
begin to equilibrate with left atrial pressure with a period of diastasis following if the 
pressures in the two chambers equalise.  With the onset of atrial systole, left atrial pressure 
again exceeds left ventricular pressure and a second, active wave of filling begins.  The 
duration of this active phase of filling is determined less by left atrial pressure than its 
primary determinant, the atrio-ventricular delay.  Once the wave of depolarisation exits the 
atrioventricular node and depolarises the ventricles, the far greater bulk of the ventricle 
almost immediately overcomes left atrial pressure and the mitral valves closes, ending 
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diastole.  These processes are perhaps best understood when visualised with Doppler 
echocardiography (Figure 1-1). 
Figure 1-1 – Left ventricular and atrial pressure traces in relation to mitral inflow and surface 
ECG 
 Mc = Mitral valve closure, Mo = Mitral valve opening, Ac = Aortic valve closure, IVRT = isovolumetric relaxation 
time, DT = deceleration time, MVF = mitral valve flow 
 
From a clinical perspective, diastolic function can be broken down into a series of 4 
processes which combine what is happening at a cellular level as well as a mechanical 
level.  These processes are closely interrelated and an abnormality in one will have 
consequences further down the chain. 
1.2.1 Relaxation 
For diastole to commence, the active contraction of systole must cease and the changes in 
the ventricle brought about by this must be reversed; the ventricle must begin to relax.  It 
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would be easy to regard diastole as a primarily passive process given that much of the 
driving force comes from the pressure gradient between the left atrium and left ventricle 
that exists at the end of systole as a result of passive filling of the left atrium by pulmonary 
venous return.  This simplified view of the process neglects key aspects of the process that 
are far from passive. 
At a cellular level, systole ends with the hydrolysis of ATP and unlinking of the actin-
myosin cross bridges responsible for systolic contraction.  In order for this to occur, the 
high intracellular level of calcium necessary for excitation-contraction coupling must be 
lowered by active reuptake of calcium into the sarcoplasmic reticulum.  This energy 
dependent process fuelled by ATP underlines the fact that diastole is both an active and 
passive process. 
1.2.2 Suction 
As the ventricle relaxes, the elastic recoil exhibited by the myocardium in early diastole 
results in a suction effect.  This actively draws blood into the ventricular cavity by 
enhancing the pressure gradient that exists between the atrium and ventricle.  Although not 
itself requiring any energy, elastic recoil should be regarded as an active process as it is the 
driving force behind the suction effect rather than being the consequence of ventricular 
filling. 
1.2.3 Filling 
Although ventricular filling is the overall result of diastole, its raison d’être, it is the result 
of several processes happening in synchrony.  Two of these have already been discussed, 
relaxation and suction, both active processes.  A substantial component to left ventricular 
filling is passive, occurring by virtue of venous return through the pulmonary veins.  Much 
of what is measured as diastolic function is this passive component. 
Pulmonary venous return to the left atrium is determined by several components.  It is 
highly dependent on pre-load and many studies of diastolic function have focussed on 
manipulation of this, either by pharmacological means such as venous dilatation with 
nitrates, volume loading with intravenous fluids, or by using the Valsalva manoeuvre to 
manipulate venous return to the heart. 
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The left atrium is a thin walled chamber which, under normal conditions, is able to expand 
to accommodate varying filling patterns.  Left atrial volume, indexed to body surface area. 
has been found to correlate well with diastolic function, this being independent of systolic 
function(7). 
1.2.4 Atrial Contraction 
As the heart ages, the contribution of atrial contraction to ventricular filling becomes 
increasingly important.  This is commonly seen as first an equalisation, then a reversal in 
the E/A ratio of mitral inflow using Doppler echocardiography.  This has the potential to 
be over-interpreted as a pathological process and, hence, as diastolic dysfunction.  An 
increase in the relative contribution of atrial contraction to ventricular filling has been 
shown to be a normal finding in the healthy elderly population(8), and hence a normal part 
of the ageing process.  The precise point at which this changes from normal to pathological 
is a grey area.  For this reason, multiple age stratified normal ranges for the E/A ratio have 
been published(9-13), none of which have been shown to perform robustly(6). 
The importance of atrial contraction is recognised in the current European Society 
guidelines for the diagnosis of diastolic heart failure(14).  Atrial fibrillation is considered 
equal to demonstrable abnormalities of standard Doppler parameters for supporting a 
diagnosis of diastolic heart failure where tissue Doppler is equivocal. 
1.3 Defining Heart Failure 
The definition of what we mean by heart failure, the physical signs, symptoms and 
abnormal investigations we associate with heart failure, is essential before we can define 
the patient group we are addressing.  Most important in this is precisely which and how 
many of these clinical features we require to fulfil a diagnosis of heart failure.  The criteria 
adopted for a study will have major implications not only in terms of overall prevalence of 
the condition, but also in the exclusion of valid cases of heart failure by overly strict 
criteria or the inappropriate inclusion of subjects who do not have heart failure due to lax 
criteria.  Several different systems have been developed which range from the easily 
applied Framingham criteria which specify major and minor criteria to the more complex 
Boston system which attributes a score to various signs and symptoms, giving an overall 
probability to the diagnosis.  The commonly used systems are summarised in Table 1-1, 
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Table 1-2, Table 1-3 and Table 1-4.  Although many clinical trials use these standard 
criteria, or minor modifications of them, a large number use either their own criteria or are 
not specific. 
Table 1-1 – Framingham Criteria for Diagnosing Heart Failure(15) 
Major Criteria Minor Criteria 
Paroxysmal nocturnal dyspnoea 
Neck vein distension 
Rales 
Radiographic cardiomegaly 
Acute pulmonary oedema 
S3 gallop 
Central venous pressure >16 cm H2O 
Circulation time ≥ 25 sec 
Hepatojugular reflux 
Pulmonary oedema, visceral congestion, or 
cardiomegaly at autopsy 
Weight loss  4.5 kg in 5 days in response to 
treatment of congestive heart failure 
Bilateral ankle oedema 
Nocturnal cough 
Dyspnoea on ordinary exertion 
Hepatomegaly 
Pleural effusion 
Decrease in vital capacity by one third from maximal 
value recorded 
Tachycardia (rate ≥ 120 beats/min)   
 
Requires simultaneous fulfilment of 2 major or 1 major and 2 minor criteria 
 
Table 1-2 – European Society of Cardiology criteria for diagnosing heart failure(16)  
 Appropriate Symptoms Dyspnoea, fatigue, fluid retention 
Clinical Signs of Fluid Retention Pulmonary or peripheral 
Abnormal Cardiac Structure or Function Necessary but not sufficient for diagnosis 
Response to treatment confirms if doubt  
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Table 1-3 – Boston Criteria for diagnosing heart failure(17) 
Category I: 
History 
Rest dyspnoea 
Orthopnoea 
Paroxysmal nocturnal dyspnoea 
Dyspnoea walking on level area  
Dyspnoea while climbing 
4 
4 
3 
2 
1 
Category II: 
Physical examination 
Heart rate abnormality 
  91 to 110 beats per minute 
  >110 beats per minute 
Jugular venous elevation 
  > 6 cm H2O 
  > 6 cm H2O + hepatomegaly or oedema) 
Lung crackles 
  Basilar 
  More than basilar 
Wheezing 
Third heart sound  
 
1 
2 
 
2 
3 
 
1 
2 
3 
3 
Category III: 
Chest x-ray 
Alveolar pulmonary oedema 
Interstitial pulmonary oedema 
Bilateral pleural effusion 
Cardiothoracic ratio > 0.5 
Upper zone flow redistribution 
4 
3 
3 
3 
2 
Maximum of 4 points from each 
category – possible maximum 
12 points. 
 
8-12 – Definite heart failure 
5-7 – Possible 
≤ 4 – Unlikely 
 
Table 1-4 – Cardiovascular Health Study criteria(18) 
 
1.4 The Misdiagnosis of Heart Failure 
The signs and symptoms of heart failure are unfortunately insensitive and non-specific(19).  
In patients referred with suspected heart failure, dyspnoea only had an 18% positive 
Symptoms 
Dyspnoea, fatigue, orthopnoea, PND 
 
Physical Signs 
Oedema, rales, tachycardia, gallop rhythm, displaced apex beat 
 
Any of the following sufficient but not necessary 
Cardiomegaly, pulmonary oedema on chest x-ray, dilated ventricle, global or segmental 
wall motion abnormalities with impaired systolic function 
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predictive value for left ventricular systolic dysfunction.  Even a history of oedema 
combined with dyspnoea had sensitivity of 46% and specificity of 52%. 
1.4.1 Noncardiogenic Pulmonary Oedema 
Even pulmonary oedema, the hallmark of acute heart failure, is not specific for 
demonstrable cardiac dysfunction.  Both clinical and radiological pulmonary oedema can 
result from a range of conditions unrelated to either fixed or transient cardiac dysfunction.  
Noncardiogenic pulmonary oedema usually results from an increase in pulmonary capillary 
permeability, allowing protein rich fluid to leak into the alveoli.  This situation may arise 
in several common clinical conditions such as pneumonia, sepsis, aspiration pneumonitis 
and with major trauma particularly with large volume blood transfusion(20).  It is not 
uncommon for patients presenting with infective exacerbations of chronic obstructive 
pulmonary disease to be treated with both antibiotics and loop diuretics due to diagnostic 
doubt in the acute situation.  Some of the subsequent clinical improvement may then be 
attributed to treatment of  “heart failure” by the diuretic rather than an improving 
pneumonic process.  When preserved left ventricular systolic function is subsequently 
demonstrated, it is all too easy to arrive at a diagnosis of diastolic heart failure.  This is 
particularly true in the elderly in whom a degree of systolic or valvular dysfunction are 
more common and the risk factors associated with diastolic dysfunction are often present. 
Neurogenic pulmonary oedema is a poorly understood and uncommon cause of pulmonary 
oedema usually seen in the context of significant brain injuries such as subarachnoid 
haemorrhage or trauma which result in elevated intracranial pressure.  It has also been 
reported in up to one third of patients with status epilepticus and may also be seen with 
non-haemorrhagic stroke.  The mechanism appears to be a combination of changes in 
pulmonary capillary permeability and haemodynamic effects resulting from an increase in 
sympathetic tone.  This results in pulmonary venoconstriction which increases capillary 
hydrostatic pressure and can result in pulmonary oedema in the absence of elevated left 
heart pressures.  It may also result in elevated left heart pressures through a combination of 
increased venous return, systemic hypertension and direct impairment of left ventricular 
function by the catecholamine excess. 
Despite the difficulties in distinguishing clinically between cardiogenic and 
noncardiogenic pulmonary oedema, a number of radiological features have been identified 
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which may aid in this(21, 22).  Pleural effusions, Kerley B lines and peribronchial cuffing 
are usually present with cardiogenic pulmonary oedema but not so with noncardiogenic.  
Whilst an increased cardiothoracic ratio is supportive of cardiogenic pulmonary oedema 
due to left ventricular systolic dysfunction, a normal cardiac size would not be regarded as 
confirming a non cardiac cause as this is still compatible with diastolic heart failure. 
1.4.2 Dependent oedema 
Dependent oedema, whilst being commonly seen in inadequately treated patients with left 
ventricular systolic dysfunction, may also be caused by several other processes such as 
venous or lymphatic insufficiency, obesity, arthritis or other joint trauma, 
hypoproteinaemia, hypo or hyperthyroidism, renal or hepatic dysfunction.  It is also 
associated with several classes of drugs most noticeably calcium channel blockers with the 
dihydropyridine group being most commonly associated with this.  Clinically detectable 
peripheral oedema has been reported in 33% of patients in response to treatment with 
amlodipine and symptoms of leg swelling in 64% overall(23).  Other common 
pharmacological causes of oedema include both steroidal and non-steroidal drugs, tricyclic 
antidepressants and antipsychotic drugs such as chlorpromazine. 
The response of oedema to diuretics should not be taken as evidence that heart failure was 
the underlying cause as the salt and intravascular volume depletion caused by these drugs, 
particularly loop diuretics, will result in significant fluid shifts from the interstitium to the 
vascular compartment regardless of cause. 
1.4.3 Dyspnoea 
Many disease processes include dyspnoea as part of their symptomatology.  Respiratory 
disease in the form of either reversible or fixed large airways disease, interstitial lung 
disease or destruction of the alveoli by an emphysematous process is the most obvious 
cause of dyspnoea.  A recent UK survey found an overall COPD prevalence of 13% in 
those aged over 35.  This rose to 15% in ex-smokers and 20% in current smokers over the 
whole age group.  In current smokers over the age of 65, the prevalence of COPD 
approached 40%(24).  In 80% of those with COPD defined by abnormal spirometry, no 
prior respiratory diagnosis had been made. 
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Although the number of smokers in the UK is declining and will eventually result in a 
reduced incidence of COPD, another condition, obesity, is on the rise.  In England and 
Wales in 2003 65% of men and 56% of women were either overweight or obese(25).  
Obesity can cause dyspnoea by several mechanisms.  Firstly, the simple physical effort of 
carrying the additional body mass may result in dyspnoea either by exceeding the exercise 
capacity in an otherwise healthy individual or by unmasking subclinical disease in other 
systems.  Obesity can also have a direct effect on respiratory function by increasing the 
intrathoracic pressures required to achieve adequate ventilation.  This can be seen on 
pulmonary function testing as a restrictive defect with a decreased expiratory reserve 
volume being characteristic. 
The anginal equivalent is a well recognised clinical entity where myocardial ischaemia 
results not in chest pain, but in dyspnoea.  Since the development of pain occurs further 
down the cascade of myocardial ischaemia than the development of impaired diastolic 
function or wall motion abnormalities, it is easy to see how ischaemia below the threshold 
required to cause angina could result in dyspnoea.  This atypical presentation of angina is 
more common in the elderly(26). 
Not only are there multiple causes of dyspnoea, the problem is compounded by the fact 
that dyspnoea is a highly subjective symptom.  Several scales attempt to quantify dyspnoea 
in different settings – the New York Heart Association (NYHA) scale (27)stratifies heart 
failure by symptoms, the BORG scale(28), and the Medical Research Council (MRC) 
dyspnoea score(29) is used to assess those with chronic respiratory disease.  Although the 
NYHA and MRC scales apply a degree of objectivity on the part of the assessor by relating 
dyspnoea to the extent of limitation of normal daily activities, the underlying subjective 
nature of dyspnoea still exerts an influence. 
What does not appear to be in doubt is that dyspnoea is an important symptom which has 
prognostic significance.  Self reported dyspnoea as a symptom has been shown to be an 
independent predictor of both cardiac and all-cause mortality in a group of nearly 18,000 
patients undergoing myocardial perfusion imaging(30).  As might be expected, the level of 
inducible ischaemia was higher in patients with known coronary artery disease.  However, 
it was similar in patients with dyspnoea and asymptomatic individuals without known 
coronary disease despite a fourfold increase in cardiac death in the dyspnoeic group.  The 
study is limited by the fact it is derived from a nuclear cardiology database including 
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symptoms and demographic data documented at the time of scanning.  It therefore does not 
include any assessment of respiratory pathology or diastolic function.  It should be noted 
that this patient group were not classified on the presence of clinical heart failure, the 
presence of dyspnoea itself was sufficient to confer an adverse prognosis. 
1.5 Assessing Diastolic Function 
The various methods devised to assess diastolic function reflect the fact that there is not 
one single parameter that fully encompasses this complex entity.  Many of the parameters 
measured do not assess ventricular relaxation directly but instead assess the haemodynamic 
effects of ventricular relaxation by way of patterns of ventricular filling and techniques to 
estimate ventricular filling pressures.  This is due to the fact that the accurate measurement 
of myocardial relaxation and stiffness by non-invasive means remains an elusive goal.  For 
the routine assessment of diastolic function in a high volume of patients, invasive 
measurements are neither feasible nor desirable.  In clinical practice, therefore, one is 
limited to non-invasive measures.  Each of these has its own pitfalls and caveats partly 
related to the parameter itself, its reproducibility and dependence on intrinsic factors such 
as pre-load and after-load, and limitations of the modality used to measure the parameter.  
A further complicating factor is the fact that many of these parameters behave differently 
with preserved versus impaired systolic function.  Mitral inflow Doppler parameters, 
whilst showing good predictive power for left ventricular filling pressure in the presence of 
impaired systolic function, are unreliable in isolation with preserved systolic function due 
to significant variation in filling pressures in this patient group.  The net effect of this is 
that one non-invasive parameter alone cannot adequately assess diastolic function – 
multiple parameters must be measured and integrated to grade diastolic function. 
 
1.5.1 Echocardiography 
Since echocardiography is universally available, non-invasive, and relatively easy to 
perform to at least a basic standard, it is an obvious modality of choice for assessing 
diastolic function.  Numerous different parameters have been employed ranging from basic 
pulsed wave Doppler to new applications of colour flow mapping and new developments 
in the form of tissue Doppler(31).  The grading of diastolic dysfunction from grade 1 
(normal) to grade 4 using the mitral E/A ratio, deceleration time and the response of these 
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to the Valsalva manoeuvre is appropriate to subjects with an ejection fraction less than 
50%.  Where systolic function is preserved, these measures must be supplemented with 
tissue Doppler assessment and left atrial volume.  Pulmonary vein Doppler and mitral 
inflow propagation velocity may be used to provide additional evidence of elevated filling 
pressures. 
1.5.1.1 Mitral Doppler 
By placing a pulsed wave Doppler envelope in the left ventricular cavity just beyond the 
tips of the mitral leaflets parallel to flow, the velocity time profile of ventricular filling can 
be measured (Figure 1-2). 
Figure 1-2 – Transmitral flow – E, A and DT 
 
The E wave of early ventricular filling represents passive ventricular filling.  In theory it 
provides an index of the pressure gradient between the left atrium and left ventricle at the 
onset of diastole as well as a measure of how this pressure gradient decays over time, 
measured as the deceleration time (DT), the time taken from peak E wave velocity to 
intercept the X axis. 
The A wave represents atrial contraction.  The ratio between E and A waves indicates the 
relative contribution of passive and active filling.  As passive filling is impaired by 
diastolic dysfunction, there is a shift from passive to active filling as the force of atrial 
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contraction is required to overcome a stiff ventricle.  As filling pressures increase, 
pseudonormalisation of the E/A ratio occurs (grade 2 dysfunction).  At this stage, the 
underlying abnormality can be unmasked with pre-load alteration such as the Valsalva 
manoeuvre.  As diastolic dysfunction progresses further, the E/A ratio becomes fixed with 
a short DT indicating restrictive physiology. 
1.5.1.2 Isovolumetric Relaxation Time 
If a pulsed wave Doppler sample envelope is placed adjacent to the left ventricular outflow 
tract such that it overlaps mitral inflow and aortic outflow, an additional parameter can be 
measured, isovolumetric relaxation time (IVRT).  This is the period immediately following 
the end of systole and aortic valve closure where the ventricle has begun to relax but left 
ventricular intracavity pressure has not yet fallen below left atrial pressure.  This is 
illustrated in Figure 1-3 where the artefact of aortic valve closure can be clearly seen.  
IVRT is measured from this point to the beginning of the mitral E wave, the onset of 
ventricular filling. 
Figure 1-3 – Isovolumetric relaxation time 
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In theory, a ventricle which has impaired relaxation i.e. diastolic dysfunction, will manifest 
this as a prolongation in this period.  However, IVRT is influenced by multiple factors 
which confound it as a solitary measure of diastolic function: 
• Active ventricular relaxation (Ca2+ transport, ATP dependent) 
• Elastic ventricular recoil 
• Pre-load – any factor which increases pre-load will increase left atrial pressure, 
which in the absence of any change in the ventricle itself, decreases the atrio-
ventricular pressure gradient and shortening the time taken for left ventricular 
pressure to fall below atrial and allow mitral valve opening.  Conversely, a 
reduction in preload reduces left atrial pressure and increases IVRT. 
• After-load – the resistance which the left ventricle must pump against in the form 
of afterload is determined by systemic vascular tone.  Its mechanism of influence 
on IVRT can be seen by the interaction between diastolic blood pressure, 
predominantly influenced by systemic vascular resistance, and left ventricular end 
systolic pressure.  Assuming that left ventricular end systolic pressure and its rate 
of decay with ventricular relaxation remains the same, a rise in diastolic blood 
pressure reduces the pressure gradient between the aorta and left ventricle, thereby 
shortening the time to aortic valve closure and prolonging IVRT. 
• Aortic regurgitation.  An incompetent aortic valve allows ventricular filling to 
occur retrogradely during what should be an isovolumetric period.  Left ventricular 
intracavity pressure will therefore decay more slowly than it otherwise would and 
increase the time taken for this to fall below left atrial pressure and permit mitral 
valve opening.  Although in this instance what is being measured is not strictly 
speaking IVRT, the time period is still easy to measure and is usually still referred 
to as IVRT.  As the severity of aortic regurgitation increases, IVRT becomes 
progressively less reliable as an isolated measure of diastolic function. 
 
1.5.1.3 Pulmonary Venous Doppler 
By placing a pulsed wave Doppler envelope in either the left or right upper pulmonary vein 
it is possible to profile left atrial inflow as shown in Figure 1-4.  As can be seen by 
comparing this tracing from a real patient with the idealised representation of Figure 1-5, 
the quality of the tracings obtained can make analysis difficult.  It should be possible to 
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obtain interpretable data in up to 80% of subjects(32).  This is very dependent on 
echogenicity of the subject but may be improved with the use of contrast agents such as 
SonoVue™. 
Three distinct waves occur in pulmonary venous flow; 2 antegrade and one retrograde.  
The only retrograde wave, PVa, occurs with atrial contraction and corresponds to the P 
wave on the surface ECG.  The first antegrade wave occurs with ventricular systole and 
may be biphasic, something more commonly seen in older patients(33).  The first part of 
this wave, PVs1, begins immediately upon mitral valve closure and is primarily due to 
rapid filling of the atrium with the blood which has backed up in the pulmonary veins 
during atrial systole.  As ventricular contraction begins in earnest, longitudinal contraction 
of the heart towards its apex creates a suction force drawing blood into the left atrium 
resulting in the PVs2 wave.  This flow slows as the point of peak ventricular contraction is 
passed and the pressure gradient between the left atrium and the pulmonary veins falls. 
Figure 1-4 – Pulsed valve pulmonary venous Doppler – acquisition and typical waveform 
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Figure 1-5 – Idealised pulmonary venous waveform 
 
With the onset of diastole, the mitral valve opens and passive ventricular filling begins – 
the E wave of mitral inflow.  This re-establishes the pressure gradient between atrium and 
pulmonary vein resulting in the PVd wave. 
It has been shown that in subjects with normal left atrial pressure measured as pulmonary 
capillary wedge pressure, systolic flow is the predominant wave in the pulmonary veins.  
In subjects with elevated left atrial pressure, diastolic flow is predominant(34).  This, 
however must be interpreted with caution as impaired left ventricular systolic function, as 
assessed by fractional area shortening in this study, confounded this relationship.  It should 
also be noted that in this, and other studies of pulmonary venous Doppler and left 
ventricular filling(35), transoesophageal echocardiography was used.  This is not the case 
in routine clinical practice where transthoracic echocardiography is typically used.  
Transoesophageal echocardiography allows the Doppler sample envelope to be more 
reliably placed within the pulmonary vein, rather than at its ostium.  This may result in a 
lower rate of detection of atrial reversal (PVa) (36) than transoesophageal 
echocardiography as atrial, rather than pulmonary venous, flow is being sampled. 
The duration of the pulmonary venous A wave in relation to the duration of the mitral 
inflow A wave has been shown to correlate to left ventricular end diastolic pressure(37).  
PVa duration exceeding mitral A duration by more than 30ms has a high specificity for 
elevated LVEDP. 
1.5.1.4 Colour Flow M-Mode 
The limitations of peak transmitral velocities having been recognised, attention turned to 
alternative ways of assessing early ventricular filling.  The use of colour M-Mode to 
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measure flow propagation through the mitral valve into the left ventricle was first proposed 
by Brun in 1992(38).  It was subsequently validated in animals and humans that 
Propagation Velocity (vp) correlated well with tau, the time constant of isovolumetric 
pressure decay.  Further work by Garcia et al(39) demonstrated that vp was largely 
independent of alterations in preload in anaesthetised dogs undergoing caval clamping and 
humans undergoing partial cardiopulmonary bypass.  It showed good correlation with tau 
when lusitropic conditions were altered with dobutamine and esmolol.  Overall the 
relationship could be described by the equation tau = 775.63(vp)-0.7718, with a correlation 
coefficient of 0.78. 
In an apical 4 chamber view, colour flow Doppler is placed over mitral inflow, extending 
to the left ventricular apex.  An M-mode cursor is than placed through this and a suitable 
sweep speed chosen to maximise the size of jet being measured, and hence, minimise 
measurement error.  The slope of the leading edge of the inflow jet is measured to give a 
propagation velocity (Figure 1-6). 
Figure 1-6 – Colour flow M-mode mitral inflow propagation – technique and typical 
appearance 
 
However, the technique is limited by the fact that there are methodological differences 
between different authors who have employed this technique(40, 41) who disagree on 
exactly how and where to measure the slope of the propagation wave(42).  Depending on 
how the aliasing velocity is configured and whether the propagation wave is measured at 
its leading edge or at the first aliasing velocity, the propagation velocity will be different, 
limiting general applicability until a standard approach can be agreed. 
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1.5.1.5 Tissue Doppler 
Tissue Doppler, also referred to as Tissue Velocity Imaging (TVI), represents a relatively 
new development in echocardiography which allows quantification of the low velocity 
motion of the myocardium and related structures (typically velocities <20cm/s).  This is 
achieved by inverting the low pass filters applied to standard Doppler and only allow 
through signals from structures travelling at low velocity.  The technique was first utilised 
to examine subtle abnormalities in systolic and diastolic function in ischaemic heart 
disease(43). 
Figure 1-7 – Pulsed wave spectral tissue Doppler obtained from mitral annulus 
 
For the assessment of mitral annular velocities, tissue Doppler is obtained in the apical 4 
chamber view.  A pulsed wave sample volume is placed over either the lateral or medial 
mitral annulus and, with tissue Doppler mode enabled rather than standard Doppler, a 
signal like than in Figure 1-7 is obtained.  Care should be taken not to have the Doppler 
gain set too high as this can lead to an overestimate of the peak velocity due to artefact 
being interpreted as part of the waveform.  It can be seen that the waveform is relatively 
broad and a range of possible velocities may be measured; the innermost edge, middle or 
outermost edge.  A similar waveform may also be derived from colour coded rather than 
spectral tissue Doppler.  This has a systematically lower value as it measures the mean 
value of the waveform, rather than the outermost, true peak, value measured by tissue 
Doppler.  The published studies of left ventricular filling pressure have used spectral tissue 
Doppler and it is therefore not possible to make direct comparison with values obtained by 
colour coded tissue Doppler(44). 
Filling of the left ventricle in diastole results in movement of the mitral annulus away from 
the relatively fixed apex.  The velocity of this movement can be measured with pulsed 
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wave tissue Doppler.  In sinus rhythm this movement occurs in two phases which 
correspond to the E and A waves seen on mitral inflow Doppler.  These are usually 
referred to as E’ and A’, although they can also be labelled Ea, Em and Am, Aa.  In 
addition to peak velocity, the time to peak velocity and duration of each of these waves can 
also be measured although there has been no clinical application of these additional 
parameters as yet. 
The measurement of most interest is E’, the peak velocity of the mitral annulus with early 
passive diastolic filling.  This has been shown to be less dependent on filling conditions 
than traditional transmitral and pulmonary Doppler measurements(45). E’ itself is not a 
direct measurement of diastolic relaxation as its correlation with τ is intermediate (r = 0.46 
in one series(32). One reason for this that in addition to ventricular relaxation, another key 
determinant of E’ is the peak velocity of mitral inflow.  The ratio of E’ to peak early 
transmitral velocity (E) as the E/E’ ratio corrects for this influence and achieves far better 
correlation with invasively measured indices of relaxation and filling pressure. 
The E/E’ ratio should not be regarded as a single value, however.  Mitral annular velocity 
can be measured in four different positions – lateral and septal on the apical 4 chamber 
view, and inferior and anterior on the 2 chamber view.  Of these, only the lateral and septal 
velocities have been routinely measured.  Neither should these four measurements be 
regarded as necessarily being identical.  The structures surrounding and thus influencing 
the movement of the septal portion of the mitral annulus are markedly different to those 
related to the lateral annulus.  The relative superiority of these positions has not yet been 
clearly established – the septal velocity has been shown to correlate better with LVEDP 
than the lateral velocity(32) (the mean of the two showed the same degree of correlation 
however).  Despite this, another series used only the lateral annular velocity to look for 
correlation with pulmonary capillary wedge pressure(46).  It should also be noted that any 
regional wall motion abnormalities may have a profound impact on individual 
measurements and in this instance either a measurement from an unaffected segment or a 
mean of several segments may be more appropriate to yield a result representative of 
global function. 
Currently the most useful application of the E/E’ ratio is in the assessment of mean left 
ventricular diastolic pressure (mLVDP).  Although LV end diastolic pressure is commonly 
used as an index of left ventricular filling pressures, in fact it correlates relatively poorly 
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with mean left atrial pressure.  It has been shown that mLVDP correlates significantly 
better with mean left atrial pressure (r=0.94) than LVEDP does (r=0.82) when left atrial 
pressure is measured directly via transseptal puncture(47). 
In a series of 100 patients Ommen et al(32) found that all patients with a septal E/E’ ratio 
of ≥ 15 were found to have an elevated mLVDP (>12mmHg having been defined as 
abnormal).  Although the majority of patients falling into this category had left ventricular 
systolic dysfunction (ejection fraction <50%), it was also observed in a small number of 
patients with preserved systolic function.  Of 27 patients with an E/E’ ratio of <8, only 4 of 
these were found to have an elevated mLVDP giving a negative predictive value of 85%.  
Two of these patients had preserved systolic function.  The cut-off values of 8 and 15 were 
derived via ROC analysis which gave an area under the curve of 0.82 for the septal annulus 
and a definition of >12mmHg as abnormal.  However, a substantial number of patients fell 
into the indeterminate region with ratios between 8 and 15.  Other techniques for 
differentiating normal from elevated filling pressures must therefore be employed in this 
group. 
The utility of the E/E’ ratio for non-invasive estimation of pulmonary capillary wedge 
pressure is less clear and various series have yielded seemingly contradictory results.  
Nagueh et al(48) found E’ to be a preload independent index of left ventricular relaxation.  
Using the lateral mitral annulus, the E/E’ ratio correlated well with invasively measured 
pulmonary wedge pressure with the formula PCWP = 1.9 + 1.24(E/E’) giving an r value of 
0.87.  Further work by this group validated the E/E’ ratio in sinus tachycardia of up to 132 
beats per minute(49).  By combining this patient group with their previous group, a unified 
formula covering a patient group of 180 was produced:  PCWP = 2 + 1.3(E/E’lateral).  The 
E/E’ ratio was found to be relatively independent of heart rate with no change in the 
predictive accuracy for PCWP when heart rate was included in stepwise regression 
analysis(49). 
Sundereswaran et al(46) reported on a series of fifty cardiac transplant recipients 
undergoing simultaneous right heart catheterisation and Doppler echocardiographic 
studies, including tissue Doppler analysis. Left ventricular systolic function was generally 
well preserved with a mean ejection fraction of 56% (range 20% - 70%).  It was found that 
an E/E’ ratio of >8 detected a wedge pressure of ≥15mmHg with a sensitivity of 87% and 
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specificity of 81%.  Little additional clinical data is given, however, which may limit its 
general application. 
In contrast Firstenberg and colleagues found no correlation between the E/E’ and 
pulmonary wedge pressure(50). Seven normal healthy subjects of mean age 37 with no 
history of cardiovascular disease underwent simultaneous right heart catheterisation and 
echocardiography at rest and during preload manipulation by lower body negative pressure 
and saline infusion.  All subjects had normal wedge pressures at baseline, rising to a 
maximum of 20mmHg with volume loading.  Although the septal E’ and peak E velocities 
correlated strongly with wedge pressure, when combined as the E/E’ ratio there was no 
statistically significant relationship with wedge pressure.  However, the authors have also 
demonstrated that the response of the E’ velocity, which in this group of normal subjects 
increased with increasing preload and wedge pressure and so maintained an unchanged 
E/E’ ratio, is dependent on underlying diastolic function(51). In dogs with impaired 
relaxation induced by esmolol, as shown by an increase in tau, the effect of preload on E’ 
was diminished giving rise to the relationship between E/E’ and wedge pressure seen 
elsewhere. 
1.5.1.6 Left Atrial Volume 
The fact that the left atrium dilates in response to chronic pressure overload has been 
recognised for a number of years(52).  It is only more recently that the utility of this in 
assessing diastolic function has been appreciated.  In much the same way as glycosylated 
haemoglobin is used to assess medium term control in diabetes mellitus, left atrial volume 
may be used to assess left atrial pressure in the medium to long term. 
A number of methods may be used to measure left atrial volume.  Simpson’s rule of discs, 
most commonly use to calculate left ventricular volumes and ejection fraction, may also be 
applied to the left atrium.  The left atrial border, excluding the orifices of the pulmonary 
veins, is traced round in the apical 4 and 2 chamber views at ventricular end systole, 
immediately prior to mitral value opening.  The other commonly used technique is the area 
length method.  Here atrial volume is calculated from only 3 measurements – left atrial 
length and width on the apical 4 chamber view, and anteroposterior diameter on the 
parasternal long axis view.  As real-time 3 dimensional echocardiography becomes more 
widely used, it too will have a role to play.  It has been shown that 3D echo yields higher 
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volumes than 2D, this perhaps being the reason for its superior correlation with clinical 
events(53). 
It is necessary to index left atrial volume to body surface area (left atrial volume index, 
LAVI) as, like other echocardiographic measurements such as left ventricular mass, left 
atrial volume is directly related to body surface area.  Failure to correct for this will 
diminish its correlation with left atrial pressure.  Reference ranges for LAVI have 
previously been published (54).   The 95th centile in females is 30ml/m2, and 33ml/m2 in 
males. 
One limitation of left atrial volume is that it is affected by valvular heart disease, 
particularly mitral valve disease.  This will result in atrial dilatation even in the absence of 
a primary left ventricular abnormality.  A diagnosis of valvular, rather than diastolic, heart 
failure is more appropriate here.  Left atrial volume is also affected by arrhythmias, 
particularly atrial fibrillation.  It has been shown than, in patients with chronic lone atrial 
fibrillation, there is progressive left atrial dilatation from an initially normal size(55). 
1.5.2 Radionuclide Ventriculography 
1.5.2.1 Resting RNVG 
Prior to the advent of cardiac MRI, radionuclide ventriculography was regarded as the 
most accurate and reproducible means of calculating left ventricular ejection fraction.  
Given the limited availability, higher costs and limitations in individuals with metallic 
foreign bodies including pacemakers and defibrillators, radionuclide ventriculography 
(RNVG), commonly referred to as MUGA (MUltiple Gated Acquisition), still has a major 
role to play.  RNVG uses an intravenously injected radioactive tracer, technetium-99m, to 
create an area of activity within the chambers of the heart, either by following a first-pass 
bolus through the heart or by attaching the tracer to red blood cells to create a stable blood 
pool.  Since the activity detected within the left ventricle is proportional to the blood 
volume, the activity-time curve is equivalent to a volume-time curve thus allowing 
calculation of ejection fraction and other parameters of ventricular emptying and filling. 
Using the LV volumes obtained during contrast ventriculography at cardiac catheterisation, 
it has been shown that peak filling rate (PFR) is significantly reduced in patients with 
coronary artery disease compared with normal subjects(56).  It was suggested that this was 
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due to decreased compliance or impaired relaxation, in this case secondary to ischaemia.  
However, once these patients are controlled for age it is not possible to distinguish them 
from normal subjects due to considerable overlap between the two groups.  There is an age 
related decline in PFR in otherwise healthy subjects(57) highlighting the need for age 
specific normal ranges.  This relationship between diastolic function and age is seen in 
other imaging modalities such as echocardiography(58). 
PFR, however, has a disadvantage in that it assesses ventricular filling at a variable point in 
diastole.  Although there is not an age related increase in Time to PFR, each individual is 
likely to have a different point in diastole assessed.  Filling in specific parts of diastole can 
be assessed by arbitrarily dividing diastole into thirds and quantifying the proportion of 
total ventricular filling occurring during each third.  Early passive ventricular filling in the 
form of First Third Fractional Filling (FTFF) has attracted most interest.  Abnormalities 
have been demonstrated in FTFF at rest in patients with ischaemic heart disease and 
normal systolic function(59) with an increase in diastolic dysfunction induced by exercise. 
The utility of assessing diastolic function on exercise has been shown in two other ways.  
Although improvements in diastolic function have been observed following angioplasty, 
one group of investigators found that this was only demonstrable during exercise rather 
than at rest(60).  Diastolic function seems to be an important determinant of exercise 
capacity, with PFR on exercise being the most important determinant of exercise capacity 
in patients with ischaemic heart disease and left ventricular systolic dysfunction(61). 
Other processes such as left ventricular hypertrophy and hypertension may also result in 
relaxation abnormalities.  RNVG offers a non-invasive method of determining these 
potentially useful values.  It is also likely to be more accurate given it does not involve the 
direct injection of contrast into the left ventricle with the haemodynamic and 
arrhythmogenic effects this has.  It should also be borne in mind that calculation of left 
ventricular volumes from 2D data relies on geometric assumptions and uniformity of 
function.  RNVG does not make these assumptions as it samples a 3D dataset. 
1.5.2.2 Exercise RNVG 
The demonstration in 1958 that, in patients with coronary artery disease and normal resting 
left ventricular function, exercise induced an increased in pulmonary capillary wedge 
pressure and by implication, left ventricular dysfunction (62), offered an alternative route 
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to the diagnosis of ischaemic heart disease.  The observation that a decrease in left 
ventricular ejection fraction as measured by contrast angiography occurred on exercise in 
patients with ischaemic heart disease whilst it increased in normal subjects (63) could be 
put into routine clinical use as a non invasive tool for the diagnosis of ischaemic heart 
disease when nuclear cardiology developed sufficiently to allow this to be reproduced 
using radionuclide ventriculography(64). 
Although the initial studies reported sensitivities and specificities of over 90% (65), 
superior to those of exercise electrocardiography, they involved highly selected patient 
groups with a high prevalence of previous myocardial infarction or more severe coronary 
artery disease.  The control subjects used tended to be fitter than the population who were 
to undergo the procedure as a diagnostic test for ischaemic heart disease.  Once exercise 
RNVG was put in to routine use as a diagnostic tool in patient groups more representative 
of normal clinical practice, it became clear that it did not live up to the initial hopes.  
Whilst its sensitivity was within an acceptable range, its specificity dropped to as low as 
50%(66) and a negative stress RNVG was associated with an annual event rate of up to 
3%(67).  This compares to rates of less than 1% for myocardial perfusion scintigraphy or 
stress echo(68).  An abnormal left ventricular ejection fraction response to exercise is not 
exclusive to coronary artery disease – it can be observed in several conditions where 
myocardial function is abnormal such as aortic regurgitation where, although resting 
systolic and diastolic function is preserved, the left ventricle’s reserve capacity to respond 
to exercise is impaired.  These false positives further limited the utility of exercise RNVG 
as a tool for the initial diagnosis of coronary artery disease. 
Techniques 
There are two different techniques for acquiring the RNVG data – the first pass technique 
and the equilibrium method. 
First-pass angiography refers to the method where technetium not fixed to any constituent 
of the patients’ blood is observed on its first pass through the heart following bolus 
administration.  The theoretical advantage of this is that it will allow wall motion and 
ejection fraction to be calculated for a very specific point in time – of significant benefit in 
exercise RNVG where the timing of this may be critical.  It has been shown that the 
ejection fraction may recover to, or rebound above, pre-test values if the acquisition is 
delayed by as little as 30-60 seconds post peak exercise even in patients with 
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angiographically proven coronary disease whose peak exercise ejection fractions would 
have yielded a positive result (69). 
However, there are problems with this approach.  The technique by which the bolus is 
administered is critical.  If the tracer is administered or flushed slowly this will result in a 
prolonged delivery of tracer to the heart with the consequence that temporal resolution of 
the tracer between the two ventricles will be lost and no calculations will be possible.  This 
is because no positioning of the camera to achieve septal separation prior to injection is 
possible and images are typically acquired in an anterior view resulting in spatial overlap 
of the right and left ventricles. 
The second problem is that of equipment.  The high tracer activity levels and count rates 
required to obtain adequate data in such a small time frame (typical time from entry of 
tracer into RV to exit from LV is 30 seconds) are not suitable for the single crystal gamma 
cameras in routine use due to their count rate response being non-linear at these levels.  For 
accurate calculation of ejection fraction these studies have to be carried out with multi-
crystal cameras. 
Equilibrium angiography has been regarded as the less technically demanding of the two 
techniques.  Here the red blood cells of the patient are labelled with technetium, typically 
by means of stannous pyrophosphate prior to commencing image acquisition.  Image data 
are acquired over a period of several minutes until a predetermined number of counts or 
cardiac cycles have been acquired, or a set time elapsed.  This in effect gives a time-
activity curve which is a mean of usually several hundred cardiac cycles and allows data 
from ectopic beats to be excluded from analysis.  In atrial fibrillation it ensures that the 
data accepted for analysis is representative of overall ventricular function, rather than the 
very limited number of beats acquired with the first pass technique whose cycle lengths 
may be extreme values for that patient. 
Exercise versus pharmacological stress 
There has been debate as to whether dynamic exercise or a pharmacological agent is the 
optimal choice for stress testing not only with exercise RNVG but also latterly with 
myocardial perfusion imaging. 
There are some aspects of pharmacological stress which are clearly superior to dynamic 
exercise.  First is the virtual elimination of motion artefact – the drug can be infused with 
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the patient at rest under the camera.  Second is the standardisation that such a protocol 
allows.  With dynamic exercise the duration and intensity of stress achieved will vary 
markedly between patients.  With a standard dose of stressor drug, normally calculated by 
body weight, identical levels of stress can, in theory, be induced in every patient.  In 
practice, patients will vary in their response to a specific dose of a stressor.  This may be 
due to the influence of drugs such as beta blockers or, in the case of dipyridamole or 
adenosine stress, theophyllines or other methylxanthines such as caffeine.  While these 
may be withheld prior to stress, the biological half-life of these drugs may mean they are 
still present in sufficient quantities to attenuate the response to the stressor.  Disease states 
may also influence the response to a stressor.  Myocardial beta adrenoceptors, for instance, 
are downregulated in heart failure(70), resulting in a reduced chronotropic and inotropic 
response to stress(71). 
There are drawbacks however.  Given that dobutamine will tend to increase ejection 
fraction unless substantial coronary disease is present, the sensitivity of dobutamine stress 
RNVG for the diagnosis of coronary heart disease is poor, with values as low as 33% for 
induction of wall motion abnormalities reported in one study (72) and 14% for an 
abnormal ejection fraction response in another once patients with resting wall motion 
abnormalities were excluded (73).  Dipyridamole requires even more severe disease than 
dobutamine to yield a positive result and thus has even lower sensitivity, albeit with high 
specificity (74).  It should be noted that these agents perform substantially better when 
used in myocardial perfusion imaging (72).  Perhaps more important is the information 
obtained from the exercise itself.  A patient’s exercise capacity and their haemodynamic 
response to that exercise provides important diagnostic and prognostic information which 
would otherwise not be obtained(75). 
Erect versus supine exercise 
Both erect and supine positions can be used for stress RNVG.  Supine exercise is 
technically easier to perform and the degree of patient motion is minimised compared to 
upright exercise.  Although the left ventricular ejection fraction and wall motion responses 
are no different in erect and supine exercise(76), the same is not necessarily true of 
diastolic function.  In this group, in the absence of coronary artery disease, left ventricular 
end-diastolic volume remained static during supine exercise but increased by 25% during 
upright exercise.  Equal ejection fraction responses were the result of a greater decrease in 
end-systolic volume during supine exercise. 
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1.5.2.3 RNVG Parameters of Systolic and Diastolic Function 
A variety of parameters derived from RNVG have been used to describe systolic and 
diastolic function.  The most common of these are ejection fraction, peak filling rate, time 
to peak filling and first third fractional filling.  These parameters and their derivation are 
summarised below. 
Parameter Abbreviation Normalisation Units 
Ejection fraction EF None % 
First third fractional filling FTFF None % 
Second third fractional filling STFF None % 
PFRrr RR interval % of EDC per cardiac cycle Peak filling rate 
PFRdt Diastole duration % of EDC per diastolic period 
ttFTFs None Seconds 
ttFTFrr RR interval Cardiac cycles 
Time to first third full 
ttFTFdt Diastole duration Diastolic periods 
ttPFs None Seconds 
ttPFrr RR interval Cardiac cycles 
Time to peak filling 
ttPFdt Diastole duration Diastolic periods 
PERrr RR interval % of EDC per cardiac cycle Peak emptying rate 
PERst Systole duration % of EDC per systolic period 
ttPEs None Seconds 
ttPErr RR interval Cardiac cycles 
Time to peak emptying 
ttPEst Systole duration Systolic periods 
ttFTEs None Seconds 
ttFTErr RR interval Cardiac cycles 
Time to first third empty 
ttFTEst Systole duration Systolic periods 
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In the calculations for the indices derived from the activity-time curve, the following 
definitions are used:   
t = time   tf = frame time 
f = frame   d is at end-diastole 
c = count   s is at end-systole 
R = RR interval  a is at start of atrial filling 
Normalisation – Volume 
Both filling and emptying rates must be normalised to a unit of volume.  Here both have 
been normalised to end diastolic counts, this being proportional to end diastolic volume.  
Whilst this is the most practical means of normalising these indices, it does have 
drawbacks.  Unlike an index expressed in terms of absolute volume or flow rates, indices 
normalised to end diastolic counts are subject to change if the end diastolic volume 
changes.  This introduces a degree of error when there is a change in ventricular volumes 
or loading conditions between serial studies and limits comparability between patients who 
may have markedly different ventricular volumes. 
Ideally, these indices should be normalised to absolute volumes.  However, this requires 
the drawing of a blood sample to determine the activity level in each millilitre of blood.  
Using this information, the activity-time curve can be converted into a volume-time curve.  
The drawbacks of this approach are the infection control and radiation protection issues 
involved in the processing of a radioactive blood sample. 
Normalisation - Temporal 
Any parameter which describes either a period of time or rate requires a unit of time to be 
expressed in.  Although the simplest and easiest unit of time to deal with is the second and 
its divisions such as milliseconds, in this case it is not necessarily the most useful.  The 
parameters being measured in terms of their rate or time of occurrence are themselves 
contained within an event, the cardiac cycle, which is itself of variable duration.  Any 
parameter which is measured in terms of absolute time cannot be reliably compared 
between different heart rates unless one can be absolutely sure that it is linearly related to 
any changes in heart rate.  Normalisation is the process whereby these parameters are 
adjusted so that they are expressed relative to the cardiac cycle length or definable portions 
thereof. 
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Parameters such as ejection fraction, first third fractional filling and second third fractional 
filling are either not expressed in terms of time in the case of ejection fraction, or are 
already expressed in terms of their relative duration within the cardiac cycle in the case of 
FTFF and STFF. 
RR Interval 
The simplest and most intuitive form of normalisation is to the cardiac cycle length.  
Instead of times being expressed as an absolute time in seconds from the beginning of the 
cardiac cycle, they are expressed as a number of cardiac cycles.  This is achieved by 
dividing the time by RR interval duration thus: 
Equation 1-1 – Normalisation to cardiac cycle length 
 
As the times being dealt with are all less than 1 cardiac cycle it can be useful in some 
circumstances to express them as a percentage of the cardiac cycle.  This is done by 
multiplying the result of Equation 1-1 by 100. 
Diastole Duration 
With increasing heart rate there are changes in the relative proportions of the cardiac cycle 
occupied by systole and diastole.  It might therefore be beneficial to look at the timing of 
events within diastole and normalise not only for heart rate but to remove the additional 
factor of how systole and diastole interact with alterations in heart rate.  Although 
electrical and mechanical systole have a relatively linear relationship with heart rate(77), 
diastole does not.  The relationship of diastole duration and the echo Doppler derived 
components of this – the E wave duration, diastasis and A wave duration – have had their 
response to heart rate change with supine bicycle exercise measured(78). The following 
equation has been derived to predict mechanical diastole duration (MDD) with an r2 value 
of 0.98: 
Equation 1-2 – Mechanical diastole duration 
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This can be used to model the change in diastole duration over a range of heart rates with 
the result expressed as a percentage of cardiac cycle duration (Figure 1-8) 
Figure 1-8 – Plot of percentage diastole duration predicted by the model in Equation 1-2 
 
As can be seen the proportion of the cardiac cycle occupied by diastole initially falls 
linearly with heart rate but becomes non-linear at about 90bpm.  Above heart rates of 120 
the equation predicts an essentially fixed diastole duration.  This is due to the E and A 
wave durations showing only minimal relationship to heart rate with only an 18% 
shortening of E duration for a 100% increase in heart rate.  The majority of shortening of 
diastole occurs in the diastasis period – once this is zero, further shortening of diastole will 
be minimal.  Given this complex relationship, it seemed reasonable to attempt to look at 
diastole in isolation. 
To normalise to diastole duration, the absolute time is divided by the duration of diastole.  
Diastole duration is defined here as the time from end systole as defined by the minimum 
point on the activity-time curve to the end of the cardiac cycle.  The absolute duration of 
diastole can be calculated by multiplying the number of frames from end systole to the end 
of the cardiac cycle by the frame duration in milliseconds.  This is either predetermined in 
the case of fixed frame acquisition or can be calculated by dividing the cycle length by the 
number of frames per cardiac cycle used in variable frame width acquisition.  The resulting 
units are therefore Diastole Periods in the case of measures of time and counts per diastolic 
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period in the case of rates.  As with normalisation to heart rate, the unit of time Diastole 
Duration can be multiplied by 100 to be expressed as a percentage of diastole. 
Systole Duration 
As diastole diminishes as a proportion of the cardiac cycle with increasing heart rate, so 
must systole increase even though its absolute duration decreases. 
The duration of systole can be determined by the QT interval, although it is important to 
note that this is electrical, rather than mechanical systole.  The duration of mechanical 
systole is, on average, 3-5% shorter than electrical systole (79).  The relationship of the QT 
interval to heart rate has been extensively studied (80).  Correction of the QT interval for 
heart rate is an essential tool to allow this important marker to be compared between 
individuals and compared with a standard range in order to risk stratify arrhythmogenic 
potential.  Three equations have been used to correct the QTc  interval in routine practice: 
Equation 1-3 – Bazett(81) 
 
 
Equation 1-4 – Fridericia(82) 
 
 
Equation 1-5 – Hodges(83) 
 
These equations can be manipulated to determine what the QT interval and, by inference, 
the duration of systole will be at different heart rates.  These predicted QT durations can 
then be used to determine the proportion of the cardiac cycle systole will occupy at a given 
heart rate. 
! 
QTc =  
QT
RR(s)
! 
QTc =  
QT
RR(s)3
! 
QTc =  QT +  1.75(HR - 60)
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Figure 1-9 – Prediction of systole duration derived from QTc models of Bazett, Fredericia 
and Hodges. 
 
The accuracy of the most commonly used formula for correction of the QT interval, the 
Bazett equation which dates back to 1920, has been questioned(83), particularly at the 
extremes of heart rate.  In our model above (Figure 1-9), Bazett predicts that at a heart rate 
of 140 systole will occupy 98% of the cardiac cycle.  Clearly, this cannot be so.  In fact, 
the curve which most closely mirrors the observed data on systole duration is the Hodges 
formula. 
As with normalisation to diastole duration, normalisation to systolic duration is achieved 
by dividing absolute time by duration of systole, systolic duration being defined from the 
activity-time curve as the period from the beginning of the activity-time curve to its 
minimum point. 
Ejection Fraction 
Left ventricular ejection fraction is the most widely used parameter of cardiac function and 
can be calculated using several imaging modalities in addition to radionuclide 
ventriculography including echocardiography and cardiac magnetic resonance imaging.  Its 
strength is the prognostic information it imparts and the fact that so much of the risk 
stratification and clinical decision making process is based around this single measure. 
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Radionuclide ventriculography has the advantages of superior reproducibility to 
echocardiography and a lack of reliance on the patient being a good imaging subject.  It 
also makes no assumptions whatsoever about uniformity of ventricular regional wall 
motion which can lead to inaccuracies in assessment of ejection fraction even with biplane 
measurements on echocardiography. 
From a background corrected activity-time curve, ejection fraction is calculated by 
Equation 1-6 where end diastolic counts (Cd) are defined as the initial curve maximum and 
end systolic counts (Cs)as the minimum point on the curve.  These points are determined 
automatically by the software.  Due to limitations in the software, additional steps are 
required to ensure correct automatic determination of end systolic counts when using 
activity-time curves generated from fixed-frame width acquisitions.  These steps are 
described in section 3.1.2.4. 
Figure 1-10 – Calculation of ejection fraction from activity-time curve 
 
Equation 1-6 – Ejection Fraction 
 
 
First Third Fractional Filling 
First third fractional filling is defined as the proportion of total ventricular filling which 
takes place within the first third of diastole and is typically expressed as a percentage.   
Following determination of the end systolic frame from the minimum point of the activity-
time curve, the number of frames to the end of the cardiac cycle is counted.  This is divided 
by 3 and this number to divide diastole into equal thirds.   
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Figure 1-11 – First third fractional filling 
 
The value of the activity-time curve at the first of these three points is used in the 
following equation to calculate FTFF. 
Where c1/3, the counts one third of the way into diastole, is defined as: 
c1/3 = (1-b)ca + bca+1 where a is the integer part and b is the fractional part of  
€ 
fd − fs( ) /3
and  and  are the end diastolic and end systolic frames respectively, first third 
fractional filling is calculated by Equation 1-7. 
Equation 1-7 – First Third Fractional Filling 
€ 
FTFF = c1 / 3 − cscd − cs ×100 
Time to First Third Full 
In addition to determining the proportion of ventricular filling occurring in a specified 
time, it is also possible to determine the time taken to achieve a specified proportion of 
ventricular filling.  Instead of dividing the diastolic time period into thirds, end systolic and 
end diastolic counts are determined as before.  The difference between these is divided into 
thirds and the time taken from end systole to achieve this increase in counts is measured.  
The initial measurement is made in frames, the basic unit of time of the activity-time 
curve.  This is then converted to an absolute time by multiplying by the frame duration and 
can be normalised either to cardiac cycle length or diastole duration as previously 
described. 
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Figure 1-12 – Time to first third full 
 
Second Third Fractional Filling 
Second third fractional filling refers to the proportion of total ventricular filling which has 
occurred by the end of the second third of diastole.  Similarly to FTFF it is calculated by 
dividing diastole into thirds and then determining counts at the end of the second third.  
This value is used in essentially the same equation as FTFF.  It should be noted that the 
value generated is not only the proportion of ventricular filling occurring in the second 
third of diastole, it also includes that which has already taken place in the first third.  First 
third fractional filling must be calculated separately and subtracted if one wishes to know 
the proportion of filling occurring solely during the second third of diastole. 
Figure 1-13 – Second third fractional filling 
 
Peak Filling Rate 
Using both the raw activity-time curve and 3 point linear regression, the slope of the 
diastolic filling curve can be examined to determine the maximal rate of positive change in 
counts.  The accuracy of this determination will be limited by two main factors.  Firstly, 
the temporal resolution of the curve and portion of the curve being examined i.e. the 
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number of frames per cardiac cycle and the number of frames within diastole, has a 
significant impact.  With greater temporal resolution more data points are available on the 
activity-time curve and more subtle changes in filling rate can be determined.  Even with 
acceptable temporal resolution, a very short diastolic period may contain too few frames to 
accurately determine peak filling. 
Secondly, the overall count statistics for the activity-time curve are important.  All activity-
time curves generated by radionuclide imaging are subject to a degree of artefact either due 
to motion artefact or random variations in radioactive decay.  This is tempered to a degree 
by some smoothing of the curves prior to analysis.  The degree of smoothing must, 
however, be limited as overly aggressive smoothing of the activity-time curve will distort 
any values ultimately derived from it. 
These two factors interact with each other.  If the number of frames per cardiac cycle is 
increased to improve temporal resolution, a trade-off must take place with count statistics.  
Unless the acquisition time is increased, the total number of counts available for generation 
of the activity-time curve must remain the same.  For an increase in frame rate from 24 to 
32 frames per cycle, this fixed quantity of data is divided into smaller bins resulting in 
fewer counts per frame. 
Equation 1-8 – Peak Filling Rate 
 
Where ci = counts in frame i, d1 = end diastolic frame, s = end systolic frame, cd = counts at end diastole, and tf = 
frame duration. 
By regression, intermediate points between the acquired frames may be interpolated.  Peak 
filling rate may be calculated using these interpolated points to improve temporal 
resolution. 
Time to Peak Filling 
The time from end systole to the point at which peak filling occurs is calculated by: 
 
where imax is the frame number giving the maximum difference in Equation 1-8.  The initial units are seconds.  This 
can then be normalised to either the RR interval or diastole. 
! 
" max =
max[ci # ci + 1]i=s
d 1
cdtf
$100
! 
t"max = (i max# fs + 0.5)tf
Andrew C McCulloch, 2009  Chapter 1, 59 
Time to First Third Empty 
Similarly to Time to First Third Full, Time to First Third empty can be calculated be 
determining the time for the activity-time curve to fall by one third the total value of the 
difference between end systolic and end diastolic counts.  Its basic units are the same as 
ttFTF and following conversion to an absolute time, can be normalised to either cardiac 
cycle duration (RR interval) or systole duration. 
Figure 1-14 – Time to first third empty 
 
Peak Emptying Rate 
Without using regression to refine the activity-time curve beyond the resolution of the 
number of frames per cardiac cycle, the peak emptying rate, εmax, is calculated by Equation 
1-9. Without any normalisation it is expressed as the percentage of end diastolic counts per 
second. 
Equation 1-9 – Peak Emptying Rate 
 
As with peak filling rate, additional points may be interpolated by regression to improve 
temporal resolution. 
Time to Peak Emptying 
The time from end diastole to the point at which the peak emptying rate occurs is 
calculated by: 
  
where imax is the frame number giving the maximum difference in Equation 1-9.  This is 
initially calculated in absolute time and can then be normalised as required. 
! 
" max =
max[ci # ci + 1]i= d
s
cdtf
$100
! 
t"max = (i max# fd + 0.5)tf
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1.5.3 Magnetic Resonance Imaging 
Regarded by many as the gold standard in non-invasive cardiac imaging, MRI has 
predominantly been used to assess systolic function and structure.  However, it has also 
been used in the assessment of diastolic function.  Many of the techniques described to 
date simply replicate those which can be achieved with other imaging modalities.  Only 
one technique, myocardial tagging, exploits the unique capabilities of MRI.  Cardiac MRI 
does have significant advantages when compared with alternative imaging techniques.  
However, it also has several disadvantages. 
1.5.3.1 Advantages of MRI 
Foremost in the advantages of MRI is its superlative image quality.  Its spatial resolution 
far exceeds that of nuclear techniques, either perfusion scintigraphy or ventriculography, 
and either transthoracic or transoesophageal echocardiography.  Unlike nuclear techniques 
it does not involve exposure to ionising radiation.  Unlike echocardiography it is not 
limited by the adequacy of acoustic windows either in terms of image quality or achievable 
imaging plane. 
MRI is also exceptionally versatile, allowing an increasingly diverse range of methods of 
cardiac assessment.  From simple visual assessment of cardiac motion, through 
quantitative assessment of systolic and diastolic myocardial motion, assessment of 
perfusion and scarring with the use of gadolinium to magnetic resonance spectroscopy 
allowing examination of tissues at the molecular level, MRI has been hailed as a ‘one stop 
shop’ for cardiac assessment. 
1.5.3.2 Disadvantages of MRI 
Such a wide range of possible scanning techniques comes at a cost: the more 
comprehensive an examination undertaken, the longer that examination takes.  Whilst a 
comprehensive cardiac MRI examination should not take longer than the equivalent 
examination by a combination of other modalities, a disadvantage unique to MRI becomes 
more problematic.  Current MRI scanners are enclosed devices, far more so than CT 
scanners or the gamma cameras used in nuclear cardiology.  As a result, a proportion of 
patients are unable to undergo even brief MRI examinations due to claustrophobia.  As 
imaging time increases, the problem is exacerbated. 
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MRI also has issues with temporal resolution.  Depending on the scanning protocol being 
used and magnetic field strength, most cardiac MRI has a temporal resolution of 30 to 50 
milliseconds.  A temporal resolution of 30 milliseconds will yield 33 frames per cardiac 
cycle at a heart rate of 60 beats per minute, more than adequate for most applications.  
However, a resolution of 50 milliseconds at 80 beats per minute will result in only 15 
frames per cycle.  Although this may be adequate for ejection fraction analysis, more 
advanced volume-time curve analysis may be unreliable.  With increasing heart rates this 
problem is exacerbated and even ejection fractions may be unreliable if true end-systole 
and end-diastole are missed due to inadequate temporal resolution. 
1.5.3.3 Myocardial Tagging 
It is possible to locally saturate the magnetisation of the myocardium in such a way that a 
dark stripe, or tag, is imprinted on the myocardium.  As the myocardium moves and 
deforms, the tag moves with it.  This, therefore, provides a means of tracking the 
magnitude, vector and velocity of myocardial motion.  This tagging process is typically 
carried out on multiple short axis slices with the tag lines appearing black against the grey 
myocardium, although tagging in any plane is possible.  The technique was initially 
described in 1988(84), applying radial tag lines centred on the left ventricular cavity.  The 
technique was refined, with parallel stripes being created(85), and was referred to as 
SPAMM, SPAtial Modulation of Magnetisation.  Further refinement came with the 
application of two perpendicular sets of stripes(86), creating a lattice.  The technique was 
primarily used for assessment of regional systolic function. 
The assessment of diastolic function was impeded by tag line fading in diastole.  The 
technique was subsequently refined and CSPAMM, Complementary SPAtial Modulation  
of Magnetisation evolved(87). 
Torsion 
The spiral arrangement of fibres within the myocardium of the left ventricle means that, as 
the ventricle contracts, it twists about its base.  Conversely, as it relaxes, it untwists.  The 
magnitude and rate of this torsional deformation can be measured with tagging.  If a series 
of radial tags are applied to short axis slices, the torsion angle is measured as the angle 
between a tag line on any slice and the corresponding tag line on the basal slice.  This can 
be measured throughout the cardiac cycle to give an overall magnitude and instantaneous 
torsion rates.  When studied in a canine model, this technique reveals that the majority of 
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this untwisting occurs during isovolumetric relaxation, prior to mitral valve opening(88).  
By doing so, it causes left ventricular pressure to fall below left atrial pressure more 
rapidly than it would otherwise do.  This is measured indirectly as the isovolumetric 
relaxation time, although this is confounded to a degree by pre-load and after-load. 
Strain/Strain Rate 
The concept of myocardial strain, defined as fractional tissue deformation in response to 
applied stress was first described in 1973(89).  Along with its derivative strain rate, it 
offered a quantitative, rather than qualitative, means of describing regional myocardial 
function.  Until the advent of tagged cardiac magnetic resonance imaging, it remained 
impractical to measure in routine clinical practice, although M-mode echocardiography 
was proposed (90).  The use of myocardial tagging to quantify 3 dimensional deformation, 
and thereby strain, was first described in 1995(91).  Circumferential shortening had been 
described several years earlier(92). 
Although systolic strain and strain rate were well established and used to validate tissue 
Doppler derived strain in 2002(93), the first utilisation of MRI derived strain to assess 
diastolic function was in 2004(94).  In this canine model of reperfused acute myocardial 
infarction, persistent diastolic dysfunction was demonstrated despite full recovery of 
systolic function. 
1.5.3.4 Velocity Encoded MRI 
Velocity encoded MRI is the technique whereby the velocity of blood flow within vessels 
or across valves can be measured.  It may be performed using several MRI techniques 
including ‘Time of Flight’ (TOF) where unsaturated spins moving into a gradient echo 
slice produce signal enhancement.  Phase contrast angiography may also be used.  This has 
several advantages over TOF in that there is complete suppression of stationary tissues – 
tissues with a short T1 relaxation time such as fat may produce artefact.  It may also be 
acquired with gradient echo cine sequences to produce Velocity Encoded Cine MR, 
velocity maps with high temporal resolution(95). 
Much of the early work with this technique concentrated on measurement of velocities 
within the aorta and pulmonary arteries, and in quantifying cardiac output(96).  Although 
this was already achievable by means of Doppler echocardiography, the ability to make 
these measurements with MRI added another facet to the perception of MRI as a ‘one stop 
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shop’ for cardiac assessment.  In addition, it allowed assessment in patients with poor echo 
windows and in those with complex anatomy not amenable to standard echo approaches. 
It has been shown to be technically possible to assess pulmonary venous and transmitral 
velocities using MRI(97).  The feasibility of this in clinical practice and its accuracy when 
compared to Doppler echocardiography has been assessed(98).  Transmitral flow was 
assessed in both the vertical and horizontal long axes with 2D and 3D velocity encoded 
MRI.  Mitral E wave velocity had a correlation coefficient of 0.68-0.69 in the four 
modalities.  E/A ratio correlation was similar, other than for 3D horizontal long axis values 
which had a correlation coefficient of 0.84.  Pulmonary venous flow also showed good 
correlation with coefficients of 0.74 and 0.83 for the X velocity and X/Y ratio respectively.  
An advantage of MRI becomes apparent here.  It was possible to record the Y velocity in 
all patients with MRI whereas this was not so with echocardiography. 
However, there are caveats.  The temporal resolution of velocity encoded MRI is poor, 
particularly with 3D encoding where a frame width in excess of 100 milliseconds results in 
averaging of data between frames.  In comparison, Doppler has a temporal resolution of 
just a few milliseconds depending on the velocity range being sampled and sample depth.  
With the young age and relatively low heart rates of Hartiala’s normal subjects, this results 
in a temporal resolution of 16 frames per cardiac cycle.  Whilst this is adequate for the E/A 
ratio, it is inadequate for mitral deceleration time or isovolumetric relaxation time.  In an 
older population with higher heart rates, the number of frames per cycle will be even 
poorer.  This lack of temporal resolution results in a systematic under estimate of 
velocities.  Thus, normal ranges are not directly translatable from echo to MRI. 
Another significant limitation of velocity encoded MRI in comparison with Doppler 
echocardiography is the length of time necessary to acquire the data.  Disregarding the 
time required by both modalities to align the imaging plane correctly, adequate Doppler 
data can be acquired in less than 10 seconds with a minimum of 3 cardiac cycles samples.  
Velocity encoded MRI requires 4 to 5 minutes of data acquisition and a longer analysis 
time. 
1.5.3.5 Volume-Time Curves 
Cine MRI, particularly when used with a balanced steady state free precession technique, 
allows high quality images with high blood pool to endocardium contrast to be generated.  
Andrew C McCulloch, 2009  Chapter 1, 64 
By tracing the ventricular cavity area over a series of short axis slices, multiplying this by 
the slice thickness added to any inter-slice gap(99), the ventricular volume may be 
calculated over the entire cardiac cycle.  Whilst the most common application of this is the 
calculation of ejection fraction, any parameter which can be derived from the activity-time 
curve of radionuclide ventriculography may also be calculated from MRI.  Peak filling rate 
calculated in this manner has been used as a parameter of diastolic function in several 
studies(100-102). 
Several key differences should be considered when comparing RNVG and MRI derived 
ventricular volume curves.  Firstly, RNVG makes no geometric assumptions about the left 
ventricle.  The entire ventricle is sampled and, in the absence of any operator error, is 
included in the derived curve.  MRI, when adopting a slice based approach, must make 
assumptions about the ventricular contours for the entire thickness of the slice and any 
inter-slice gap.  Where slice thickness is small this should be of little or no clinical 
significance as the far superior spatial resolution of MRI, approximately 1.5 x 2 mm2 
should more than offset this. 
Secondly, temporal resolution and possible framing modes are different between RNVG 
and MRI.  As previously discussed, MRI has a fixed temporal resolution of between 30 
and 50 milliseconds per frame for most acquisition sequences.  As heart rate increases, the 
number of frames per cardiac cycle decreases.  RNVG, however, can be acquired in list 
mode where raw data is acquired continuously and retrospectively formatted with variable 
frame durations to maintain a constant number of frames per cycle independent of heart 
rate.  This has an additional benefit in that RNVG is better able to cope with arrhythmias 
such as atrial fibrillation.  In such circumstances, or where patients are unable to perform 
the breath holds required for routine MRI acquisitions, MRI can be acquired in real time at 
the expense of temporal and spatial resolution.  Typically resolutions of 3 x 3 mm2 at 90 
milliseconds per frame can be achieved(103, 104). 
1.5.3.6 Myocardial Velocities and Tissue Tracking 
In a technique analogous to tissue Doppler echocardiography, velocity encoded phase 
contrast MRI can be used to measure instantaneous myocardial velocities by analysing 
phase shifts in bipolar velocity encoded gradients(105).  The velocities obtained can be 
used to calculate displacement and hence strain and strain rate(106) by tracking tissue over 
time without the need for myocardial tagging.  However, errors in velocity measurement 
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result in progressive errors as the cardiac cycle progresses, although this can be reduced 
with improved tracking algorithms(107, 108). 
A newer technique, DENSE (Dual Encoding with Stimulated Echoes), solves this problem 
by using a process similar to tagging to encode displacement information within the phase 
signal.  The tag is applied at the R wave and read back at a point later in the cardiac cycle 
giving a measurement of displacement relative to end-diastole.  The development of cine 
DENSE techniques(109, 110) have replaced the single cardiac phase that was initially read.  
A temporal resolution of 34 milliseconds and spatial resolution of 2.5 x 2.5 x 8 mm3 has 
recently been achieved(111).  
1.5.4 Invasive Assessment of Left Ventricular Filling Pressures 
1.5.4.1 Pulmonary Capillary Wedge Pressure 
The fact that left heart pressures are transmitted retrogradely through the pulmonary 
vasculature has been recognised for over 100 years.  The measurement of pulmonary 
capillary wedge pressure (PCWP) was first demonstrated in 1948(112) and, with advances 
in left heart catheterisation, were taken to be equivalent to left atrial pressure. The key 
advantage of PCWP was that it involved venous rather than arterial puncture, thereby 
reducing complication rates.  The underlying principle of PCWP is that the balloon isolates 
the distal pressure sensor from the pulmonary arterial side of the circulation, leaving it 
solely exposed to the pressure waves transmitted back through the pulmonary capillary 
bed. 
However, the correlation between PCWP and directly measured left atrial pressure is not 
perfect and significant discrepancies have been shown, particularly at higher pulmonary 
arterial pressures(113).  The reason for this is that the pressure wave must traverse the 
pulmonary capillary bed.  Damage to this bed means that the pressure wave is not 
transmitted faithfully.  This may either be from long standing backpressure from left 
ventricular dysfunction, left sided valvular disease, or from pulmonary pathology such as 
interstitial lung disease, thromboembolic disease or intrinsic lung disease. 
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1.5.4.2 Left Ventricular End Diastolic Pressure 
The association between left ventricular dysfunction and elevated left ventricular end 
diastolic pressure (LVEDP) has been recognised since the early days of left heart 
catheterisation (114).  This has also been observed where systolic function is preserved and 
a diagnosis of diastolic dysfunction has been made by other criteria (115).  The choice of 
end diastolic pressure, rather than another point during diastole or mean pressure, is one 
based partly on pragmatism and the limited diagnostic facilities of the time.  End diastole is 
an easily identified point on the left ventricular pressure trace.  This, therefore, improves 
reproducibility between studies and between different operators.  Analogue acquisition of 
the pressure trace also meant that instantaneous, as opposed to mean, pressures were much 
simpler to measure. 
1.5.4.3 Mean Left Ventricular Diastolic Pressure 
Although left ventricular end diastolic pressure is convenient and does correlate with 
filling pressure, it does not necessarily equal mean left atrial pressure(116).  Mean left 
ventricular diastolic pressure, although more cumbersome to calculate, requiring either 
digitisation of a pressure trace or native digital acquisition, has been shown to correlate 
more closely with mean left atrial pressure than LVEDP(47). 
1.5.4.4 Tau 
Tau (τ) is the time constant of isovolumetric pressure decline in the left ventricle and is 
measured in milliseconds.  This is measured by means of a catheter placed in the left 
ventricle and calculations performed on the acquired pressure tracings.  In theory, this goes 
a step beyond the relatively crude measurement of IVRT by measuring what happens to 
left ventricular pressure during this period rather than simply its duration.  As left 
ventricular pressure is being measured at a time when no ventricular filling occurs, this has 
been shown to be independent of preload(117). 
Tau may be calculated by several techniques.  The original description of tau used a natural 
log plot of left ventricular pressure against time and assumed a monoexponential pressure 
decline to zero(118).  This was later refined to accommodate a non-zero endpoint of 
pressure decline by using a negative plot of dP/dt versus left ventricular pressure(119).  
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The third method, essentially a simplification of the original method, calculates the time 
for left ventricular pressure to fall by half from peak negative dP/dt(120). 
However, tau is not fully load independent.  It has been shown that it is affected by 
afterload in that an increase in afterload increases tau(121).  The same has been seen in 
studies primarily concerned with preload where volume loading was sufficient to also 
affect afterload(122). 
1.5.5 BNP 
Brain natriuretic peptide (BNP) and the n-terminal fragment of its precursor proBNP (NT-
proBNP) are cardiac neurohormones secreted primarily by the ventricles in response to 
volume and pressure overload.  The apparent misnomer arises from the fact it was initially 
isolated from preparations of brain tissue.  They have been shown to be elevated in patients 
with left ventricular systolic dysfunction and their levels correlate both with NYHA 
functional class and prognosis(123-125).  It has also been shown that BNP is elevated to an 
intermediate level in patients presenting with heart failure with preserved systolic function 
compared to those with systolic dysfunction(126).  The level of BNP correlates with grade 
of diastolic dysfunction with higher levels being seen in patients with a restrictive pattern 
of mitral inflow(127). 
NT-proBNP has several advantages over BNP.  It is more stable in patient samples with 
frozen plasma remaining suitable for analysis at least 4 months after collection(128).  NT-
proBNP also has a longer plasma half-life than BNP (70 versus 5 minutes) (129).  This 
gives a better indication of average filling pressures and is of more use in acute volume 
overload where the secretion of natriuretic peptides decreases once their reservoir is 
exhausted. 
BNP is, however, not specific for either systolic or diastolic dysfunction.  BNP is known to 
be elevated in any condition which elevates right ventricular pressures such as pulmonary 
embolism, pulmonary hypertension, and fluid overload states such as cirrhosis and dialysis 
dependent renal failure.  This is not surprising given that BNP is not specific for the left 
ventricle and merely indicates volume or pressure overload rather than the aetiology of 
this.  It is therefore predictable that BNP is also raised in conditions that increase left 
ventricular wall stresses without necessarily causing overt dysfunction such as systemic 
hypertension or left ventricular hypertrophy. 
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1.6 Diagnostic Criteria for Diastolic Heart Failure 
The biggest problem in diagnosing diastolic heart failure is the lack of standardised criteria 
which perform reliably in the real world where co-morbidity and confounding diagnoses 
are common.  Several schemes have been proposed for integrating multiple parameters of 
systolic and diastolic function in an attempt to more reliably diagnose and grade diastolic 
function.  The most widely accepted of these come from the European Study Group on 
Diastolic Heart Failure(130).  Originally published in 1998, these guidelines were updated 
in 2007 to include recent advances in diagnosing diastolic dysfunction such as tissue 
Doppler imaging, MRI and neurohormones such as BNP(14). 
The 1998 European criteria require three conditions to be met simultaneously for a 
diagnosis of diastolic heart failure to be made: Signs or symptoms of heart failure; 
preserved left ventricular systolic function; and evidence of abnormal diastolic function. 
Table 1-5 – 1998 European Society of Cardiology criteria for diastolic heart failure 
Signs/symptoms Systolic Function Diastolic Function 
<30y  >92ms 
30-50y >100ms 
IVRT:  
>50y >105ms 
E/A<50y < 1.0 and DT<50y >220ms 
E/A>50y <0.5 and DT>50y  >280ms 
Pulmonary venous flow: S/D<50y >1.5 
    S/D>50y >2.5 
PV A duration >30ms greater than MV A duration 
PV A flow > 35cm/s 
PFR <160ml/s/m2 or 
    PFR<30 <2.0 EDV/s 
    PFR30-50 <1.8 EDV/s 
    PFR>50 <1.6 EDV/s 
LVdP/dtmin <1100mmHg/s 
τ > 48ms 
LVEDP>16mmHg or PCWP>12mmHg 
Exertional dyspnoea 
Orthopnoea 
Gallop sounds 
Lung crepitations 
Pulmonary oedema 
LVEF ≥ 45% 
 
And 
LVEDIDI < 3.2cm/m2 
Or 
LVEDVI <102ml/m2 
Increased LV chamber/muscle stiffness: 
    b >0.27 and/or b’ >16 
LVEDIDI = left ventricular end-diastolic internal dimension index; LVEDVI = left ventricular end-diastolic volume 
index 
The 2007 revision of the European Society criteria (14) retains this requirement for a triad 
of signs or symptoms of heart failure, preserved systolic function and objective evidence of 
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diastolic dysfunction.  Tissue Doppler is given a prominent role in establishing diastolic 
dysfunction with an E/E’ ratio of greater than 15 being sufficient to make the diagnosis.  
An E/E’ ratio between 8 and 15 requires either elevated biomarkers or one of the additional 
markers to be abnormal.  Biomarkers play a key role, although elevated BNP or NT-
proBNP require confirmation with an additional abnormal parameter.  Standard Doppler 
(E/A < 0.5 and deceleration time >280ms) is relegated to a confirmatory role along with 
left ventricular hypertrophy, atrial fibrillation, left atrial volume index >40ml/m2 and 
pulmonary vein Doppler. 
In 2000, Vasan and Levy proposed criteria for diagnosing diastolic heart failure based on 
the principles of the European criteria but introducing a hierarchy of diagnostic 
certainty(131).  Diastolic heart failure was categorised as definite, probable and possible 
based on whether normal left ventricular systolic function was documented within 72 hours 
of an index heart failure event and whether there is objective evidence of abnormal 
diastolic function (Table 1-6).  All three levels of diagnostic certainty require definite 
evidence of congestive heart failure in the form of clinical signs and symptoms, supportive 
investigations such as chest X-ray, and a typical clinical response to diuretic treatment. 
Table 1-6 – Vasan criteria for the diagnosis of acute diastolic heart failure 
Definite DHF Probable DHF Possible DHF 
LVEF ≥ 50% within 72hrs 
and 
Abnormal LV relaxation, filling or 
distensibility on cardiac 
catheterisation 
LVEF ≥ 50% within 72hrs 
but 
No conclusive evidence on 
diastolic function 
LVEF ≥ 50% outwith 72hrs 
and 
No conclusive evidence on 
diastolic function 
 
The presence of features such as significant hypertension during the heart failure episode, 
left ventricular hypertrophy or clinical improvement as a result of treating a cause of 
diastolic dysfunction such as tachycardia are cited as reasons to upgrade a diagnosis from 
possible to probable diastolic heart failure. 
The absence of specific criteria for abnormal diastolic function and the reliance of invasive 
rather than non-invasive measures limits the usefulness of the Vasan criteria.  Ommen and 
Nishimura(31) provide a useful scheme for differentiating normal from elevated filling 
pressures in the presence of preserved systolic function (Figure 1-15). 
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EF > 50% 
E/E’ < 8 E/E’ 8-15 E/E’ >15 
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Once abnormal filling pressures are identified, it may be useful to go on to describe the 
severity of the abnormality in diastolic function.  Diastolic dysfunction may be graded as 
grade I to IV based primarily on the E/A ratio and its response to the Valsalva manoeuvre.  
To refine this categorisation, cut-off values have been published for other commonly 
measured echocardiographic parameters (Table 1-7)(132). 
Table 1-7 – Echocardiographic parameters in relation to diastolic dysfunction grade 
 Normal Grade I Grade II Grade III-IV 
E/A >1 <1 1-2 ≥2 
DT (ms) 160-210 >220 150-200 <150 
IVRT (ms) 70-90 >95 60-95 <60 
S/D 1.3-1.5 1.6-2.0 <1 0.4-0.6 
E’ (cm/s) >8 <8 <8 <5 
Vp (cm/s) >55 <45 <45 <35 
E/E’ <8   >16 
E/Vp    >2.5 
 
Figure 1-15 – Scheme for diagnosis of elevated LV filling pressures.  Adapted from 
Ommen and Nishimura(31) 
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1.7 The Aetiology of Diastolic Heart Failure 
Diastolic dysfunction should result from any process which interferes with the normal 
components of diastolic function. 
Left ventricular hypertrophy arises either as a consequence of systemic hypertension, aortic 
stenosis, as part of hypertrophic cardiomyopathy or as a compensatory change following 
myocardial infarction.  Whatever the underlying disorder, the endpoint and its 
consequences for diastolic function are the same.  The increased myocardial mass itself 
does not appear to be responsible for impairment of diastolic function.  In the physiological 
hypertrophy seen in athletes, diastolic function is preserved compared with similarly aged 
subjects with the same degree of left ventricular hypertrophy due to hypertension(133).  In 
pathological LVH, myocyte hypertrophy is accompanied by excess collagen production.  
Fibrosis occurs – it is this that is responsible for impairing ventricular relaxation by 
reducing compliance and increasing stiffness.  Passive ventricular filling is impaired and, 
as fibrosis progresses, elastic recoil is impaired, reducing the suction effect. 
The active component of ventricular relaxation will be impaired by any process which 
either reduces the energy available to the myocardium or increases the energy required to 
drive the calcium exchange required for relaxation.  In ischaemic heart disease, ischaemia 
caused by coronary stenosis results in abnormal relaxation at an earlier point in the 
ischaemic process than the systolic dysfunction seen with stress echo.  The resulting rise in 
ventricular pressure is transmitted back through the pulmonary veins and may in part 
account for the clinical syndrome of effort dyspnoea as an “anginal equivalent”. 
LVH also results in thickening of coronary artery walls and damage to the 
microcirculation, reducing coronary flow reserve.  Again the athlete’s heart differs from 
pathological LVH.  Using myocardial contrast echo and dipyridamole as a coronary 
vasodilator, it has been shown that abnormalities in microcirculation can be seen in 
hypertensive LVH(134).  A different pattern is seen in athletes where function is enhanced 
above that seen in normal control subjects. 
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1.7.1 Prevalence of Diastolic Heart Failure 
Estimating the prevalence of diastolic heart failure, or heart failure with preserved 
function, is a task which ought to be straightforward but is in fact beset with difficulties 
ranging from variations in what constitutes preserved systolic function, what constitutes 
diastolic dysfunction and whether diastolic function even needs to be assessed.  Even 
something as fundamental as the criteria used to define heart failure can vary substantially 
from series to series. 
As part of the MONICA project, Fischer et al(135) examined the prevalence of 
abnormalities of diastolic function as defined by the European Study Group on Diastolic 
Heart Failure(130) in a group of 1678 randomly selected individuals.  Only 1418 had 
echocardiographic images of sufficient quality to determine left ventricular ejection 
fraction and 1274 of these had mitral Doppler signals suitable for analysis.  Overall, the 
prevalence of “abnormal” diastolic function was 11.1% with a strong correlation with age 
– the prevalence rose from 2.8% in the 25-35 year age group to 15.8% in the 65-75 year 
age group (subjects aged over 75 years old were not included in the study).  The presence 
of diastolic dysfunction, or diastolic heart failure, was not itself specifically studied but 
instead was inferred from the use of diuretics and/or left atrial enlargement.  Using this 
flawed inference, the prevalence of diastolic dysfunction was calculated at 3.1%. 
The prevalence of abnormal diastolic function was strongly associated with the presence of 
traditional risk factors, namely hypertension, left ventricular hypertrophy and coronary 
artery disease.  It is therefore not surprising that the prevalence of diastolic abnormalities is 
significantly higher in males from this population in whom these risk factors, particularly 
coronary artery disease, are more common.  This is in contrast to other studies where 
patients presenting with a diagnosis of heart failure with preserved systolic function have a 
striking female preponderance. 
In Olmstead County, Minnesota during the year 1991, a total of 216 people from a total 
population of 106,470 received a new diagnosis of heart failure(136), retrospectively 
validated with a minor modification of the Framingham criteria.  Although only 137 of 
these had an assessment of left ventricular ejection fraction, systolic function was 
preserved in 59 patients (43%).  Only 5 of these patients had haemodynamically significant 
valvular heart disease to account for their heart failure.  Thus, although diastolic function 
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was not specifically measured, the proportion of isolated diastolic dysfunction is an 
estimated 39.4% of the 216 patients, giving an incidence of 0.8 cases /1000 population / 
year.  69% of these were female, in contrast to those with a reduced ejection fraction, 
where only 41% were female. 
There is significant variation in the proportion of patients diagnosed with heart failure with 
preserved systolic function.  Cowie et al(137)found only 16% of patients to have normal 
left ventricular systolic function in a cohort of 332 patients identified via a hospital based 
rapid access heart failure clinic in a 15 month period.  Mean age was 75 with 54% males 
over the group as a whole with no breakdown given between subgroups defined by LV 
systolic function.  Vasan et al(138) found 51% of a cohort of 73 patients from the 
Framingham population with a diagnosis of heart failure to have normal left ventricular 
systolic function with a 65% female preponderance and a mean age of 72 within this 
group. 
It may be that the difference in prevalence of heart failure with preserved systolic function 
is due to different criteria used to diagnose heart failure.  Cowie et al(137) use the  
European Society criteria for heart failure(16) whereas the Framingham criteria(15) were 
used by Vasan(138).  Similar degrees of variation have been reported by other authors.  
Gardin(12) reported a 47% prevalence in a community based cohort whereas Madsen(139) 
reported only a 14% prevalence.  Unfortunately, neither author of these two papers report 
their criteria for diagnosing heart failure, and only Madsen specified the LV ejection 
fraction cut-off used for preserved function – 53% in this case. 
The true figure appears to lie between these two extremes.  In the largest series to date, 
Masoudi et al(140) retrospectively reviewed 19,710 Medicare recipients over the age of 65 
admitted to hospital with a validated diagnosis of heart failure.  All of these patients had 
documentation of left ventricular systolic function, with normal being defined here as an 
ejection fraction ≥ 50%.  When the percentage of patients with preserved systolic function 
is plotted for each 5 year cohort of patients (Figure 1-16), the inexorable rise in this with 
age is clear, rising from 30% in the 65-70 year group to 45.7% in patients over 90 years of 
age. 
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Figure 1-16 – Percentage of patients with heart failure in whom ejection fraction is ≥50% in 
relation to age (adapted from Masoudi et al.(140)) 
 
What is also striking from this data set is the striking female preponderance of heart failure 
with preserved systolic function.  Over the whole group, female gender conferred an 
unadjusted odds ratio of 2.49.  Even when adjusted for medical history, admission 
characteristics and race (Caucasians have a higher risk compared with non-Caucasians, 
especially African-Americans), female gender confers a relative risk of 1.71.  It has been 
suggested that the reason for this discrepancy is, in part, a difference in left ventricular 
response to haemodynamic stress between the sexes, with different responses to aortic 
stenosis(141) and systemic hypertension(142).  In Masoudi’s group, adjusting for medical 
history should have removed the influence of any co-morbidity, assuming the model was 
robust.  Two possibilities remain to explain this.  Either factors not accounted for have 
influenced LV function or female gender itself exerts an influence independent of any 
underlying pathological processes. 
1.7.2 Heart Failure With Preserved Systolic Function 
The concept of preserved systolic function comes from the recognition that systolic and 
diastolic heart failure commonly co-exist and a desire to designate patients as having 
predominantly systolic or diastolic heart failure based on a cut-off point in systolic 
function(143).  It is unclear whether this designation is in fact valid, given that a group of 
patients with a normal ejection fraction but abnormal invasively measured parameters of 
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diastolic filling can be demonstrated, these patients having isolated diastolic dysfunction.  
While “preserved systolic function” will indeed include a proportion of patients with 
normal ejection fractions, it will also include a substantial proportion of patients with mild 
left ventricular systolic dysfunction.  Is the primary problem in this subset of patients 
actually mild systolic dysfunction rather than diastolic dysfunction?  If so, is diastolic 
dysfunction even present? 
The cut point for preserved versus impaired systolic function will clearly have a substantial 
effect on the incidence of diastolic dysfunction if one accepts the definition of predominant 
diastolic dysfunction rather than isolated diastolic dysfunction.  Even when not considering 
varying imaging modalities and the variation in normal ranges introduced by this, the cut 
point for preserved systolic function varies significantly in the literature.  For radionuclide 
ventriculography this has ranged from as low as 45%(144) to as high as 53% (139).  With 
echocardiographic assessment of systolic function there is not only the issue of varying 
definitions of normality, there are also different techniques for assessing systolic function.  
The commonly used indexes are the subjective eyeball assessment of function, fractional 
shortening and ejection fraction.  Even here there are multiple techniques which can be 
employed for calculating one index, ejection fraction – Simpson’s biplane, the modified 
Quinones formula(145) and the Teicholtz formula.  Although the echocardiographic 
ejection fraction definition of preserved systolic function is relatively consistent at between 
50(146-148) and 55%(149, 150), the variation for fractional shortening, a parameter widely 
regarded as inferior to measurement of ejection fraction by Simpson’s rule but potentially 
available when image quality precludes this, is more substantial.  Fractional shortening 
values as low as 17% have been regarded as preserved systolic function(151), whilst other 
series have required values of 25%(152, 153) or even 30%(154). 
1.8 Treatment of Diastolic Heart Failure 
Before evidence based strategies for treating diastolic dysfunction can be developed it is 
necessary to develop a robust measure of diastolic function, and the response of this 
parameter to drug intervention must be measured.  As has been discussed previously, the 
fundamental problem with this to date has been the lack of a universally accepted 
parameter of diastolic function that can be monitored in the manner and quantity necessary 
to provide evidence of treatment efficacy, or lack thereof. 
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As a surrogate for directly measuring diastolic function, it is possible to measure the effect 
of interventions on the risk factors and disease processes known to cause diastolic 
dysfunction. 
Clearly it is possible to cause regression of left ventricular hypertrophy by adequate long-
term control of blood pressure.  However, the question remains as to how closely the 
structural changes of myocardial fibrosis correlate with left ventricular hypertrophy and its 
regression.  Is it sufficient to measure changes in left ventricular hypertrophy and assume 
that the more challenging to measure indices of myocardial fibrosis have responded in the 
same manner?  Or can changes in myocardial fibrosis be seen even without observable 
alterations in LVH?  Indeed, to what extent is myocardial fibrosis reversible? 
Some of these questions have been answered by Brilla et al(155) in a small study involving 
35 patients with hypertension and LVH who were randomised to treatment with either 
lisinopril or hydrochlorothiazide for six months.  Patients with left ventricular systolic 
dysfunction or any cardiovascular disorder other than left ventricular hypertrophy were 
excluded.  Myocardial fibrosis was evaluated biochemically by hydroxyproline 
concentration from left ventricular endomyocardial biopsies and by collagen volume 
fraction following histological staining of the endomyocardial biopsies with a collagen-
specific dye, Sirius Red.  All patients had evidence of myocardial fibrosis at baseline.  Left 
ventricular hypertrophy was determined by left ventricular mass index on 
echocardiography and by myocyte diameter from biopsy specimens.  Despite no significant 
change in either index of LVH and no change in blood pressure from 24 hour recordings in 
the lisinopril group, there was a significant decrease in both parameters of fibrosis at 6 
months, with the decrease in hydroxyproline concentration being highly statistically 
significant with a p valve < 0.00001.  No significant change in myocardial fibrosis was 
seen in the hydrochlorothiazide group despite a significant decrease in myocyte diameter 
and a non-significant trend toward decreased left ventricular mass index. 
Diastolic function was assessed by three non-invasive techniques, the E/A ratio, IVRT and 
transmitral A wave duration, and invasively by the stiffness constant k, calculated from 
pressure-volume measurements obtained at left ventricular angiography(89).  The lisinopril 
group showed statistically significant increases in E/A ratio and A wave duration and a 
significant decrease in IVRT compared to baseline whereas these changes were not seen in 
the hydrochlorothiazide group.  In neither group was any significant change seen in the 
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stiffness constant measured at left ventricular catheterisation raising the possibility that 
there was no genuine treatment effect on diastolic function.  However, the authors 
highlight several significant methodological weaknesses in the technique which assumes 
that myocardial structure and function is homogenous, and in their equipment.  The use of 
fluid filled catheters to obtain pressure tracings is potentially inadequate when compared 
with more sensitive high fidelity pressure wires for detecting small changes over the 
observation period. 
Heart rate 
Tachycardia has been recognised as common precipitating factor in diastolic heart failure.  
Since the relative proportion of the cardiac cycle diastole occupies decreases as heart rate 
rises, any impairment of diastolic function at rest will be exacerbated at higher heart rates.  
Clearly pathologically elevated heart rates are deleterious and have been associated with 
tachycardiomyopathy.  In theory by reducing heart rate and increasing diastolic filling 
time, diastolic function will be improved.  The role of rate limiting therapy with heart rates 
in the normal range is less clear.  Improvement in diastolic function with regression of 
LVH has been observed with verapamil(156).  No significant change in heart rate was seen 
however.  This has also been seen where there has been no change in left ventricular 
mass(157).  First third fractional filling does however improve when the heart rate is 
reduced from 77 to 60 with metoprolol(158).  This improvement is lost on exercise, 
however, despite an albeit attenuated heart rate increase suggesting that despite diastolic 
function being related to heart rate, rate limiting drugs have complex effects beyond heart 
rate reduction. 
1.8.1 Evidence Based Treatment of Diastolic Heart Failure 
The lack of an evidence base in the approach to treating diastolic heart failure is striking.  
Until recently the only source of evidence was based largely on small scale observational 
studies and on extrapolation from trials with heart failure and impaired systolic function.  
Although both the American Heart Association(159) and the European Society of 
Cardiology(160) have published guidelines in recent years which included expert 
consensus opinions on the management of diastolic heart failure, data from large scale 
randomised clinical trials have been sadly lacking. 
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1.8.1.1 CHARM-Preserved 
As a pre-defined substudy of the main CHARM trial(161), CHARM-Preserved(1) assessed 
the impact of candesartan on the combined end point of cardiovascular mortality or 
admission to hospital for worsening heart failure.  Patients here were diagnosed as having 
heart failure with preserved systolic function on the basis of symptomatic heart failure 
(NYHA II-IV), a history of hospital admission for cardiac reasons and an ejection fraction 
≥ 40%.  Diastolic function itself was not measured either at enrolment or during follow-up 
and was not used to assess the efficacy of candesartan. 
A total of 3025 patients were randomised, with approximately 60% in NYHA class II and 
38% NYHA class III heart failure.  After a median follow-up of 36.6 months there was no 
significant difference in either the primary composite endpoint or in cardiovascular death 
alone.  However, there was a significant reduction in single hospitalisation for heart failure 
(230 vs 279, p=0.017) as well as a trend towards a reduction in the number of patients with 
multiple admissions.  There was no difference in the number of hospital admissions for any 
cause, however. 
The CHARM population were, on the whole, a sick patient group.  68.7% had previously 
been admitted to hospital for heart failure.  Nearly 45% of patients had previously suffered 
a myocardial infarction with 27.5% suffering angina at enrolment.  Prior coronary 
revascularisation was common – overall 21.6% having had coronary artery bypass grafting 
and 17.3% with percutaneous revascularisation.  Unsurprisingly, the primary cause of heart 
failure was judged to be ischaemic in 56% of patients.  Given that the role of inhibition of 
the renin-angiotensin system in stable coronary artery disease has been established by the 
HOPE (162) and EUROPA(163) trials, it is possible that the treatment benefit seen here is 
due to a beneficial effect of candesartan on coronary artery disease rather than diastolic 
function. 
1.8.1.2 PEP-CHF 
The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) trial(164), which 
began in 1999 and was due to report in 2001, was finally presented at the World Congress 
of Cardiology in Barcelona, 2006.  The substantially increased trial duration was 
necessitated by an event rate lower than predicted in combination with slow recruitment.  
In addition there was a high rate of cessation of blinded therapy with open-label ACE 
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inhibitor use.  The trial compared perindopril at a target dose of 4mg with placebo in 
patients aged 70 and over with a diagnosis of diastolic heart failure.  To qualify, patients 
were required to have had a cardiovascular hospitalisation in the 6 months leading up to 
randomisation and have a left ventricular ejection fraction of greater than 40%.  In 
addition, patients were required to meet at least 3 clinical and 2 echocardiographic criteria 
from the following: exertional dyspnoea; orthopnoea or paroxysmal nocturnal dyspnoea; 
ankle swelling; improved dyspnoea with diuretic therapy; increased jugular venous 
pressure; prior episode of clinical pulmonary oedema; prior MI; cardiothoracic ratio >0.55; 
and previous radiological pulmonary oedema.  Echocardiographic criteria were mild left 
ventricular systolic dysfunction (ejection fraction 40-50%); left atrial diameter >40mm or 
25mm/m2 body surface area; left ventricular hypertrophy; and one or more abnormal 
parameters of diastolic function defined by the European Society of Cardiology Study 
Group on Diastolic Heart Failure(130).  Any patients in atrial fibrillation were regarded as 
meeting this last criterion. 
The primary endpoint was a composite of all-cause mortality and unplanned heart failure 
related hospitalisation.  After a mean follow up of 26 months there was no difference 
between treatment and placebo groups for the primary endpoint.  A decrease approaching 
statistical significance was seen at 12 months (p=0.055) at which point 90% of patients 
randomised to the active arm were receiving 4mg of perindopril. Thereafter the Kaplan-
Meier curves converge.  By 18 months only 60% of the treatment group were receiving 
their study medication and by the end of the study 36% of all patients were receiving open-
label ACE inhibitors.  Although this may account for the apparent loss of treatment benefit 
beyond 1 year, it is also possible that the low event rate combined with short follow-up 
time has exaggerated the treatment benefit at 1 year.  The increasing trend for 
discontinuation of randomised trials for early treatment benefit has attracted criticism 
partly for this reason(165, 166). 
As with other trials looking at diastolic heart failure, the combination of a lack of a gold 
standard definition of diastolic heart and necessarily loose entry criteria allow inclusion of 
patients without heart failure but signs and symptoms due to other causes.  Such a situation 
results in a heterogenous group of patients with multiple co-morbidities which will dilute 
and contaminate the treatment effect of the drug in question. 
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1.8.1.3 I-Preserve 
The I-Preserve trial (167, 168) aimed to build on the encouraging findings on the use of 
angiotensin receptor blockers seen with candesartan in the CHARM-Preserved trial(1).  
Here irbesartan was used in a double blind placebo controlled manner in 4128 patients 
followed up for a mean of 49.5 months.  The primary end points were all cause mortality 
and cardiovascular hospitalisation (a composite of worsening heart failure, unstable angina, 
myocardial infarction, ventricular or atrial arrhythmia or stroke).  The sample size was 
increased in April 2004 from 3600 due to a lower than anticipated event rate, similar to the 
problem which befell PEP-CHF. 
The key difference from CHARM were the additional criteria required in an attempt to 
strengthen the diagnosis of diastolic heart failure.  Although diastolic function was not 
itself measured, these criteria aim to add additional weight to the heart failure diagnosis 
with the implication that in the presence of “preserved” systolic function (here defined as 
left ventricular ejection fraction ≥ 45%), the diagnosis must be diastolic dysfunction.  To 
be enrolled, patients required either ongoing NYHA class II or worse symptoms with a 
hospitalisation for heart failure within the previous 6 months or ongoing NYHA III or IV 
symptoms with at least 1 of chest x-ray evidence of pulmonary congestion, ECG or 
echocardiographic evidence of moderate or severe left ventricular hypertrophy, left bundle 
branch block on ECG or an enlarged left atrium in the absence of atrial fibrillation. 
There was no difference in the mortality rate between the irbesartan or placebo group (52.6 
and 52.3 per 1000 patient years respectively).  There was a non statistically significant 
decrease in the other primary endpoint of cardiovascular hospitalisation in the irbesartan 
group (70.6 versus 74.3 per 1000 patient years, p=0.44).  There was also no significant 
difference in any of the secondary endpoints which included disease specific quality of life, 
assessed by the Minnesota Living with Heart Failure scale(169). 
1.8.1.4 Hong Kong Diastolic Heart Failure study 
This pilot study(170) assessed the efficacy of ramipril and irbesartan in 150 patients of 
mean age 74.  Diastolic heart failure was defined as a clinical history of heart failure 
supported by a chest x-ray showing pulmonary congestion, and left ventricular ejection 
fraction of >45% on echo.  Patients were randomised to diuretic alone, diuretic plus 
ramipril, or diuretic plus irbesartan. 
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With only 50 patients in each subgroup, the study was under-powered to detect any 
difference between the treatments for one of the primary outcomes, quality of life score 
measured by the Minnesota Heart Failure Symptom Questionnaire.  There was, however, a 
significant improvement within each subgroup from baseline.  There was no significant 
difference in exercise capacity, with a small but not statistically significant increase in 6 
minute walking distance.  The other primary outcome, echo derived left ventricular mass 
and tissue Doppler derived E’ and E/E’ showed no significant difference at 1 year.  An 
important error in the methodology should be noted with regards the tissue Doppler values.  
The authors have used colour coded tissue Doppler which yields systematically lower 
values for E’ than spectral Doppler(44), the modality used in the main reference papers(32, 
48, 49), one of which is used as a reference by the authors.  This results in the E/E’ values 
for the patients in this study being artefactually high when compared to this reference data. 
NT-proBNP was measured at baseline and during follow-up.  There was a very large 
spread at baseline with a range of 5-4748pg/ml.  Statistically significant reductions were 
seen in the ramipril and irbesartan subgroups. 
1.8.1.5 SWEDIC 
The SWEDIC trial(171) evaluated the use of carvedilol in patients with symptoms of heart 
failure but preserved systolic function as assessed by echocardiography.  A total of 97 
patients completed the study, having being randomised to either carvedilol (target dose 
25mg bd or 50mg bd depending on body weight) or placebo for a total of 6 months.  Entry 
to the trial required one of several markers of diastolic function to be abnormal: 
• E/A ratio < age related reference range 
• IVRT > age related reference range 
• Normal E/A ratio with abnormal pulmonary venous flow 
Patients with chronic obstructive pulmonary disease, significant valvular heart disease, 
unstable angina, atrial fibrillation, restrictive or hypertrophic cardiomyopathy, evidence of 
conducting system disease and either hypotension or uncontrolled hypertension were 
excluded.   
The results were disappointing.  The only parameter that showed any statistically 
significant change from baseline, albeit borderline, was the E/A ratio which rose from 0.71 
to 0.76 in the placebo group and from 0.72 to 0.83 in the treatment group with a quoted p 
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value of 0.046.  More importantly, there was no significant change in patients’ symptoms.  
In fact, there was a trend toward patients doing better on placebo than carvedilol with 12 
compared to 2 improving their NYHA class, and 8 compared to 14 deteriorating.  The lack 
of change in patients’ status can also be seen in their BNP levels.  BNP was 8 pmol/L in 
both groups at baseline and was unchanged in the placebo group, rising to 12 in the 
carvedilol group.  Perhaps the reason for the lack of any clinical effect relates more to the 
lack of evidence of heart failure than the lack of efficacy by carvedilol. 
1.8.1.6 SENIORS 
The SENIORS(172) trial set out to address the issue of the role of beta blockade in the 
treatment of heart failure in a patient group largely excluded from previous trials, the 
elderly.  To qualify for this placebo controlled trial of nebivolol, a vasodilating β1 selective 
blocker, patients had to be aged at least 70 and either have a hospital admission with 
discharge diagnosis of heart failure within the last year or documented left ventricular 
ejection fraction within the last month.  Patients with heart failure secondary to valvular 
heart disease and those with coronary artery disease awaiting either surgical or 
percutaneous revascularisation were excluded.  A left ventricular ejection fraction of 35% 
was used to dichotomise preserved and impaired systolic function, with 35% of patients 
having preserved function.  Diastolic function was not specifically used to include or 
exclude any patients from the preserved systolic function group but was monitored in an 
echocardiographic substudy(173). 
After a mean follow-up of 20 months, the primary endpoint, a composite of all-cause 
mortality or hospital admission for cardiovascular cause was seen in 31.1% of patients 
treated with nebivolol compared to 35.3% given placebo, an absolute risk reduction of 
4.2% with a p value of 0.039.  No significant difference was seen between those with 
preserved and those with impaired left ventricular systolic function suggesting that 
improved outcome is seen with nebivolol in heart failure with preserved systolic function. 
However, the diagnosis of diastolic heart failure was never robustly established in this 
patient group.  Although diastolic function was measured as far as the E/A ratio, mitral 
deceleration time and left atrial area, these parameters were not used to further categorise 
patients.  Baseline parameters were essentially normal with a mean E/A ratio of 0.9 and 
deceleration time of 200ms.  These parameters did not change over a 12 month treatment 
period.  This therefore raises the question as to whether these patients ever had heart 
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failure, let alone diastolic heart failure.  The accuracy of hospital discharge diagnoses must 
always be regarded with some caution.  The fact that this will have been used as a sole 
entry criterion in all of the patients with “preserved” systolic function and a proportion of 
those with ejection fractions <35% must be viewed as a weakness.  Given that diastolic 
function as measured could be regarded as probably normal at baseline and no treatment 
effect could be discerned, it might be reasonable to infer that the improved outcomes were 
due to beneficial effects on co-morbidities rather than diastolic function. 
1.8.1.7 Caldaret (MCC-135)  
Caldaret, also known as MCC-135, is a compound modulating sarcoplasmic calcium 
handling.  It has been investigated as an agent for attenuating intracellular calcium 
overload and reducing infact size in reperfusion injury models(174). In clinical trials, as an 
adjunct to percutaneous coronary intervention, no benefit was seen(174).  The MCC-135-
GO1 trial(175) is a phase II randomised double blind placebo-controlled trial in 500 
patients with heart failure, 230 of whom have diastolic heart failure.  Although data 
collection has been completed, and the study due to report in 2004, no results have been 
published to date. 
1.9 Background to this Thesis 
The concept of the clinical entity of diastolic heart failure has been with us for many years 
now.  However, it is a diagnosis which, although in theory easy to define and therefore 
apply to patients, is in practice beset with difficulties not only in establishing widely 
applicable diagnostic criteria but also in applying these criteria in the presence of 
confounding diagnoses.  In 2000 Caruana et al(176) reported on a series of patients 
referred to an open access echocardiography service with suspected heart failure.  In the 
two thirds of their patients who did not have left ventricular systolic dysfunction diagnoses 
other than diastolic dysfunction, where found, were assumed to account for symptoms.  
Although pulmonary function was assessed by means of spirometry and was abnormal in 
92% of the group, ischaemic heart disease was not assessed beyond a self reported history 
and ECG, and diastolic function was not assessed beyond the E/A ratio of mitral inflow. 
From this starting point it is clear that when assessing patients with suspected heart failure 
and preserved systolic function we must consider alternative diagnoses as well as diastolic 
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dysfunction.  However, the presence of these diagnoses should not in themselves be taken 
as evidence that diastolic dysfunction is not present.  To properly characterise this group of 
patients we need not only to assess the presence of alternative diagnoses formally, but also 
robustly assess diastolic function using multiple techniques.  Another factor we must 
consider is the suitability of echocardiography in its role as sole arbiter of left ventricular 
systolic function.  It is well recognised that echocardiography becomes more difficult to 
perform reliably in the presence of obesity and respiratory disease.  Yet, it is precisely 
these conditions that are so predominant in the patients studied by Caruana et al. 
Radionuclide ventriculography is well established as a reliable and reproducible means of 
assessing left ventricular systolic function and is not affected by the factors that make 
echocardiography difficult.  In addition it provides another modality for assessing diastolic 
function by means of first third fractional filling, peak filling rate and other indices.  Stress 
RNVG has previously been used in the assessment of systolic function and diagnosis of 
myocardial ischaemia.  It has been used to a lesser extent in the assessment of diastolic 
function.  An improvement in diastolic function on exercise following percutaneous 
coronary revascularisation has been shown by stress RNVG(60).  Since the symptoms 
associated with diastolic dysfunction are, like cardiac ischaemia, largely present on 
exertion rather than at rest, it would therefore be reasonable to assume that assessment of 
diastolic function should also be performed under stress conditions.  The key question to 
be answered is whether the assessment of diastolic function on stress will indeed improve 
our diagnostic accuracy, and whether stress RNVG is the correct tool for this purpose. 
Central to this is the reproducibility of the RNVG parameters of interest.  This will have a 
critical influence on the normal ranges which must be defined both at rest and on stress.  
The interplay between reproducibility and breadth of the normal range will determine 
which, if any, of the RNVG parameters are of diagnostic utility. 
Taking the work of Caruana et al as a starting point, a protocol was developed to identify a 
similar group of patients in whom diastolic heart failure could be diagnosed on clinical 
grounds.  Detailed characterisation of this patient group beyond that which had previously 
been undertaken would be achieved by: 
• Formal assessment of ischaemic heart disease by myocardial perfusion scanning. 
• Spirometry in all patients. 
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• Use of tissue Doppler to enhance the echocardiographic assessment of diastolic 
function. 
• The assessment of left ventricular ejection fraction by RNVG to validate its 
echocardiographic evaluation. 
• The assessment of diastolic function both at rest and stress by RNVG. 
• The addition of VO2 to stress RNVG to improve the differentiation of respiratory 
and cardiac limitation to exercise. 
• The use of NT-proBNP to provide biochemical evidence of heart failure. 
1.10 Hypothesis 
The assessment of diastolic function on stress by RNVG is more sensitive and correlates 
better with other indices of diastolic function than assessment at rest. 
In addition, with the support of a successful BHF Project Grant, this thesis sought to 
answer a further series of questions: 
In patients presenting with suspected heart failure and normal left ventricular systolic 
function: 
• In what proportion of patients is the limitation in effort capacity due to cardiac 
causes?  Other causes of limitation, including respiratory disease and lack of 
physical fitness without evidence of cardiopulmonary abnormalities, will be 
documented. 
• What is the prevalence of left ventricular diastolic dysfunction as measured by 
radionuclide ventriculography? 
• Among patients with exercise induced left ventricular diastolic dysfunction, what 
proportion will have evidence of reversible myocardial ischaemia? 
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2. Methods 
2.1 Recruitment – Patients 
Patients were primarily identified through contact with the local open access 
echocardiography service following referral for assessment of dyspnoea of suspected 
cardiac cause.  This involved a combination of ongoing prospective identification of 
patients as well as the retrospective identification and reassessment of patients previously 
referred to the service.  It was also possible to recruit a small number of patients from other 
sources on an ad-hoc basis. 
Inclusion criteria: 
• Exertional dyspnoea 
• Preserved left ventricular systolic function by visual echo assessment 
• Able to exercise using bicycle ergometer 
• Pulmonary rales – not an absolute requirement 
• Peripheral oedema – not accepted as an entry criterion if present without dyspnoea 
 
Exclusion criteria: 
• Established ischaemic heart disease 
• Previous myocardial infarction 
• Previous coronary revascularisation – either percutaneous or surgical 
• Angiographically proven coronary artery disease 
• Angina confirmed on stress testing 
• Significant valvular heart disease i.e. any valvular stenosis or regurgitation greater 
than mild in severity 
• Morbid obesity with BMI >40 
• Chronic obstructive pulmonary disease confirmed by pulmonary function testing 
 
Although parameters of diastolic function were measured as part of the echocardiogram at 
entry to the study, these did not form any part of inclusion or exclusion criteria. 
Ethical approval for the study was granted by the North Glasgow Research Ethics 
Committee (project number 02MC005). 
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2.1.1 Prospective Open Access Echo Recruitement 
A GP open access echocardiography service has been established at Glasgow Royal 
Infirmary for many years.  Patients are primarily referred for assessment of left ventricular 
function in suspected heart failure, for assessment of murmurs, and for assessment of 
hypertensive heart disease.  Thirteen slots are available per week across two sessions.  
Each patient would have an electrocardiogram followed by a transthoracic echocardiogram 
performed and interpreted by an experienced echocardiographer.  From a retrospective 
audit of the service, approximately 50% of referrals were for assessment of left ventricular 
function with the vast majority having normal or “preserved” systolic function without 
significant valvular heart disease.  It was therefore estimated that that this source would 
yield between two and four suitable patients per week 
Potentially suitable patients were identified prior to arrival on the basis of referral 
indication and past medical history provided by the General Practitioner on the referral 
form.  A cardiac and respiratory history was obtained prior to echocardiography and the 
symptoms of the patient were assessed.  Where the symptoms were not consistent with a 
cardiac cause of dyspnoea, the patient was not assessed further for recruitment purposes.  
Patients who gave a previously undisclosed cardiorespiratory history at this stage were 
similarly excluded. 
Provided the echocardiogram met the entry criteria on the basis of left ventricular systolic 
function and valvular function, the patient was invited to participate.  Subsequent 
participation involved a single day visit for all other elements of the study protocol.  Where 
possible, this was arranged with the patient at the time of recruitment.  Patients were given 
an information leaflet that included contact details and were free to withdraw from the 
study at any point. 
2.1.2 Retrospective Open Access Echo Recruitment 
Due to patient co-morbidity being higher than anticipated, the number of patients meeting 
inclusion criteria prospectively from the open access echocardiography service was 
significantly lower than anticipated.  Therefore, it became necessary to augment 
recruitment from other sources. 
Using archived results from Glasgow Royal Infirmary, patients who had attended the open 
access echocardiography service over the previous three years were assessed for eligibility 
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for the study.  As key exclusion criteria for recruitment to the prospective arm were 
established diagnoses of ischaemic heart disease or respiratory disease, a screening process 
was undertaken.  The echocardiogram result and referral information were initially 
reviewed to create a list of patients of potential interest.  The clinical history given here 
was augmented by examining the computerised records of each patient’s hospital clinic 
attendances with particular regards cardiology and respiratory clinics.  These records 
typically extended in excess of 5 years.  These clinic attendances were used to enable a 
targeted search for previous myocardial perfusion scanning and pulmonary function testing 
Where a patient had attended a cardiology clinic, the records of nuclear cardiology were 
searched for any thallium scans relating to that patient.  Where the thallium scan was 
abnormal or no scan was found, the patient was excluded from further consideration.  
Patients with negative scans subsequently discharged from clinic were considered 
potentially suitable.  Those with more than one clinic visit post scan were disregarded. 
For patients who had attended respiratory clinics, a search was made for previous results of 
pulmonary function testing.  Patients with normal spirometry, or full pulmonary function 
tests if that is what had been performed, were considered potentially suitable.  All others 
were disregarded. 
For the remaining cohort of potentially suitable patients, the general practitioner of each 
patient was contacted via post announcing our intention to contact the patient and invite 
them to participate.  No objections were raised by any general practitioner.  Telephone 
contact was then made with the patient.  The nature and purpose of the study were briefly 
explained to the patient.  Provided they were agreeable in principle, their symptoms were 
verified with respect to whether they were still present, had progressed, and were 
potentially consistent with a cardiac cause.  Medical history was also explored to identify 
disqualifying medical conditions.  Patients remaining suitable at this stage underwent an 
echocardiogram to update left ventricular systolic function if none had been performed in 
the last 6 months.  If this was within acceptable limits the patient was formally recruited. 
A similar open access echocardiography service also exists at Stobhill Hospital.  The 
archived results for the previous two years were screened and patients recruited in a similar 
fashion to that described above. 
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2.1.3 Ad-Hoc 
Patients thought to have an anginal equivalent, the syndrome of exertional dyspnoea due to 
myocardial ischaemia but without typical chest pain, were another potential source of 
patients.  Those in whom ischaemia was excluded on perfusion imaging were considered to 
meet entry criteria provided they had been demonstrated to have normal left ventricular 
systolic function and either proven normal respiratory function or a low index of suspicion 
for pulmonary disease.  Given that myocardial perfusion imaging was typically further 
down the line of diagnostic tests than echocardiography or spirometry, this could be 
assumed for the majority of patients in this category and subsequently verified. 
Patients, from any source, whose request form indicated suspected heart failure were 
screened prior to appointment.  These were then scheduled appropriately to enable all the 
additional tests required for the study to be performed, subject to consent for study 
participation being obtained and the thallium scan showing no significant abnormality.  
The stress perfusion images, along with the patient’s suitability for stress RNVG, were 
reviewed immediately after acquisition.  Only patients with normal stress perfusion were 
recruited – those with perfusion defects, even if these were thought likely to be due to 
tissue attenuation, were not. 
2.2 Recruitment – Control Subjects 
2.2.1 Exercise RNVG 
To enable an in-house reference range for exercise RNVG parameters to be constructed it 
was necessary to recruit normal subjects of approximately the same age as the patients 
being recruited.  As the sole purpose of these subjects was to generate these reference data, 
they did not have echocardiography or spirometry performed and did not have their blood 
taken for NT-proBNP assay.  VO2 max and anaerobic threshold were not required either in 
these subjects and they therefore did not have their exhaled gases collected during the 
exercise RNVG. 
A similar method to the ad-hoc method of patient recruitment was employed to recruit 
control subjects for exercise RNVG.  Potentially suitable patients were identified on the 
basis of their referral criteria being either atypical chest pain, or typical angina with 
angiographically normal coronary arteries 
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Inclusion criteria: 
• No significant perfusion defect on thallium scintigraphy 
• Normal resting ECG 
 
Exclusion criteria: 
• Established ischaemic heart disease 
• Previous myocardial infarction 
• Previous coronary revascularisation – either percutaneous or surgical 
• Angiographically proven coronary artery disease 
• Angina confirmed on stress testing 
• Exertional dyspnoea or documented left ventricular dysfunction 
• Chronic obstructive pulmonary disease 
As before, subjects pre-screened as being potentially suitable had their thallium scan 
scheduled at an appropriate time to permit exercise RNVG later that day provided they 
proved to be suitable.  Those meeting criteria with normal stress perfusion were recruited 
as before.  Those with perfusion defects thought to be consistent with tissue attenuation 
had their redistribution perfusion images reviewed.  They were considered suitable if the 
whole stress-redistribution thallium scan showed only tissue attenuation artefact but no 
significant reversible perfusion defect. 
2.2.2 Rest RNVG 
An archive of request forms, final reports, demographic, medication and co-morbidity data 
is maintained on all patients undergoing thallium scanning at Glasgow Royal Infirmary.  In 
addition, an electronic archive is kept of the formatted studies for all thallium scans and 
RNVGs.  This includes the regions of interest used to generate the left and right ventricular 
ejection fractions issued on the final report.  Using similar criteria to those used in the 
prospective recruitment of control subjects for exercise RNVG, this archive was searched 
for patients meeting entry criteria.  Patients with incomplete data, typically prescribed 
medication, were excluded.  Where necessary the perfusion images were reviewed to 
resolve any ambiguity in the report. 
2.3 Study Protocol 
For the majority of patients who were recruited at echocardiography, the following tests 
were scheduled to take place over the course of a single day in order to answer the 
questions posed by the thesis: 
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• Myocardial perfusion imaging 
• Resting radionuclide ventriculography 
• Stress radionuclide ventriculography with VO2 measurement 
• Spirometry 
• Repeat echocardiography by a second operator 
• N-terminal proBNP measurement 
The sequence and timescale of these is illustrated in Figure 2-1.  A minimum of 2.5 hours 
is required between thallium stress and redistribution/rest images.  During this window, the 
second echocardiogram and spirometry were performed. 
Figure 2-1 – Typical patient study pathway 
 
Patient arrival
Venflon inserted - NT-proBNP sample obtained
Thallium stress images acquired
Stress test, thallium injection
Spirometry
Echocardiogram (2nd operator)
Thallium rest images acquired
Stress RNVG / VO
2
 measurement
Recovery phase of stress RNVG
70°LAO rest supine RNVG
40°LAO rest supine RNVG
Technetium injection
Rest erect RNVG
15 mins
5 mins
2! hours
15 mins
10 mins
5 mins
6 mins
5-10 mins
5 mins
Approx 20 minutes from 
end stress to  start of rest 
RNVG for quantitative 
analysis
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2.4 Echocardiography 
2.4.1 Equipment 
Three echo machines were used in the course of this work.  On the Glasgow Royal site, the 
majority of echos were carried out on a GE Vingmed Vivid7 equipped with a M3S probe.  
The remainder were carried out on a GE Vingmed Vivid3 using a 3S probe.  Both 
machines were linked to an EchoPac machine enabling a combination of on and off-line 
image analysis.  On the Stobhill site all echos were performed using a Vingmed Vivid5 
machine, also linked to EchoPac software. 
2.4.2 Operators 
All patients had an echocardiogram performed by AMcC.  In order to assess inter-observer 
and intra-observer reproducibility of  the parameters being used to assess systolic and 
diastolic function, all patients also had a second echocardiogram performed.  These were 
predominantly carried out by the author, or by one of two British Society of 
Echocardiography (BSE) accredited sonographers (JJ and LF).  Although JJ and LF were 
not blinded to the participation of the patients in the study, the results of other 
investigations on the patients were not available to them.   Their analysis and interpretation 
of the second echocardiogram was carried out without reference to the first study. 
2.4.3 Protocol 
A standard set of 2D views were obtained on all patients, allowing for patient echogenicity.  
This was based on the minimum BSE dataset and comprised: 
• Parasternal long axis (PLAX) 
• Parasternal short axis, papillary muscle level (PSAX).  Aortic valve, mitral valve 
and apical levels were also examined and stored. 
• Apical 4 chamber (4ch) 
• Apical 2 chamber (2ch) 
• Subcostal, including view of inferior vena cava 
 
At least one cardiac cycle was acquired in each of the views.  Images were stored digitally 
as raw data, using magneto-optical disks for long term storage to enable retrospective data 
analysis.  Valvular regurgitation was assessed by colour flow Doppler in at least 2 imaging 
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planes with quantitative evaluation by spectral Doppler in the appropriate plane for the 
valve concerned.  All images were acquired using 2nd harmonic imaging.  It has been 
observed that 2nd harmonic imaging may produce a systematic overestimate of left 
ventricular mass compared with fundamental imaging(177).  This should be kept in mind 
with all measurements here. 
Table 2-1 – Standard 2D and M-Mode Echocardiographic Measurements 
Measurement Preferred Modality View Used 
Left atrial diameter M-Mode PLAX 
Aortic root diameter M-Mode PLAX 
RV diastole, systole M-Mode PLAX 
IVS diastole, systole M-Mode PLAX 
LV end diastole M-Mode PLAX 
LV end systole M-Mode PLAX 
Posterior wall diastole, systole M-Mode PLAX 
Left ventricular mass index M-Mode derived PLAX 
LV ejection fraction (Teicholtz) M-mode derived PLAX 
LV ejection fraction (Simpson’s Biplane) 2D planimetry 4ch, 2ch 
IVC inspiration, expiration 2D Subcostal 
 
All M-mode measurements were carried out using the leading edge to leading edge 
method. 
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Table 2-2 – Standard Doppler Measurements 
Measurement Modality 
Mitral E velocity Pulsed wave Doppler 
Mitral A velocity Pulsed wave Doppler 
Mitral E/A ratio Pulsed wave Doppler 
Mitral deceleration time Pulsed wave Doppler 
Isovolumetric relaxation time Pulsed wave Doppler 
Aortic valve peak velocity Continuous wave Doppler 
Aortic valve velocity time integral Continuous wave Doppler 
Tricuspid valve peak regurgitant velocity Continuous wave Doppler 
Mitral E’ velocity – septal, lateral annulus Pulsed wave tissue Doppler 
Mitral E/E’ ratio – septal, lateral annulus Derived 
 
A sweep speed of 100mm/s was used for all measurements.  A minimum of sequential 3 
cardiac cycles with adequate quality were averaged to obtain values.  Extra-systolic and 
post extra-systolic beats were not used for any measurements. 
2.5 Perfusion Imaging 
Thallium 201 was used as the myocardial perfusion agent in all patients.  A one day stress-
redistribution protocol was used in all patients with a single 60MBq dose of thallium 
administered for the stress images.  As a high sensitivity collimator was used for all image 
acquisition, similar counts could be collected at this reduced dose compared to an 80MBq 
dose imaged with a general purpose collimator.  Redistribution images were obtained after 
a minimum 2½ hour period, typically around 3 hours.  Patients did not receive a second 
dose of thallium for rest images and there was no-reinjection of thallium in the event of 
persisting defects. 
2.5.1 Stress Protocol 
Upright bicycle exercise was employed as the stressing modality of choice.  A significant 
proportion of the department’s workload consists of patients unable to exercise adequately 
on the treadmill.  Resting heart rate, blood pressure and 12 lead ECG were obtained in all 
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patients.  Exercise would then commence at an initial workload of 50W.  Continuous 
monitoring of the 12 lead ECG was carried out and blood pressure was measured after 2 
minutes at each workload using a manual anaeroid sphygmomanometer.  After 3 minutes 
the workload would be increased by either 25W or 50W based on a judgment of the 
remaining exercise capacity of the patient.  A minimum of 3 minutes exercise at 50W was 
accepted as adequate stress.  Failure to achieve this prompted a switch to pharmacological 
stress.  This threshold was chosen rather than a heart rate target on the basis of previous in-
house validation that showed no difference in sensitivity for ischaemia detection compared 
to dipyridamole stress. 
The criteria for terminating exercise were:  ECG changes diagnostic of ischaemia, 
significant chest pain, limiting dyspnoea, significant arrhythmia, fall in systolic blood 
pressure of ≥ 20mmHg or fatigue.  Patients were asked to indicate when they felt they were 
approaching maximal exercise capacity.  Thallium was injected at this stage with an 
appropriate flush.  Exercise was continued for a further 30 seconds beyond injection time 
to permit adequate myocardial uptake.  As thallium has a myocardial extraction fraction of 
approximately 85%, this 30 second period permits 2 passes through the coronary 
circulation and therefore ≥ 95% of the total myocardial uptake of thallium occurring whilst 
at peak exercise. 
For a minority of patients unable to exercise at sufficient intensity to adequately stress the 
heart, pharmacological stress was undertaken using intravenous dipyridamole.  Patients 
were given a total of 0.56mg/kg dipyridamole over a period of 4 minutes.  Following this a 
3 minute period of either low intensity cycling or isometric isometric arm lifts using 1kg 
weights was undertaken.  Thirty seconds before the end of this period thallium was 
injected. 
Beta blockers and other heart rate limiting medication was not discontinued for the stress 
test.  This is standard departmental policy on the basis that the symptoms of presumed 
myocardial ischaemia were present despite beta blockade and should therefore still be 
detectable on perfusion imaging.  There is also a small but non-zero risk in discontinuing 
beta blockers for stress testing which was a second factor in this policy decision. 
2.5.2 Image Acquisition 
Both stress and redistribution perfusion images were acquired using one of 3 gamma 
cameras, these being a General Electrics (GE) CamStar 3000, GE StarCam or GE Optima.  
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A high sensitivity parallel collimator was used for all image acquisition.  Planar images 
were acquired in 3 views: anterior, 40° LAO, and 70° LAO projections.  Raw ECG gated 
data were acquired in List Mode from the camera using Link MAPS 10000 software 
running on Sun workstations.  This allows accurate reconstruction of a representative 
cardiac cycle.  Images were acquired for a total of 5 minutes in each projection and were 
formatted after acquisition was complete.  Acquisition of all 3 stress images was completed 
within 25 minutes of injection of thallium. 
When processing the raw data, all heart beats regardless of cycle length or likelihood of 
artefact were accepted.  A cine loop of 8 frames per cardiac cycle was created for all stress 
and rest images to permit wall motion scoring.  A single frame comprising all data 
collected during each image acquisition was generated by summating these 8 frames. 
2.5.3 Image Analysis 
All image analysis was on a dual reporter basis as is standard practice within our 
department.  Stress and rest perfusion along with wall motion scoring would be undertaken 
first by one experienced observer.  A second observer would later review the images along 
with the first observer’s interpretation of them.  Minor modifications could be made to the 
initial analysis without further review but where a significant difference of opinion 
remained over interpretation, either the dispute would be resolved by further review and 
mutual agreement or a third observer would make a determination.  In practice significant 
differences of opinion are uncommon and usually restricted to cases where image quality is 
suboptimal for either technical reasons or patient factors such as high lung or high 
subdiaphragmatic uptake of thallium.  The latter can be a particular problem with 
dipyridamole stress where there has been a minimal exercise component or with an 
unfavourable body habitus. 
Images were reported using a standard template depicting all 3 acquired projections with 
stress and rest images being reported on separate parts of the template.  The left ventricle 
was divided into 5 segments on each of the 3 projections which were from the top right 
segment in each projection (Figure 2-2 and Table 2-3). 
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Figure 2-2 – Planar myocardial perfusion assessment scheme 
 
Table 2-3 – Planar myocardial segment designation 
Segment Anterior 40° LAO 70° LAO 
1 Basal anterior Basal septal Basal anterior 
2 Mid/distal anterior Mid/distal septal Mid/distal anterior 
3 Apical Apical Apical 
4 Mid/distal infero-septal Mid/distal lateral Mid/distal posterior 
5 Basal infero-septal Basal lateral Basal posterior 
 
Additionally, the right ventricle was divided into 3 segments.  Although the right ventricle 
could not usually be seen on the summated image due to its significantly lower myocardial 
bulk, it is usually easily discernable when viewing the 8 frame cine images using a sixteen 
shade greyscale display. 
Images were displayed with a default background setting of 30%.  Overall gain/saturation 
was determined automatically by the software based on having a standard number of pixels 
of maximum intensity.  Where another organ or artefact created an object of higher count 
intensity than the myocardium this would result in the myocardial counts being scaled 
down.  In this case background and gain settings were adjusted to give 3 to 4 pixels within 
the myocardium of maximum intensity.  It should be noted that both the automatic and 
manual approach rely on the assumption that at least one portion of the myocardium within 
the field of view has normal perfusion.  It is possible that this assumption may not be valid 
if there is widespread uniform ischaemia.  Where this is the case abnormally high lung 
uptake will usually be present, whether this is due to ischaemia induced lung uptake of 
thallium or to artefact produced by the scaling changes required to elevate a portion of the 
myocardium to maximal perfusion. 
Perfusion images are displayed using a 16 colour rainbow scale (Figure 2-3).  In this 
example, background has been left at its default setting of 30 causing everything below this 
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threshold to be displayed as black.  The image can be optimised by adjusting either end of 
the scale, expanding or compressing it accordingly. 
The top four colours in the scale are defined as normal perfusion (Figure 2-3, above dotted 
line).  Abnormal perfusion is defined as any segment of myocardium with a lower colour 
on the scale than this threshold.  The lower down the scale, the more severe the perfusion 
defect. 
Figure 2-3 – Myocardial perfusion colour scale with enlargement showing cutoff between 
normal and abnormal perfusion 
Using the template, each segment of myocardium is shaded in according to the displayed 
images.  This provides an objective physical record of what has been seen and how it has 
been interpreted for future review and co-reporting.  A score is calculated from the number 
of segments not normally perfused with mild defects being scored as ½.  Defect size is then 
graded accordingly. 
Defect size and location and degree of reperfusion are then integrated with wall motion for 
an overall conclusion.  The difficulty of tissue attenuation is ameliorated by the 
information gleaned from wall motion scoring – a fixed defect in a characteristic area with 
preserved regional wall motion has a high likelihood of being tissue attenuation artefact. 
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2.6 Radionuclide Ventriculography 
2.6.1 Resting RNVG 
Equilibrium gated radionuclide ventriculography was routinely carried out immediately 
following acquisition of redistribution thallium images unless time constraints necessitated 
stress RNVG be delayed.  Thallium 201 has, in addition to its main energy peak at 77 keV, 
a second energy peak at 140 keV which overlaps that of technetium-99m.  The 
substantially higher counts from technetium at 140 keV means that any contribution from 
thallium to the counts obtained during RNVG acquisition is, however, negligible. 
For patients undergoing both stress and rest RNVG, stress RNVG was performed first.  
Although it would have been more desirable to perform rest RNVG first to ensure no 
hangover effect from stress affecting resting ventricular function, the shorter acquisition 
times needed during each stage of stress imaging required optimal count statistics to 
generate analysable images.  The 15 minutes required for acquisition of resting supine 
images in addition to the setup time required to reconfigure the gamma camera and move 
in the stress equipment would result in a drop in activity sufficient to make analysis of the 
subsequently acquired stress images substantially more difficult. 
Two steps were taken to minimise the impact of this approach.  Firstly an upright RNVG 
was acquired immediately prior to any stress, allowing comparison with the later supine 
images.  Secondly, the supine 70° LAO image which is not used for generation of activity-
time curves was always acquired first.  This results in a gap of at least 10 minutes between 
stress and rest.  In addition, the 10 minute 40°LAO acquisition was formatted into two 5 
minute halves as well as in its entirety.  Any residual effect of stress will diminish during 
the acquisition and be detectable as a difference between parameters measured in the first 
and second five minutes. 
2.6.1.1 Image Acquisition 
Following in-vivo labelling of red cells with stannous pyrophosphate, each patient was 
administered 600MBq of technetium-99m.  This is lower than the maximum permissible 
800MBq due to the increased counts detected by the high sensitivity collimator used.  
Images were acquired in two projections:  40°LAO adjusted to give best septal separation, 
and 70°LAO.  Although the most common application of RNVG is calculation of ejection 
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fraction, it also affords an excellent opportunity to evaluate regional wall motion.  The 
70°LAO projection allows additional assessment and complements the wall motion scoring 
from thallium scanning, particularly for the infero-posterior wall of the left ventricle. 
As with the thallium images a high sensitivity parallel collimator was used.  A 20% energy 
window was used, centred around 140KeV.  Data were acquired in List Mode using Link 
MAPS 10000 software as before.  The 70°LAO image was acquired for a total of 5 
minutes, the 40°LAO image for 10 minutes.  In practice, images of sufficient quality for 
reliable ejection fraction can be acquired in 5 minutes or less.   The additional time 
improves image quality, making wall motion analysis and ejection fraction calculation 
easier. 
The data were formatted as follows:  a histogram showing the cycle lengths of all acquired 
beats along with the mode of the values was displayed; an appropriate window of cycle 
lengths accepted for processing was then calculated, typically 10% above and below the 
mode of the cycle lengths.  Images were formatted as 24 frames per cardiac cycle with 
variable bin widths (List Mode).  The final processed image was checked along with the 
cycle lengths accepted for processing before deletion of the raw data. 
2.6.1.2 Image Analysis and Generation of the Activity-Time Curve 
The activity-time curve generated by radionuclide ventriculography can be used to 
generate multiple indices of both systolic and diastolic performance, the most basic and 
commonly used of these being the ejection fraction.  The basic underlying principle of the 
technique is that the volume of a chamber is directly proportional to the activity, or number 
of counts, detected by the gamma camera as coming from that chamber.  Thus, although 
the units will be different, one may construct a series of data with essentially the same 
information as a volume-time curve but without the need for invasive measurements.  In 
principle, if volumetric data are absolutely essential, this can be calculated to a reasonable 
degree of accuracy by obtaining a blood sample at the time of data acquisition and 
extrapolating from the number of counts per millilitre of blood. 
There are a number of important factors to consider in constructing the activity-time curve 
from raw data.  First, the number of regions of interest used to describe each ventricle will 
have a significant effect on both the accuracy of our measure of activity within the 
ventricular region of interest, but will also affect our estimate of background activity.  
Second, these regions may be either created manually, semi-automatically, or in a fully 
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automatic manner.  Third, the issue of how background activity is estimated and the 
activity-time curve corrected for this is important. 
All activity-time curves in this thesis have been generated using a manual single region of 
interest technique.  This will now be discussed along with the alternative techniques and 
the effects of this on the resulting curves.  Link Medical MAPS 10000 software running on 
Sun workstations was used in all image and activity-time curve analysis.  Custom scripts 
written in C Shell were used to drive the basic software.  This allowed sufficient flexibility 
to adjust analysis routines to optimise performance and reproducibility as well as 
extracting data not normally used in routine practice. 
Manual Single Region of Interest 
This technique has been previously shown to provide the most reproducible measure of left 
ventricular ejection fraction of all the techniques of RNVG analysis (179).  It is this fact 
that makes it the most appropriate for use where any serial measurement of ventricular 
function is contemplated, such as in monitoring the response to treatment in heart failure or 
in detecting subtle early deteriorations as a side effect of cardiotoxic chemotherapy. 
With this technique a single region of interest is manually drawn around the left ventricle 
in end diastole typically using end-systolic, end diastolic, stroke-volume and paradox 
images (Figure 2-4).  It is also possible to use amplitude and phase images here but great 
care must be taken as these can cause the left ventricular size to be overestimated, thereby 
leading to an underestimate of ejection fraction.  Their main role is in verifying the 
accuracy of regions of interest, particularly as aneurysmal segments are often best seen on 
the phase image.  The atria are often better seen on the phase image than on the paradox 
view allowing confirmation that ventricular or background regions of interest have not 
inadvertently incorporated the atria. 
A background region of interest is then created for the left ventricle.  This extends in an arc 
from the left ventricular apex to a point on the lateral wall of the left ventricle half way 
between the apex and valve plane.  This region is typically 2-3 pixels in width. 
This process is then repeated for the right ventricle.  However, the background region for 
the right ventricle is often determined by two factors.  Firstly is the position of the right 
atrium which can be of substantial size when right sided pressures are elevated, thus 
limiting the size of background region which can be created.  Secondly, the close 
anatomical relationship between the inferior surface of the right ventricle and the liver can 
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cause substantial problems.  If the liver is particularly close to the right ventricle it may not 
be possible to create a background region in the usual area without including part of the 
liver in this.  If this then creates an erroneously high estimate of right ventricular 
background activity, the calculated right ventricular ejection fraction can be substantially 
elevated. 
It is a matter of routine in our institution that these regions are then immediately drawn for 
a second time.  Although one set of regions (one LV, one RV region of interest and a 
background region to accompany each) is sufficient to produce background corrected 
activity-time curves for both left and right ventricles, it is possible that an error can be 
made in either the ventricular or background regions that is not appreciated on visual 
inspection.  It is unlikely that any substantial error will be duplicated on a second occasion.  
Therefore, if a second set of regions are drawn, this gives a total of four combinations of 
ventricular and background region of interest for each ventricle thus: LV1 BG1, LV1 BG2, 
LV2 BG1 and LV2 BG2 and equivalents for the right ventricle. The 4 background 
corrected activity-time curves generated from these are then analysed separately, giving 4 
possible values for each parameter being measured.  A mean and standard deviation are 
calculated for each value.  A high standard deviation for the ejection fraction, typically 
greater than 2.0, indicates either an error has been made in at least one of the regions, or 
there is sufficient uncertainty as to where the regions should be placed to cause significant 
variation in the activity-time curves.  In either case the regions are rejected and the process 
begun again. 
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Figure 2-4 – Typical images used in RNVG activity-time curve creation 
Left and right ventricular, and background regions of interest are shown.  ED = end diastole; ES = end systole 
 
Figure 2-4 shows the typical set of images used in creating activity-time curves.  
Clockwise from top left are end-diastole, end-systole, paradox and stroke-volume images.  
Superimposed on each are the regions of interest which have been created. 
The second stage of region checking is shown in Figure 2-5.  Clockwise from top left are 
the amplitude, phase, right ventricular activity-time curves and left ventricular activity-
time curves with regions of interest superimposed on the amplitude and phase images.  
Visually these regions are acceptable and standard deviations on both ejection fractions are 
0.816 which is within acceptable limits. 
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Figure 2-5 – RNVG amplitude and phase images with superimposed regions of interest for 
left and right ventricles, and background regions. 
Left and right ventricular ejection fraction results are shown along with activity-time curves for both ventricles. 
 
A third stage of region checking comes when a second observer repeats the visual check of 
ROI accuracy. 
The main consequence of only creating regions around the ventricles in end-diastole is that 
background activity is systematically underestimated.  This is due to the activity sampled 
adjacent to the ventricles in end-diastole being lower than the true level behind the heart.  
Background activity behind the heart includes activity from the mediastinum which is 
higher than the areas of lung which have been sampled.  This results in a lower ejection 
fraction and will also decrease peak emptying and filling rates.  Provided a normal 
reference range is established and quoted, there should be no major difficulties in 
comparing ejection fractions thus derived with those obtained from other techniques. 
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Two Regions of Interest 
The systematic underestimation of left ventricular ejection fraction by a single region of 
interest approach can lead to difficulties in comparing results between 2 imaging 
modalities such as echocardiography and RNVG.  It also creates the potential for confusion 
for those not used to dealing with a different “normal” range.  Other analysis techniques 
are available which do not have this limitation. 
If a similar process as is used to generate end diastolic regions of interest is applied to end 
systole, a pair of ROIs is generated.  As the ROI generated at end systole is drawn to 
reflect the actual size of the ventricle rather than tracking a fixed ROI throughout the 
cardiac cycle, the overestimate of end systolic counts, and therefore underestimate of 
ejection fraction, with a single ROI approach is avoided. 
However, a two region of interest approach has drawbacks.  Firstly, its reproducibility is 
reduced compared to a single region approach as two ventricular and two background 
ROIs must be generated thus increasing the potential for error and interaction of errors 
between the ROIs.  Secondly, and more fundamentally for our purposes here, it does not 
generate an activity-time curve as such.  Only two points are determined – end diastolic 
counts and end systolic counts.  Whilst sufficient for ejection fraction analysis, no other 
parameters can be readily extracted. 
Multiple Regions of Interest 
In order to generate more familiar ejection fraction results but retain the ability to generate 
a full activity-time curve and derive the required parameters of systolic and diastolic 
function, additional regions of interest must be created.  For each frame in the cardiac 
cycle, a ventricular ROI can be created to generate a point on the activity-time curve.  To 
do this manually would not be feasible and so the process is generally either fully or semi-
automated where the regions are computer generated using edge detection algorithms and 
then manually checked and adjusted. 
The drawbacks of this technique are firstly that there is either a heavy reliance on 
automated ROI generation programs or a time consuming ROI checking and alteration 
process must be used.  Secondly, it is more prone to errors than the single region 
technique.  As every data point is generated from a different ROI, each point is subject to 
random error.  With a single region approach any error introduced by an imperfect ROI 
will be systematic.  Therefore although inter-study reproducibility may be affected by such 
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an error, one can be more certain that the change in counts from point to point on the 
activity-time curve are reliable. 
Background Correction 
An essential step in the generation of the activity-time curve and of deriving accurate 
indices from this is the estimation of background activity.  Background regions of interest 
are created as described in section 2.6.1.2.  As these regions are smaller in area than the 
ventricular ROIs the activity measured within the background region must be corrected for 
area in every frame of the cycle thus: 
Equation 2-1 – Area corrected background activity
 
 
Background activity was assumed to be essentially constant throughout the cardiac cycle.  
Therefore, prior to correction of background activity for ROI area, each curve was 
smoothed using 100 iterations of a cyclical smoothing algorithm. 
2.6.2 Stress RNVG 
Stress RNVG was performed immediately after completion of redistribution thallium 
image acquisition.  
2.6.2.1 Equipment 
The same gamma camera used in rest supine RNVG imaging was used for stress RNVG.  
The head of this camera is able to be swung out to the side of the camera gantry to a 
sufficient degree to allow either a patient to be imaged in a chair or, as in this case, seated 
on a bicycle ergometer.  Erect stress was used exclusively as a supine ergometer was not 
available. 
The same bicycle ergometer used in stress thallium imaging was used.  This was placed at 
an approximate 40° angle to the camera head and several centimetres back so that once 
seated on the bicycle, the patient would have to lean forward slightly in order to make 
contact between their chest wall and the camera head.  This gap was necessary to allow 
enough clearance between their left leg and the camera head to permit them to pedal 
unimpeded.  The exact angle the bicycle was placed at was adjusted immediately after 
administration of technetium in order to obtain best septal separation. 
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Patients were fitted with a mouth piece and nose clip several minutes prior to commencing 
exercise to allow collection of baseline gases and permit the patient to become accustomed 
to the mouthpiece.  This is expanded upon in section 2.6.2.5 
ECG gating of gamma camera and VO2 data was by means of single lead ECG.  As none 
of the patients exhibited significant ECG changes during stress thallium testing, something 
which was reviewed on a per patient basis, it was not felt necessary to carry out full 12 
lead ECG monitoring during stress RNVG. 
2.6.2.2 Stress Protocol 
Patients underwent a symptom limited exercise test using the bicycle ergometer in an 
upright position as described in section 2.6.2.1.  None of the tests had to be terminated for 
technical or other clinical reasons.  Following approximate positioning of the patient using 
a best guess and the residual thallium activity, the quality of the ECG gating was checked.  
Firstly electrode position and lead configuration were adjusted to obtain a large dominant 
R wave on the monitor free of significant interference at rest.  This was then tested under 
exercise conditions by asking the patient to pedal gently against no resistance.  If this 
resulted in sufficient artefact to result in inaccurate gating, the electrodes were replaced 
following additional skin preparation. 
Following this 600MBq of technetium was administered, having been preceded by 
administration of stannous pyrophosphate 10 to 15 minutes previously.  The position of the 
patient and bicycle were then adjusted to give optimal septal separation and sufficient 
space on either side of the left and right ventricle to allow for minor degrees of patient 
movement.  The left and right heart borders were marked on the camera header display to 
enable continuous monitoring of cardiac position without having to refer to the acquisition 
workstation display.  One member of staff was positioned behind the patient and was 
responsible for maintaining close patient apposition to the camera head and limiting lateral 
and vertical motion during exercise. 
A 5 minute pre-exercise acquisition was then commenced with the mouthpiece and nose 
clip being applied at the start of this.  Following a final check of patient position, exercise 
commenced.  A 3 minute ramping protocol was used, beginning with unladen exercise and 
increasing by 25W at the end of each stage.  The degree of patient fatigue was monitored 
by asking the patient to make non-verbal signals in response to questions as to whether 
they felt able to continue with exercise and were able to cope with an increase in workload.  
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Where patients indicated they would be unable to continue if the workload were to 
increase, exercise was either discontinued at the end of that 3 minute stage or a workload 
increment of less than 25W was attempted.  Where a patient was unable to complete the 
full 3 minutes of a workload increment they were vigorously encouraged to complete at 
least 2 minutes, even if this necessitated a small reduction in workload to achieve.  Initial 
trials of non-study volunteers undergoing RNVG for routine clinical reasons had shown 
that an RNVG acquisition of less than 2 minutes acquired under these conditions was 
generally not analysable.  This was primarily due to the low count statistics rendering the 
images needed for ROI creation very difficult to interpret. 
Exhaled gases were continuously monitored during exercise and an approximate indication 
given as to whether and when anaerobic threshold was reached.  For the majority of 
patients who did reach anaerobic threshold, encouragement was given to continue exercise 
for at least 2 minutes beyond this point in order to create an RNVG image exclusively 
looking at the post anaerobic threshold exercise phase. 
Following completion of exercise the patient was kept in place and data acquisition 
continued for a further 6 minutes in order to monitor recovery from exercise.  Collection of 
exhaled gases was terminated at the start of this recovery phase. 
2.6.2.3 Image Processing 
Raw RNVG data were acquired in List Mode into two files that were processed after 
exercise was complete.  The pre-exercise rest phase was acquired into a file labelled R.  
Exercise and recovery data were acquired as a single continuous acquisition beginning a 
few seconds after the patient had commenced cycling (allowing their body position to 
stabilise) and terminated 6 minutes after exercise had ceased.  All processing was with 
Link Medical MAPS 10000 software.  This permits the raw data to be processed using 
specified time windows to effectively create multiple temporally separate acquisitions 
within the one file.  The stress acquisition (S) was divided and formatted thus: 
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Table 2-4 – Stress RNVG  image naming and processing scheme 
Label Start time (mins) End time (mins) Description 
1 0 3 Unladen exercise 
2 3 6 25W exercise 
3 6 9 50W exercise 
P1 9 12 First 3 minutes of recovery 
P2 12 15 Second 3 minutes of recovery 
A AT – 2 AT 2 minutes leading up to AT time 
B AT AT +2 2 minutes leading on from AT time 
AT = time anaerobic threshold is reached 
Where patients were able to exercise for longer than 9 minutes, that is to stages 4 and 5, 
exercise was continued and the time windows for P1 and P2 are adjusted accordingly.  
Processing of these time windows was achieved with a custom written script which 
automatically calculated the necessary parameters and relayed these to the actual 
formatting software once it had been provided with the number of exercise stages, duration 
of last exercise stage and time of anaerobic threshold.  A separate script was used for 
patients who did not reach anaerobic threshold, which did not attempt to create images A 
and B. 
All images were formatted as 24 frame per cardiac cycle List Mode files (variable bin 
width).  In addition the same raw data were formatted as 32 frame List Mode and 24 frame 
fixed bin width (Frame Mode) images.  These were stored separately and were used to 
compare the results obtained using different temporal resolutions (24 versus 32 frame) and 
different bin width modes (variable versus fixed).  All 3 formats used identical limits 
around the mode of heart rate accepted for inclusion in the formatted image at each stage.  
These limits were generally similar to those applied in routine resting RNVG formatting as 
heart rate tended to rise only a modest amount during each workload increment.  This is by 
virtue of the fact that the workload increments were 25W at most.  Where a very narrow 
peak was seen on the cycle length histogram these limits were tightened by examining the 
minimum and maximum cycle length present within the peak. 
2.6.2.4 Image Analysis 
The same manual single region of interest technique used for routine resting supine RNVG 
analysis was used for creation of activity-time curves for stress RNVG.  The same process 
of verification of ROI accuracy was also performed.  Although movement artefact was 
minimised, a small degree was inevitable.  In addition, any change in left ventricular end 
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diastolic volume throughout the various stages of exercise and recovery, although unlikely 
to be of any significant magnitude, would have to be accounted for.  For this reason 
separate regions of interest were created for each stage of exercise and recovery. 
For technical reasons a small number of scans were difficult to analyse using the usual 
method.  For these images, custom analysis scripts were written to utilise the amplitude 
image, phase image or both to provide additional information to guide ROI creation.  
These images are not used routinely in ROI creation as they have a tendency to 
overestimate the end diastolic dimensions of the left and right ventricles and hence cause a 
reduction in the measured ejection fraction.  Any other parameter derived from the 
activity-time curve would also be affected.  Any ROIs created using this method were 
rigorously checked to ensure no gross errors had been made and the ROIs were the best 
that could be created with the data quality available. 
2.6.2.5 VO2 
Exhaled gases were continuously collected during the stress RNVG by means of a 
mouthpiece and nose clip.  Prior to each test the equipment was calibrated for flow rate and 
the oxygen and carbon dioxide sensors calibrated with reference gases.  Exhaled CO2 and 
O2 were measured on a breath to breath basis.  The VO2/VCO2 slope was continuously 
plotted and used to determine anaerobic threshold.  Peak oxygen consumption rate, VO2 
max, was determined after exercise had been completed.  Respiratory rate was calculated 
in breaths per minute. 
2.7 Spirometry 
Spirometry was performed on all patients.  In addition, all patients had earlobe capillary 
blood obtained as an approximation to an arterial blood gas sample.  This permitted 
measurement of pO2, pCO2, bicarbonate, carbon monoxide and, where the sample obtained 
was of sufficient volume, haemoglobin concentration. 
As a minimum data set the following were measured: 
• Forced Vital Capacity (FVC) 
• Forced Vital Capacity in 1st second (FEV1) 
• FEV1/FVC ratio 
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The expiratory flow was also plotted graphically and flow rates at 50-75% and 75-100% of 
the expiratory phase were available to allow assessment of small airways disease. 
Where a significant abnormality was found, more complete pulmonary function testing 
was performed including lung volumes and transfer factor. 
2.8 NT-proBNP 
N-terminal proBNP is significantly more stable than BNP, both in terms of short term 
biological variability and after the blood sample has been obtained.  It is therefore not 
necessary to ensure that the patient is rested and supine prior to sampling.  Upon arrival for 
myocardial perfusion imaging, the patients were seated and, after approximately five 
minutes, an intravenous cannula was inserted and 10ml of blood withdrawn into a 
Vacutainer containing potassium edetate.  This was centrifuged and the plasma frozen 
within 2 hours of the initial blood draw.  The samples from all study subjects were 
processed in a single batch by Ian Morton at the Western Infirmary, Glasgow using a 
commercially available assay.  This was the Roche NT-proBNP assay which was 
performed on an Elecys (2000) analyser. 
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3. Normal Ranges and Reproducibility of Resting 
and Stress Systolic and Diastolic Function by 
RNVG 
3.1 The Effect of Acquisition Mode and Framing Rate on 
Parameters of Systolic and Diastolic Function 
By its very nature, equilibrium RNVG requires a large number of cardiac cycles to be 
summated to produce an average cycle with sufficient data for analysis.  If the heart rate 
was constant throughout the acquisition, summating the acquired cardiac cycles would be 
simple.  However, with the exception of patients with a permanent pacemaker and in 
advanced heart failure, there is a significant variation in heart rate in normal sinus rhythm.  
In atrial fibrillation this variability of heart rate is even more pronounced.  In order to 
acquire an image within a reasonable time frame, a range of cycle lengths, typically 10 to 
15% around the mean cycle length, must be accepted.  As this variation in cycle length is 
dealt with differently by the two different acquisition modes commonly in use, list mode 
and frame mode, there are implications firstly for the comparability of results between 
modes and secondly for the accuracy of the results. 
The variation in heart rate is further complicated by the fact that different phases of the 
cardiac cycle are affected to a different degree by changing heart rate.  Although the P-R 
interval does show a statistically significant negative linear relationship with heart rate on 
exercise, very little variability is seen within an individual between 80 and 120 bpm (178). 
The duration of systole and diastole also exhibit a negative linear relationship with heart 
rate. Systole and diastole are not affected to the same degree by changes in heart rate, 
however.  Diastole is shortened proportionally more than systole for the same change in 
heart rate.  How the different methods of acquiring and processing RNVGs are affected by 
the proportionally greater effect of normal heart rate variation on the duration of diastole 
therefore becomes important if one wishes to move beyond the assessment of ejection 
fraction. 
Another factor which must be considered when comparing radionuclide ventriculogram 
data is the number of frames per cardiac cycle the data are divided into.  A tradeoff must 
be made when the number of frames per cardiac cycle is decided.  A higher number of 
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frames will increase temporal resolution at the expense of lower counts per frame and a 
greater impact of random fluctuation.  How this affects the parameters of systolic and 
diastolic function being measured will be examined here by comparing the standard 24 
frame per cardiac cycle list mode acquisition with 16 and 32 frame per cycle acquisitions. 
3.1.1 Acquisition Modes 
3.1.1.1 Frame Mode 
The most commonly used acquisition mode is frame mode.  Here the variation in cardiac 
cycle length is effectively ignored and the heart rate regarded as fixed.  Prior to 
commencing data acquisition, the heart rate is monitored and a mean heart rate is 
determined.  This mean heart rate is used to determine the duration of the individual frames 
the cardiac cycle will be divided into and the data bins into which data will be acquired for 
the whole of the acquisition by the formula:  Bin Width = Mean Cycle Length / Number of 
frames.  A heart rate of 80 bpm, cycle length 750ms, will yield bin widths of 31.25ms for a 
24 frame per cycle acquisition.  As the duration of each frame is preset, data can be 
processed in real time into the data bins thereby minimising the quantity of raw data which 
must be stored either in the computer’s memory or on disk.  For cardiac cycles which fall 
outwith the tolerances set on cycle length, the data from the affected cycle will need to be 
discarded before processing the following frame as this cannot be identified until the cycle 
ends.  In the early days of radionuclide ventriculography, this was an effective solution to 
the technical limitations of the systems of the time and expensive, low capacity hard disk 
drives. 
This approach has its drawbacks, however.  Cardiac cycles which do not precisely match 
the predetermined mean cycle length but are still within the tolerance limits will either 
have too little or too much data to contribute to the image being acquired.  Cycles which 
are shorter than the mean cycle length do not have data to contribute to the terminal frames 
of the image.  The impact of this can be seen in the drop off in the number of counts in the 
terminal frames of the image, with up to three frames being affected in patients in sinus 
rhythm, or more in atrial fibrillation.  The end of diastole will be additionally distorted by 
atrial systole of these shorter cycles being superimposed on the end of the passive phase of 
diastolic filling of the longer frames. 
Cycles longer than the mean length will still have data available when the final frame ends 
which must then be discarded.  Data from the passive filling phase of diastole of these 
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cycles will be counted as part of atrial systole of the final image, with the atrial phase being 
discarded as there is nowhere to place the data. 
The impact this has on systole and, therefore, the calculation of ejection fraction will be 
minimal given the fact that the duration of systole is relatively fixed compared to diastole 
and will vary very little within the limits of tolerance which have been set on cardiac cycle 
length.  Diastole is more variable in duration and will be affected by these variations. 
The overall effect this has on the activity-time curve can be seen in Figure 3-1 and Figure 
3-2.  In this 24 frame curve, the decline in counts from both the left ventricle and 
background regions can be seen beginning at the 21st frame.  By the 24th frame there has 
been a marked drop which has grossly distorted end diastole.  When this curve is compared 
to one generated by List Mode processing from the same raw data, the importance of 
processing mode becomes clear.  But, given that the parameters we wish to measure are 
typically in early diastole, prior to this drop in counts, does this matter?   If the effect is 
limited to these macroscopic appearances, it should make no difference which mode is 
used when assessing diastolic function.  If, however, the distortion extends beyond this and 
affects portions of the curve earlier in the cardiac cycle without causing a visible change, 
the indices of diastolic function will be similarly affected and will be inaccurate.  
Figure 3-1 – Typical Frame Mode activity-time curve demonstrating tail drop 
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3.1.1.2 List Mode 
List mode takes into account the normal variation in heart rate by not fixing the cycle 
length and duration of the frames in to which data is divided.  Instead, each cardiac cycle 
which falls within the limits of tolerance is divided into 24 frames of equal duration.  
Figure 3-2 – Typical List Mode activity-time curve 
 
3.1.2 Study Design 
3.1.2.1 Patient Characteristics 
In a group of 67 consecutive patients undergoing routine radionuclide ventriculography, 
the raw data acquired from a single acquisition were formatted as both List Mode and 
Frame Mode.  Indications for the test were as follows:  Ischaemic heart disease (32), Heart 
failure (26), Chemotherapy (6), Arrhythmia (2), Cardiac transplant follow-up (1).  Ethical 
approval was not sought for this as this section of the study involved reusing anonymised 
data acquired as a routine part of a clinically indicated study. 
The patients each received 600MBq of technetium 99m following administration of 
stannous pyrophosphate.  Raw data were acquired directly from the camera head of a 
General Electrics Camstar 3000 fitted with a high sensitivity parallel collimator.  Data 
were acquired for 10 minutes in best septal separation.  Using Link Medical MAPS 10000 
software the raw data were formatted as both List Mode and Frame Mode images using 
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identical beat limits, set at a maximum of 15% on either side of the average heart rate 
during the acquisition. 
3.1.2.2 Simultaneous Acquisition of Multiple Framing Modes 
By acquiring raw data directly from the gamma camera along with an ECG gating signal, 
the X, Y and Z coordinates of every count detected be stored and retrospectively formatted.  
The formatting process is highly configurable and can be driven by user designed scripts, 
or can be performed manually.  The raw data are not altered during the formatting process 
and can be formatted multiple times with different parameters applied to it.  Therefore, a 
single RNVG acquisition can be formatted both as list and frame mode, and at different 
framing rates.  The data here were formatted as 16, 24 and 32 frame per cycle variable 
frame width (list mode) images, and as 24 frames per cycle fixed frame width (frame 
mode). 
3.1.2.3 Generation of Activity-Time Curves 
As each of the sub formats is identical in terms of ventricular position, the approach used 
in chapter 3, where a set of regions of interest are generated from a reference image and 
applied across the others, is also valid here.  The 24 frame per cycle variable width has 
been used as the reference image and a manual single region of interest technique used as 
previously described. 
3.1.2.4 Correction of Frame Mode Images 
Due to limitations in the processing and analysis software used it was necessary to correct 
the count drop-off at the end of frame mode curves.  The first of these limitations prevents 
the correct generation of amplitude and phase images when the drop-off is sufficiently 
large to cause the counts to fall below the value at end systole, which should be the lowest 
point in the cardiac cycle.  The second limitation arises during the calculation of peak 
emptying and filling rates as the curve analysis program is unable to differentiate between 
the distorted and undistorted segments of the curve. 
Two options exist for dealing with these frames.  The first of these is to simply delete the 
frames which exhibit significant count drop-off.  This results in a truncated cardiac cycle.  
Whilst this is unimportant for the calculation of ejection fraction, any parameter which is 
expressed as a function of cycle length, such as filling and emptying rates normalised to 
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cycle length rather than absolute time, will be changed and will no longer be valid.  The 
alternative is to preserve the length of the original cardiac cycle by replacing the affected 
frames with arbitrary data by duplicating the last frame in the cycle not deemed to be 
affected by the problem. 
A left ventricular activity-time curve was generated using a roughly drawn region of 
interest.  This was then displayed along with the number of counts from each frame along 
with the percentage decrease from the previous frame.  The total number of frames which 
required correction could therefore be identified.  Frames were defined as abnormal if they 
had ≥ 3% fewer counts than the preceding frame. 
Due to statistical fluctuation in the number of counts detected, the standard deviation in 
counts between two identical acquisitions is approximately 1%.  A 95% confidence 
interval can then defined as ± 2 standard deviations, and any frame at the end of the Frame 
Mode image falling outwith this defined as abnormal.  As the left ventricular regions of 
interest being used were only rough outlines rather than the final regions used for analysis, 
this limit was increased to 3% to allow for this error except where there was still clear 
drop-off seen between 2 and 3%. 
3.1.3 Results 
3.1.3.1 Comparison of 24 Frame Fixed and Variable Frame Width 
There is no significant difference in the values obtained for left ventricular ejection 
fraction, first third fractional filling, time to peak filling and peak emptying rate between 
list and frame mode acquisitions (Table 3-1).  There is a trend towards higher first third 
fractional filling with fixed frame width data but this does not reach statistical significance.  
There is, however, a significant difference with peak filling rate which is an average of 
5.75 lower with frame mode data compared with list mode data.  As has already been 
shown, the activity-time curve becomes distorted at end diastole (Figure 3-1).  The peak 
filling rate may occur later in diastole than the period over which first third fractional 
filling is measured, accounting for the significant difference in one but not the other.  This 
is further confirmed by the absence of any significant difference in the values obtained for 
peak emptying rate.  This is obtained very early in the cardiac cycle before the progressive 
effect of fixed frame durations can exert a significant effect on the data. 
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Table 3-1 – Comparison of parameters of left ventricular systolic and diastolic function 
using 24 frame list mode and 24 frame fixed frame width radionuclide ventriculography 
 Mean value 
(24 frame, list mode) 
Difference 
(list – frame mode) 
p (paired 
samples T-test) 
Ejection Fraction (%) 33.1 -0.13 0.24 
First Third Fractional 
Filling (%) 46.8 1.13 0.19 
Peak Filling Rate 
(%EDC/cycle) 135.3 -5.75 0.01 
Time to Peak Filling 
(cycles) 0.21 0 0.99 
Peak Emptying Rate 
(%EDC/cycle) 149.7 0.38 0.7 
 
3.1.3.2 Comparison of 16, 24 and 32 Frame Variable Width (List Mode) 
Although left ventricular ejection fraction determined from 32 frame per cycle data is only 
0.35% higher than the mean 24 frame per cycle result, this is statistically significant with a 
p value of 0.001 (paired samples T-test).  With 16 frame data, the ejection fraction is a 
mean 1.21% lower and the difference is highly statistically significant (p < 0.001) (Table 
3-2).  This indicates that a frame rate of 16 per cycle undersamples the data and results in 
the true trough value of the activity-time curve being missed.  First third fractional filling 
shows a similar pattern with a marginal increase in the value measured with 32 frame data, 
although not statistically significant, and a decrease with 16 frame data.  The difference 
with 16 frame data is more marked than with ejection fraction and is approaching the level 
where it may be distinguishable from measurement error on serial studies. 
Although peak filling rate is normalised to cycle length and should, therefore, be relatively 
independent of the number of frames per cycle, both peak filling rate and peak emptying 
rate show a positive linear correlation with frame rate (Table 3-2). 
Table 3-2 – Comparison of parameters of left ventricular systolic and diastolic function 
using 16, 24 and 32 frame list mode radionuclide ventriculography (paired samples T-test) 
 Mean value (24 frame) 
Difference 
(24 – 32 frame) p  
Difference 
(24 – 16 frame) p 
Ejection Fraction (%) 33.1 -0.35 0.001  1.21 <0.001 
First Third Fractional 
Filling (%) 46.8 -0.31 0.66  3.0 <0.001 
Peak Filling Rate 
(%EDC/cycle) 135.3 -31.6 <0.001  23.0 <0.001 
Time to Peak Filling 
(cycles) 0.21 -0.04 0.001  0.01 0.15 
Peak Emptying Rate 
(%EDC/cycle) 149.7 -11.6 <0.001  15.4 <0.001 
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3.1.4 Conclusions 
Although there is no statistically significant difference between list and frame mode data 
for the indices of interest with the exception of peak filling rate, there is evidence that data 
quality is compromised by fixed frame duration.  Peak filling rate is systematically 
overestimated and there is a non-significant trend to underestimate first third fractional 
filling.  Therefore, list mode data should be used in preference to frame mode, particularly 
for indices of diastolic function. 
List mode data with 32 frames per cycle shows minimal difference to that derived from 24 
frame data for the two parameters of most interest, ejection fraction and first third 
fractional filling.  Results derived from 16 frame data do show differences that are not only 
statistically significant, but of sufficient magnitude to be of clinical significance also.  
Sixteen frame data are, therefore, inadequate and a minimum of 24 frames per cardiac 
cycle must be used.  At this standard acquisition length (10 minutes), there is little to chose 
between 24 and 32 frame per cycle data.  However, problems with low counts per frame 
will become more pronounced as acquisition time is significantly shortened during stress 
testing.  Therefore 24 frame per cardiac cycle list mode data is required for stress 
radionuclide ventriculography.  The effect of framing rate on peak filling and emptying 
rates means that these values are not interpretable using reference ranges for other framing 
rates. 
3.2 The Reproducibility of Systolic and Diastolic 
Function by RNVG 
The reproducibility of a test is crucial to its utility as a diagnostic tool.  Firstly, in the serial 
evaluation of a patient where change in the result obtained should be due to a change in the 
parameter being measured rather than variation intrinsic to the measurement technique.  
Secondly, in the one-off assessment of patients where there must be confidence that a 
result is either normal or abnormal to the degree found, and that this would not vary 
significantly were it to be repeated by the same or a different operator. 
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3.2.1 Factors Affecting Reproducibility 
The reproducibility of a test will be governed by these factors: 
• Short term biological variability 
• Number of operators carrying out test 
• Operator experience 
• Difficulty in measuring the variable 
• Precision to which variable is measured 
 
3.2.1.1 Short Term Biological Variability 
This refers to the minute to minute constancy of the variable being measured.  This may be 
constant such as a patient’s weight, it may be independently variable such as heart rate, or 
it may be variable dependent on another physiological parameter.  The majority of 
parameters of interest in terms of systolic and diastolic function such as ejection fraction 
and first third fractional filling are dependent on other variables such as heart rate, loading 
conditions and inotropic-lusiotropic state for their short term variability.  In sinus rhythm at 
rest and in the absence of external manipulation of other factors, biological variability 
should be minimal and any observed variability largely due to technical factors. 
In atrial fibrillation, however, there may be significant beat to beat variation in heart rate.  
This can result in significant differences in filling times and rates depending how truncated 
or prolonged the current cardiac cycle is compared to the mean.  Parameters of systolic 
function will be similarly affected – a short preceding beat will result in a reduced stroke 
volume and vice versa.  Whilst this is a significant problem for echocardiography, meaning 
multiple, typically 5, beats must be measured and averaged, it affects RNVG to a lesser 
degree.  As the majority of RNVG is carried out using the equilibrium method rather than 
first pass, an intrinsic part of the technique is the averaging of a large number of beats over 
several minutes.  Thus RNVG may give a more accurate estimate of ventricular function in 
this situation by virtue of averaging more heart beats.  The reproducibility will be largely 
determined by the mean heart rate from one study to the next and the breadth of the heart 
rate range accepted for analysis. 
3.2.1.2 Operator Experience 
It is widely recognised that a minimum level of experience is required in order to reliably 
acquire and interpret a test, whether this is echocardiography, myocardial perfusion 
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imaging or radionuclide ventriculography.  This is reflected in professional accreditation 
schemes stipulating a minimum level of experience in order to hold the qualification.  An 
inexperienced operator will be more subject to errors in both acquiring or correctly 
interpreting the data.  This will be seen as a changing result where there is no genuine 
change. 
3.2.1.3 Number of Operators 
As the number of operators increases, there is a tendency to an increase the degree of 
variability seen in a test due to systematic differences in acquisition or analysis between 
operators.  One technique commonly employed to limit this source of variability is to limit 
the number of operators.  Whilst this will be of benefit in a research situation where it is 
desirable to minimise this potential source of variability, it is less feasible in routine 
clinical practice where it is unlikely that the same operator will carry all serial 
examinations on a specific patient.  This will introduce a degree of uncertainty when a test 
that has been shown to have good reproducibility under these artificial conditions is used 
routinely. 
Standardised acquisition and analysis protocols aim to limit this source of variability.  This 
aims to limit any systematic error introduced by an experienced operator differing slightly 
in their technique, but in a consistent manner.  An inexperienced operator, however, will 
vary randomly and thus have more poorly reproducible results. 
3.2.1.4 Difficulty in Measuring Variable 
Logic dictates that a variable which is technically difficult to measure will be more prone 
to errors of measurement, and hence variability with repeated measurement, than one 
which can be measured easily.  For example, left ventricular ejection fraction measured by 
Simpson’s biplane rule on echocardiography will be subject to greater variability of 
measurement than measurement of mitral inflow velocities.  This is due to it requiring high 
quality 2D echocardiography images rather than an easy to acquire Doppler signal. 
In terms of RNVG, each parameter is effectively derived from one measurement – the 
activity-time curve.  Anything that compromises the generation of this will reduce the 
accuracy of any variables measured.  Poor ventricular separation, poor image quality or 
overlapping structures interfering with either ventricular or background regions of interest 
will globally affect the activity-time curve.  It is possible, even with experienced technical 
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staff, for random and systematic variation to occur in the positioning of the gamma camera.  
Whether or not this significantly affects either ROI generation or the derived parameters 
will be assessed. 
3.2.1.5 Acquisition Time and Data Quality 
For the assessment of systolic and diastolic function during stress to be a worthwhile 
endeavour, it will be necessary to demonstrate that the short acquisition times required by 
this do not adversely affect the parameters being measured by virtue of the lower counts 
obtained.  Any parameters which are significantly affected in this way cannot be used to 
reliably assess systolic or diastolic function.   
However, not all parameters are equally affected.  Lower count numbers in combination 
with unavoidable random variation in counts between frames results in an activity-time 
curve that has sharp bumps.  Although this is overcome to an extent by smoothing the 
curve and using regression techniques to measure some parameters, this does introduce a 
margin of error for the peak filling and emptying rates and the times at which they occur.  
If such a bump occurs at the end of the first third of diastole, first third fractional filling 
will also be affected.  The ejection fraction is less susceptible to this as the framing rate is 
usually sufficient such that the trough seen at end-systole occupies 2 frames and thus can 
be more reliably smoothed. 
To assess the validity of the 2 and 3 minute acquisition times necessary for stress RNVG, 
values obtained by analysing the first 2 or 3 minutes of a 10 minute continuous acquisition 
will be compared with the value obtained when analysing the 10 minute acquisition as a 
whole. 
3.2.2 Assessing Reproducibility 
Reproducibility can be measured in several different ways: 
• One observer, multiple analyses of same data (intra-observer reproducibility) 
• Multiple observers, one or more analysis each of same data (inter-observer 
reproducibility) 
• One observer, one or more analysis of multiple data sets (inter-study reproducibility) 
• One observer, multiple analyses of data within one study (intra-study 
reproducibility) 
• Multiple observers, one or more analyses of multiple data sets. 
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The following experiment was designed to assess inter-observer, inter-study and intra-
study reproducibility of RNVG derived parameters.  Intra-observer reproducibility was not 
specifically examined as this is carried out as a routine part of ROI creation where a 
standard deviation of >2 in the ejection fraction result obtained from the 2 ventricular and 
2 background ROIs created for each ventricle is taken as inaccurate ROI creation.  The 
process of ROI creation is repeated until this value is <2. 
3.2.2.1 Design 
Radionuclide ventriculography is performed as a routine adjunct to myocardial perfusion 
imaging in this institution as well as a standalone investigation for evaluation of ventricular 
function where echocardiography is not felt to be adequate in terms of reproducibility.  The 
standard protocol involves a 10 minute acquisition in best septal separation (typically 40° 
LAO) used for ejection fraction as well as wall motion analysis, followed by a 5 minute 
70° LAO acquisition solely for wall motion analysis.  For the purposes of this study, a 
second 40° LAO acquisition was then carried out, this time for 5 minutes.  For this extra 
acquisition the camera would be repositioned by a different technician, effectively creating 
a new study with camera position and short-term biological variability the only factors to 
have changed. 
As previously described, raw List mode data were acquired.  These were formatted as our 
standard 24 frame per cardiac cycle List mode format (24L).  In addition, 32 frame per 
cycle and fixed frame width images were also produced from the same raw data (Table 
3-3).  This enables reproducibility between frame width (24 frames/cycle vs 32 
frames/cycle) and frame mode (variable/list and fixed frame width) to be assessed.  In 
addition it will be possible to determine whether any of these schemes has superior or 
inferior reproducibility. 
Table 3-3 – Summary of framing modes and rates formatted from raw data 
 Framing Mode Framing Rate (frames/cycle) 
24L Variable Width 24 
32L Variable Width 32 
24M Fixed Width 24 
 
Manipulation of the program which formats the 10 minute acquisition allows the data to be 
formatted not only in their entirety, but also between any two time points in the 
acquisition.  The 10 minute acquisition was therefore divided into two halves – the first 
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and second five minutes.  In order to also examine the effect on reproducibility of 
shortening acquisition time to the durations to be used during stress RNVG, the first 2 and 
first 3 minutes of both the 10 minute acquisition and the repositioned 5 minutes acquisition 
were also formatted.  This, therefore, produced the following separate acquisitions from 
which measurements could be made: 
Table 3-4 – Acquisition subformats used in the assessment of reproducibility 
Position 1 Position 2 
2 0-2 minutes 2R 0-2 minutes 
3 0-3 minutes 3R 0-3 minutes 
5 0-5 minutes 5R 0-5 minutes 
S 5-10 minutes   
A 0-10 minutes   
 
3.2.2.2 Patients 
Patients undergoing RNVG for any indication were recruited on an ad hoc basis dependent 
on availability of gamma camera and technician time.  No inclusion or exclusion criteria 
were used.  As the study did not involve any additional drug or radioactivity 
administration, merely being a repeat view of a test they were already undergoing for a 
clinical indication, and no activity was required of the patient other than to lie on the 
gamma camera table for an extra five minutes, formal consent was not obtained.  Verbal 
consent was obtained by explaining the purpose of the repeat acquisition and its short 
duration.  No patients declined to participate. 
66 patients (35 male, 31 female) were studied with a mean age of 55.3.  Clinical 
indications for the studies were: 
Table 3-5 – Reproducibility study patients RNVG indications 
Indication Number Percentage 
Ischaemic Heart Disease 32 48.5% 
Heart Failure 19 28.8% 
Transplant Follow-up 1 1.5% 
Pre-transplant Assessment 6 9.1% 
Chemotherapy 6 9.1% 
Arrhythmia 2 3% 
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3.2.2.3 Analysis 
Using the standard procedure, ROIs and activity-time curves were generated by two 
observers (AMC and AR) for both acquisitions.  For position 1, ROIs were created using 
acquisition A; for position 2, acquisition 5R was used.  Since acquisitions 2, 3, 5 and S are 
a subset of acquisition A and have an identical camera and patient position, ROIs valid for 
acquisition A are also valid for the other 4 sub-acquisitions.  The ROIs generated for 
acquisition A were therefore applied to these to generate activity-time curves.  By doing 
so, an important factor in reproducibility, variability in ROIs, is eliminated and differences 
between acquisitions 5 and S will more closely reflect variability due to the technique 
itself.  A degree of short term biological variability will remain but will be minimised by 
the continuous acquisition over a short time with no patient movement.  This technique 
also allows the comparison of sub-acquisitions 2 and 3 with A to solely reflect the impact 
of reduced counts on the activity-time curve rather than the combined effect of this and 
region of interest variation. 
Paired samples T-tests have been used to assess the degree of agreement between 
observers and within each study.  Bland-Altman plots were generated to assess the degree 
of intra and inter-observer variation.  In all plots the thick dashed line represents the mean 
difference between the paired values.  The thinner dashed lines represent +2 standard 
deviations and -2 standard deviations. 
3.2.2.4 Results 
An overview of the results obtained is given below.  Additional supporting data are 
presented in Appendix 1. 
Heart Rate 
There was no significant difference in heart rate either within the sub-acquisitions of the 10 
minute study, or between the first and second studies.  There is small decline in mean heart 
rate between the first and second 5 minutes of the 10 minute acquisition (5-S).  This is only 
0.258 beats per minute and does not achieve statistical significance.  After this initial 
decline, heart rate remains steady with a mean difference of only 0.02 beats per minute 
between the S and 5R acquisitions. 
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Ejection Fraction 
Intra-study/Intra-observer Reproducibility 
Within the two five minute halves of the 10 minute A acquisition there is no significant 
difference in left ventricular ejection fraction for either operator.  There is near perfect 
correlation between the two, with a correlation coefficient of 0.99 for all three acquisition 
modes and both observers.  The small and statistically non-significant decrease in heart 
rate seen between these sub-acquisitions also has no significant effect on ejection fraction 
(Table Ap1-1).  The mean differences in ejection fraction range from 0.004% to 0.2% 
depending on acquisition mode and framing rate.  This represents the absolute limit of 
reproducibility under optimal conditions, and is far superior to that seen in any real world 
situation. 
Intra-study/Inter-observer Reproducibility 
Comparing the ejection fraction obtained for each sub-acquisition between the two 
operators, there is a significant systematic difference between the two values.  Left 
ventricular ejection fractions obtained by AMC are, on average, 1.7% lower than those 
obtained by AR (Table Ap1-2).  This is seen regardless of acquisition time and acquisition 
mode.  The correlation between results is, however, excellent with a correlation coefficient 
of 0.98 for all sub-acquisitions. 
Bland-Altman analysis reveals a tendency for better correlation at lower ejection fractions 
and an ejection fraction threshold of around 50% where variability increases (Figure 3-3).  
In clinical terms this is acceptable as a change in ejection fraction of 5% or more in 
patients with an ejection fraction of less than 40%, the lower limit of normal for this 
technique, is greater than the same apparent magnitude of change for patients with ejection 
fractions well within the normal range.  The reason for this difference was examined and 
was found to be a minor variation in technique where left ventricular ROIs produced by 
AR were tighter to the ventricle that those of AMC, resulting in a higher estimate of 
background activity and, hence, higher ejection fraction. 
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Figure 3-3 – Bland-Altman plot of LV Ejection Fraction - AR-AMC comparison, 24 frame 
variable width, 10 minute acquisition 
 
Intra-observer/Inter-study Reproducibility 
For a single observer analysing serial studies on a patient, there was no significant 
difference in ejection fraction (Table Ap1-3).  This is unaffected by acquisition mode or 
framing rate.  There is an extreme outlier with AR’s data where there is an apparent change 
in ejection fraction of more than 20%.  This subject has a similar change in ejection 
fraction with AMC.  This indicates that the apparent change is either a genuine change in 
the patient’s ejection fraction over this time period or is due to technical issues with either 
the first or second scan rather than an analysis problem. 
The agreement between studies is, as expected, less than that within the same acquisition 
although still excellent with correlation coefficients greater than 0.95 for all sub-
acquisitions and formats.  A modest improvement in reproducibility can be seen by 
increasing acquisition time from 2 to 3, then 5 minutes with a small decrease in the mean 
ejection fraction change and reduction of the standard deviation.  This trend could be 
expected to be even more pronounced when acquisition time is increased to 10 minutes, 
although a second full 10 minute acquisition was not performed. 
There is no significant effect from increasing the number of frames per cardiac cycle to 32 
(mean difference -0.59 (8.98, -10.15) or from using fixed frame duration (mean difference 
-0.25 (8.72, -9.21) 
Inter-observer/Inter-study Reproducibility 
The most likely scenario in clinical practice is that different observers will analyse serial 
studies on a patient.  There was a significant systematic difference between the two 
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observers when reanalysing the same data, this is also the case when they independently 
analyse serial studies (Table Ap1-4).  Again, the results obtained by AMC are 
systematically lower than those of AR.  This difference has increased to between 2.1 and 
2.5% with the greatest differences being seen with 2 minute acquisitions and the smallest 
with 5 minute acquisitions.  These differences are all significant at a level of < 0.01 (paired 
samples T-test).  The Pearson correlation coefficient is 0.95 (Table Ap1-5), the same as 
that for intra-observer/inter-study reproducibility. 
Short Acquisition Time Effect 
With the 24 frame list mode format, there is no significant difference in ejection fraction 
measured with either 2 or 3 minutes of data compared to the full 10 minute acquisition 
time (Table Ap1-6).  However, this is not the case with either 32 frame list mode or 24 
frame fixed width acquisitions.  Correlation between results is, again, very high with 
correlation coefficients for each of the acquisition modes and observers being 0.99 or 
greater. 
Fixed frame mode results in a statistically significant difference in ejection fraction with a 
2 minute acquisition for one observer, and a trend for the other observer which is almost 
significant (p = 0.069).  The mean difference in ejection fraction is, however, only 0.5% 
but nonetheless, this suggests that list mode (variable frame width) is the superior of the 
two when using such limited acquisition times.  With an acquisition time of 3 minutes, the 
difference becomes non-significant for both observers. 
The results for 32 frame list mode are interesting.  Although no significant difference was 
seen between sub-acquisitions 5 and S (Table Ap1-1), the ejection fraction is significantly 
lower when measured using either the 2, 3 or 5 minute sub-acquisitions compared to the 
full 10 minute A acquisition.  The effect becomes more pronounced as acquisition time is 
reduced further with differences of 1.1%, 0.6% and 0.4% at 2,3 and 5 minutes respectively. 
First Third Fractional Filling 
Intra-study/Intra-observer Reproducibility 
Within the 5 and S sub-acquisitions there is no statistically significant difference in first 
third fractional filling result.  There is however, a large standard deviation and, as can be 
seen from the Bland-Altman plot (Figure 3-4), a moderate degree of scatter which remains 
constant across all values of FTFF.  As these sub-acquisitions should be identical in all 
respects other than a 5 minute time difference, the differences seen here partly represent 
the limitations inherent in this technique.  It is likely that this is due to the filling curves 
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being produced are not smooth enough to be analysed more reproducibly.  There are 2 
ways to improve this – either by increasing temporal resolution, a trade-off that decreases 
the counts per frame, or by increasing the acquisition time to increase the number of counts 
per frame.  An increase from 24 to 32 frames per cycle does not improve reproducibility, if 
anything it decreases it with a greater mean difference and greater standard deviation 
(Table 3-6 and Table Ap1-7). 
It should be remembered that there was a small decrease in heart rate between these two 
sub-acquisitions.  Whilst this did not reach statistical significance or affect ejection 
fraction, first third fractional filling is heart rate dependent and is likely to be more 
sensitive to changes in heart rate.  This will serve to exaggerate the technical issues of 
curve smoothness. 
Figure 3-4 – Bland-Altman Plot of left ventricular first third fractional filling intra-study/intra-
observer reproducibility (24L AMC 5-S acquisitions) 
 
Table 3-6 – Left ventricular first third fractional filling Intra-study/Intra-observer 
reproducibility (5-S comparison) – Pearson correlation coefficient 
 24L 32L 24M 
AMC 0.718 0.658 0.718 
AR 0.778 0.740 0.683 
 
Intra-study/Inter-observer Reproducibility 
The inter-observer reproducibility (Table Ap1-8) is, perhaps surprisingly, superior to the 
intra-study reproducibility.  The correlation coefficient for inter-observer reproducibility is 
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in excess of 0.93 for all bar one of the sub-acquisitions.  This suggests that the magnitude 
of effect of the heart rate changes between sub-acquisitions is significantly higher than that 
of re-analysis of the same data by a second observer. 
Acquisition duration seems to have only a modest effect on reproducibility.  The standard 
deviation for the measurement pairs for acquisition lengths of 3 minutes or greater is fairly 
constant at around 5 (Table Ap1-9, Table Ap1-10 and Table Ap1-11).  At an acquisition 
length of 2 minutes, there is a higher degree of variability which is particularly marked 
with the repeat (R) acquisition where a standard deviation of 12.48 is seen with 32 frame 
per cycle formatting (Table Ap1-10).  This may be explained by the interaction of lower 
count statistics on the second study and short acquisition time exaggerating any minor 
differences in region of interest definition between the two observers. 
Intra-observer/Inter-study Reproducibility 
Inter-study reproducibility initially appears much poorer than inter-observer 
reproducibility.  However, heart rate again plays a factor here.  The mean heart rate is 0.27 
beats per minute higher in the 5 sub-acquisition versus 5R.  Between S and 5R the 
difference is only 0.02 beats per minute.  This has the effect of reducing the standard 
deviation from 14.04 for the 5-5R comparison to 12.21 for the S-5R comparison. 
There is an improvement in reproducibility with increasing acquisition length.  There is a 
progressive improvement in correlation coefficient with increasing acquisition time which 
is reasonably consistent across the different frame rate / mode combinations (Table 
Ap1-12).  24 frame list mode data show an increase from a correlation coefficient of 0.55 
at 2 minutes, to 0.65 at 3 minutes and 0.67 at 5 minutes.  The standard deviation also 
improves from 16.15 for AMC and 17.57 for AR at 2 minutes to 14.04 and 14.29 
respectively at 5 minutes.  
The results for 24 frame variable width and 24 frame fixed width acquisition show no 
statistically significant difference (paired samples T-test) (Table Ap1-13 and Table 
Ap1-14).  Although there is also no significant difference with 32 frame list mode data, the 
reproducibility of first third fractional filling is poorer (Table Ap1-15) with standard 
deviations 2 or 3 points higher.  This is likely to be due to the temporal resolution / counts 
per frame trade-off which has already been discussed. 
Inter-observer/Inter-study Reproducibility 
Correlation here is very similar to that seen when a single observer analyses serial studies.  
The correlation coefficients for 5 minute acquisitions are 0.66 for 24 frame list mode data, 
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0.58 for 24 frame fixed width data, and 0.63 for 32 frame list mode data.  There is no 
significant difference between the paired values for any of the formats at either 2, 3 or 5 
minutes. 
Short Acquisition Time Effect 
By reducing the acquisition time to 2 or 3 minutes, there is no significant difference in first 
third fractional filling when compared to a 10 minute acquisition (Table Ap1-16).  This is 
true for all 3 acquisition modes both at 2 and 3 minutes.  Both observers have similar 
results.  There is, however, an improvement in correlation from 0.72 to 0.85 seen with the 
3 minute acquisition as opposed to the 2 minute data (Table Ap1-17). 
It can be seen that the degree of variability here is lower than the intra-observer/inter-study 
variability of FTFF.  The reduction in data quality from a short acquisition time is 
outweighed by other sources of variation.  It is therefore safe to conclude that values of 
first third fractional filling from 3 or even 2 minute acquisitions are just as valid as those 
from longer acquisitions. 
 Peak Filling Rate (3 point regression) 
Intra-study/Intra-observer Reproducibility 
There is no significant difference in left ventricular peak filling rate between the two 5 
minute sub-acquisitions of the 10 minute study (Table Ap1-18).  The mean difference and 
standard deviation is higher for the 32 frame variable width acquisition than for either of 
the 24 frame formats.  This is reflected in a correlation coefficient of 0.83 to 0.84 for 32 
frame data compared to 0.92 to 0.94 for variable and fixed width 24 frame data.  A small 
increase in the degree of variability is seen with increasing peak filling rates (Figure 
Ap1-1). 
Intra-study/Inter-observer Reproducibility 
Correlation between both observers is excellent for all acquisition durations and modes 
with correlation coefficients of between 0.98 and 0.99.  There is a small but statistically 
significant difference in the values between the two observers with AMC obtaining lower 
values than AR by between 5 and 6 points (Table Ap1-19).  This becomes more 
pronounced at higher peak filling rates (Figure Ap1-2) and also during the repeat 5 minute 
acquisition. 
Intra-observer/Inter-study Reproducibility 
Inter-study reproducibility is good with correlation coefficients around 0.88 for 3 and 5 
minute acquisitions using 24 frame per cycle variable width format (Table Ap1-20).  The 
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correlation is slightly poorer for the equivalent 2 minute acquisition (0.817 for AMC, 0.834 
for AR).  The fixed frame width 24 frame format has similar reproducibility at 5 minutes 
but a dip at 3 minutes.  Reproducibility is reduced when 32 frames per cycle are used.  
Here the correlation coefficient falls to 0.8 even with 5 minute data. 
Although there is no statistically significant difference in the values obtained (Table 
Ap1-21), there is a large standard deviation (30-40) in relation to the values observed, the 
mean value depending on observer and format being approximately 135.  This is seen with 
all 3 acquisition modes. 
Inter-observer/Inter-study Reproducibility 
The correlation is good with a coefficient of 0.86 for 24 frame fixed and variable width 
data using 5 minute acquisitions.  For 32 frame list mode data, the correlation is slightly 
poorer at 0.79 and the values obtained are significantly different (paired samples T-test).  
The mean difference using 5 minutes of data is 17.2 which compares to a mean difference 
of 6.0 with 24 frame list mode data, a difference which is not significant. 
Short Acquisition Time Effect 
It has already been seen that there is a reduction in intra-observer/inter-study 
reproducibility when acquisition time is reduced to 2 minutes.  The correlation between 
values obtained at 2 minutes compared to a full 10 minute acquisition is also marginally 
poorer than when 3 minutes of data is acquired (Table Ap1-22).  The correlation 
coefficient for 24 frame list mode data rises from 0.93 with 2 minute data to 0.96 with 3 
minutes of data.  There is a statistically significant difference between both 2 and 3 minute 
values and the 10 minute acquisition (Table Ap1-23).  The mean difference for 24 frame 
list mode data is 8.7 at 2 minutes and 5.3 with 3 minute data.  For 32 frame list mode data 
these differences are higher at 15.9 and 11.3 for 2 and 3 minute data respectively. 
Time to Peak Filling 
Intra-study/Intra-observer Reproducibility 
Correlation between the two sub-acquisitions is moderate for 24 frame variable width 
acquisition (correlation coefficient 0.53 – 0.59) but poor for fixed frame width (0.32) and 
32 frame per cycle acquisition (0.29-0.35) despite the superior temporal resolution. 
There is no statistically significant difference in left ventricular time to peak filling 
between the 5 and S sub-acquisitions (paired samples T-test, Table Ap1-24).  This is 
regardless of observer or acquisition mode.  The degree of variability, however, is large in 
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relation to the values observed which are clustered between 0.1 and 0.25 (10-25% of the 
RR interval).  It is possible that some of this variability is accounted for by the change in 
heart rate between these two sequential acquisitions.  However, the parameter is 
normalised to the RR interval, which should minimise the impact of this. 
Intra-study/Inter-observer Reproducibility 
The correlation between 2 observers is excellent when the same data are re-analysed 
(Table Ap1-25).  The correlation coefficients for 24 frame list mode data range from 0.79 
to 0.97 across the various sub-acquisitions with no relationship to acquisition length.  This 
is significantly better than the intra-study correlation indicating that the poorer correlation 
there was due to differences in the underlying data rather than region of interest issues.  
Although it is not possible to be certain, this is likely to be due to poor temporal resolution 
and an unfavourable trade-off when frame rate is increased.  A small change in time to 
peak filling is translated into a relatively large random fluctuation in the measured value. 
The degree of variability is lower here than with the 5-S comparison, indicating that heart 
rate was indeed playing a significant role despite normalisation.  The standard deviation 
when the same acquisition is analysed by two separate observers is, at 0.03, between one 
third and one sixth that of the 5-S intra-observer comparison (Table Ap1-26). 
Other than the comparison for the 3R sub-acquisition formatted with 24 frame variable 
width, there is no statistically significant difference between the two observers.  This 
appears to be a statistical aberration rather than a genuine difference, as it is not reproduced 
with either of the other two formats. 
Intra-observer/Inter-study Reproducibility 
The degree of variability here is similar to that seen with the 5-S comparison, although the 
correlation coefficients are slightly lower, particularly with 2 minute acquisition times 
where a correlation coefficient of 0.24 is seen for 24 frame list mode data, and 0.14 for 32 
frame list mode data (Table Ap1-27).  This indicates two things.  Firstly, heart rate is 
clearly a significant factor in variability of Time to Peak Filling.  Secondly, the impact of a 
second acquisition, with different regions of interest, is less than the heart rate factor.  
There is no statistically significant difference between the paired samples with the 24 
frame variable width format (Table Ap1-28) or with the other two formats. 
Inter-observer/Inter-study Reproducibility 
Correlation here is similar to that seen for single observer serial study analysis.  For 5 
minute 24 frame list mode data the Pearson correlation coefficient is 0.52.  However, this 
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falls to 0.29 with 2 minute data and is also poor with frame mode or 32 frame list mode 
data.  Although there is no statistically significant difference in the paired data, the 
standard deviation is large (approximately 50%) in relation to the values being measured. 
Short Acquisition Time Effect 
A reduction in acquisition time to 2 or 3 minutes does not yield statistically different 
results compared to a 10 minute acquisition.  This is unaffected by acquisition mode or 
observer (Table Ap1-29).  The correlation here (Table Ap1-30) is similar to that between 
the two 5 minute acquisitions, although there is no consistent improvement with increasing 
from 2 to 3 minute data. 
Peak Emptying Rate (RR) 
Intra-study/Intra-observer Reproducibility 
Correlation is excellent (correlation coefficient of 0.96 for fixed and variable width 24 
frame data, and 0.93 for variable width 32 frame data).  There is no significant difference 
in Peak Emptying Rate between the 5 and S sub-acquisitions (Table Ap1-31).  The degree 
of variability is acceptably low with a standard deviation for 24 frame (variable width) of 
approximately 22 and the majority of measured values between 50 and 200.  Peak 
emptying rate is affected by framing rate with the mean value for 32 frame formats being 
10-20 higher than the 24 frame format, a difference which is statistically significant. 
Intra-study/Inter-observer Reproducibility 
Although correlation remains very high (Table Ap1-32), there is a statistically significant 
difference between the two observers in all sub-acquisitions and in all 3 formatting modes 
(Table Ap1-33).  The values obtained by AMC are systematically lower than AR, a 
difference that becomes more pronounced as the peak emptying rate increases (Figure 3-5).  
The same systematic difference in values was seen with left ventricular ejection fraction.  
Since ejection fraction and peak emptying rate are related, the same factor arising from the 
systematic difference in region of interest creation between the 2 observers is likely to be 
responsible. 
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Figure 3-5 - Bland-Altman plot of LV Peak Emptying Rate (RR) - AMC-AR comparison (A 
sub-acquisition) 
 
 
Intra-observer/Inter-study Reproducibility 
Inter-study correlation is very good with Pearson correlation coefficients of 0.87 to 0.92 
for both 24 frame per cycle formats (Table Ap1-34).  The 32 frame per cycle list mode 
format performs slightly poorer with correlation coefficients between 0.84 and 0.88.  There 
is a statistically significant difference in peak emptying rate between the two studies, the 
second study being a mean 8 to 12 points higher for 24 frame fixed and variable width 
formats (Table Ap1-35 and Table Ap1-36).  The magnitude of the mean difference is also 
high with the 32 frame variable width format with an even higher degree of statistical 
significance (Table Ap1-37). 
This difference is seen with both observers.  No such difference was seen with the intra-
study/intra-observer comparison.  Heart rate may account for this as there was a reduction 
in heart rate between the 5 and S sub-acquisitions and a further reduction with the 5R sub-
acquisition.  These heart rate changes were small and it may be that the magnitude of 
change over the 3 sub-acquisitions is the minimum necessary to produce a significant 
change. 
Inter-observer/Inter-study Reproducibility 
Reproducibility is good here with correlation coefficients ranging from 0.84 for 2 minute 
32 frame data to 0.91 for 5 minute data (both frame and list mode).  This is very similar to 
the intra-observer/inter-study correlation.  However, here there is a statistically significant 
difference in the values obtained by the two observers (p < 0.001, paired samples T-test).  
The results obtained by AMC were around 20 points lower for 24 frame formats and 30 
-­‐100	  
-­‐80	  
-­‐60	  
-­‐40	  
-­‐20	  
0	  
20	  
40	  
0	   50	   100	   150	   200	   250	   300	   350	   400	  
D
if
fe
re
n
ce
	  
Mean	  Peak	  Emptying	  Rate(%EDC/cycle)	  
Andrew C McCulloch, 2009  Chapter 3, 136 
points lower for 32 frame formats, approximately double the difference seen with inter-
observer/intra-study comparsions. 
Short Acquisition Time Effect 
Although correlation appears very good (Table Ap1-38), significant differences are seen 
between 2 and 3 minutes sub-acquisitions and the full 10 minute acquisition.  This 
difference is greater with the 2 minute sub-acquisition.  The same magnitude and direction 
of effect is seen for both observers for the 24 frame formats (Table Ap1-39).  Again, it is 
greater for the 32 frame per cardiac cycle format.  The increase in magnitude and standard 
deviation with a reduction from 3 to 2 minutes indicates that data quality is being adversely 
affected. 
Similar differences are seen if, in an attempt to minimise in-patient variation, the 2 and 3 
minute sub-acquisitions are compared with the 5 minute sub-acquisition (Table Ap1-40).  
The standard deviations are of the same magnitude as with the 10 minute comparison, 
although the mean difference is slightly lower. 
The direction of change is the opposite of that seen with the inter-study comparison.  The 
direction of any heart rate change should, however, be the same for both comparisons.  
Therefore, heart rate is unlikely to be responsible for one or both of the differences seen.  
The logical conclusion, therefore, is that peak emptying rate is poorly reproducible and 
should not be used as an index of ventricular function. 
3.2.2.5 Summary 
The reproducibility data for the 5 parameters of interest are shown in Table 3-7 and Table 
3-8.  To standardise the comparisons, only data from 5 minute, 24 frame list mode 
acquisitions were included in this summary rather than the full 10 minutes of the first 
acquisition. 
Left ventricular ejection fraction, peak filling rate and peak emptying rate all show very 
good correlation between studies and observers.  However, both ejection fraction and peak 
emptying rate showed a significant systematic difference between the two observers.  Peak 
filling rate showed a statistically significant difference for only the inter-observer/inter-
study combination.  However, the mean difference for the inter-observer/inter-study 
combination was marginally larger but did not reach statistical significance. 
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First third fractional filling performed reasonably well in terms of the correlation of results 
and had no significant difference in the paired values.  The inter-observer/inter-study 
difference was much smaller for first third fractional filling than for ejection fraction (0.3% 
versus 2.2%). 
Time to peak filling performed poorly with an inter-observer/inter-study correlation 
coefficient of only 0.52.  Although there was no significant mean difference, this is more 
likely to reflect the limited temporal resolution available to describe this parameter. 
Table 3-7 – Summary of inter/intra observer and inter/intra study correlation for RNVG 
parameters of left ventricular systolic and diastolic function (Pearson correlation 
coefficient) 
 
Intra-observer 
Intra-study 
Inter-observer 
Intra-study 
Intra-observer 
Inter-study 
Inter-observer 
Inter-study 
Ejection Fraction 0.99 0.98 0.96 0.95 
FTFF 0.78 0.97 0.67 0.66 
PFR 0.92 0.98 0.89 0.86 
ttPF 0.59 0.95 0.54 0.52 
PER 0.96 0.98 0.92 0.91 
 
Table 3-8 – Summary of inter/intra observer and inter/intra study mean differences for RNVG 
parameters of left ventricular systolic and diastolic function 
 
Intra-observer 
Intra-study 
Inter-observer 
Intra-study 
Intra-observer 
Inter-study 
Inter-observer 
Inter-study 
Ejection Fraction (%) 0.2 (NS) 1.6 (p <0.001) 0.5 (NS) 2.2 (p = 0.004) 
FTFF (%) 0.2 (NS) 1.1 (NS) 0.8 (NS) 0.3, NS 
PFR (%EDC/cycle) 4.0 (NS) 5.9 (p <0.001) 0.1 (NS) 6.0, NS 
ttPF (cycles) 0.005 (NS) 0.004 (NS) 0.02 (NS) 0.02, NS 
PER (%EDC/cycle) 2.8 (NS) 9.4 (p <0.001) 9.0 (NS) 18.4, (p <0.001) 
Values given are in the relevant units for each parameter with the p value (paired samples T-test) if the difference is 
statistically significant.  NS = not significant 
The effect of shortening acquisition time to that expected to be used during stress RNVG is 
summarised in Table 3-9.  Left ventricular ejection fraction performs extremely well with 
near perfect correlation and a small mean difference in values.  Peak filling rate and peak 
emptying rate also show excellent correlation but have significant differences in the mean 
paired value.  First third fractional filling performs strongly with good correlation and 
almost no difference in the mean paired values.  As seen before, time to peak filling 
performs poorly. 
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Table 3-9 – Summary of the effect of reducing acquisition time from 10 to 3 minutes on 
parameters of systolic and diastolic function 
 Pearson Correlation Coefficient 
Mean 
Difference p 
Ejection Fraction (%) 0.99 0.14 0.42 
FTFF (%) 0.85 0.02 0.98 
PFR (%EDC/cycle) 0.96 5.25 0.04 
ttPF (cycles) 0.48 0.005 0.69 
PER (%EDC/cycle) 0.98 4.87 0.02 
24 frame per cycle list mode data are used for all calculations.  Mean difference is given in the relevant units for 
each parameter.  Paired samples T-test has been used to calculate the p value for mean difference 
3.2.2.6 Conclusion 
Left ventricular ejection fraction provides a reproducible measure of left ventricular 
function even with short acquisition times.  Peak filling and emptying rates also perform 
well but show significant differences when acquisition time is reduced.  First third 
fractional filling performs particularly well under these challenging conditions suggesting 
that it is at least as good, if not superior to the more commonly used peak filling rate in the 
assessment of diastolic function.  Time to peak filling is a weak, poorly reproducible 
parameter that is unlikely to be of utility. 
3.3 The Effect of Posture on Systolic and Diastolic 
Function 
3.3.1 Background 
The majority of tests of cardiac physiology and function are performed with the subject in 
the supine position.  Whilst this is convenient and comfortable for both subject and 
operator, it must be borne in mind that the assumption of an erect rather than supine 
posture, and vice versa, has haemodynamic consequences. 
Upon standing, an exercise reflex and mechanical squeeze is produced on arterial 
resistance vessels and venous capacitance vessels which initially outweighs the 
gravitational pooling of blood in the lower limbs and increases venous return.  Squeezing 
of the arterial resistance vessels increases peripheral resistance and hence blood pressure.  
The combination of increased venous return leading to increased cardiac output with 
increased peripheral resistance significantly increases blood pressure.  This, however, is 
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attenuated by a baroreceptor reflex that decreases sympathetic outflow and decreases total 
peripheral resistance by up to 40%, leading to an overall fall in blood pressure of up to 
20mmHg.  The heart rate initially increases due to reflex parasympathetic withdrawal and 
then falls to a nadir by about 20 seconds after posture change.  After the initial increase in 
venous return this declines and sympathetic tone must rise again to increase peripheral 
resistance and maintain blood pressure, thus achieving a steady state with a largely 
unchanged blood pressure compared to supine. 
When the erect posture is achieved passively, either by sitting or in head-up tilt table 
testing, the haemodynamic responses differ from active standing as the exercise reflex and 
mechanical squeeze are significantly less.  The gravitational shift of blood from the central 
to peripheral venous circulation is therefore largely unopposed and the decreased venous 
return causes stroke volume to decrease by up to 40% initially.  The reflex withdrawal of 
parasympathetic and increase in sympathetic activity that results limits the fall in cardiac 
output to 20% and maintains blood pressure by increased heart rate and total peripheral 
resistance. 
The net effect of changing from a supine to erect posture could therefore be summarised as 
a decrease in preload due to decreased venous return and an increase in afterload due to 
increased sympathetic activity and increased total peripheral resistance.  Both preload and 
afterload have significant effects on many of the indices used to describe diastolic function.  
The effect of reduced preload on diastolic function is well documented.  Where diastolic 
function is impaired but early diastolic filling is preserved by increased preload causing a 
pseudonormal E/A ratio, manoeuvres to reduce pre-load such as the Valsalva manoeuvre 
unmask this and decrease the mitral E wave velocity.  Increased afterload affects diastolic 
function by decreasing the pressure gradient across the aortic valve in systole.  This results 
in left ventricular pressure falling below systemic arterial pressure at an earlier stage in late 
systole.  The isovolumetric relaxation period therefore begins earlier and, assuming 
preload has remained constant, isovolumetric relaxation time will be prolonged. 
Increased sympathetic tone also has an inotropic effect which may have multiple effects on 
diastolic function both passively through enhanced elastic recoil of the ventricle as a 
consequence of more vigorous contraction, to increased myocardial oxygen demand and 
the impairment of active ventricular relaxation due to increased levels of intracellular 
calcium which requires yet more myocardial energy to return to the sarcoplasmic reticulum 
and allow relaxation. 
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The increase in heart rate is also significant.  A strong relationship between first third 
fractional filling and heart rate is demonstrated in later in this chapter (section 3.5.1.4).  In 
addition, two echo Doppler parameters are related to heart rate – isovolumetric relaxation 
time and mitral deceleration time. 
As a consequence of these multiple interacting effects of posture on the heart itself and in 
the peripheral circulation, it is not safe to assume that measurements taken in one position 
are interchangeable with those taken in the other.  A comparison of diastolic function both 
whilst supine and erect in a group of patients30 is therefore necessary.  Whilst this can be 
done with the main study population, these represent a specific subgroup of patients in that 
they all have preserved left ventricular ejection fractions.  A more diverse group of patients 
is therefore required for this purpose. 
3.3.2 Methods 
35 patients undergoing radionuclide ventriculography either as part of a myocardial 
perfusion scan or as a standalone investigation were recruited.  The patients were not 
selected or excluded on any criteria other than the availability of the additional gamma 
camera scanning time necessary and an aim to include patients with a wide range of 
ejection fractions. 
Following acquisition of the normal supine 40°LAO view, each patient was sat upright in a 
chair and a further 40°LAO view was acquired.  Each pair of images was processed in the 
normal manner and analysed by a single observer to produce paired sets of measurements 
of systolic and diastolic function in each patient.  All data were acquired and formatted in 
List mode at 24 frames per cardiac cycle. 
3.3.3 Patient Characteristics 
Patients were drawn from a range of sources and included patients with and without 
ischaemic heart disease, including prior myocardial infarction and coronary artery bypass 
grafting.  Two patients with end stage heart failure were included and one patient with a 
previous cardiac transplant.  Their details are summarised in Table 3-10. 
Categorical variables are shown as absolute numbers in each group (n=35).  Continuous 
variables are shown as mean (minimum, maximum value). 
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Table 3-10 – Characteristics of patient group assessing the effect of posture on systolic and 
diastolic function 
Demographic Value 
Sex (M/F) 18/17 
Age (years) 59 (39, 81) 
Height (m) 1.66 (1.47, 1.83) 
Weight (kg) 76 (57.6, 110) 
BMI (kg/m2) 27.5 (21.1, 36.4) 
Hypertension (Y/N) 15/20 
Beta blocker (Y/N) 18/17 
RLCB (Y/N) 3/32 
RLCB = rate limiting calcium channel blocker 
3.3.4 Results 
3.3.4.1 Heart Rate 
Changing from an erect to a supine posture results in a small but statistically significant 
decrease in heart rate from a mean of 72.8 to 70.0 beats per minute (p = 0.005, paired 
samples T-test). 
3.3.4.2 Left Ventricle 
Left ventricular ejection fraction and peak emptying rate both show a statistically non-
significant decrease with supine as compared to erect posture.  In contrast, parameters of 
filling in the form of first third fractional filling and peak filling rate are higher when 
supine.  The change in peak filling rate fails to achieve statistical significance regardless of 
whether 3 point regression is used. 
The difference in first third fractional filling is highly statistically significant (p < 0.001, 
paired samples T-test) with a mean erect value of 36.97% and mean supine value of 
45.65%. 
There is a decrease in time to peak filling from 0.25 to 0.21% of the RR interval when 
changing from erect to supine.  This almost achieves statistical significance with a p value 
of 0.052. 
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Table 3-11 – Effect of posture on left ventricular function (paired samples T test) 
Paired Differences – Erect - Supine (Left ventricle) 
95% Confidence Interval of 
the Difference 
 
Erect 
(mean) 
Supine 
(mean) 
Mean 
difference Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
EF 37.23% 35.35% 1.88 7.47 -0.69 4.44 0.146 
FTFF 36.97% 45.65% -8.68 12.43 -12.95 -4.41 <0.001 
PFR3pr 
(%EDC/cycle) 133.01 140.38 -7.37 38.68 -20.66 5.91 0.267 
ttPF 
(cardiac cycles) 0.25 0.21 0.04 0.12 -0.0003 0.08 0.052 
PER 
(%EDC/cycle) 183.14 165.34 17.80 54.82 -1.03 36.63 0.063 
 
3.3.4.3 Right Ventricle 
There is statistically non-significant decrease of approximately 3% in right ventricular 
ejection fraction when moving from an erect to supine posture.  First third fractional 
filling, which showed a highly statistically significant increase for the left ventricle, also 
shows an increase with assuming a supine posture.  This achieves borderline statistical 
significance with a mean difference of 7.59% and a p value of 0.051. 
Time to peak filling, as was seen with the left ventricle, shows a small decrease which is of 
borderline significance with a p value of 0.059.  Peak filling rate and peak emptying rate 
both show no significant change with posture. 
Table 3-12 – Effect of posture on right ventricular function (paired samples T test) 
Paired Differences – Erect - Supine (Right ventricle) 
95% Confidence Interval of 
the Difference 
 
Erect 
(mean) 
Supine 
(mean) Mean 
difference Std. Deviation Lower Upper 
Sig. (2-
tailed) 
EF 34.04% 30.88% 3.16 25.08 -5.46 11.77 0.462 
FTFF 42.61% 50.2% -7.59 22.20 -15.22 0.03 0.051 
PFR3pr 
(%EDC/cycle) 116.09 108.39 7.70 90.67 -23.44 38.85 0.618 
ttPF 
(cardiac cycles) 0.23 0.18 0.05 0.15 -0.002 0.10 0.059 
PER 
(%EDC/cycle) 176.73 158.77 17.96 141.55 -30.66 66.58 0.458 
 
3.3.5 Conclusions 
Of the parameters of systolic and diastolic function examined here, only left ventricular 
first third fractional filling shows a statistically significant difference with a change in 
posture.  This can probably be accounted for by the decrease in heart rate seen when 
adopting a supine posture.  As section 3.5 will show, an increase in first third fractional 
filling with a decrease in heart rate is precisely what one would predict.  These data are not 
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able to exclude an effect from factors other than heart rate on first third fractional filling.  It 
will, therefore, be necessary to construct a reference range which takes account of this. 
3.4 Smoothing and RNVG Curve Analysis 
3.4.1 Premise 
Some of the limitations seen in the reproducibility of the parameters of filling and 
emptying derived from the activity-time curve stem from the relatively rough texture of the 
curve.  This is inevitable due to the finite number of radioactive counts available for 
analysis in any given acquisition period and the trade-off that must occur between 
acceptable acquisition time, adequate temporal resolution and adequate count statistics per 
frame.  In theory, the random fluctuations in the activity-time curve this produces can be 
minimised by smoothing the curve.  However, smoothing has its limitations.  The original 
data are altered with a potential loss of accuracy for any measurements subsequently made.  
In effect, the data are homogenised,  the end point of this being a curve which has been 
smoothed an infinite number of times, resulting in a flat line.  Therefore, a trade-off must 
be made between a level of smoothing that allows a parameter to be useable from a 
reproducibility point of view and excessive smoothing compromising the original data. 
The effect of smoothing can be seen in this series of figures.  Figure 3-6 shows a normally 
smoothed, background subtracted, 24 frame list mode left ventricular activity-time curve.  
Figure 3-6 – Left Ventricular activity-time curve - normal degree of smoothing 
 
Figure 3-7 shows an activity-time curve which has been smoothed one additional time and 
one further time in Figure 3-8.  The curve is visibly smoother with each step but it should 
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be noted that the peak number of counts in the curve (the figure at the top left of each 
curve) decreases progressively from 10092 to 10039 then 10000. 
Figure 3-7 – Left ventricular activity-time curve - 1 additional smooth 
 
Figure 3-8 – Left ventricular activity-time curve - 2 additional smooths 
 
The level of curve smoothing currently employed is optimal for calculation of ejection 
fraction.  As analysis of other RNVG parameters is not routinely undertaken, it has not 
been locally validated whether this is an appropriate level of smoothing for this purpose.  It 
is unclear whether the interpolation that smoothing imposes measurement accuracy, or 
simply homogenises the curve.  The following experiment was designed to address this 
question. 
3.4.2 Methods 
The data acquired from the patient group used to determine the reproducibility of RNVG 
activity-time curve parameters described in section 3.2 were utilised again here.  Regions 
of interest from a single observer (the author) were used.  As before, one set of ROIs was 
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generated from the 10 minute acquisition (position 1) and a second set of ROIs from the 5 
minute acquisition (position 2).  ROIs for the 5 minute subdivisions of the 10 minute 
acquisition were copied as before rather than being redrawn to eliminate any variability 
from minor ROI differences.  The acquisitions/curves are designated as follows: 
  A 10 minute acquisition, 1st position 
  5 1st 5 minutes, 1st position 
  S 2nd 5 minutes, 1st position 
  R 5 minute acquisition, 2nd position 
 
Activity-time curves were generated for each acquisition using the normal level of 
smoothing (n), with 1 extra smooth applied (1s) and with 2 extra smooths applied (2s) to 
the curve before curve analysis.  Three values were therefore generated for each parameter 
of each acquisition enabling assessment of the effect of additional curve smoothing on the 
inter- and intra-study reproducibility of each. 
Curve smoothing was performed using a cyclical filter with a 1-2-1 pattern.  For each 
group of 3 points the central point is given a weighting of 2 and the other 2 points a 
weighting of 1 each.  These values are summed and divided by 4 to give the new value for 
the central point.  This is progressively stepped through the curve, wrapping around when 
the end of the curve is reached. 
3.4.3 Parameters 
The following parameters were calculated for each acquisition: 
Parameter Abbreviation 
Ejection Fraction EF 
First Third Fractional Filling FTFF 
Peak Emptying Rate PER 
Peak Emptying Rate (3 point regression) PER3pr 
Peak Filling Rate PFR 
Peak Filling Rate (3 point regression) PFR3pr 
Time to First Third Empty (normalised to RR interval) ttFTErr 
Time to First Third Full (normalised to RR interval) ttFTFrr 
Time to Peak Emptying (normalised to RR interval) ttPErr 
Time to Peak Filling (normalised to RR interval) ttPFrr 
 
Andrew C McCulloch, 2009  Chapter 3, 146 
The parameter names are then suffixed with the acquisition they have been calculated from 
and the degree of smoothing which has been applied to the curve.  For example, the 
ejection fraction from acquisition A with 1 extra smooth applied becomes EF_A1s. 
3.4.4 Results 
3.4.4.1 Ejection Fraction 
Effect on Value 
With successive smooths, the mean ejection fraction is progressively reduced.  The 
difference between each step is statistically significant using a paired samples T test with 
all p values being <0.001. 
Table 3-13 – Mean left ventricular ejection fraction in 4 sub-acquisitions - effect of 
progressive activity-time curve smoothing 
 A 5 S R 
Normal 33.2% 33.4% 33.4% 33.7% 
1 smooth 32.2% 32.3% 32.4% 32.6% 
2 smooths 31.5% 31.6% 31.7% 31.8% 
 
Effect on Ejection Fraction Reproducibility 
As can be seen from the R2 values, there is already excellent inter- and intra-study 
reproducibility of ejection fraction with the standard level of curve smoothing.  Additional 
smoothing has virtually no effect on this, increasing the R2 value from 0.917 to 0.92 with 2 
additional smoothing steps (Table 3-14).  Therefore, although there is no benefit in terms 
of reproducibility of ejection fraction by additional curve smoothing, if this is undertaken 
for the sake of other parameters, a lower normal range should be used. 
Table 3-14 – Left ventricular ejection fraction intra- and inter-study correlation coefficient - 
effect of progressive activity-time curve smoothing 
 A/R 5/S 5/R 
Normal 0.96 0.99 0.96 
1 smooth 0.96 0.99 0.96 
2 smooths 0.96 0.99 0.96 
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Figure 3-9 – Correlation between ejection fraction from 5 and R acquisitions, normal 
smoothing 
 
It can be seen in Figure 3-9 that there is a greater degree of variability seen at higher 
ejection fraction values.  This is not affected with additional smoothing. 
3.4.4.2 First Third Fractional Filling 
Effect on Value 
As with ejection fraction, there is a decrease in first third fractional filling with smoothing 
(Table 3-15).  With the exception of the R acquisition, this is not statistically significant 
with a single extra smooth applied.  When a second extra smooth is applied, the difference 
from N to 2s is statistically significant with the exception of AN/A2s where the p value of 
0.06 is very close to significance.  
Table 3-15 – Mean first third fractional filling in 4 sub-acquisitions – effect of progressive 
smoothing of activity-time curve 
 A 5 S R 
Normal 46.5% 46.9% 48.2% 47.6% 
1 smooth 46.0% 46.4% 47.6% 46.3% 
2 smooths 45.0% 45.4% 46.6% 45.8% 
 
Effect on FTFF Reproducibility 
Reproducibility of FTFF between studies (5/R) is moderately good at the default level of 
smoothing.  Within the same study (5/S) the agreement between values is only marginally 
better showing that the limitation here is not with accuracy of camera positioning or ROI 
creation.  Also, biological variability should be minimal as the two acquisitions are only 5 
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minutes apart.  The main source of variability is the roughness of the activity-time curve 
and the random fluctuations this introduces.  There is an improvement in reproducibility 
with smoothing but this is not substantial and a significant degree of scatter can still be 
seen (Table 3-16).  Much higher degrees of smoothing would be needed to resolve this but 
would result in unacceptable distortion of the activity-time curve. 
Table 3-16 – First third fractional filling intra- and inter-study correlation (R2) – effect of 
progressive smoothing 
 A/R 5/S 5/R 
Normal 0.74 0.74 0.67 
1 smooth 0.78 0.75 0.74 
2 smooths 0.82 0.76 0.79 
  
Smoothing has minimal effect on the confidence intervals for the difference between 
values for the 5 and R studies.  Overall, a change of 3% in the value of FTFF should be 
regarded as a genuine change in the value. 
3.4.4.3 Peak Emptying Rate 
Effect on Value 
With each additional curve smooth there is a statistically significant decrease in PER (p < 
0.001 paired samples T test).  This is the case with or without curve fitting by 3 point 
regression.  The magnitude of effect of this is approximately half that of one iteration of 
curve smoothing. 
Table 3-17 – Peak Emptying Rate – mean value between sub-acquisitions and effect of 
smoothing 
 Normal 3 Point Regression 
 A 5 S R A 5 S R 
Normal 156.8 160.2 164.0 171.5 150.2 152.5 155.8 161.9 
1 smooth 146.1 146.5 149.5 154.1 141.8 142.2 145.0 149.1 
2 smooths 138.9 138.7 140.6 144.8 135.4 135.1 137.4 140.9 
All values are %End diastolic counts per cardiac cycle 
Effect on PER Reproducibility 
Reproducibility of peak emptying rate is very good with normal smoothing with only a 
modest improvement with additional smoothing.  The baseline R2 value of 0.904 for 5/S 
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indicates there is minimal short term biological variability and the resolution of the 
activity-time curve is adequate for this parameter.  3 point regression results in a small a 
small improvement in correlation against no curve fitting, but no improvement with 
additional curve smoothing. 
Table 3-18 – Peak emptying rate intra- and inter-study correlation (R2) – effect of progressive 
smoothing 
 Normal 3 Point Regression 
 A/R 5/S 5/R A/R 5/S 5/R 
Normal 0.78 0.90 0.79 0.84 0.91 0.83 
1 smooth 0.84 0.94 0.83 0.86 0.94 0.84 
2 smooths 0.86 0.95 0.85 0.87 0.95 0.85 
All values are %End diastolic counts per cardiac cycle 
 
3.4.4.4 Peak Filling Rate 
Effect on Value 
With each additional curve smooth there is a statistically significant decrease in PFR both 
with and without 3 point regression(p < 0.001 paired samples T test).  As with peak 
emptying rate, 3 point regression has an effect half that of one iteration of curve 
smoothing. 
Table 3-19 – Peak Filling Rate – mean value between sub-acquisitions and effect of activity-
time curve smoothing 
 Normal 3 Point Regression 
 A 5 S R A 5 S R 
Normal 144.4 147.1 153.0 146.0 137.0 138.0 141.9 137.0 
1 smooth 130.1 130.6 134.8 130.8 125.1 125.2 128.5 125.1 
2 smooths 121.2 120.7 125.0 122.3 117.7 116.4 120.0 117.7 
All values are %End diastolic counts per cardiac cycle 
Effect on PFR Reproducibility 
Peak filling rate shows good reproducibility with standard levels of smoothing.  There is 
only a small improvement in the R2 value with additional smoothing.  3 point regression 
provides only marginal improvement upon this. 
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Table 3-20 – Peak filling rate intra- and inter-study correlation (R2) – effect of progressive 
activity-time curve smoothing 
 Normal 3 Point Regression 
 A/R 5/S 5/R A/R 5/S 5/R 
Normal 0.79 0.82 0.74 0.79 0.86 0.76 
1 smooth 0.81 0.88 0.79 0.83 0.90 0.80 
2 smooths 0.83 0.91 0.80 0.84 0.92 0.81 
 
3.4.4.5 Time to First Third Empty 
Effect on Value 
There is an upward trend for ttFTErr with additional smoothing, although the absolute 
change is very small.  This is statistically significant with the An→A1s, Rn→R1s and 
5n→51s stages, although the difference becomes insignificant when a second smooth is 
applied suggesting that overall, the effect of smoothing is not significant. 
Table 3-21 – Time to first third empty – mean value between sub-acquisitions and effect of 
activity-time curve smoothing 
 A 5 S R 
Normal 0.174 0.174 0.174 0.171 
1 smooth 0.175 0.175 0.175 0.173 
2 smooths 0.175 0.175 0.174 0.173 
All units are Cardiac Cycles 
Effect on ttFTErr Reproducibility 
Reproducibility is already reasonable at baseline with 5n/Rn having an R2 value of 0.67.  
There is a small stepwise improvement in inter-study correlation with additional 
smoothing, with the majority of this being seen after 1 additional smooth.  The effect on 
intra-study correlation is negligible. 
Table 3-22 – Time to first third empty intra- and inter-study correlation (R2) – effect of 
progressive activity-time curve smoothing 
 A/R 5/S 5/R 
Normal 0.67 0.89 0.67 
1 smooth 0.77 0.91 0.77 
2 smooths 0.81 0.92 0.81 
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3.4.4.6 Time to First Third Full 
Effect on Value 
Smoothing has no statistically significant effect on the value of ttFTFrr.  There is no 
discernable effect on A and whereas there is a small drop with 1 smooth of 5 and S, the 
same process increases the value of R. 
Table 3-23 – Time to first third full – mean value between sub-acquisitions and effect of 
activity-time curve smoothing 
 A 5 S R 
Normal 0.173 0.174 0.170 0.167 
1 smooth 0.173 0.172 0.167 0.171 
2 smooths 0.173 0.172 0.168 0.171 
All units are Cardiac Cycles 
Effect on ttFTFrr Reproducibility 
There is moderate correlation between values with normal smoothing.  This improves 
markedly with smoothing with the majority of this benefit being seen after one iteration.  
There is benefit from a second iteration for inter-study correlation which is less apparent 
with intra-study correlation. 
Table 3-24 – Time to first third full intra- and inter-study correlation (R2) – effect of 
progressive smoothing 
 A/R 5/S 5/R 
Normal 0.42 0.59 0.37 
1 smooth 0.60 0.67 0.51 
2 smooths 0.68 0.70 0.62 
 
3.4.4.7 Time to Peak Emptying 
Effect on Value 
There is a trend to increase ttPErr with additional smoothing.  Steps 5n→52s, S1s→S2s, 
R1s→R2s and Rn→R2s achieve statistical significance with p values of 0.014, 0.049, 
0.002 and 0.01 respectively. 
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Table 3-25 – Time to peak emptying – mean value between sub-acquisitions and effect of 
activity-time curve smoothing 
 A 5 S R 
Normal 0.168 0.167 0.161 0.156 
1 smooth 0.165 0.173 0.161 0.160 
2 smooths 0.171 0.178 0.167 0.168 
All units are Cardiac Cycles 
Effect on ttPErr Reproducibility 
Reproducibility of ttPErr is poor both between studies and within the same acquisition 
(5/S).  This is not improved with additional smoothing. 
Table 3-26 – Time to peak emptying intra- and inter-study correlation (R2) – effect of 
progressive activity-time curve smoothing 
 A/R 5/S 5/R 
Normal 0.16 0.17 0.14 
1 smooth 0.23 0.06 0.16 
2 smooths 0.23 0.07 0.24 
 
3.4.4.8 Time to Peak Filling 
Effect on Value 
The steps from An to A2s and 5n to 51s are statistically significant with p values of 0.045 
and 0.021 respectively (paired samples T-test) but overall there is no significant effect 
from smoothing. 
Table 3-27 – Time to peak filling – mean value between sub-acquisitions and effect of 
activity-time curve smoothing 
ttPFrr A 5 S R 
Normal 0.20 0.21 0.21 0.21 
1 smooth 0.22 0.20 0.20 0.23 
2 smooths 0.23 0.20 0.20 0.22 
All units are Cardiac Cycles 
Effect on ttPFrr Reproducibility 
Time to peak filling is very poorly reproducible not only between studies (5/R) but also 
within the same study (5/S) where the patient has not moved and the same ROIs have been 
used.  Although smoothing seems to improve this in some cases (A/R normal → 1 
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smooth), the improvement is not consistent and the correlation deteriorates from A1s/R1s 
to A2s/R2s.  Some of this is due to poor temporal resolution of this parameter with 
relatively large gaps between possible values. 
Table 3-28 – Time to peak filling intra- and inter-study correlation (R2) – effect of progressive 
activity-time curve smoothing 
 A/R 5/S 5/R 
Normal 0.11 0.28 0.12 
1 smooth 0.51 0.33 0.22 
2 smooths 0.39 0.37 0.15 
 
3.4.5 Summary of Effect of Smoothing on Reproducibility 
Ejection fraction, peak emptying rate and peak filling rate, both with and without 3 point 
regression have very good reproducibility with only modest improvements with additional 
smoothing.  As reproducibility improves with the addition of 3 point regression without 
otherwise affecting the activity-time curve, PER3pr and PFR3pr should be used in 
preference to the standard version. 
First third fractional filling has only moderate reproducibility compared to ejection 
fraction.  However, the confidence intervals of ± 3 is adequate to allow comparisons to be 
made between patients. 
Time to first third empty has acceptable reproducibility without additional smoothing.  
Although time to first third full does show an improvement with one additional smooth, it 
is the only useful parameter to need this and it is probably not justifiable to do this unless it 
can be measured using a separately smoothed curve. 
Time to peak emptying and time to peak filling have very poor reproducibility, even with 
additional smoothing and are of limited utility. 
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Table 3-29 – Effect of progressive activity-time curve smoothing on inter-study correlation 
(R2) of common indices of systolic and diastolic function 
 5n/Rn 51s/R1s 52s/R2s 
EF 0.92 0.92 0.92 
FTFF 0.46 0.55 0.63 
PER 0.79 0.83 0.85 
PER3pr 0.83 0.84 0.85 
PFR 0.74 0.79 0.80 
PFR3pr 0.76 0.80 0.81 
ttFTErr 0.67 0.77 0.81 
ttFTFrr 0.37 0.51 0.62 
ttPErr 0.14 0.16 0.24 
ttPFrr 0.12 0.22 0.15 
 
3.5 Normal Ranges of Resting and Stress Systolic and 
Diastolic Function 
3.5.1 Resting Function 
For many years at Glasgow Royal Infirmary, RNVG has been a standard component of the 
myocardial stress perfusion imaging protocol as it provides additional data to improve the 
sensitivity and specificity of this test.  The superior radiological properties of technetium 
compared to thallium201 in terms of photon energy and count density allow better 
visualisation of ventricular wall motion, allowing better characterisation of fixed perfusion 
defects.  Essentially, if a fixed perfusion defect detected by thallium scanning is akinetic or 
has significantly impaired wall motion on RNVG, it is likely to represent an infarct.  Fixed 
defects with normal wall motion most likely represent tissue attenuation artefact.  This 
information cannot be discerned as readily using gated SPECT perfusion imaging since 
assessment of wall motion will be difficult in a segment with very low tracer uptake. 
In addition to wall motion, left and right ventricular ejection fractions are calculated for all 
studies performed regardless of whether this information has been specifically requested or 
not. 
As a result of this and the fact that RNVG image data are preserved indefinitely, a large 
body of RNVG data exists which can be retrospectively analysed and additional 
parameters of systolic and diastolic function measured beyond the original measure of 
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ejection fraction.  A substantial amount of data is recorded along with the RNVG and 
corresponding perfusion scan to characterise these patients in the form of prior cardiac 
history, medication at the time of scanning, age, sex and the original request form along 
with the referral indications. 
It is therefore possible to utilise this body of data to construct a group of normal patients in 
order to generate a reference range for the parameters of diastolic and systolic function of 
interest. 
3.5.1.1 Definition of Normal Subjects 
The following features were required in order to classify a patient as normal: 
• Left ventricular ejection fraction ≥ 37%.  The in-house lower limit of normal for this 
has previously been defined as 40%, with a margin of error of ± 3%, meaning that 
patients with technically mild impairment of left ventricular systolic function may 
be found to have a normal result if the scan were to be repeated. 
• Right ventricular ejection fraction ≥ 25%.  Due to the anatomy of the right ventricle, 
there is a greater degree of attenuation of counts arising posteriorly from the right 
ventricle than the left ventricle resulting in an apparently reduced ejection fraction 
even in the presence of normal wall motion and visually assessed systolic function. 
• Normal or borderline normal stress thallium perfusion without evidence of prior 
myocardial infarction.  Patients who had undergone percutaneous intervention were 
not excluded. 
• Drug therapy known, including whether the patient was on any medication which 
would influence heart rate and any parameters of systolic or diastolic function 
affected by this. 
 
Exclusion criteria were as follows: 
• Any major intraventricular conduction defect i.e. right or left bundle branch block.  
Minor intraventricular conduction defects were not excluded if the RNVG phase 
image was normal 
• Previous myocardial infarction 
• Previous cardiac surgery including CABG and valve replacement. 
• Recipients of cardiac transplantation. 
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• Left ventricular hypertrophy either by ECG criteria or as indicated in the referral 
information. 
• Any rhythm other than sinus. 
• A clinical history of heart failure or exertional dyspnoea as indicated in the referral 
information. 
 
3.5.1.2 Demographics 
Using the criteria listed, a total of 225 patients were identified, primarily from studies 
performed in 2002 and 2007, along with a small cohort of patients that had previously been 
identified in 1996.  Ethical approval was not sought for this study as the data collected 
were previously obtained as part of routine clinical care and were fully anonymised. 
Age 
The mean patient age was 55.4, ranging from 28 to 78.  This is normally distributed with a 
skewness statistic of 0.057 and standard error of 0.162.  This is illustrated in Figure 3-10. 
Figure 3-10 – Age distribution of resting RNVG control subjects 
 
Heart Rate and Medication 
The mean heart rate was 73.8, range 44.8 to 113.7.  The distribution is skewed to the left, 
skewness statistic 0.549, standard error 0.162.  This is illustrated in Figure 3-11. 
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Figure 3-11 – Heart rate distribution of resting RNVG control subjects 
 
 
126 patients were taking no heart rate limiting medication.  Only one patient was taking 
both a beta blocker and a rate limiting calcium channel blocker.  63 patients were taking a 
beta blocker alone, 35 patients were taking a rate limiting calcium channel blocker.  
Preparations of diltiazem accounted for the vast majority of these. 
As one might expect, there is a significant difference between the heart rate between 
patients prescribed beta blockers and those not (mean heart rate 65.2 vs 77.6, p< 0.001, 
independent samples T test).  However, there is no significant difference in resting heart 
rate between patients prescribed rate limiting calcium channel blockers and those on no 
heart rate limiting medication (mean heart rate 75.7 vs 77.6, p=0.422).  The difference 
between beta blockers and rate limiting calcium channel blockers is also highly statistically 
significant with a p value of <0.001.  In this small sample it is clear that beta blockers are 
more effective at lowering heart rate at rest compared to rate limiting calcium channel 
blockers.  With the proviso that they represent only 15.6% of this sample, rate limiting 
calcium blockers appear to have no significant effect on resting heart rate. 
This differential effect between beta blockers and rate limiting calcium channel blockers 
will clearly need to be accounted for any indices of systolic or diastolic function which are 
influenced by heart rate.  The indices will also require to be examined for any effect of 
these drugs independent of changes in heart rate. 
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3.5.1.3 LV Ejection Fraction distribution 
The distribution of left ventricular ejection fractions from all 225 patients is shown in 
Figure 3-12.  The mean ejection fraction was 48.8%, ranging from 37% to 81.25% with the 
median value being 47%. 
It can clearly be seen that the results are not normally distributed.  The long right tail in the 
histogram produces a skewness statistic of 0.977 with a standard error of 0.162 indicating a 
significant departure from symmetrical distribution.  This is due to the imposition of a 
lower limit for inclusion of 37% with no upper limit.  If a random sample of all studies 
performed were to be examined, a far more normal distribution would be expected. 
Figure 3-12 – Distribution of left ventricular ejection fraction in all resting control subjects 
 
 
The few extreme outliers with left ventricular ejection fractions in excess of 65%, the 95th 
centile for this group, are likely to represent a combination of patients with genuinely 
hypercontractile ventricles and those in whom technical issues may have artificially 
elevated the value.  If, for example, the left ventricular background region is not truly 
representative and gives an elevated estimate of background activity, the ejection fraction 
will be elevated also.  Excessively high ejection fractions are also commonly seen in 
patients with small hypertensive hearts.  Although systolic function is within the normal 
range, it tends to be overestimated as a result of the relatively low resolution of the scan. 
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Factors Affecting Left Ventricular Ejection Fraction 
In this group with left ventricular ejection fractions within the normal range, there was no 
correlation between either age (Figure 3-13) or heart rate (Figure 3-14) and left ventricular 
ejection fraction. 
Figure 3-13 – Age versus resting LV ejection fraction correlation in control subjects 
 
 
Figure 3-14 – Heart rate versus resting LV ejection fraction correlation in control subjects 
 
 
Although there is no apparent effect of heart rate on left ventricular ejection fraction, it is 
still necessary to consider the possibility of an effect from either rate limiting calcium 
channel blockers or beta blockers independent of the latter’s effect on heart rate.  The 
boxplot in Figure 3-15 shows a tendency for patients prescribed rate limiting calcium 
channel blockers to have a lower ejection fraction (mean 46.2%) than either those on no 
heart rate limiting therapy (mean 49.35%) or those prescribed a beta blocker (mean 
49.26%).  This is statistically significant for the comparison with no medication (p=0.038, 
independent samples T-test).  There is no difference between those prescribed beta 
blockers and those on no medication (p=0.945). 
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Figure 3-15 – LV ejection fraction - effect of heart rate limiting medication 
 
3.5.1.4 Correlates of Systolic and Diastolic Function 
LVEF and FTFF 
Although a close relationship can be demonstrated between left ventricular ejection 
fraction and peak filling and emptying rates, there is no such relationship between ejection 
fraction and first third fractional filling.  This is not only true for the group here with a 
preserved ejection fraction (Figure 3-16), the same lack of correlation is seen where 
systolic function is impaired (Figure 3-17).  These data are taken from the patient group 
used to assess the reproducibility of the RNVG parameters being used (see section 3.2). 
Figure 3-16 – LV Ejection Fraction / First Third Fractional Filling correlation at rest in control 
subjects 
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Figure 3-17 – LV Ejection Fraction / First Third Fractional Filling correlation with full range of 
ejection fractions 
 
 
First Third Fractional Filling and Heart Rate 
It has been recognised previously that first third fractional filling is related proportionally 
to heart rate and also that beta blockade appears to have an effect on this independent of its 
effect on heart rate.  The relationship between heart rate and first third fractional filling for 
the group as a whole is shown in Figure 3-18. 
Four different regression models have been used to try to define the relationship between 
first third fractional filling and heart rate – linear, logarithmic, quadratic and cubic.  
However, there is a significant degree of scatter about the line of best fit, especially at 
lower heart rates and it is therefore important to look separately at those whose heart rates 
have been lowered by either beta blockade or rate limiting calcium channel blockers. 
Figure 3-18 – First Third Fractional Filling relationship with heart rate 
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Within subgroups defined by heart rate limiting medication, we have already seen that the 
resting heart rate of the group on beta blockers was significantly lowered compared to no 
therapy.  Given the close inverse relationship between heart rate and first third fractional 
filling it is therefore to be expected that those on beta blockers will tend to have higher first 
third fractional filling than those not.  Mean first third fractional filling on no heart rate 
limiting therapy was significantly lower at 42.96%, compared to 53.552% for the beta 
blocker group, p<0.001 (independent samples t-test). 
As with heart rate, there is no significant difference in first third fractional filling between 
the rate limiting calcium channel blocker and no therapy group (means 45.19 vs 42.96, 
p=0.417).  The difference in first third fractional filling between calcium channel blockers 
and beta blockers was also highly statistically significant (p=0.006). 
When plotted within the subgroups of no medication, beta blockers and rate limiting 
calcium channel blockers, very similar relationships can be seen between heart rate and 
first third fractional filling (Figure 3-19).  This suggests that, at least within healthy 
individuals, there is no significant effect of beta blockers or rate limiting calcium channel 
blockers on first third fractional filling independent of the effect of these drugs on heart 
rate. 
Figure 3-19 – First Third Fractional Filling / Heart Rate relationship, including linear fit lines, 
within heart rate limiting medication subgroups 
 
The linear regression equations for these subgroup plots are shown in Table 3-30.  In 
combination with visual inspection of the data, there does not appear to be any significant 
different difference in first third fractional filling between subgroups of patients on 
different heart rate limiting drugs outwith the effect on heart rate.  It is therefore 
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unnecessary to consider patients on different cardiac medications separately when 
assessing FTFF. 
Table 3-30 – Linear regression of First Third Fractional Filling and heart Rate by heart rate 
limiting therapy 
 n Constant Coefficient (HR) Correlation Coefficient 
All subjects 225 108.4 -0.842 0.71 
No therapy 126 103.7 -0.784 0.65 
Beta blocker 63 126.9 -1.125 0.77 
RLCB 35 96.3 -0.676 0.60 
 
By using regression analysis to model the response of FTFF to changes in heart rate it is 
possible to attempt to correct FTFF such that effect of heart rate is minimised and patients 
can be better compared not only to a normal range, but also with themselves on repeated 
measurements.  Four candidate models are described in Table 3-31 and extrapolated 
beyond the heart rates observed in the control population data in Figure 3-20. 
Table 3-31 – Curve regression equations for rest supine First Third Fractional Filling 
Model R2 Equation 
Linear 0.498 FTFF = 108 - (HR x 0.84). 
Logarithmic 0.513 FTFF= 319 - (63.7 x ln(HR) 
Quadratic 0.516 FTFF = 160 - (2.22 x HR) + (0.009 x HR2) 
Exponential 0.510 FTFF = 185 x e-0.02xHR 
 
Although linear regression gives a reasonably good fit and an R2 value of 0.498, the model 
dictates that at a certain heart rate first third fractional filling will be zero and indeed will 
be negative above this threshold.  In the model generated by this data set, this will occur at 
a heart rate of 128 beats per minute, a physiologically possible heart rate.  This behaviour 
cannot hold true in the real world. 
Logarithmic regression gives a better fit to the observed data but, as with linear regression, 
this model predicts that first third fractional filling will ultimately fall to zero.  This occurs 
at heart rate of 144, still within the physiological normal range. 
The quadratic model more accurately describes what we expect to happen to FTFF in that 
it will not fall to zero or negative values.  It has a superior R2 value of 0.516 and has a 
visibly superior fit over the range of heart rates seen in this group.  However, the FTFF 
predicted by this equation begins to rise again after its plateau at a heart rate of 140.  This 
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is not what would be expected and it is clear the model is only valid within the range of 
resting heart rates observed. 
Figure 3-20 – Extrapolated First Third Fractional Filling / Heart Rate curves 
  
Compared to a linear model, the exponential model also has a superior R2 value at 0.510 
and behaves as expected both within the range of physiologically achievable heart rates 
and beyond.  Although this appears an attractive model, it is based on extrapolation from a 
relatively narrow spectrum of heart rates.  In order to create a valid model for how first 
third fractional filling behaves at levels above normal resting heart rates and to calculate an 
accurate correction factor and normal range it will be necessary to generate additional data 
by studying normal subjects during exercise (Section 3.5.2.3). 
First Third Fractional Filling and Age 
As can be seen from Figure 3-21 there is no relationship between first third fractional 
filling and age.  There is a wide spread of values seen at all ages.  The trend line for all 
patients irrespective of heart rate limiting drug therapy is essentially horizontal.  This also 
holds true when the subjects are divided into 10 year age bands (Figure 3-22). 
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Figure 3-21 – First Third Fractional Filling versus age in control subjects 
 
 
Figure 3-22 – First Third Fractional Filling in control subjects versus age in 10 year bands 
 
 
This lack of correlation with age remains when broken down into the drug therapy 
subgroups.  This demonstrates that it is not necessary to calculate an age specific normal 
range for first third fractional filling 
LVEF and PER, PFR 
It is reasonable to expect left ventricular ejection fraction to be directly related to peak 
emptying rate, as confirmed in Figure 3-23 (r2=0.61, p < 0.001).  Logically, as peak 
emptying rate falls the stroke volume must also fall, unless there is a proportional increase 
in the duration of systole to compensate for this. 
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Figure 3-23 – Relationship between left ventricular ejection fraction and peak filling rate 
 
 
The same does not necessarily hold true for peak filling rate.  Diastole occupies a greater 
proportion of the cardiac cycle.  It is therefore possible for the same total quantity of filling 
to allow a “normal” stroke volume to be spread over a greater time, resulting in a lower 
PFR.  Within this normal population, however, this does not occur and PFR has a strong 
linear relationship with ejection fraction as shown in Figure 3-24 (r2 = 0.48, p < 0.001). 
Figure 3-24 – Relationship between left ventricular ejection fraction and peak filling rate 
 
 
PER, PFR and Heart Rate 
As the duration of systole shortens in absolute terms but increases as a proportion of the 
cardiac cycle as heart rate increases, it is not unreasonable to expect that a parameter such 
as peak emptying rate, which is directly linked to the duration of systole, will show some 
relationship to heart rate.  This can be seen in Figure 3-25 where there is a modest inverse 
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relationship between PER and heart rate.  However, if PER is normalised to the duration of 
systole (PERst) rather than the entire cardiac cycle, this relationship is lost (Figure 3-26).  
It may, therefore, be more appropriate to use PERst, particularly when there is a significant 
difference between heart rates being compared.  However, the magnitude of scatter around 
the linear fit line is such that the heart rate effect with cycle length normalisation will be of 
no significance in clinical use. 
Figure 3-25 – Peak Emptying Rate (normalised to RR interval) versus Heart Rate 
 
 
 
Figure 3-26 – Peak Emptying Rate (normalised to systole duration) versus Heart Rate 
 
 
This inverse relationship is also seen with peak filling rate (Figure 3-27).  However, 
normalising PFR to diastole (PFRdt) rather than cardiac cycle length does not remove this 
association.  Conversely, it slightly strengthens it with the correlation coefficient rising 
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from 0.22 to 0.32 (Figure 3-28).  As a simple normal range would be independent of heart 
rate, this increase in heart rate dependency is the opposite of what is required. 
Figure 3-27 – Peak Filling Rate (normalised to RR interval) versus Heart Rate 
 
 
 
Figure 3-28 – Peak Filling Rate (normalised to diastole duration) versus heart rate 
 
 
3.5.1.5 Resting Normal Ranges 
First Third Fractional Filling 
If one were to disregard the clear heart rate dependency of first third fractional filling, it 
should be possible to express the normal range as the mean ± 2 standard deviations from 
our reference population. 
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With a mean of 46.33% and median of 44.85% first third fractional filling would appear to 
be normally distributed.  However, there are fewer results in the 60-70% range, resulting in 
a borderline skewed distribution (Figure 3-29). The skewness statistic is 0.313 which is 
less than 2 times the standard error of skewness 0.162.  The distribution, therefore, is 
normal and it is therefore appropriate to express the normal range for this as the mean ± 
2SD. 
By this method, the normal range for first third fractional filling is 46 ± 30.2, i.e. 15.8 to 
76.8.  This is such a wide range that it is unlikely to have any discriminatory power. 
Figure 3-29 – First Third Fractional Filling distribution within normal subjects 
 
 
Whilst a fixed reference range might be appropriate within a narrow range of heart rates it 
is clear both from the observed data within the reference population and the extrapolated 
exponential model that some account of heart rate must be taken.  There are three potential 
approaches to this. 
Individual Reference Ranges 
Individual reference ranges may be defined for narrow ranges of heart rates.  These ranges 
could be either 10 or 20 beats per minute wide.  This approach would have an advantage in 
that it would be simple to calculate these ranges, but would be likely to suffer from a 
scarcity of data at the upper and lower limits of what could be considered as a normal 
resting heart rate in a normal patient.  In this patient group only 4 subjects had a resting 
heart rate of <50 and 8 subjects had a heart rate >100.  These were merged into the 
adjacent groups as heart rate <60 and >90 respectively.  The tendency towards skewness 
when the group is taken as a whole disappears when grouped in this way.  The results for 
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these groups are shown in Table 3-32.  The normal range is the 5th to 95th centiles using a 
weighted average. 
Table 3-32 – Normal ranges for First Third Fractional Filling per 10 beat per minute heart rate 
interval 
HR (bpm) N Mean FTFF (%) SD Normal Range (%) 
<60 27 64.7 10.8 42.1-79.2 
60-69 66 53.1 12.5 34.1-76.4 
70-79 69 44.5 12.1 22.3-65.1 
80-89 38 36.8 7.8 24.9-53.4 
>90 25 28.1 8.0 16.6-43.0 
 
Continuous Reference Range FTFF 
It has already been shown that the observed reference population data may be best fitted to 
an exponential curve described by the equation FTFF = 185 x e-0.02xHR.  By plotting 2 
standard deviations on either side of the extrapolated curve a continuous reference range 
may be constructed.  A patient could then be dichotomised as normal or abnormal by 
plotting their FTFF on this graph.  The standard error for this curve was 0.001.  In a group 
of 225 patients this gives a standard deviation of 0.015.  The curves for +2SD and -2SD 
may therefore be expressed as 185 x e-0.017xHR and 185 x e-0.023xHR respectively.  These 
curves are plotted with the reference population data in Figure 3-30.  The curves are shown 
extrapolated to physiologically achievable heart rates with the reference data points 
omitted in Figure 3-31. 
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Figure 3-30 – Resting supine first third fractional filling normal range with reference data 
from normal population 
 
Broken lines represent ±  2 SEM, the upper and lower limit of the normal range 
 
A patient’s first third fractional filling result, along with heart rate, may then be plotted on 
this chart.  This will not only allow determination as to whether a patient falls outwith the 
limits of normality, but also by what extent. 
Figure 3-31 – Extrapolated supine resting FTFF continuous reference range 
 
Thick broken lines represent ±  2 SEM, the upper and lower limit of the normal range 
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Heart Rate Corrected FTFF 
A second approach using the reference equations derived above, is to use the equation for 
minus 2SD (FTFF = 185 x e-0.023xHR) to calculate the lower limit of normal for any given 
heart rate.  If a patient’s measured FTFF is lower than this calculated value, they can be 
deemed to be abnormal.  This may be less cumbersome than plotting the value on a chart. 
Peak Filling Rate 
Peak filling rate is not normally distributed.  The whole patient group has a skewness 
statistic of 0.842 with standard error of 0.162.  Mean and 2 standard deviations are 
therefore not appropriate to define the normal range.  This is better represented by the 
median and interquartile range.  For the whole group this is: 
Median 201.5 %EDC/cycle, interquartile range 162.2 – 265.1 
As peak filling rate shows a weak relationship to heart rate, it may also be appropriate to 
express its normal range as a series of normal ranges using the same heart rate subgroups 
used for first third fractional filling.  Within the heart rate subgroups, peak filling rate is 
normally distributed with the exception of the 60-69bpm group where this is skewed by 
several outliers with very high peak filling rates.  This can be seen in Figure 3-32.  The 
skewness statistic for this subgroup is 1.037 with standard error of 0.295. 
Figure 3-32 – Supine resting Peak Filling Rate (RR) distribution within heart rate subgroups 
of normal patients 
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As with first third fractional filling, the normal ranges shown in Table 3-33 are the 5th and 
95th centiles calculated using a weighted average.  Median and interquartile range is used 
for the 60-69 bpm heart rate subgroup. 
Table 3-33 – Normal ranges for Peak Filling Rate (normalised to RR interval) per 10 beat per 
minute heart rate interval 
HR (bpm) N Mean PFR(RR) SD Normal Range (%EDC/cycle) 
<60 27 230.9 47.9 145.9-335.0 
60-69 66 203.2 61.4 163.7-237.6 
70-79 69 196.4 40.3 124.5-270.8 
80-89 38 184.9 41.8 123.4-258.9 
>90 25 199.0 48.5 128.2-318.5 
 
Time to Peak Filling 
Time to peak filling, expressed as a proportion of the cardiac cycle length, is linearly 
related to heart rate with a correlation coefficient of 0.57.  This is shown in Figure 3-33.  It 
is, therefore, necessary to define normal ranges for Time to Peak Filling using the same 
heart rate subgroups already employed for first third fractional filling. 
Figure 3-33 – Relationship between Time to Peak Filling (RR) and heart rate 
 
 
As diastole shortens proportionally more than systole with increasing heart rate, one might 
expect the relationship between time to peak filling and heart rate to weaken if normalised 
to diastole duration rather than the whole cycle length.  However, the relationship is 
actually strengthened, and has a correlation coefficient of 0.71 (Figure 3-34). 
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Figure 3-34 – Relationship between Time to Peak Filling (normalised to diastole duration) 
and heart rate 
 
 
Within the 69-69 and 70-70 bpm heart rate subgroups, Time to Peak Filling has a skewed 
distribution.  The median and interquartile ranges are therefore used to define the normal 
ranges for these two subgroups as shown in Figure 3-35. 
Figure 3-35 – Normal ranges for Time to Peak Filling (normalised to RR interval) per 10 beat 
per minute heart rate interval 
HR (bpm) N Skewness Std Error Skewness 
Mean/Median 
ttPF(RR) 
Normal Range 
(cardiac cycles) 
<60 27 0.702 0.448 0.15 0.10-0.21 
60-69 66 0.759 0.295 0.19 0.15-0.19 
70-79 69 2.976 0.298 0.19 0.15-0.23 
80-89 38 0.53 0.383 0.21 0.10-0.35 
>90 25 0.589 0.464 0.28 0.16-0.44 
 
Peak Emptying Rate 
Peak emptying rate normalised to the cardiac cycle length (RR interval) shows a weak 
negative relationship with heart rate (correlation coefficient 0.2).  This was shown in 
Figure 3-25.  Normal ranges have, therefore, been calculated within heart rate subgroups 
and the group as a whole. 
Within the whole group, peak emptying rate has a skewed distribution with a skewness of 
0.786 (standard error 0.162).  The median value is 214.4 %EDC/cycle and interquartile 
range is 188.6 – 249.1. 
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Distribution is also skewed within several of the heart rate subgroups (Figure 3-36) and, 
where appropriate, median and interquartile range is used to define the normal ranges. 
Figure 3-36 – Peak Emptying Rate (RR) distribution within heart rate subgroups 
 
Figure 3-37  – Normal ranges for Peak Emptying Rate (normalised to RR interval) per 10 beat 
per minute heart rate interval 
HR (bpm) N Skewness Std Error Skewness 
Mean/Median 
PER(RR) 
Normal Range 
(%EDC/cycle) 
<60 27 0.727 0.448 231.3 175.6 – 323.0 
60-69 66 0.606 0.295 231.7 202.9 – 260.7 
70-79 69 1.155 0.289 206.2 187.1 – 226.4 
80-89 38 0.795 0.383 206.5 187.3 – 232.8 
>90 25 0.748 0.464 210.4 162.4 – 291.0 
 
3.5.2 Normal Ranges of Left Ventricular Function by Stress RNVG  
3.5.2.1 Patient Characteristics 
26 patients were recruited, 18 female, 8 male.  The mean age was 57 years, ranging from 
47 to 73. 14 patients had a history of hypertension.  3 patients were current smokers, 6 
were ex-smokers for greater than 1 year and the remaining 17 had never smoked.  No 
patients were diabetic.  The mean BMI was 27.8kg/m2, ranging from 21.3 to 39.6. 
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All patients had normal myocardial perfusion, determined by thallium scintigraphy 
performed on the same day as the stress RNVG.  Informed consent was obtained from 
these patients for this additional test.  Ethical approval for this was included in the overall 
study protocol. 
Medication and Heart Rate 
14 patients were taking no heart rate limiting medication.  7 patients were taking beta 
blockers and 5 patients were taking rate limiting calcium channel blockers.  The mean 
heart rates at rest and peak stress are summarised within these groups and within the entire 
cohort in Table 3-34.  Resting heart rate is significantly lower in the beta blocker group 
compared to the group of patients on no rate limiting medication (p = 0.013, independent 
sample T-test, equal variances demonstrated).  There is no significant difference in peak 
stress heart rates in these two groups (p = 0.237) or in change in heart rate from rest to 
stress on an individual patient basis (mean difference 1.93 bpm, p = 0.57).  As with supine 
resting studies (section 3.5.1), this significant difference in heart rate with beta blockade 
makes it very important to control for heart rate when considering highly heart rate 
dependent RNVG parameters such as first third fractional filling. 
Table 3-34 – Control stress RNVG patients mean heart rates (bpm) at rest and stress 
  Rate Limiting Medication 
 Whole group None Beta Blocker RLCB 
Rest 79.2 82.3 70.0 83.6 
Stress 130.7 135.8 125.4 123.6 
RLCB = Rate Limiting Calcium channel Blocker 
 
Resting heart rate has a skewed distribution (skewness statistic -1.187, standard error 
0.456, Figure 3-38).  As there are only 4 patients with resting heart rates less than 70 beats 
per minute, the heart rate subgroups initially defined in section 3.5.1.5 are not appropriate 
and the lower heart groups will be merged as a less than 70bpm group. 
Peak stress heart rate is normally distributed around a mean of 130.7 beats per minute.  By 
defining a 20 beat per minute group around this mean heart rate, and one group at either 
extreme of this range, 3 peak stress heart rate groups are defined.  These are < 120 bpm, 
120-140 bpm, and ≥ 140 bpm and contain 7, 12 and 7 patients respectively. 
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Figure 3-38 – Distribution of resting heart rates within control stress RNVG group 
 
 
3.5.2.2 Left Ventricular Ejection Fraction 
Erect Resting 
The mean resting erect left ventricular ejection fraction is 44%, ranging from 27.5% to 
79%.  The distribution is skewed (skewness statistic 1.174, standard error 0.456).  The 
interquartile range is 33.9% to 50.0%. 
10 of the 26 patients have a resting erect left ventricular ejection fraction of less than 40%, 
the previously defined lower limit of normal for supine ejection fraction.  This patient 
group was defined as normal on a clinical basis in conjunction with normal myocardial 
perfusion, rather than previously measured ejection fraction.  The apparent left ventricular 
systolic dysfunction may, therefore, represent low normal ejection fractions in otherwise 
healthy individuals.  The spread of erect ejection fractions is shown in Figure 3-39. 
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Figure 3-39 – Resting left ventricular ejection fraction distribution in stress RNVG control 
subjects 
 
 
Peak Stress 
The mean peak stress left ventricular ejection fraction was 46.6%.  The interquartile range 
was 40.4% to 50.5%. 
Response to Stress 
As a whole, the group showed a statistically non-significant increase in ejection fraction of 
2.6% (p = 0.183, paired samples T-test).  Individual ejection fraction responses can be seen 
in Figure 3-40.  There is a tendency for the highest and lowest resting left ventricular 
ejection fractions to converge to a midpoint.  The patient with the lowest resting ejection 
fraction showed the greatest rise with exercise, from 27.5% to 58.8%, and has one of the 
highest peak stress ejection fractions.  This would support the assumption that the patient 
population genuinely is normal, and that regression to the mean is occurring. 
A failure to increase ejection fraction with stress, or indeed a fall in ejection fraction, can 
indicate myocardial ischaemia.  This has been excluded here by the use of a more sensitive 
test, perfusion scintigraphy. 
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Figure 3-40 – Left ventricular ejection fraction change during stress RNVG in control 
subjects 
 
 
3.5.2.3 First Third Fractional Filling 
Erect Resting 
The relationship between first third fractional filling and heart rate seen with the larger 
supine control group is also seen in the rest erect subjects.  Due to the small numbers in 
even the reduced number of heart rate subgroups, use of a weighted average to calculate 5th 
and 95th centiles as the normal range is not possible.  The normal ranges quoted in Table 
3-35 are, therefore calculated as the mean ± 2 standard deviations.  The impact of small 
patient numbers is seen most clearly in the patients with a resting heart rate greater than 90 
beats per minute.  The standard deviation is particularly large with respect to the mean 
value, resulting in a lower limit of normal of only 0.4%. 
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Table 3-35 – Normal ranges for resting erect First Third Fractional Filling per 10 beat per 
minute heart rate interval 
HR (bpm) N Mean FTFF SD Normal Range (%) 
<70 4 50.8 6.7 37.4 – 64.2 
70-79 6 34.7 4.4 25.9 – 43.5 
80-89 13 26.9 6.1 14.7 – 39.1 
>90 3 26.6 13.1 0.4 – 52.8 
 
Peak Stress 
A continued decline in first third fractional filling is seen with increasing heart rate with 
stress.  The mean values and lower limits of normal in Table 3-36 again highlight the 
problem with the greater than 90 bpm rest erect subgroup. 
Table 3-36 – Normal ranges for erect peak stress First Third Fractional Filling by heart rate 
subgroup 
HR (bpm) N Mean FTFF SD Normal Range (%) 
<120 7 28.5 9.0 10.5 – 46.5 
120-140 12 25.0 5.7 13.6 – 36.4 
>140 7 20.2 5.7 8.8 – 31.6 
 
The difference in FTFF between the highest and lowest heart rate groups at peak stress is 
less than that seen between the groups at rest (Table 3-35).  This is precisely what is 
predicted by the extrapolated exponential curves shown in Table 3-33.  If the values 
obtained for rest and peak stress are considered together, that is as a heart rate/FTFF co-
ordinate in one group regardless of whether or not the patient was exercising, the data 
behaves as predicted by the exponential curves defined in section 3.5.1.4.  This is shown in 
Figure 3-41. 
Continuous Reference Range 
By considering the group as a whole, enough data points are produced to attempt curve 
regression analysis to produce the same graphs as those for the supine control subjects.  An 
exponential curve gives a similar correlation coefficient compared to linear regression (r = 
0.539 versus r = 0. 585).  As previously discussed, an exponential curve behaves in a more 
biologically plausible manner within physiological heart rates.  The regression equation for 
this patient group is FTFF = 52.8 x e-0.006xHR.  The standard error was 0.001, giving 
regression equations of   FTFF = 52.8 x e-0.004xHR and FTFF = 52.8 x e-0.008xHR for the upper 
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and lower limits of normal respectively.  These are shown in Figure 3-41 with the 
reference data included. 
Figure 3-41 – Erect First third fractional filling normal range with combined rest and stress 
reference data from control subjects.  Broken lines represent ±  2 SEM 
 
 
Response to Stress 
As would be expected from the relationship of first third fractional filling to heart rate, and 
the rise in heart rate which accompanies stress, FTFF falls with stress.  With a mean 
increase in heart rate of 51.4 beats per minute there is a 7.7 point fall in FTFF.  The 
individual responses are shown in Figure 3-42.  Although the majority of subjects show the 
predicted fall in FTFF, a small number, those with the lowest resting values, show a rise in 
FTFF with exercise.  There is a mean decrease in first third fractional filling by 0.143 
points per 1 beat per minute rise in heart rate. 
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Figure 3-42 – Individual control patients’ First Third Fractional Filling responses to stress 
 
3.5.2.4 Peak Filling Rate (RR) 
Erect Resting 
As with the supine control group (section 3.5.1.5), peak filling rate normalised to the RR 
interval shows a skewed distribution.  The skewness statistic is 1.086 with standard error 
0.456.  The normal range, defined by median and interquartile range is: 
Median 148.6 %EDC/cycle, interquartile range 113.9 – 178.4 
In view of the weak relationship with heart rate, rest erect PFR(RR) has been analysed in 
the previously defined heart rate groups for this group.  Peak filling rate is normally 
distributed within each of these subgroups.  The normal ranges quoted are the mean ± 2 
standard deviations. 
Table 3-37 – Normal ranges for erect resting Peak Filling Rate (normalised to RR interval) by 
heart rate subgroup 
HR (bpm) N Mean PFR(RR) SD Normal Range (%EDC/cycle) 
<70 4 179.7 52.6 74.5-284.9 
70-79 6 136.2 22.9 90.4-182.0 
80-89 13 132.8 33.2 66.4-199.2 
>90 3 244.1 39.7 164.7-323.5 
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Peak Stress 
At peak stress, peak filling rate is normally distributed with a skewness statistic of 0.367.  
The mean peak filling rate is 208.9 and standard deviation 45.8.  The normal range, 
defined by 5th and 95th centiles by weighted average, is 124.2 to 308.2.  Within the heart 
rate subgroups for peak stress, peak filling rate remains normally distributed. 
Table 3-38 – Normal ranges for erect peak stress Peak Filling Rate (normalised to RR 
interval) by heart rate subgroup 
HR (bpm) N Mean PFR(RR) SD Normal Range (%EDC/cycle) 
<120 7 187.4 40.3 106.8-267.8 
120-140 12 222.9 52.8 117.3-328.5 
>140 7 209.1 30.4 148.3-269.9 
 
Response to Stress 
With the exception of 2 patients, peak filling rate increases on stress.  This is shown in 
Figure 3-43.  For every 1 beat increase in heart rate, PFR increases by 1.14 points. 
Figure 3-43 – Individual control patients’ Peak Filling Rate responses to stress 
 
3.5.2.5 Time to Peak Filling 
Erect Resting 
Time to peak filling showed a strong positive correlation with heart rate in the supine 
control group.  It has, therefore, again had normal ranges defined for the heart rate 
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subgroups seen within this control group at rest.  These are shown in Table 3-39 and are 
calculated as the mean ± 2 standard deviations.  The large standard deviations in all 
subgroups other than the <70bpm group unfortunately render most of the normal ranges of 
little value. 
Table 3-39 – Normal ranges for erect resting Time to Peak Filling (normalised to RR interval) 
by heart rate subgroup 
HR (bpm) N Mean ttPF(RR) SD Normal Range (cardiac cycles) 
<70 4 0.182 0.01 0.162-0.202 
70-79 6 0.181 0.067 0.047-0.315 
80-89 13 0.271 0.109 0.053-0.489 
>90 3 0.278 0.103 0.072-0.481 
 
Peak Stress 
The peak stress normal ranges for ttPF at peak stress (Table 3-40) share the problems seen 
with rest erect.  This is due to the combination of an index that has a high inherent degree 
of variability and a small data set.  Time to peak filling is, therefore, unlikely to be either a 
reproducible or useful parameter. 
Table 3-40 – Normal ranges for erect peak stress Time to Peak Filling (normalised to RR 
interval) by heart rate subgroup 
HR (bpm) N Mean ttPF(RR) SD Normal Range (cardiac cycles) 
<120 7 0.229 0.096 0.037-0.421 
120-140 12 0.274 0.06 0.154-0.394 
>140 7 0.271 0.058 0.155-0.387 
 
Response to Stress 
As might be predicted from the above figures, the response of ttPF is not consistent.  
Approximately one third of the subjects show a fall with stress and there is no particular 
pattern seen with either high or low initial values.  This is illustrated in Figure 3-44. 
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Figure 3-44 – Individual control patients’ Time to Peak Filling responses to stress 
 
 
3.5.2.6 Peak Emptying Rate 
Erect Resting 
Whilst peak emptying rate showed a weak negative correlation with heart rate in the supine 
position, the opposite is seen whilst erect (Figure 3-45).  The correlation coefficient is 0.18.  
It is possible this is due to the smaller sample size and two outliers with unusually high 
peak emptying rates and heart rates above 90 bpm, as peak stress shows a very weak 
negative correlation (correlation coefficient 0.1).  Normal ranges for peak emptying rate 
will therefore be defined for the group as a whole and within heart rate subgroups. 
Figure 3-45 – Relationship between rest erect Peak Emptying Rate and heart rate in control 
subjects 
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The distribution is slightly skewed (skewness 1.047, standard error 0.456) in the group as a 
whole.  The median and interquartile ranges are, therefore, used to define the normal range 
in preference to mean ± 2 standard deviations.  The median is 196.1 %EDC/cycle, and 
interquartile range 160.7 – 243.2 
Within the heart rate subgroups distribution is normal.  The mean ± 2 standard deviations 
are, therefore used below to define the normal ranges within these subgroups (Table 3-41).  
The effect of the outliers in the greater than 90bpm heart rate group can be clearly seen. 
Table 3-41– Normal ranges for erect resting Peak Emptying Rate (normalised to RR interval) 
by heart rate subgroup 
HR (bpm) N Mean PER(RR) SD Normal Range (%EDC/cycle) 
<70 4 221.0 39.0 143.0-299.0 
70-79 6 190.9 36.4 118.1-263.7 
80-89 13 184.1 45.8 92.5-275.7 
>90 3 330.0 57.8 214.4-445.6 
 
Peak Stress 
Peak emptying rate is normally distributed within the group as a whole and within the heart 
rate subgroups.  For the whole group the mean is 175.9 %EDC/cycle and standard 
deviation is 44.5, giving a normal range of 86.9 – 264.9.  The normal ranges for the heart 
rate subgroups are shown in Table 3-42. 
Table 3-42– Normal ranges for erect peak stress Peak Emptying Rate (normalised to RR 
interval) by heart rate subgroup 
HR (bpm) N Mean PER(RR) SD Normal Range (%EDC/cycle) 
<120 7 160.3 26.3 107.7-212.9 
120-140 12 190.5 51.5 87.5-293.5 
>140 7 154.3 30.7 92.9-215.7 
 
Response to Stress 
There is a mean decrease of 32.3 points from rest to peak stress, a decrease of 0.9 per beat 
per minute increase in heart rate.  This is illustrated in Figure 3-46. 
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Figure 3-46 – Individual control patients’ Peak Emptying Rate responses to stress 
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4. Results 
4.1 Demographics 
83 patients completed the study protocol.  60 of these patients were recruited 
prospectively, the remaining 23 by retrospective identification from open access 
echocardiography sessions.   Summary data are presented in Table 4-1.  The study 
population, in keeping with previous studies of diastolic dysfunction is predominantly 
female, elderly (mean age 66.7), overweight and hypertensive.  It is perhaps surprising that 
nearly 50% had never smoked and, of the 42 patients who had, only 9 of these were still 
smoking.  The most likely explanation for this is selection bias.  Patients who are 
motivated sufficiently about their own health to request investigations for unexplained 
dyspnoea and to agree to participate in clinical research are presumably those for whom 
not smoking forms an essential part of their health conscious lifestyle. 
Resting ECGs were normal in 61 of the 83 patients.  For the summary statistics resting 
ST/T wave abnormalities and minor intraventricular conduction defects have been 
classified as a minor abnormality, LVH with or without strain and bundle branch block has 
been classified as a major abnormality.  All patients were in sinus rhythm. 
All of the study patients with the exception of 3 had symptoms compatible with NYHA 
class 2.  The remaining 3 (3.6%) patients had class 3 symptoms. 
Table 4-1 – Summary demographic details of all study patients 
  Percentage 
Age (mean, min/max) 66.7 (39 / 80)  
Sex (M/F) 15 / 68 18.1% / 81.9% 
BMI (kg/m2) (mean, min/max) 31.3 (20.3 / 42.0)  
Hypertension (Y/N) 60 / 23 72.3% / 27.7% 
Mean Systolic BP 150 mmHg  
Mean Diastolic BP 83 mmHg  
Diabetes (Y/N) 11 / 72 13.3% / 86.7% 
Smoker (Never/Ex/Current) 41 / 33 / 9 49.4% / 39.8% / 10.8% 
ECG (Normal/Minor/Major abnormality) 61 / 20 / 2 73.5% / 24.1% / 2.4% 
NYHA Class (Mean) 2  
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Table 4-2 – Summary demographics of prospectively recruited study patients 
  Percentage 
Age (mean, min/max) 66.6 (39/80)  
Sex (M/F) 10/50 16.7% / 83.3% 
BMI (kg/m2) (mean, min/max) 31.1 (20.3 / 42.0)  
Hypertension (Y/N) 42 / 18 70% / 30% 
Mean Systolic BP 151 mmHg  
Mean Diastolic BP 84 mmHg  
Diabetes (Y/N) 6 / 54 10% / 90% 
Smoker (Never/Ex/Current) 31 / 24 / 5 51.7% / 40% / 8.3% 
ECG (Normal/Minor/Major abnormality) 46 / 12 / 2 76.7% / 20% / 3.3% 
NYHA Class (Mean) 2  
 
4.1.1 Hypertension 
Hypertension was both highly prevalent and poorly controlled.  46 patients had systolic 
blood pressures greater than 140mmHg at rest.  This is the threshold for grade 1 
hypertension as defined in the 2004 British Hypertension Society guidelines(180).  35 of 
these patients had an established diagnosis of hypertension suggesting that, on the whole, 
blood pressure control, even in this motivated patient group, is suboptimal.  Of the 
remaining 11, 3 had systolic blood pressures greater than 160mmHg, a level which if 
sustained, would mandate treatment under the current British Hypertension Society 
guidelines. 
4.1.2 Resting Heart Rate 
To facilitate comparison between patients who were either relatively bradycardic or 
tachycardic at rest, the following cut-offs were defined.  Bradycardia was defined as a 
resting heart rate less than 60 beats per minute.  As there were so few patients with a 
resting heart rate greater than 100, statistical tests on this subgroup would be meaningless.  
Tachycardia was, therefore, defined as a resting heart rate of 90 beats per minute or 
greater.  Even with this less stringent classification of tachycardia, only 5 patients have 
resting heart rates of 90 beats per minute or greater.  The remaining central group was 
divided into two groups with heart rates of 60-74 and 75-89 beats per minute. 
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Table 4-3 – Study Patients Heart Rate Groups 
Heart Rate N Percent 
<60 17 20.5 
60-74 36 43.4 
75-89 25 30.1 
>90 5 6.0 
Total 83  
 
Table 4-4 – Supine Resting Control Patients Heart Rate Groups 
Heart Rate N Percent 
<60 27 12 
60-74 112 49.8 
75-89 61 27.1 
>90 25 11.1 
Total 225  
 
4.1.3 Drug Therapy 
A summary of the cardiac and respiratory drugs being taken by the study patients at the 
time of enrolment is shown in Table 4-5.  In keeping with the diagnosis of suspected heart 
failure, one third of patients were being treated with a loop diuretic in the form of 
frusemide.  One third of patients were receiving either an ACE inhibitor or an angiotensin 
receptor blocker.  No patients were receiving both agents. 
Table 4-5 – Cardiorespiratory drugs therapy taken by study patients at time of enrolment 
Drug Number taking (%) 
Frusemide 27 (32.5%) 
ACE Inhibitor 20 (24.1%) 
Angiotensin Receptor Blocker 10 (12%) 
Beta Blocker 26 (31.3%) 
Calcium Channel Blocker Non-rate limiting - 11 (13.3%) 
Rate limiting - 4 (4.8%) 
Thiazide Diuretic 27 (32.5%) 
Other anti-hypertensive therapy 9 (10.8%) 
Aspirin 28 (33.7%) 
Oral nitrate 3 (3.6%) 
Statin 28 (33.7%) 
Bronchodilators 5 (6%) 
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4.2 Echocardiography 
4.2.1 Left Ventricular Dimensions 
Complete left ventricular dimension measurements were available on all except 2 patients 
who were poorly echogenic.  In one patient only measurement of diastolic dimensions was 
possible, in the other patient neither systolic nor diastolic measurements were possible.  
Left ventricular mass and end diastolic dimensions were, therefore, assessable in 82 of 83 
patients. 
The mean left ventricular end diastolic diameter (LVEDD) was 44.6mm with all patients 
being within the normal limit of 57mm.  48 patients had left ventricular hypertrophy by 
wall thickness criteria with either the septum or posterior wall being greater than 11mm in 
diastole on the parasternal long axis view. 
Left ventricular mass index (LVMI) was calculated by dividing left ventricular mass 
(measured on the parasternal long axis view) by body surface area.  Previously published 
normal ranges(181) were used for males and females.  The upper limit of normal for males 
was 96g/m2, for females 76.5g/m2.  8 of 15 (53%) males and 48 of 68 females (70.6%) had 
left ventricular hypertrophy by these criteria.  43 of those with left ventricular hypertrophy 
by wall thickness also had hypertrophy by LVMI.  In contrast, 14 of the 56 patients with 
left ventricular hypertrophy by LVMI had wall thicknesses within the normal range.  This 
highlights the fact that, although LVMI is more cumbersome in that it requires a 
contemporaneous height and weight, approximately 1 in 4 patients with left ventricular 
hypertrophy will otherwise be missed.  Overall 67.5% of the patients had a left ventricular 
mass index above the upper limit of normal for their sex.  This is illustrated in Figure 4-1. 
Since hypertension and left ventricular hypertrophy are associated with diastolic 
dysfunction, it is to be expected that their prevalence is high in a patient group suspected of 
having diastolic dysfunction. 
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Figure 4-1 – Distribution of left ventricular mass index by sex 
Broken lines represent upper limits of normal for males and females 
 
4.2.2 Left Ventricular Systolic Function 
All patients had normal left ventricular systolic function by visual assessment.  All except 
2 patients had an ejection fraction calculable by the Teicholtz method.  Whilst this has its 
limitations, it is an acceptable measure of left ventricular ejection fraction where left 
ventricular geometry is normal.  It is only valid where there are no regional wall motion 
abnormalities that will be under or overrepresented by measuring basal wall motion on the 
parasternal long axis view.  Calculation of ejection fraction by Simpson’s biplane method 
was also attempted.  As left ventricular opacification contrast was not available, only 26 of 
the 83 patients had echocardiographic images with sufficiently good endocardial definition 
to allow calculation of ejection fraction by Simpson’s biplane method. 
The mean left ventricular ejection fraction by the Teicholtz method was 77% and 63.9% by 
Simpson’s rule.  The difference between the two was highly statistically significant (p 
<0.001, paired samples T-test).  There was no significant correlation between left 
ventricular ejection fraction measured by the two methods (Pearson correlation coefficient 
0.11, p=0.62).  In only 1 patient was the Teicholtz ejection fraction less than 50%.  In this 
patient it was not possible to calculate an ejection fraction by Simpson’s rule.  The ejection 
fraction was, however, normal by radionuclide ventriculography. 
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4.2.3 The Left Atrium 
4.2.3.1 Antero-Posterior Diameter 
The left atrial antero-posterior (AP) diameter was measured in all 83 patients.  The mean 
was 36.1mm, ranging from 23.9 to 48.6.  16 patients had a left atrial diameter greater than 
40mm.  Left atrial AP diameter did not correlate significantly with any other index of 
elevated left atrial pressure (Table 4-6).  As continuous variables, however, left atrial 
diameter did correlate significantly with left ventricular mass index (Pearson correlation 
coefficient 0.4, p<0.001) and left atrial volume index (Pearson correlation coefficient 0.5, 
p=0.008) 
Table 4-6 – Correlation between left atrial dilatation by antero-posterior diameter and other 
indices of left atrial pressure dichotomised as normal or abnormal. 
 Spearman Correlation Coefficient 
p 
Elevated LA Volume Index 0.11 0.59 
LVH by LV Mass Index 0.19 0.08 
Hypertension 0.18 0.10 
E/A Ratio  -0.11 0.32 
Abnormal E/E’ Septal ratio 0.15 0.17 
Abnormal E/E’ Lateral ratio 0.13 0.24 
 
4.2.3.2 Left Atrial Volume Index 
Left atrial volume index (LAVI) was retrospectively calculated in a subset of 27 patients.  
The mean LAVI was 26.4ml/m2, ranging from 8.7 in a patient with an AP diameter of 
27mm to 41.8 ml/m2.  In 8 of the 27 patients LAVI was above the upper limit of normal for 
gender (30ml/m2 in females, 33ml/m2 in males).  There was no significant correlation 
between left atrial dilatation by AP diameter and by LAVI (Spearman correlation 
coefficient 0.11, p=0.59).  There was a moderate correlation between a dilated left atrium 
by LAVI and an elevated septal E/E’ ratio (Table 4-7). 
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Table 4-7 – Correlation between left atrial dilatation by left atrial volume index and other 
indices of left atrial pressure 
 Spearman Correlation Coefficient p 
Elevated LA AP Diameter 0.11 0.59 
LVH by LV Mass Index 0.23 0.25 
Hypertension -0.1 0.59 
E/A Ratio  0.24 0.22 
Abnormal E/E’ Septal ratio 0.4 0.04 
Abnormal E/E’ Lateral ratio 0.25 0.2 
 
4.2.4 Indices of Diastolic Function 
Mitral E/A ratio, deceleration time and isovolumetric relaxation time were obtained in all 
patients.  Septal diastolic mitral annular velocity (E’ sep) was not evaluable in one patient 
due to poor quality Doppler signals. 
Table 4-8 – Mean Echocardiographic Results 
 Mean 
Ejection Fraction (Teich) 76.2% 
LV Mass Index 95.3g/m2 
LA A-P Diameter 36.7mm 
LA Volume Index 24.6ml/m2 
E/A Ratio 0.9 
E/E’ Lateral 11.3 
E/E’ Septal 14.9 
Mitral DT 229ms 
IVRT 103ms 
 
4.2.4.1 E/E’ Ratio 
Using the criteria defined by Ommen et al(32) where mean left ventricular diastolic 
pressure could be categorised as normal (E/E’ ratio <8), equivocal (E/E’ 8-15) and elevated 
(E/E’ >15) using the septal E/E’ ratio, 36 of the patients have evidence of elevated filling 
pressures.  All patients who had a septal E/E’ ratio in the abnormal range, also had an 
abnormal lateral annulus E/E’ ratio. 
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Table 4-9 – Tissue Doppler E/E’ ratios in study patients 
E/E’ Ratio 
 
<8 8-15 >15 
N 
Septal 5 41 36 82* 
Lateral 17 55 11 83 
*Septal annular velocity was not obtained on 1 patient 
Although both septal and lateral ratios have a large number of subjects within the 8-15 
equivocal category, there are a significantly higher number of subjects falling into the 
abnormal category.  The E/E’ ratio is significantly higher using the septal ratio by a mean 
of 3.59 (p<0.001, paired samples T-test).  The lateral E/E’ ratio has a very high proportion 
of patients which fall into the equivocal range.  The lateral mitral annular velocity does, 
however, have advantages in that it is easier to obtain and is more reproducible than the 
septal velocity.  
The lateral annular ratio has also been used to predict elevated filling pressures with a cut-
off ratio of 10 yielding optimal sensitivity of 78% and specificity of 95%(49).  By this 
criterion 48 patients (57.8%) had a pulmonary capillary wedge pressure of >12mmHg. 
By combining the Ommen and Nagueh criteria it should be possible to utilise the 
reproducibility of the lateral ratio with the septal cut-offs that acknowledge the degree of 
imprecision inherent in the technique.  This is summarised in Table 4-10.  The results were 
wholly concordant in 39 of 82 patients (septal E/E’ was not available for one patient) with 
only 5 patients having normal filling pressures by both criteria.  Of the 41 patients with 
equivocal filling pressures by the Ommen criteria (septal E/E’ 8-15), 14 of these were 
confirmed as having elevated filling pressures by the Nagueh criteria.  In only 2 patients 
were the results discordant with septal E/E’ being <8 and lateral E/E’ >10.  This may be 
explained by the technical disadvantages of the septal annulus measurement.  Inadvertent 
anterior angulation of the echo probe whilst measuring the septal E’ velocity may cause the 
view to move from 4 chamber to 5 chamber with the result that the pulsed wave sample 
volume partially includes the left ventricular outflow tract. 
Overall, 48 patients can be classified as having impaired diastolic function by the E/E’ 
ratio.  The only patient in whom a septal E/E’ ratio was not recorded on either the first or 
second echocardiogram had a lateral ratio of 9.13 and is therefore classified as normal. 
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Table 4-10 – Combined Ommen and Nagueh E/E’ Criteria 
 Frequency Percent 
Both Positive 34 41.5 
Nagueh Positive, Ommen Equivocal 14 17.1 
Nagueh Negative, Ommen Equivocal 27 32.9 
Both Negative 5 6.1 
Nagueh Negative, Ommen Positive 2 2.4 
Total 82 100.0 
 
4.2.4.2 Standard Doppler 
Assessment of diastolic function by pulsed wave Doppler alone has partly fallen by the 
wayside in favour of more sophisticated techniques using tissue Doppler.  However, the 
indices derived from this – mitral E/A ratio, mitral deceleration time and isovolumetric 
relaxation time, are readily obtained and reported.  The E/A ratio, in particular, continues 
to be quoted as an indicator of diastolic function.  The criteria used here (Table 4-11) are 
those quoted in the 1998 rather than 2007 iteration of the recommendations of the 
European Study Group on Diastolic Heart Failure.  This is due to the shift in focus away 
from these parameters in the current guidelines.  Routine clinical practice, however, has yet 
to make the same shift and the previous guidelines remain in use.   In this patient group no 
patients were aged less than 30 years old.  The guidelines can therefore be simplified by 
removing the IVRT cutoff of 95ms for the under 30 age group. 
Table 4-11 – Simplified 1998 European Study Group criteria for diastolic dysfunction 
Age (yrs) IVRT 
(ms) 
E/A ratio DT (ms) 
30 – 50 >100 <1.0 >220 
>50 >105 <0.5 >280 
 
By these criteria only 2 patients had an abnormal E/A ratio, 13 had an abnormal mitral 
deceleration time and 36 an abnormal IVRT.  All 3 parameters were normal in 44 patients.  
A single parameter was abnormal in 28 patients, 2 of 3 abnormal in 10 patients and all 3 
abnormal in 1 patient.  If an additional category of equivocal E/A ratio is introduced for 
those aged over 50 years with an E/A ratio between 0.5 and 1.0, an additional 61 patients 
can be categorised as having borderline abnormal diastolic function. 
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This apparent lack of diastolic dysfunction is in stark contrast to the results obtained from 
tissue Doppler where 48 of the 83 patients had abnormal diastolic function.  The poor 
specificity inherent in these parameters, which has led to their less prominent role in 
current guidelines, necessitates more extreme cutoff values and a drop in sensitivity. 
4.2.4.3 Reproducibility of Echo Criteria 
81 of the 83 patients completing investigations underwent a second echocardiogram, 
primarily by the same second operator (JJ – 57 patients) with a minority by other operators 
(LF – 10, AMC – 7, others – 7).  The operator performing the study carried out the analysis 
of each echo.  The reproducibility of the following measures of diastolic function was 
assessed along with the left ventricular ejection fraction (Teicholtz method): Lateral and 
septal E/E’ ratio, mitral E wave velocity, mitral E/A ratio, mitral deceleration time and 
isovolumetric relaxation time.  The reproducibility of left ventricular ejection fraction by 
Simpson’s biplane method was not assessed as too few patients were able to have this 
measured on both studies.  The mean time between studies was 69.6 days with a range of 0 
to 330.  
Table 4-12 – Inter-observer correlation of echocardiographic indices of diastolic and 
systolic function 
  Mean N Std. Deviation Correlation Sig. 
Operator 1 11.1 60 3.81 
E/E’ lat 
Operator 2 10.4 60 3.95 
0.48 <0.001 
Operator 1 14.7 60 4.78 
E/E’ sep 
Operator 2 12.4 60 4.59 
0.49 <0.001 
Operator 1 0.74m/s 79 0.18 
MV E 
Operator 2 0.77m/s 79 0.20 
0.64 <0.001 
Operator 1 0.88 79 0.26 
E/A 
Operator 2 0.93 79 0.28 
0.69 <0.001 
Operator 1 228ms 77 61.49 
MV DT 
Operator 2 226ms 77 57.58 
0.38 0.001 
Operator 1 105ms 70 20.10 
IVRT 
Operator 2 110ms 70 21.62 
0.27 0.029 
Operator 1 77.0% 76 9.07 
EF Teich 
Operator 2 72.6% 76 8.02 
0.21 0.08 
 
It is to be expected that there is a degree of correlation between the two results for each 
parameter given it is simply a repeat measurement and there was no significant clinical 
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change observed in any of the patients between the two studies.  The strength of correlation 
here reflects a combination of biological variability in each of the parameters and their ease 
of measurement.  It can be seen from Table 4-12 that the two parameters with the strongest 
correlation and, hence, greatest inter-study reproducibility are the E/A ratio and mitral E 
wave velocity.  These are the simplest parameters to measure, requiring only a peak 
velocity to be marked at 2 points on a spectral Doppler trace.  The E/E’ ratio is also 
relatively simple to measure although does present more technical difficulties in terms of 
obtaining an adequate tissue Doppler signal. 
The difference between first and second operator is significant for the septal E/E’ ratio and 
left ventricular ejection fraction by the Teicholtz technique (Table 4-13).  The difference 
for isovolumetric relaxation time approaches, but does not achieve, statistical significance 
(p=0.07) 
Table 4-13 – Differences in inter-observer measurements of echocardiographic indices of 
diastolic and systolic function (paired samples T-test) 
95% Confidence Interval of the 
Difference  Mean Difference Std. Deviation 
Lower Upper 
Sig. 
(2-tailed) 
E/E' lat 0.65 3.98 -0.37 1.68 0.21 
E/E' sep 2.35 4.74 1.12 3.57 <0.001 
MV E -0.02m/s 0.16 -0.06 0.01 0.19 
E/A -0.04 0.21 -0.09 0.01 0.12 
MV DT 2.78ms 66.5 -12.32 17.88 0.72 
IVRT -5.57ms 25.2 -11.57 0.44 0.07 
EF Teich 4.33% 10.8 1.86 6.80 0.001 
 
4.3 NT-proBNP 
N-terminal proBNP samples were obtained in 82 of the 83 study patients.  These were 
obtained and stored as previously described.  Once all samples were collected, they were 
processed in a single batch to eliminate the assay as a source of variability within the 
results.  In the one remaining patient, a NT-proBNP sample was obtained in September 
2008 in the context of very frequent hospital admissions with dyspnoea and chest pain.  
The level of this was 45pg/ml, below the reference level of 100pg/ml. 
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NT-proBNP rises with increasing age and with comorbidities such as hypertension and 
renal dysfunction that also increase in incidence with advancing age.  It can, therefore, be 
viewed either in terms of dichotomous cut points, or as a continuous variable.  A single age 
cutoff of 75 years has been used here with NT-proBNP levels of 125pg/ml and 450pg/ml 
being the upper limits of normal for age less than 75 years and age 75 years old or greater, 
respectively. 66 of 82 patients were aged 75 years or less, 16 patients were 75 years or 
older. 
Using these values, 61 of 82 patients had normal NT-proBNP levels for their age.  One of 
these patients was reassessed in February 2007 and found to have an elevated NT-proBNP 
level of 224pg/ml.  All 21 patients with an elevated NT-proBNP level were aged less than 
75 years old and, therefore used the 125pg/ml upper limit of normal.  The median NT-
proBNP level within this group was 185pg/ml, ranging from 127pg/ml to 871pg/ml.  When 
the patients with a normal NT-proBNP are compared to those with an elevated level by 
means of an independent samples T-test, most indices one would expect to be abnormal in 
light of an elevated NT-proBNP show no significant difference (Table 4-14).  The E/A 
ratio is marginally higher in those with an elevated NT-proBNP (1.01 compared to 0.84) 
although, this is of borderline statistical significance and does not take account of age 
related changes in the E/A ratio. 
However, the resting heart rate is significantly lower in those with an elevated NT-
proBNP.  This can be explained by the higher proportion of patients with an elevated NT-
proBNP who are being treated with beta blockers (13 of 21 versus 13 of 61, p = 0.001, Χ2 
test). 
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Table 4-14 – Characteristics of patients with elevated or normal NT-proBNP levels 
 NT-proBNP N Mean Std. Deviation Sig.(2-tailed) 
Normal 61 66.7 9.11 
Age (years) 
Elevated 21 66.0 5.87 
0.69 
Normal 61 31.32 5.05 
BMI (kg/m2) 
Elevated 21 31.29 4.11 
0.98 
Normal 61 45.43 9.85 
LV Ejection Fraction (%) 
Elevated 21 44.25 7.19 
0.62 
Normal 61 0.84 0.19 
Mitral E/A ratio 
Elevated 21 1.01 0.37 
0.05 
Normal 61 10.91 3.85 
E/E’ Lateral 
Elevated 21 12.38 5.10 
0.171 
Normal 60 14.75 5.06 
E/E’ Septal 
Elevated 21 15.30 3.93 
0.65 
Normal 61 96.32 23.28 
LV Mass Index (kg/m2) 
Elevated 21 90.73 26.50 
0.36 
Normal 61 151.34 25.36 
Systolic BP (mmHg) 
Elevated 21 146.43 20.56 
0.43 
Normal 61 83.95 11.08 
Diastolic BP (mmHg) 
Elevated 21 80.24 9.93 
0.18 
Normal 61 76.64 14.48 
Resting Heart Rate (bpm) 
Elevated 21 66.33 10.01 
0.003 
Normal 22 24.52 9.27 
LA Volume Index (ml/m2) 
Elevated 5 25.19 7.99 
0.88 
Normal 61 36.49 5.58 
LA diameter (mm) 
Elevated 21 35.03 5.14 
0.3 
Normal 60 44.59 5.01 
LV End Diastolic Diameter (mm) 
Elevated 21 44.52 4.92 
0.96 
Normal 61 4.93 4.24 Thallium Reversible Ischaemia 
Score Elevated 21 4.95 4.30 
0.99 
Normal 52 9.57 3.21 
VO2 max (ml/kg/min) 
Elevated 19 9.73 3.09 
0.85 
Normal 52 52.51 14.22 
VO2 max (% predicted) 
Elevated 19 57.20 15.22 
0.23 
Normal 60 100.83 18.23 
FEV1 (% predicted) 
Elevated 21 95.90 18.87 
0.29 
Normal 60 95.05 10.06 
FEV1/FVC (% predicted) 
Elevated 21 93.24 7.88 
0.46 
 
In this group, NT-proBNP does not discriminate between normal and abnormal even when 
these indices of diastolic dysfunction are considered as categorical, rather than continuous, 
variables.  Only an abnormal E/E’ lateral ratio shows a relationship with elevated NT-
proBNP (Table 4-15) which approaches statistical significance.  Here, 16 of 21 patients 
with elevated NT-proBNP have an abnormal E/E’ ratio compared to 32 of 61 patients with 
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a normal NT-proBNP.  It would be reasonable to assume that this would reach significance 
in a larger group.  The relatively poor performance of the septal E/E’ ratio is due to the 
large group of patients with an equivocal result.  A trend can be seen, however, within the 
abnormal NT-proBNP group with 3, 7 and 11 patients having a normal, equivocal or 
abnormal E/E’ septal ratio respectively.  The results are summarised in Table 4-15 where 
the Chi-Square test is used throughout. 
Table 4-15 – Association between abnormal NT-proBNP and indices of abnormal diastolic 
function (Chi-Square test) 
 P value 
Abnormal Supine FTFF 0.45 
LA dilatation (AP diameter) 0.4 
LA dilatation (LAVI) 0.57 
LVH by LV mass index 0.78 
Abnormal E/A ratio 0.19 
Abnormal E/E’ Lateral 0.06 
Abnormal E/E’ Septal 0.49 
 
As a continuous variable, NT-proBNP has a skewed distribution with the majority of 
subjects having a level of less than 100pg/ml and one extreme outlier with a level of 
871pg/ml.  This is shown in Figure 4-2.  Other than resting heart rate, which becomes non-
significant when controlled for beta blocker use, there is no statistically significant 
correlation between NT-proBNP level as a continuous variable and the indices previously 
examined in Table 4-14.  There are, however, two indices which have weak correlations 
which approach statistical significance.  Age has a Pearson correlation coefficient of 0.2 at 
a significance level of 0.07 indicating a trend towards rising NT-proBNP with increasing 
age.  Body mass index shows a weak negative correlation with NT-proBNP with a 
correlation coefficient of -0.21 and p value of 0.054.  This association has been observed 
previously in patients without heart failure(182, 183).  More recently, reduced natriuretic 
peptide levels have been demonstrated in individuals with features of the metabolic 
syndrome, independent of body mass index(184).  The direction of causality is not yet 
clear.  Activation of the renin-angiotensin system by low natriuretic peptide levels may 
cause insulin resistance.  Conversely, adipose tissue contains high concentrations of 
natriuretic peptide clearance receptors(185) which remove natriuretic peptides from the 
circulation. 
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Figure 4-2 – Distribution of NT-proBNP levels within study patients 
 
4.4 Spirometry 
4.4.1 Definition of COPD 
Airflow obstruction, the underlying mechanism for the symptoms of chronic obstructive 
pulmonary disease, can be described in simple terms using two parameters derived from 
spirometry.  These are the Forced Expiratory Volume in 1 second (FEV1), usually 
expressed as a percentage of the value predicted by age and sex; and the FEV1:FVC ratio 
with FEV1 usually being expressed as a percentage of the forced vital capacity.  Although 
these two parameters do not provide the detailed information, such as total lung volume 
and functional residual capacity, required to characterise the gas trapping and 
hyperinflation seen in obstructive diseases, and the reduced lung volumes of restrictive 
diseases such as pulmonary fibrosis, they are sufficient as a screening test. 
As a single parameter, FEV1 may allow respiratory function to be characterised as normal 
or abnormal to varying degrees.  The FEV1:FVC ratio adds a degree of refinement to this 
by separating subjects into either obstructive (<70%) or restrictive physiology (ratio in 
normal range of 75-80%).  A number of severity classification scales have been produced 
with some placing weight on the patients’ symptoms.  Whilst there were significant 
differences previously, the more recently issued joint American Thoracic Society / 
European Respiratory Society guidelines harmonise many of these and introduce a 
smoother grading scale, albeit with arbitrarily defined cut-off points.  Three of these scales 
are summarised in Table 4-16.  It should be noted that both the GOLD and ATS/ERS 
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scales do not define an upper boundary between mild airflow obstruction and normality.  
These criteria are intended primarily for obstructive lung disease which will, by definition, 
have an FEV1:FVC ratio of <70% thus delineating normal from abnormal respiratory 
function. 
Table 4-16 – Staging Criteria for Obstructive Lung Disease 
 ATS / ERS (2005) BTS / SIGN (2004) GOLD (2003) 
Stage FEV1 (%) FEV1 (%) FEV1 (%) Symptoms 
I (mild) > 70 50-80 ≥ 80 ± 
II (moderate) 60-69 30-49 50-79 + 
IIb (moderately severe) 50-59    
III (severe) 35-49 < 30 30-49 ++ 
IV (very severe) <35  <30 +++ 
 
Subjects with an abnormal FEV1:FVC ratio but FEV1 within the normal range, >80% 
predicted by British Thoracic Society 2004 guidelines represent an interesting subgroup.  
In subjects with definite obstructive airways disease an increase in morbidity and mortality 
is seen compared to normal subjects.  In apparently healthy subjects, in whom the 
abnormality is detected as a part of screening, it is of uncertain significance with more 
detailed pulmonary function testing identifying disease in some.  In others, it is thought to 
represent a physiological variant. 
4.4.2 Results 
Spirometry results were available in 82 of the 83 patients.  Two classifications will be used 
here to describe the result.  The first is a simple division into normal or abnormal 
respiratory function with an FEV1:FVC ratio of <70% being the cut-off.  These are then 
classified as to severity of airflow obstruction using the ATS/ERS criteria.  Spirometry was 
normal in 58 patients and abnormal in 24.  Of these, 20 had mild airflow obstruction and 4 
had moderate.  Of the 40 patients who had never smoked, 31 had normal spirometry and 9 
had mild airflow obstruction. 
4.5 Myocardial Perfusion 
With the exception of patient 100, all patients underwent routine gated planar thallium 
scanning with a stress/redistribution protocol.  Patient 100 underwent SPECT scanning, 
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also using thallium with a stress/redistribution protocol, at another local hospital less than 6 
months prior to recruitment.  It was not felt to be ethically justifiable to repeat the 
perfusion scan within this timescale for the sole purpose of the study. 
4.5.1 Exercise Tolerance Test 
Details of the exercise tolerance test were available for all patients other than the patient 
who underwent SPECT scanning.  Of the remaining 82 patients, 76 underwent bicycle 
stress and 6 underwent vasodilator stress with dipyridamole at 0.56mg/kg.  The resting 
ECG was normal in 61 of 83 patients.  There were minor ST or T wave changes in 12 
patients and a minor intraventricular conduction defect in 8 patients.  The full breakdown 
is shown in Table 4-17. 
Table 4-17 – Resting ECG types in study patients 
 N Percent 
Normal 61 73.5 
Resting ST/T abnormality 12 14.5 
Minor IVCD 8 9.6 
RBBB 1 1.2 
LVH 1 1.2 
 
Only 2 stress tests were electrically positive with planar ST depression of 1.5mm.  32 tests 
were negative and 48 were classified as inconclusive.  This was on the basis of failure to 
achieve target heart rate, or ST depression which was either upsloping or less than 1mm in 
magnitude.  The mean exercise test duration was 3 minutes 44 seconds, ranging from 2 
minutes 40 seconds to 7 minutes.  The mean rate-pressure product at peak stress for those 
undergoing bicycle stress was 24917, ranging from 8200 to 39750.  This was normally 
distributed. 
4.5.2 Thallium Scan 
All scans were reported by a single operator (WM).  Both stress and redistribution scans 
were scored for defect size and depth using the previously described 5 segments per 
projection model.  The difference between the stress and redistribution scans, the 
ischaemia score, was classified on the following basis: 0-4 – no significant perfusion 
abnormality (NSPA), 5-8 – minor ischaemia, >8 – definite ischaemia.  The differentiation 
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between minor and definite ischaemia is made in the basis that small, usually partially 
reversible, perfusion defects are often associated with angiographically normal coronary 
arteries.  Although 46 of the 83 patients had myocardial perfusion within normal limits, 17 
patients had evidence of minor ischaemia, and 20 had significant reversible ischaemia 
demonstrated.  The highest ischaemia score was 16, representing a large area of ischaemia.  
The mean stress perfusion score and overall ischaemia scores are shown in Table 4-18.  
The stress perfusion scores are significantly higher than the ischaemia scores by virtue of 
the fact that the former does not take account of attenuation artefact.  Attenuation artefact 
is particularly common in women due to breast tissue.  It is usually possible to differentiate 
this fixed defect from infarcted myocardium by its preserved regional wall motion and 
typical location. 
Table 4-18 – Study patient thallium myocardial perfusion results 
 N Mean Stress Score 
Mean Ischaemia 
Score 
No significant perfusion abnormality 46 6.93 1.65 
Minor ischaemia 17 11.71 6.94 
Definite ischaemia 20 15.75 10.75 
 
A detailed breakdown of the myocardial perfusion scans showing definite ischaemia is 
given in Table 4-19.  There were only 2 troponin positive acute coronary syndromes 
documented in this group, one occurring 2 years post scan, the other 5 years post.  The first 
of these patients was the only patient in the entire cohort to undergo coronary 
revascularisation.  This took place after a second acute coronary syndrome and repeat 
angiography which showed progression of previously non-obstructive right coronary artery 
disease.  Perfusion scintigraphy had shown an antero-apical perfusion defect with 
substantial reversibility and had been attributed to left anterior descending artery disease. 
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Table 4-19 – Detailed breakdown of myocardial perfusion scans showing definite ischaemia 
and subsequent coronary events 
ID Date Scan 
Stress 
Score 
Ischaemia 
Score 
Predicted 
Territory ACS Angio PCI 
1 16/05/03 9 9 RCA N N N 
5 10/06/03 18 16 LAD N N N 
15 13/08/03 14 9 LAD N 15/2/08 N 
19 22/10/03 18 8 LAD N N N 
25 12/11/03 16 12 LAD N N N 
32 06/02/04 14 14 RCA N 4/6/04 N 
35 27/02/04 13 12 RCA N N N 
40 04/02/04 12 9 LAD N N N 
43 18/02/04 26 12 RCA N N N 
51 12/03/04 16 9 LCx N N N 
56 23/03/04 17 14 RCA N N N 
57 07/05/04 16 10 RCA N N N 
63 26/05/04 21 9 LAD N N N 
65 16/04/04 14 9 LAD N N N 
67 23/06/04 21 16 RCA N N N 
68 22/06/04 18 9 LAD N N N 
71 09/07/04 10 10 RCA N N N 
78 25/08/04 22 9 RCA N N N 
79 01/09/04 10 9 LAD 10/7/06 17/7/06 14/4/07 (RCA) 
87 29/09/04 10 10 RCA 22/11/09 N N 
ACS = Acute Coronary Syndrome; Angio = Coronary angiography; PCI = Percutaneous Coronary Intervention 
Figure 4-3 shows the stress and rest scintigraphy from patient ID number 32 with a large 
reversible perfusion defect in the inferior, septal and apical regions (ischaemia score 14).  
Reverse redistribution can be seen in the anterior wall (70° LAO projection).  Coronary 
angiography 2 months following this scan showed only plaque disease in the first diagonal 
artery.  No acute coronary events were documented in a 6 year follow-up period for this 
patient. 
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Figure 4-3 – Stress and rest myocardial scintigraphy from patient with large reversible 
inferior, septal and apical perfusion abnormalities 
 
The results of these scans were provided to each patient’s General Practitioner along with a 
recommendation for changes in drug therapy or referral to clinic if appropriate.  Only 4 of 
the cohort of 83 patients underwent coronary angiography between the date of their scan 
and January 2010.  Of these patients, 1 had possible ischaemia and 3 had definite 
ischaemia on thallium scanning.  One of the 3 patients with definite ischaemia went on to 
have percutaneous revascularisation 31 months after their thallium scan.  This particular 
patient had suffered a troponin positive acute coronary syndrome 22 months after their 
scan with angiography at that point showing non-obstructive disease. 
A total of 4 patients suffered an acute coronary syndrome during this extended follow-up 
period.  These events occurred at 22 months (definite ischaemia), 24 months (minor 
ischaemia), 44 months (no ischaemia), and 61 months (definite ischaemia). 
One patient was confirmed to have died, 61 months after the scan was performed.  This 
was due to a non-cardiac cause (pancreatitis).  The vital status of 5 patients could not be 
confirmed by searching either local hospital records or laboratory databases which 
included blood samples collected by local General Practitioners.  
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4.5.3 Lung Uptake of Thallium 
Elevated lung uptake of thallium on stress has been independently associated with adverse 
cardiovascular prognosis in a number of situations.  These include left ventricular systolic 
dysfunction(186), following coronary artery bypass grafting (187), and in patients with 
myocardial perfusion defects even in the absence of reversibility (188).  Lung uptake was 
assessed visually by a single operator (WM) using a semi-quantitative scale: none, mild, 
moderate, or severely increased uptake. 
There was no lung uptake in 38 patients, mild uptake in 33, moderate in 8 and severely 
increased uptake in 4 patients.  Perfusion scintigraphy from one of the patients (patient 67, 
see also Table 4-19) with severely increased lung uptake of thallium is shown in Figure 
4-4.  In this patient there is a large perfusion defect on stress affecting the septum, apex 
and infero-septal walls which shows substantial reversibility.  Across the whole group, 
however, lung uptake did not correlate significantly with thallium stress or ischaemia 
scores, left ventricular ejection fraction, left atrial diameter or volume index, NT-proBNP 
level, E/E’ ratio (either septal or lateral), age, or smoking history.  Of borderline statistical 
significance was a weak negative correlation with VO2 max (Pearson correlation 
coefficient -0.22, p=0.06), left ventricular mass index (Pearson correlation coefficient -
0.21, p=0.054), and a weak positive correlation with body mass index (Pearson correlation 
coefficient 0.19, p=0.09). 
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Figure 4-4 – Stress and rest thallium scintigraphy in a patient with severely increased lung 
uptake of thallium and large reversible infero-septal and apical perfusion abnormality. 
 
4.6 Resting Radionuclide Ventriculography 
4.6.1 Left and Right Ventricular Systolic Function 
Although all patients had a normal left ventricular ejection fraction as determined by visual 
qualitative assessment at echocardiography, 27 of the 83 patients had a radionuclide 
ejection fraction below the 40% lower limit of normal in routine clinical use at this 
institution.  Of these, 16 patients had ejection fractions of between 35% and 40% 
indicating borderline left ventricular dysfunction.  Local inter-study reproducibility has 
previously been estimated at ± 3% meaning 9 patients with ejection fractions of 37-40% 
may be classified as normal on repeat scanning.  The lowest measured ejection fraction 
was 30%, corresponding to mild systolic dysfunction.  The mean ejection fraction was 
44.95%.  Although the data are not normally distributed, being skewed to the right, median 
ejection fraction is the same at 44%.  The distribution of ejection fractions is shown in 
Figure 4-5. 
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Figure 4-5 – Left ventricular ejection fraction by RNVG distribution in study patients 
 
No significant differences were seen between the pre-defined heart rate subgroups.  
Although the difference in left ventricular ejection fraction between those with a resting 
heart rate of less than 60 and those in the 75-89 group approaches statistical significance 
with a p value of 0.076, this trend is not seen with the heart rate greater than 90 group.  
This may be because there are only 5 patients with a resting heart rate greater than 90, thus 
impairing the statistical power of any tests applied to this group. 
Right ventricular ejection fraction has also had a lower limit of normal of 40% defined by 
this particular RNVG technique.  Applying the same criteria as for left ventricular ejection 
fraction, 30 patients had a normal right ventricular ejection fraction, 43 abnormal, and 10 
equivocal (37-40%).  The mean right ventricular ejection fraction was 38.4%, ranging from 
19.5% to 81%.  If, however, the group of patients used to define the normal supine resting 
range for left ventricular systolic and diastolic function in Chapter 3 are used to define a 
normal range for the right ventricle, a lower limit of 27% is arrived at (5th centile, weighted 
average).  By this criterion, right ventricular ejection fraction was abnormal in only 11 of 
83 patients.  It should be borne in mind that these patients were selected on the basis of 
normal left ventricular function, rather than right ventricular.  It should also be considered 
that measurement of right ventricular function by RNVG is more challenging than the left 
ventricle. This is due to the close proximity of the right ventricle to the liver which often 
interferes with background region of interest creation.  Any under or overestimate of 
background activity secondary to this can have a substantial effect on ejection fraction. 
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However, accepting these limitations, right ventricular ejection fraction is lower than 
predicted in this group as only 4 patients should have an ejection fraction below the 5th 
centile.  This, therefore, suggests that right ventricular systolic dysfunction may be a 
contributing factor in the symptomatology of these patients.  It is also interesting that the 
only significant correlation with right ventricular ejection fraction is left ventricular 
ejection fraction (R=0.35, p=0.001). 
4.6.2 Left Ventricular Diastolic Function 
4.6.2.1 First Third Fractional Filling 
By applying the heart rate corrected lower limit of normal equation described in section 
3.5.1.5, FTFF = 185 x e-0.023xHR , it is possible to categorise the resting supine FTFF of each 
patient as normal or abnormal.  By this criterion, first third fractional filling was normal in 
53 of 83 patients, and abnormal in 30.  The precise spread of results is shown in Figure 4-6 
where the broken lines represent the upper and lower limits of normal. 
Figure 4-6 – Rest supine left ventricular first third fractional filling in study patients 
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4.6.2.2 Peak Filling Rate 
By using the heart rate subgroup normal ranges defined in section 3.5.1.5, 18 of the 83 
patients had an abnormally low peak filling rate as determined by the lower limits of 
normal defined for each heart rate subgroup previously.  As can be seen in Table 4-20, the 
majority of these are accounted for by the 60-69 bpm subgroup which has a substantially 
higher lower limit of normal than the other groups.  This, however, is almost identical to 
the lower limit of the interquartile range when heart rate is disregarded.  By using the 
interquartile range to define normality 32 of the 83 patients have an abnormally low peak 
filling rate. 
Table 4-20 – Rest supine peak filling rate (normalised to RR interval).  Normal versus 
abnormal results by heart rate subgroup 
HR (bpm) Lower Limit of Normal Normal Abnormal 
<60 145.9 16 1 
60-69 163.7 13 12 
70-79 124.5 22 2 
80-89 123.4 10 2 
>90 128.2 4 1 
 
4.6.2.3 Time to Peak Filling 
As time to peak filling showed a strong positive correlation with heart rate, it has been 
analysed exclusively by heart rate subgroup.  A total of 17 patients had a time to peak 
filling below the lower limit of normal.  As with peak filling rate, the majority of these 
occurred within the 60-69bpm heart rate range.  This may simply be coincidence as there is 
little overlap between the patients who had abnormal diastolic function by the two criteria.  
Only 4 subjects had both abnormal peak filing rate and time to peak filling. 
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Table 4-21 – Rest supine tine to peak filling (normalised to RR interval).  Normal versus 
abnormal results by heart rate subgroup 
HR (bpm) Lower Limit of Normal Normal Abnormal 
<60 0.10 16 1 
60-69 0.15 11 14 
70-79 0.15 22 2 
80-89 0.10 12 0 
>90 0.16 5 0 
 
4.6.3 Visual Assessment of Diastolic Filling Curves 
Much as it is possible to visually assess left ventricular systolic function on 
echocardiography, it is also possible to gain an impression of diastolic function by 
inspecting the activity time curve from RNVG.  Although this qualitative assessment has 
been eschewed in favour of the quantitative first third fractional filling, it may be of use in 
routine practice if the two correlate well.  The author undertook blinded assessment of the 
left ventricular activity-time curves of each of the 83 patients.  These were graded as either 
normal or abnormal on the basis of subjectively slow early diastolic filling.  This was 
performed a total of three times, separated by at least 1 hour to minimise recall bias, for 
each of the curves.  The third iteration was used to resolve any discrepancy between the 
first two.  The process was carried out with both background subtracted and non-
background subtracted curves since FTFF is derived from the former and it is the latter 
which is displayed on screen routinely.  The activity-time curves used for visual 
assessment were the same curves from which the supine resting first third fractional filling 
was calculated. 
Visual assessment of ventricular filling correlated well with quantitative assessment using 
both types of curves, although agreement was better with non-background subtracted 
curves.  The Chi-Square statistic for non-background subtracted curves was 30.5, p < 
0.001, and was 7.6, p = 0.006 for background subtracted curves.  The relative performance 
of the two can be seen in Table 4-22 and Table 4-23.  
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Table 4-22 – Visual assessment of diastolic function using non-background subtracted left 
ventricular activity-time curves versus first third fractional filling 
   Quantitative supine resting FTFF 
   Normal Abnormal Total 
N 46 8 54 
Normal 
% abnormal supine 
resting FTFF 86.8% 26.7% 65.1% 
N 7 22 29 
Visual 
assessment 
Abnormal 
% abnormal supine 
resting FTFF 13.2% 73.3% 34.9% 
 
Table 4-23 – Visual assessment of diastolic function using background subtracted left 
ventricular activity-time curves versus first third fractional filling 
   Quantitative supine resting FTFF 
   Normal Abnormal Total 
N 47 19 66 
Normal 
% abnormal supine 
resting FTFF 88.7% 63.3% 79.5% 
N 6 11 17 
Visual 
assessment 
Abnormal 
% abnormal supine 
resting FTFF 13.2% 36.7% 20.5% 
 
4.7 Stress RNVG 
4.7.1 Exercise Details 
72 of the entire group of patients were able to undergo stress RNVG.  The mean duration 
and haemodynamic responses are summarised in Table 4-24.  Although the initial 
workload was reduced below the initial workload of the thallium stress test, several 
patients only managed to complete 3 minutes of stress.  In all cases this was due to the 
combination of the expired gas collection mouthpiece and close proximity to the gamma 
camera being too cumbersome to tolerate for any longer. 
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Table 4-24 – Summary of study patient stress RNVG details 
 Mean Range 
Duration (seconds) 424.8 180-720 
Peak Heart Rate (bpm) 119.9 80-170 
Change in Heart Rate (bpm) 44.2 6-81 
Peak Systolic Blood Pressure (mmHg) 190.2 135-262 
 
4.7.2 Left Ventricular Ejection Fraction 
The mean rest erect left ventricular ejection fraction was 42.7%, ranging from 27.3% to 
66.5%.  On stress this rose by a mean 2.9% to 45.6%.  This was statistically significant 
with a p value of 0.002 (paired samples T-test).  The individual responses to exercise are 
shown in Figure 4-7.  Although the majority do exhibit the expected increase in ejection 
fraction with stress, several show a fall.  This was also seen in the control group where it 
was attributed to a limitation of the technique as myocardial ischaemia had already been 
excluded in this group by perfusion imaging.  A total of 27 of 72 patients in the study 
group showed a fall in left ventricular ejection fraction with exercise.  16 of these occurred 
within the group with no significant perfusion abnormality.  In the group with definite 
myocardial ischaemia, 10 patients showed an increase in ejection fraction whereas only 
one showed a fall.  This is summarised in Table 4-25. 
 
Table 4-25 – Response of left ventricular ejection fraction to stress depending on thallium 
scan result in study patients 
Ischaemia on Thallium Perfusion 
 
None Minor Definite Total 
Rise 26 9 10 45 
LV Ejection fraction 
Fall 16 5 6 27 
 Total 42 14 16 72 
 
 
Andrew C McCulloch, 2009  Chapter 4, 216 
 
Figure 4-7 – Left ventricular ejection fraction response to stress in study patients 
 
The relative failure of ejection fraction to increase on stress does not appear to be 
attributable to the continued use of beta blockers in 22 of the 72 patients (Table 4-26).  
Although resting and peak stress heart rate is significantly lower in those patients taking 
beta blockers, the rise in heart rate is not.  There is no significant difference in the resting, 
peak stress or change in ejection fraction between those beta blocked and those not 
(individual samples T-test). 
Table 4-26 – Response of heart rate and left ventricular ejection fraction during stress RNVG 
depending on beta blockade 
 No ß Blocker ß Blocker p 
Resting heart rate (bpm) 80.5 65.7 <0.001 
Change heart rate (bpm) 46.7 104.4 <0.001 
Resting LV EF (%) 43.4 41.3 0.26 
Change LV EF (%) 3.1 2.4 0.67 
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The most likely explanation for this ejection fraction behaviour is the combination of 
upright exercise and the manual single region of interest technique used to define the left 
ventricle here.  In contrast to supine exercise, left ventricular end diastolic volume 
increases with erect exercise.  The manual single ROI technique underestimates ejection 
fraction by underestimating background counts contributed by mediastinal structures.  As 
end-diastolic volume increases with exercise, the background ROI moves further away 
from the mediastinum, further underestimating background activity and reducing the 
apparent ejection fraction further.  By this mechanism, the expected rise in ejection 
fraction with exercise may be attenuated or even reversed. 
4.7.3 Right Ventricular Ejection Fraction 
Mean right ventricular ejection fraction was 33.2% at rest which rose by 3.8% to 37% at 
peak stress.  This was also statistically significant with a p value of 0.004. 
4.7.4 First Third Fractional Filling 
By applying the lower limit of normal equation derived for the control stress patients in 
section 4.2.3.3 (FTFF = 52.8 x e-0.008xHR) it is possible to categorise the observed FTFF at 
stress and rest in each patient as normal or abnormal.  At rest 38 of the 72 patients (53%) 
undergoing stress RNVG had abnormal erect first third fractional filling.  This is greater 
than the proportion who had abnormal resting supine FTFF (36%).  At peak stress, only 25 
patients (35%) were categorised as abnormal.  22 patients who were abnormal at rest fell 
back within the normal range at peak exercise.  9 patients who were normal at rest became 
abnormal on stress.  An example of this is shown in Figure 4-8 where there is visible 
attenuation of the rate of ventricular filling in early to mid diastole.  Of those who showed 
no change in status, 16 remained abnormal and 25 remained within the normal range. 
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Figure 4-8 – Background subtracted left ventricular activity-time curves at rest and peak 
stress from patient with normal first third fractional filling at rest which becomes abnormal 
on stress 
 
4.7.5 Peak Filling Rate 
Peak filling rate at both rest and stress fell within the normal range for the majority of 
study subjects.  By using the interquartile range for erect resting, 7 patients fell outwith the 
normal range.  The same number were defined as abnormal using the heart rate subgroups 
(Table 4-27). 
Table 4-27 – Rest erect peak filling rate in study patients by heart rate subgroup 
HR (bpm) Lower Limit of Normal Normal Abnormal 
<70 74.5 24 0 
70-79 90.4 14 2 
80-89 66.4 17 0 
>90 164.7 7 5 
 
At peak stress only 1 patient fell outwith the normal range using the heart rate subgroups 
(Table 4-28).  Using the 5th centile as a cutpoint for the whole group only 3 patients were 
abnormal.  The apparent disparity in results between first third fractional filling and peak 
filling rate is likely to be secondary to the wide normal ranges for peak filling rate reducing 
its sensitivity below a useful level. 
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Table 4-28 – Peak erect stress peak filling rate in study patients by heart rate subgroup 
HR (bpm) Lower Limit of Normal Normal Abnormal 
<120 106.8 35 0 
120-140 117.3 23 1 
>140 148.3 13 0 
 
4.7.6 Time to Peak Filling 
Similar numbers of patients are found to be abnormal by time to peak filling at rest (Table 
4-29) and peak stress (Table 4-30) as was the case with peak filling rate.  Again, this very 
low yield of patients with abnormal results likely reflects the weakness identified in this 
parameter by virtue of its very wide normal range. 
Table 4-29 – Rest erect time to peak filling in study patients by heart rate subgroup 
HR (bpm) Lower Limit of Normal Normal Abnormal 
<70 0.162 22 5 
70-79 0.047 16 0 
80-89 0.053 17 0 
>90 0.072 11 1 
 
Table 4-30 – Peak erect stress time to peak filling in study patients by heart rate subgroup 
HR (bpm) Lower Limit of Normal Normal Abnormal 
<120 0.037 35 0 
120-140 0.154 24 0 
>140 0.155 12 1 
 
 
4.8 VO2 Assessment 
Of the 72 patients who underwent stress RNVG, it was possible to perform VO2 max 
testing on 69 of these.  Only 6 of these patients did not reach anaerobic threshold during 
exercise.  The level of peak oxygen consumption achieved was, on the whole, low.  The 
spread of results is shown in Figure 4-9.  However, maximal oxygen consumption is age 
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and gender dependent.  The lower limit of normal for the average female of age 70-79 
years old is 20ml/kg/min which adds a degree of perspective to the results.  The mean VO2 
max achieved was 9.6ml/kg/min.  This ranged from 4.7 to 21ml/kg/min. 
What is more useful is to examine is the achieved percentage of the predicted VO2 max for 
each patient’s age and gender (Figure 4-10).  The group achieved an average of 53.8% of 
their predicted VO2 max, ranging from 30.3% to 92.3%. 
Figure 4-9 – Distribution of VO2 max results in study patients 
 
 
Figure 4-10 – Distribution of VO2 max results as percentage of predicted 
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4.8.1 Correlates of VO2 Max 
There was only a weak positive correlation between exercise duration and percentage of 
predicted VO2 max achieved (correlation coefficient 0.23, p=0.059).  This is shown in 
Figure 4-11. 
Figure 4-11 – Correlation between exercise duration and percentage of predicted VO2 max 
achieved 
 
There was no significant correlation between percentage VO2 max achieved and the other 
measured indices of respiratory function, FEV1 and FEV1/FVC.  In addition, there was no 
correlation in this patient group with left ventricular ejection fraction, the E/E’ ratio, the 
E/A ratio, thallium ischaemia score or body mass index. 
4.8.2 Anaerobic Threshold 
VO2 at anaerobic threshold was assessed in the same manner as VO2 max, that is expressed 
as a percentage of the age and gender specific normal achieved.  The mean percentage 
achieved was 42.2%, ranging from 24% to 81%.  The spread of results (Figure 4-12) is 
similar to that seen with VO2 max.  As with VO2 max there is no significant correlation 
with left ventricular ejection fraction, the E/E’ ratio, the E/A ratio, thallium ischaemia 
score, body mass index, or other indices of respiratory function. 
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Figure 4-12 – Distribution of VO2 at anaerobic threshold results as percentage of predicted 
 
 
 
4.9 Resting First Third Fractional Filling as a Reference 
Standard 
4.9.1 Rationale 
The lack of a single, universally accepted, gold standard for diastolic function means that it 
is necessary to adopt a reference standard from the parameters assessed here.  The other 
parameters may then be compared to this.  Its performance may, in part, assessed by the 
prevalence of conditions such as left ventricular hypertrophy and hypertension where 
diastolic dysfunction might be expected.  The resting supine left ventricular first third 
filling fraction has been chosen as this reference standard as it is this that is most widely 
available.  First third fractional filling at peak stress will be considered separately to assess 
whether this performs better.  Due to the heart rate dependency of FTFF, it has been 
dichotomised as normal or abnormal as described in section 4.6.2.1. 
4.9.2 Correlation With Predictors of Diastolic Dysfunction 
4.9.2.1 Sex 
Although diastolic dysfunction, or heart failure with preserved ejection fraction, is 
predominantly a condition affecting females, this may be due to a higher prevalence of 
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ischaemic heart disease and systolic dysfunction in men.  In this group there was no 
association between abnormal FTFF and female sex (p = 0.4, Χ2 test). 
4.9.2.2 Hypertension 
A history of hypertension was present in 23 of the 30 patients with an abnormal resting 
FTFF (76.7%), and in 37 of the 53 patients (69.8%) with a normal FTFF.  There was no 
evidence of a significant correlation (p = 0.34, Fisher’s Exact Test).  In those with a 
systolic blood pressure of 160mmHg or greater at rest, irrespective of an established 
history of hypertension, the findings were similar with 13 of 30 (43.3%) of hypertensive 
patients having diastolic dysfunction and 20 of 53 (37.7%) having normal diastolic 
dysfunction.  Again, although there is a slightly higher prevalence of hypertension in 
patients with abnormal resting FTFF, this did not achieve statistical significance (p = 0.39, 
Fisher’s Exact Test). 
Table 4-31 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and either history of hypertension or presence of systolic blood pressure ≥  
160mmHg 
  Supine Resting FTFF 
  Normal Abnormal Total 
No 16 7 23 
History of hypertension 
Yes 37 23 60 
No 33 17 50 
Uncontrolled BP 
Yes 20 13 33 
 
4.9.2.3 Obesity 
Although there is an association between obesity and diastolic dysfunction(189, 190), this 
is not seen with resting first third fractional filling (Table 4-32).  The difference between 
those with normal and abnormal FTFF is not significant over the spectrum of obesity seen 
(p = 0.52, Chi-square test). 
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Table 4-32 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and obesity (body mass index) 
  Supine Resting FTFF 
  Normal Abnormal Total 
<25 7 3 10 
25-30 12 10 22 
30-35 25 10 35 
BMI 
>35 9 7 16 
 
4.9.2.4 Left Atrial Size 
Left atrial size, dichotomised as normal or dilated at an antero-posterior diameter of 40mm, 
shows no significant correlation with abnormal resting first third fractional filling (p = 
0.59, Fisher’s Exact Test).  The proportion of patients with dilated atria and normal or 
abnormal FTFF are almost identical at 20.8% and 20% respectively (Table 4-33). 
Table 4-33 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and left atrial dilatation by antero-posterior diameter 
  Supine Resting FTFF 
  Normal Abnormal Total 
Normal 42 24 66 
Left atrial size 
Dilated 11 6 17 
 
Left atrial volume index does show some promise in that the left atrium is dilated in 5 of 
11 patients (45.5%) with abnormal FTFF and only 3 of 16 patients (18.8%) with normal 
FTFF.  However, this does not achieve statistical significance (p = 0.14, Fisher’s Exact 
Test).  This may be due to left atrial volume index only being available in 27 of the 83 
study patients. 
4.9.2.5 Left Ventricular Hypertrophy 
Left ventricular hypertrophy as defined by a left ventricular mass index above the sex 
corrected upper limit of normal is slightly more prevalent in those with abnormal resting 
FTFF.  Left ventricular hypertrophy is present in 23 of 29 (79.3%) of patients with 
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diastolic dysfunction and in 34 of 53 (64.1%) of those without.  The correlation is, 
however, not statistically significant (p = 0.12, Fisher’s Exact Test) 
Table 4-34 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and left ventricular hypertrophy by left ventricular mass index 
  Supine Resting FTFF 
  Normal Abnormal Total 
No LVH 19 6 25 LVH by LV 
Mass Index LVH 34 23 57 
 
4.9.2.6 Left Ventricular Ejection Fraction 
It has already been shown in section 4.1.4.1 that there is no relationship between left 
ventricular ejection fraction and first third fractional filling uncorrected for heart rate.  This 
is also the case once first third fractional filling has been corrected for heart rate.  Left 
ventricular ejection fraction was abnormal in 6 of 30 patients (20%) with abnormal FTFF, 
and in 12 of 53 (22.6%) patients with normal FTFF.  This is not statistically significant (p 
= 0.59, Chi-square test). 
Table 4-35 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and normal, borderline or abnormal left ventricular ejection fraction 
  Supine Resting FTFF 
  Normal Abnormal Total 
Normal 34 22 56 
Borderline (37-40%) 7 2 9 
LV Ejection 
Fraction 
Abnormal 12 6 18 
 
4.9.2.7 E/E’ Ratio 
Neither the septal nor lateral E/E’ ratio show a significant relationship with an abnormal 
resting first third fractional filling (p = 0.47 and p = 0.09 respectively, Chi-square test).  
There is almost no difference in the percentage of patients with an elevated septal E/E’ 
ratio and normal (44.2%) or abnormal FTFF (43.3%) (Table 4-36).  There is actually a 
preponderance of patients with normal FTFF and elevated E/E’ lateral ratio compared to 
abnormal FTFF (Table 4-37). 
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Table 4-36 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and normal, equivocal or elevated septal E/E’ ratio 
  Supine Resting FTFF 
  Normal Abnormal Total 
Normal 10 9 19 
Equivocal 19 8 27 E/E’ septal 
Elevated 23 13 36 
 
Table 4-37 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and normal or elevated lateral E/E’ ratio 
  Supine Resting FTFF 
  Normal Abnormal Total 
Normal 19 16 35 
E/E’ lateral 
Elevated 34 14 48 
 
4.9.2.8 E/A Ratio 
There is a statistically significant association between an abnormal resting FTFF and an 
E/A ratio outwith the normal range (p = 0.02, Chi-Square test).  No patients with a normal 
FTFF have an abnormal E/A ratio and only 3 (10%) of patients with an abnormal FTFF 
have a normal E/A ratio (Table 4-38). 
Table 4-38 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and normal, equivocal or abnormal E/A ratio 
  Supine Resting FTFF 
  Normal Abnormal Total 
Normal 17 3 20 
Equivocal 36 25 61 
Abnormal 
E/A ratio 
Abnormal 0 2 2 
 
4.9.2.9 NT-proBNP 
NT-proBNP does not show any statistically significant association with abnormal first 
third fractional filling (p = 0.32, Fisher’s Exact Test).  The breakdown of patients is shown 
in Table 4-39. 
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Table 4-39 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and normal or elevated NT-proBNP 
  Supine Resting FTFF 
  Normal Abnormal Total 
Elevated 15 6 21 
NT-proBNP 
Normal 38 23 61 
 
4.9.2.10 Myocardial Ischaemia 
Although a relationship has previously been observed between the presence of inducible 
ischaemia on myocardial perfusion imaging and impaired first third fractional filling (191), 
an inverse relationship is seen in this group.  The trend for higher levels of diastolic 
dysfunction in the absence of inducible ischaemia seen in Table 4-40 is statistically 
significant (p = 0.046, Chi-Square test). 
Table 4-40 – Correlation between abnormal resting supine left ventricular first third 
fractional filling and extent of inducible myocardial ischaemia on thallium scintigraphy 
 Supine Resting FTFF 
 Normal Abnormal Total 
Normal 24 22 46 
Minor ischaemia 13 4 17 
Definite ischaemia 16 4 20 
 
4.9.2.11 Failure to Reach Anaerobic Threshold 
The failure to reach anaerobic threshold on exercise suggests a cardiac, rather than 
respiratory, limitation to exercise.  In the absence of other causes such as valvular heart 
disease, systolic dysfunction or ischaemia this may indicate diastolic dysfunction.  In this 
patient group there was no significant difference in the proportions with those with 
abnormal FTFF (2 of 23, 8.7%) and those with normal FTFF (6 of 48, 12.5%) failing to 
reach anaerobic threshold (p = 0.49, Fisher’s Exact test). 
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4.9.3 Summary 
Of the indices one might expect to correlate with diastolic dysfunction and abnormal 
resting first third fractional filling, only the E/A ratio behaves as expected and is 
statistically significant.  The lack of correlation with other indices and the counterintuitive 
relationship with myocardial ischaemia leads to the conclusion that first third fractional 
filling, at least at rest, is no better than other indces of diastolic function in this patient 
group.  There is overall a poor correlation between these indices. 
 
4.10 Peak Stress First Third Fractional Filling as a 
Reference Standard 
4.10.1 Correlation With Predictors of Diastolic Dysfunction 
4.10.1.1 Sex 
As with resting FTFF there is no significant association between female sex and abnormal 
peak stress first third fractional filling (p = 0.51, Fisher’s Exact test).  The proportions of 
females and males with abnormal peak stress FTFF are 35.6% and 30.8% respectively. 
4.10.1.2 Hypertension 
Neither a history of hypertension nor uncontrolled hypertension at baseline showed a 
significant association with abnormal peak stress FTFF (p = 0.12 and p = 0.47 respectively, 
Fisher’s Exact test).  The proportion of patients with abnormal peak stress FTFF and a 
history of hypertension was 80% compared to 63.8% of patients who had normal FTFF.  
Of those with uncontrolled hypertension these proportions were 40% and 36.2% 
respectively. 
4.10.1.3 Obesity 
There is no significant association between increasing body mass index and abnormal peak 
stress first third fractional filling (p = 0.3, Chi-Square test). 
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4.10.1.4 Left Atrial Size 
Although there is a higher proportion of patients with a dilated left atrium by antero-
posterior diameter with abnormal peak stress FTFF (28% vs 14.9% with normal FTFF), 
this difference is not statistically significant (p = 0.15, Fisher’s Exact test). 
4.10.1.5 Left Ventricular Hypertrophy 
Left ventricular hypertrophy, defined by left ventricular mass index, is also slightly more 
common in patients with abnormal peak stress FTFF (76% vs 60.9% with normal FTFF).  
As with left atrial size, the difference is not statistically significant (p = 0.15, Fisher’s 
Exact test). 
4.10.1.6 Left Ventricular Ejection Fraction 
Just as myocardial ischaemia showed the opposite relationship to first third fractional 
filling at rest, left ventricular ejection shows a similarly unexpected relationship to peak 
stress FTFF (Table 4-41).  Patients with a depressed left ventricular ejection fraction are 
more likely to have normal peak stress first third fractional filling than abnormal FTFF.  
This is statistically significant (p = 0.02, Chi-Square test) and is particularly unexpected 
given the lack of any relationship with resting FTFF, even in the larger control group 
(section 4.1.4.1). 
Table 4-41 – Correlation between abnormal peak exercise supine left ventricular first third 
fractional filling and left ventricular ejection fraction 
  Peak stress FTFF 
  Normal Abnormal Total 
Normal 26 22 48 
Borderline 
(37-40%) 7 1 8 
LV Ejection 
Fraction 
Abnormal 14 2 16 
 
4.10.1.7 E/E’ Ratio 
Both the septal and lateral E/E’ ratios show no significant relationship to abnormal peak 
stress FTFF (p = 0.86 and p = 0.96 respectively, Chi-Square test).  This can be seen in 
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Table 4-42 and Table 4-43 where the proportion of subjects with a normal or elevated E/E’ 
ratio shows almost no difference between the normal or abnormal stress FTFF groups. 
Table 4-42 – Correlation between abnormal peak stress left ventricular first third fractional 
filling and normal, equivocal or elevated septal E/E’ ratio 
  Peak Stress FTFF 
  Normal Abnormal Total 
Normal 12 5 17 
Equivocal 15 9 24 E/E’ septal 
Elevated 20 10 30 
 
Table 4-43 – Correlation between abnormal peak stress left ventricular first third fractional 
filling and normal or elevated lateral E/E’ ratio 
  Peak Stress FTFF 
  Normal Abnormal Total 
Normal 21 11 32 
E/E’ lateral 
Elevated 26 14 40 
 
4.10.1.8 E/A Ratio 
Whilst the E/A ratio showed a significant correlation with resting first third fractional 
filling, this relationship disappears with peak stress FTFF (p = 0.13, Chi-Square test). 
4.10.1.9 NT-proBNP 
As with resting first third fractional filling, abnormal peak stress FTFF has no significant 
relationship with an elevated NT-pro BNP level (p = 0.15, Chi-Square test).  Of those with 
normal peak stress FTFF 15 of 47 patients (31.9%) had an elevated NT-proBNP compared 
with 4 of 25 patients (16%) with abnormal FTFF. 
4.10.1.10 Myocardial Ischaemia 
The trend for first third fractional filling to correlate inversely with myocardial ischaemia 
on thallium scintigraphy, significant at rest, is also seen with peak stress FTFF (Table 
4-44).  It is, however, not statistically significant at peak stress (p = 0.3, Chi-Square test).  
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This suggests that the significant result at rest may be a statistical aberration due to the 
relatively small patient numbers. 
Table 4-44 – Correlation between abnormal peak exercise supine left ventricular first third 
fractional filling and extent of inducible myocardial ischaemia on thallium scintigraphy 
 Peak stress FTFF 
 Normal Abnormal Total 
Normal 25 17 42 
Minor ischaemia 9 5 14 
Definite ischaemia 13 3 16 
 
 
4.10.1.11 Failure to Reach Anaerobic Threshold 
Unlike its resting equivalent, peak stress first third fractional filling shows a significant 
association with failure to reach anaerobic threshold (p = 0.01, Fisher’s Exact test).  Of the 
23 patients with abnormal peak stress FTFF 5 (21.7%) failed to reach anaerobic threshold 
compared to 1 of 46 (2.2%) with normal FTFF (Table 4-45). 
Table 4-45 – Correlation between abnormal peak exercise supine left ventricular first third 
fractional filling and failure to reach anaerobic threshold 
  Peak stress FTFF 
  Normal Abnormal Total 
No 1 5 6 Anaerobic threshold 
reached 
Yes 45 18 63 
 
4.10.2 Summary 
Like resting first third fractional filling, peak stress FTFF shows a generally poor level of 
correlation with predictors of and other parameters of diastolic dysfunction.  However, a 
statistically significant correlation which behaves as expected is with failure to reach 
anaerobic threshold on exercise.  This is potentially useful as it shows correlation between 
an objective measure of diastolic dysfunction and reduced exercise capacity of a 
potentially cardiac cause. 
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Like the unexpected inverse correlation between myocardial ischaemia and resting FTFF, 
the association between impaired left ventricular systolic function and normal FTFF on 
stress is the opposite one would expect.  This does raise doubts as to the reliability of first 
third fractional filling as an index of diastolic function.  It is clear that, with the exception 
of the correlation with anaerobic threshold, assessment of FTFF on stress is no more 
reliable than at rest, at least in this patient group.  This is a heterogeneous patient group 
and although they could be labelled as having diastolic dysfunction on the basis of 
symptoms and signs, many of them may not actually have this condition.  This limitation is 
not exclusive to this work, the lack of a reliable gold standard means it is inherent in all the 
major trial work published to date.  This may explain the disappointing results and lack of 
firm evidence base in diastolic heart failure.  A drug can only be proven effective where 
the correct pathology has been identified. 
4.11 Conclusions 
4.11.1 RNVG in the Diagnosis of Diastolic Dysfunction 
The prevalence of diastolic dysfunction as defined by abnormal first third fractional filling 
was 60% (53 of 83 patients) at rest and 35% (25 of 72 patients) on stress.  The reason for 
this large change with exercise is unclear.  At rest RNVG performs poorly against the 
better regarded markers including NT-proBNP, tissue Doppler echocardiography and left 
atrial dimensions.  The addition of assessment during stress does little to improve these 
correlations with the exception of providing a link between reduced exercise capacity and 
the failure to reach anaerobic threshold with an objective measurement of diastolic 
function.  It is therefore difficult to argue that the observed change in abnormal FTFF with 
exercise is due to an improvement in accuracy with stress assessment.  The poor 
correlation with other markers of diastolic function may reflect weakness in these other 
markers and the lack of a gold standard. 
There are a number of reasons which RNVG and in particular stress RNVG has not 
performed as well as hoped for.  First and foremost amongst these is the small, 
heterogeneous patient group studied.  The presence of confounding diagnoses was almost 
universal despite attempting to screen out these patients at the recruitment stage.  This 
coupled with the lack of a gold standard indicator of diastolic dysfunction means that the 
proportion of the patients recruited who actually had diastolic dysfunction may have been 
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relatively small.  This will have substantially reduced the power of the study to 
demonstrate the utility of assessing diastolic function on exercise by RNVG. 
The difficulty in defining a normal range for parameters of diastolic function by RNVG, 
particularly those that are highly heart rate dependent, is another source of weakness.  A 
novel approach has been taken here in the correction of first third fractional filling for heart 
rate.  Whilst data from a large control group has been used to generate the resting formal 
range for FTFF, data from control subjects on stress is more limited.  The wide confidence 
intervals seen with all of the parameters of diastolic function examined greatly increase the 
probability of a false negative diagnosis. 
Stress RNVG is no longer in routine use for the diagnosis of ischaemic heart disease, 
having been surpassed by myocardial perfusion scintigraphy.  As a tool for assessing 
diastolic function, stress RNVG is unlikely to enter routine use but there has been further 
research interest in this field recently.  At present, however, stress RNVG, whilst attractive 
in concept, has not been shown here to be a useful tool for the assessment of diastolic 
function.  The hypothesis that stress RNVG is more sensitive and correlates better with 
other indices of diastolic function than assessment at rest has, therefore, not been proven. 
4.11.2 Diagnoses Other Than Diastolic Dysfunction 
The very high prevalence of confounding diagnoses other than diastolic dysfunction is the 
most striking aspect of this study.  In only one patient of the 83 was none of these 
prespecified alternative diagnoses found.  The virtual ubiquity of these diagnoses illustrates 
that, even if diastolic dysfunction was to be disregarded as a potential diagnosis, significant 
pathology is present and requires appropriate investigation to uncover. 
In 56 of the 83 patients evidence of at least one cardiac source of dyspnoea, either 
abnormal systolic function by RNVG, ischaemia or an elevated NT-proBNP was found.  
Left ventricular systolic dysfunction not detected on echocardiography was present in 18 of 
83 patients and was borderline abnormal in a further 9.  The ability of echocardiography to 
accurately assess ventricular function is dependent both on operator experience and on 
image quality.  The patients in this cohort were assessed by two experienced operators, 
reducing the impact of this factor.  However, image quality can be significantly degraded 
by obesity and respiratory disease, both of which were common here.  Right ventricular 
systolic dysfunction, which is difficult to assess by echocardiography, was present in 43 
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patients and was borderline in 10 patients.  There was, therefore evidence of LV systolic 
dysfunction in nearly one third of patients and RV systolic dysfunction in nearly two 
thirds. 
Previously undiagnosed ischaemic heart disease was also common.  37 of the 83 patients 
had some evidence of inducible myocardial ischaemia.  20 of these had significant, 
unequivocal evidence of ischaemia.  Of the 25 patients with diastolic dysfunction 
demonstrated on exercise only 8 had myocardial ischaemia demonstrated.  Although 
ischaemia was common, with a follow-up time of between 6 and 7 years, this patient group 
has proven itself to be at relatively low cardiovascular risk.  Only 4 patients suffered an 
acute coronary syndrome, an annual incidence of 0.7%, and one patient died of non-
cardiovascular causes 
Obesity was a common finding.  Only 10 patients had a normal body mass index of 25 or 
less. 22 patients were overweight with BMIs of 25-30, 35 patients were obese with a BMI 
of 30-35, and 16 patients had a BMI of greater than 35. 
Of the 82 patients with spirometry results available, 58 had normal spirometry, 20 had mild 
airflow obstruction and 4 had moderate airflow obstruction. 
4.11.3 Agreement Between Assessments of Diastolic 
Function 
First third fractional filling at rest supine correlated strongly with rest erect FTFF, but not 
with peak stress FTFF.  Similarly it correlated well with resting values of peak filling rate, 
but not stress values.  There was also a modest correlation with an abnormal E/A ratio (R=-
0.3, p=0.007).  However, it only correlated with the E/E’ septal ratio when the rest erect 
value was used. 
A similar pattern was seen between the other indices examined.  Where statistically 
significant correlations were seen, these were generally weak and inconsistent between 
supine, erect and stress measurements. 
NT-proBNP level did not correlate with any of the measured indices of diastolic function 
either at rest or at peak stress. 
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With the proviso that this is a small group, albeit representative of usual clinical practice, 
the parameters of diastolic function measured either by echocardiography, rest or stress 
radionuclide ventriculography, or biochemical marker such as NT-proBNP show generally 
poor correlation with each other.  By measuring a wide number of indices, the majority of 
patients can be shown to have at least 1 abnormal parameter of diastolic function.  Partly 
due to the heterogeneity of the group, possible alternative diagnosis are almost universal. 
  
5. Discussion – Multimodality Imaging of 
Suspected Diastolic Dysfunction 
5.1 Scope of this Study 
This thesis set out to look in detail at a common clinical problem, the assessment of 
patients referred from primary care with suspected heart failure but normal systolic 
function on echocardiography.  Specifically, this thesis has examined the role of 
radionuclide ventriculography in the assessment of diastolic function and whether the use 
of stress RNVG improves this assessment.  In this respect, stress RNVG has been found 
wanting.  However, this should not be regarded as the end of the road for RNVG and stress 
RNVG.  The biggest limitation of this study is that many of the recruited patients, in all 
likelihood, did not have diastolic heart failure.  Only 21 of the 83 patients had an NT-
proBNP level above the reference range suggesting that stress RNVG only had an 
opportunity to show its worth in a much smaller patient group than anticipated.  If a 
population with a higher probability of a positive finding, for example those with an 
elevated NT-proBNP level and a recent acute hospital admission with heart failure, were to 
be studied, the finding may have been significantly different. 
The most significant findings of this study were the very high frequency of alternative 
diagnoses such as ischaemic heart disease and respiratory disease, and the relatively poor 
performance of echocardiography. 
5.2 Identification of Confounding Diagnoses 
It has been demonstrated, both in this work and previously, that diagnoses other that 
diastolic dysfunction are frequently present in patients with dyspnoea without 
echocardiographic evidence of systolic dysfunction.  What is also clear from this work is 
that there is often not a single diagnosis in each patient.  Many of the diagnoses identified 
may not only cause dyspnoea and clinical signs of heart failure in their own right, but are 
also potential causes of diastolic dysfunction.  In the investigation of the breathless patient, 
it should no longer be sufficient to simply document normal left ventricular systolic 
function on echocardiography and not investigate further.  Where there is sufficient clinical 
suspicion that there is pathology to account for symptoms beyond physical deconditioning 
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or obesity, these should be actively sought.  This work has demonstrated that a significant 
number of new diagnoses of ischaemic heart disease and chronic obstructive pulmonary 
disease can be made in this patient group.  This, therefore, allows inappropriate medication 
to be discontinued and more appropriate management strategies pursued. 
Although some patients will ultimately undergo as comprehensive an assessment as 
undertaken here, a more discriminating approach should normally be taken.  Where a 
patient has a definite history of ischaemic heart disease, the initial focus, after 
echocardiography, should be on identifying myocardial ischaemia.  The most effective 
means of doing this has been the subject of much debate with each modality championed 
by enthusiasts.  It is well recognised that the treadmill test is often unhelpful.  
Notwithstanding the limited sensitivity of treadmill testing, tests may be inconclusive on 
the basis of poor exercise capacity.  Dyspnoea as a limiting symptom in exercise tolerance 
testing may simply reflect physical deconditioning but may also be a symptom of cardiac 
ischaemia that the ECG is too insensitive to show.  Myocardial perfusion imaging with 
either thallium or technetium based tracers is more sensitive and offers the possibility of 
pharmacological stress.  There are two downsides to nuclear imaging.  First, its specificity 
is imperfect and small perfusion defects may be false positive results, necessitating a 
degree of subjectivity in interpretation.  Second, it involves exposure to ionising radiation.  
Whilst this is not a feature of stress echocardiography, image quality can be significantly 
impaired by obesity and respiratory disease even with the use of echocardiographic 
contrast agents.  Whilst the avoidance of radiation exposure is desirable, the correct 
investigation must be selected for the correct patient.   
Where the main issue is dyspnoea rather than clinical signs of heart failure, the most 
appropriate initial investigation may not be echocardiography. If the likelihood of 
respiratory disease is high, a 12 lead ECG may be an appropriate initial screening tool 
given the low probability of left ventricular systolic dysfunction with a normal ECG.  
Ultimately, most patients will have an echocardiogram.  This may be to exclude right heart 
pathology in respiratory disease, assess valvular pathology, or simply to provide 
reassurance and confirm the result of more basic tests. 
Perhaps the most important distinction to make is between cardiac and non-cardiac 
pathology.  A wrong supposition at an early stage may lead to a delay in the correct 
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diagnosis and treatment as each specialty pursues its own set of diagnoses and battery of 
tests. 
The cardiac causes of heart failure-like symptoms which should be considered are: 
• Left ventricular systolic dysfunction  
• Valvular heart disease 
• Ischaemic heart disease and the anginal equivalent in the absence of fixed 
ventricular dysfunction 
• Arrhythmias, including atrial fibrillation which may be symptomatic even with a 
controlled ventricular response, or show an exaggerated heart rate response to even 
minimal exertion. 
• Diastolic dysfunction, or normal ejection fraction heart failure 
Diastolic dysfunction is intentionally placed at the bottom of this list, partly as it should be 
considered a diagnosis of exclusion.  It is also outranked by the other cardiac diagnoses as, 
in contrast to these, it does not have a solid evidence base of treatment. 
The non-cardiac diagnoses which should be considered are: 
• Respiratory pathology including chronic obstructive pulmonary disease and 
interstitial lung disease 
• Obesity 
• Physical deconditioning – this may include patients with unrealistic expectations 
where their symptoms reflect the normal aging process rather than pathology. 
• Anaemia 
• Hypothyroidism 
• Depression – this may have prominent symptoms of fatigue, exercise intolerance 
and dyspnoea.  There may be a degree of overlap with chronic fatigue syndrome, 
although this remains a controversial diagnosis. 
5.3 The Diagnostic Accuracy of Open Access 
Echocardiography 
The concept of echocardiography services being directly available to general practitioners 
has been with us for more than a decade now.  But does the service achieve what it set out 
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to do, or is the yield of pathology insufficient to justify the quantity of resources devoted to 
it?  Another question that must be addressed when evaluating the service is whether or not 
the results are sufficiently robust given this may be the patient’s only contact with 
secondary care.  There is no reason to suspect that the patient group here is different to that 
presenting to any other open access echocardiography service.  Yet, despite assessment by 
two experienced operators, mild left ventricular systolic dysfunction was not detected in up 
to 1 in 3 patients. 
5.3.1 Origins and Scope of the Service 
Whilst some pilot schemes existed prior to 1995 (192), a major expansion began in the 
field of open access echocardiography in this year.  A telephone survey of 100 hospitals of 
greater than 300 beds in 1996 (193) found that 30 of these offered a service of some 
description and of these, 21 had opened the service within the past year.  Such a rate of 
expansion has not been maintained – a survey of western European primary care 
physicians in 2000 found that only 22% of respondents had direct access to 
echocardiography from the community.  This is partly due to some schemes which had 
been funded by pharmaceutical companies closing once this funding was withdrawn (194). 
The impetus for open access echocardiography comes from observations that heart failure 
was being neither adequately investigated nor optimally treated(195).  A task force set up 
by the European Society of Cardiology reiterated in 1995 that evidence of cardiac 
structural abnormality was essential for the accurate diagnosis of heart failure, with 
echocardiography being the key investigation (16).  This conclusion had already been 
reached in 1994 by Dargie and McMurray(196) who suggested that the provision of readily 
available direct access echocardiography services to general practitioners was crucial in 
addressing this. 
With the background of a desire to improve the diagnosis and management of heart failure 
in the community, some early services focussed solely on this to the exclusion of other 
structural cardiac disease.  The service in Edinburgh (152) invited referrals solely for 
suspected heart failure, whether treated or not, and of patients at risk of having 
asymptomatic left ventricular dysfunction.  This was not a universally held opinion 
however.  The open access echocardiography service launched in Brighton in 1994 (192) 
was also intended to assess murmurs.  Of the 106 patients referred in the first ten months of 
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the service, 46 were referred solely for the assessment of murmurs.  25 of these were found 
to have no abnormality. A negative finding in this context is as beneficial as a positive one 
as is will have avoided an unnecessary referral to a cardiologist.  Further to this, unless 
patients could be guaranteed echocardiography on the same day as their first clinic visit, 
patients being evaluated by a non direct access route would have at least one additional 
hospital visit and additional delay in definitive diagnosis. 
5.3.2 The Missed Diagnosis 
Almost one third, 27 of 83, of the patients in this study had a radionuclide ejection fraction 
below the reference range of 40%.  Whilst 16 of these had only borderline impairment and 
the remainder mild systolic dysfunction, this highlights the potential weakness of 
echocardiography in this population.  This is an area where evidence based treatment is 
available and represents a missed opportunity to influence prognosis in a positive manner.  
Whether or not this degree of systolic dysfunction is sufficient to account for the symptoms 
present does not affect its prognostic significance.  The SOLVD(197) and SAVE(198) 
trials examined the use of the ACE inhibitors captopril and enalapril in asymptomatic left 
ventricular systolic dysfunction.  Both showed significant reductions in morbidity and 
mortality, with a reduction in hospitalisations due to heart failure of up to one third.  Even 
in a population with no history of cardiovascular disease asymptomatic left ventricular 
dysfunction carries an adverse prognosis(199). 
In this patient group the primary echocardiographic parameter of left ventricular systolic 
function was the qualitative visual assessment.  Whilst this is limited by its subjective 
nature, it better reflects the real world and usual clinical practice than the Simpson’s 
biplane ejection fraction.  This was only possible in a modest subset of the patients here.  
Previous studies from a similar population locally managed to measure ejection fraction by 
this method in approximately 90% of patients(200).  The reason for the discrepancy is not 
clear but many patients in this study were rejected for biplane ejection fraction 
measurement on the basis of suboptimal image quality.  The rationale in this case was that 
a qualitative assessment was preferable to the potentially inaccurate ejection fraction due to 
‘guessing’ the contours of the endocardial border.  Had ejection fraction been measurable 
with confidence in more patients, the number of missed diagnoses of left ventricular 
systolic dysfunction may have been fewer. 
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There are two sources of inaccuracy in the echocardiographic assessment of suspected left 
ventricular dysfunction.  These are patient related factors, and operator related factors with 
a degree of interplay between the two. 
The patient related factors are well recognised and impact upon image quality.  Obesity, an 
increasingly common problem, particularly in this patient population, may significantly 
reduce image quality.  The greater depth the ultrasound has to penetrate to results in a 
lower image frame rate, making the assessment of subtle wall motion abnormalities more 
challenging.  Lower ultrasound frequencies may also be necessary in order to achieve 
adequate tissue penetration.  This results in poorer spatial resolution, again reducing 
diagnostic confidence in less obvious abnormalities.  This has been a more significant 
problem historically than at present due to the advent of harmonic imaging.  Harmonic 
ultrasound combines the advantages of low frequency transmitted pulses to achieve tissue 
penetration with the use of secondary harmonics reflected back from the tissue.  These 
secondary harmonics are typically at double the transmitted frequency and have far 
superior spatial resolution.  In comparison, traditional fundamental imaging transmits and 
receives at the same frequency resulting in poor image quality in patients requiring lower 
frequencies. 
Respiratory disease also has a significant impact on the performance of echocardiography.  
Ultrasound is not efficiently transmitted through air and, as air trapping and hyperinflation 
of the lungs may be a feature of chronic respiratory disease, image quality is degraded.  
Hyperinflation of the lungs may also render standard transthoracic echocardiography 
windows useless.  An experienced operator may be able to salvage the study with a 
comprehensive subcostal examination, but Doppler measurements may be inaccurate due 
to the beam not being parallel to flow from this angle. 
Operator experience is a critical factor in echocardiography.  Ultrasound, unlike other 
imaging techniques such as computed tomography, is reliant on a comprehensive set of 
images being acquired at the time of the study.  If a particular view or Doppler 
measurement is not present, it may necessitate a repeat study.  An experienced operator is 
more likely to acquire a comprehensive set of images, and to optimise these well, 
compensating for any adverse patient factors.  Experience is also important in the 
interpretation of echocardiography.  The most common method of assessing left ventricular 
systolic function is the qualitative visual assessment.  As this is a subjective assessment, a 
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degree of experience is required to differentiate the sluggish ventricle of a heavily beta 
blocked patient from genuine dysfunction.  Experience is also required to integrate mitral 
regurgitation assessment and the effect this has on flattering an impaired left ventricle by 
offering a low pressure escape route. 
The problem with the often subjective nature of left ventricular function assessment may, 
in part, be overcome by the use of more objective quantitative methods.  Foremost amongst 
these is the calculation of ejection fraction by means of the Simpson’s biplane method.  
This is less reliant on geometrical assumptions than the Teicholtz method but is still 
subject to errors.  It is very dependent on image quality on two fronts.  As the technique 
involves tracing the endocardial border at end systole and end diastole, poor endocardial 
border definition can result in inaccurate volume estimation.  Although this can be partly 
overcome with the use of left ventricular contrast, this is not commonly used outwith 
specialist settings such as stress echocardiography.  Its administration requires venous 
access and the presence of a physician, making its use in routine, technician delivered, 
echocardiography unlikely to expand significantly. The use of left ventricular contrast 
agents for all studies would also be prohibitively expensive and expose patients to a small 
(1 in 10,000) risk of serious adverse reaction. 
The second image quality related issue, that of image foreshortening, cannot be solved 
with left ventricular contrast.  Often it is necessary to move the ultrasound probe one rib 
space higher than the true apex due to a poor acoustic window.  This has the effect of 
reducing the left ventricular volumes measured and usually results in an elevation in 
measured ejection fraction.  The apical 2 chamber view is particularly affected as the probe 
lies obliquely across the ribs.  Matrix probes which allow the acquisition of three 
dimensional or tri-plane images may overcome this problem in some patients but the large 
probe footprint results in acoustic access problems in more challenging patients. 
 
5.3.3 The Appropriateness of Echocardiography in Suspected 
Heart Failure 
The yield of left ventricular systolic dysfunction in those referred with suspected heart 
failure varies from 1 in 4 to 1 in 5(152, 201).  This modest yield partly reflects the 
difficulties inherent in the accurate diagnosis of heart failure in the community.  Given this, 
and the high rates of mild left ventricular dysfunction not appreciated on 
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echocardiography, its usefulness in this setting must be questioned.  With the use of 
screening investigations it should be possible to improve the proportion of those found to 
have impaired left ventricular function by creating a more targeted lower volume, higher 
quality service. 
5.3.3.1 ECG as a screening tool? 
Although data for diastolic dysfunction are lacking, the 12 lead ECG has shown promise as 
an effective screening tool for the detection of left ventricular systolic dysfunction.  
However, different series have yielded significantly different results.  Davie et al (202) 
found that a ‘normal’ ECG had a 98% negative predictive value for left ventricular 
dysfunction.  534 patients referred with suspected heart failure to an open access 
echocardiography service were reviewed, of whom 96 (18%) had left ventricular systolic 
dysfunction, a level broadly in keeping with other similar series.  Of these, 90 had what 
was regarded as a major ECG abnormality (atrial fibrillation, left ventricular hypertrophy, 
bundle branch block, left axis deviation, or previous myocardial infarction).  The 
remaining 6 had minor ECG abnormalities – none had an entirely normal ECG.  Of the 438 
patients with normal ventricular function, 269 had a ‘normal’ ECG and 169 had a major 
ECG abnormality.  Therefore, although it would appear that 6.25% (6/96) of LVSD would 
be missed by ECG screening, only 2.2% (6/275) of those with a normal ECG had LVSD.  
Therefore, a normal ECG is highly sensitive for normal LV systolic function; an abnormal 
ECG is, however, rather non-specific with 65% (169/259) of these having normal LV 
function. 
The sensitivity and specificity of the ECG is, of course, dependent on the patient 
population.  In a population with a significantly higher prevalence of left ventricular 
systolic dysfunction, the ECG performed less well(203).  Of the 200 patients in this series 
only 35 had normal LV function. Perhaps because of the clearly different population being 
seen in this series, a normal ECG was a poor predictor of normal LV function – 53% of 
those with a normal ECG had LVSD.  It should be noted that in the whole series only 34 
ECGs were regarded as normal.  There was also a difference in how the ECGs were 
interpreted.  Two of the three interpreters were general practitioners who had to make a 
binary decision of normal or abnormal.  This, therefore, raises the possibility of 
misinterpretation – either overreporting of minor abnormalities, or more subtle 
abnormalities being missed. 
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The question then arises as to whether the automated analysis software found in most 
modern ECG machines should be relied on instead.  Many general practitioners rely on 
these automated reports and so this is not unreasonable.  An attempt was made to answer 
this question which was unfortunately flawed by the failure to distinguish between valvular 
disease and left ventricular dysfunction in the analysis of the sensitivity of the ECG as a 
screening tool (204).  UnforECG has not been proposed as a screening tool for valvular 
heart disease – that is the role of the stethoscope. 
Whether entrusting ECG analysis and potentially the decision on echocardiography to such 
a system is wise is a matter of concern.  Whilst electronic ECG analysis improved the 
speed and accuracy of interpretation by cardiologists without increasing false positive 
diagnoses (205), primary care physicians tended to be misled by incorrect ECG analysis 
and could potentially miss important diagnoses missed by the computer (206).  This is 
presumably a matter of training, clinical experience and an awareness of the potential 
limitations of automated analysis.  Indeed the American College of Cardiology have 
published guidelines suggesting that following an initial training process of 500 supervised 
ECG interpretations and formal assessment of competency, a minimum of 100 ECGs 
should be interpreted each year to maintain competency (207). 
To suggest that a patient should be denied echocardiography on the basis of a normal ECG 
is clearly wrong.  This is not to say that it cannot be used as a valuable screening tool.  In a 
case where heart failure is considered as a possible diagnosis, a normal ECG should be 
used to cast significant doubt on the diagnosis and alternative diagnoses actively 
considered and investigated.  An echocardiogram ordered where an alternative diagnosis is 
unlikely or excluded, would represent the most appropriate and effective use of resources. 
5.3.3.2 B-type Natriuretic Peptides 
In asymptomatic populations, screening for left ventricular systolic dysfunction by means 
of either plasma(208) or combined urinary and plasma NT-proBNP(209) followed by 
echocardiography in those with a positive result has been shown to be cost effective and 
accurate.  In a symptomatic population this should allow more appropriate targeting of 
echocardiography and earlier identification of the correct investigation and treatment 
pathways. 
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NT-proBNP did not perform as well in the identification of left ventricular hypertrophy, a 
possible cause of diastolic dysfunction.  It should also be remembered that other conditions 
such as atrial fibrillation and renal dysfunction will confound this and result in elevated 
BNP levels in the absence of left ventricular systolic dysfunction. 
BNP is not yet universally available either in primary or secondary care.  Where it is, 
however, it is able to function as an excellent screening tool, at least for systolic heart 
failure.  The diagnostic confidence it provides beyond simple tools such as clinical 
examination and the ECG should streamline the process of differentiating heart failure 
from non-cardiac pathology. 
5.3.3.3 The Use of Non-cardiac Investigations 
When presented with a patient with suspected heart failure one must keep an open mind to 
other potential diagnoses and the use of screening tests to identify these.  In terms of 
simple tests which do not require specialist knowledge to obtain or interpret, and are 
universally available, blood tests such as a full blood count should be regarded as a 
standard baseline investigation.  Significant anaemia may result in dyspnoea in the absence 
of any other pathology.  It may also exacerbate the symptoms of left ventricular 
dysfunction, valvular disease, pulmonary disease or obesity and is therefore an essential 
test even when other pathology is proven or strongly suspected. 
Although more common in a hospital setting than in the community, hypoalbuminaemia 
may result in significant peripheral oedema which may be mistaken for heart failure.  Also, 
given the insidious nature of hypothyroidism which may mimic many of the features of 
heart failure, including myxoedema, this should also be actively considered. 
Although the chest x-ray is relatively insensitive for the detection of chronic obstructive 
pulmonary disease, it may nonetheless provide useful information.  Increased lung 
volumes secondary to emphysema may be seen, or evidence of interstitial lung disease.  A 
normal cardiothoracic ratio and no radiographic evidence of pulmonary venous congestion 
may provide evidence against a diagnosis of heart failure.  Depending on local policy, open 
access echocardiography may not be available, in which case chest radiography might be 
an acceptable prelude to more definitive investigation.  Even where open access 
echocardiography is available, a chest x-ray can usually be obtained far more rapidly. 
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5.4 Comprehensive Assessment of the Dyspnoeic Patient 
The sequence of investigations employed here will identify any significant 
cardiorespiratory disease but is clearly not suitable for all patients.  It is resource intensive, 
particularly if cardiopulmonary exercise testing is employed, and may represent over-
investigation of patients whose initial tests suggest there is no pathology to be found.   
5.4.1 Sequence of Investigations 
Prior to referral to secondary care, simple readily available tests should be performed 
which would allow triage to the most appropriate specialty.  A full blood count, ECG and 
chest x-ray would allow the identification of anaemia and significant cardiorespiratory 
disease.  Depending on local policy it might be desirable to require some of these prior to 
referral to secondary care. 
Once presented with the dyspnoeic patient in secondary care, a tiered approach to 
assessment should be adopted.  The simplest, broadest and least invasive investigations are 
performed on the first tier, more advanced and focussed tests on the second tier, and the 
most specialised investigations on a third tier.  This should be reserved for patients with 
objective evidence of pathology but inconclusive results from investigations on a lower 
tier. 
Tier 1 
Exercise tolerance test (treadmill); spirometry; BNP 
Tier 2 
Echocardiography; myocardial perfusion scintigraphy, radionuclide ventriculography 
Tier 3 
Cardiopulmonary exercise testing 
A number of patients may progress beyond the scope of the investigations untaken in this 
thesis.  Cardiac catheterisation may be appropriate for those in whom significant ischaemia 
has been detected, although cardiac CT now offers a non-invasive alternative with 
excellent negative predictive accuracy.  Cardiac catheterisation may also be necessary to 
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formally document intracardiac pressures, of particular relevance in pericardial constriction 
where non-invasive measures may be inconclusive. 
5.4.2 The Undiagnosable Patient 
Ultimately, a proportion of patients will have no pathology identified to account for their 
symptoms.  This is a situation encountered not infrequently in clinical practice and may 
result in frustration on the part of the patient.  Where no abnormality has been discovered 
there are three possible explanations: the patient has been insufficiently investigated; the 
investigations used failed to identify an abnormality that was present; or there is no 
abnormality to be found.  Inappropriate expectations on the part of the patient should be 
considered when there is no objective evidence of heart failure and investigations do not 
reveal any cardiorespiratory disease.  There is a normal age related decline in cardiac and 
respiratory function and it may be difficult for some patients, particularly those who have 
led active lives, to accept this. 
If one were to accept the argument that measurement of diastolic function is unnecessary 
by virtue of the fact that some evidence of abnormality can usually be found, these patients 
would all be labelled with diastolic heart failure.  Desirable as it is to give a patient a 
diagnosis, no diagnosis is preferable to an incorrect diagnosis given the unnecessary 
treatment, worry and insurance implications this may have. 
It is important to identify this category of patient efficiently in order to minimise the 
sequence of ultimately fruitless investigations.  This will also minimise the impact on out 
patient clinics in secondary care.  Unfortunately for primary care, the burden of long term 
follow up of these patients must fall to them.  There must be a good relationship between 
primary and secondary care with regards these patients to them being repeatedly passed 
back and forth for reassessment. 
5.5 Future Directions 
Despite the theoretical promise of the assessment of diastolic function during stress, the 
radionuclide parameters have failed to produce conclusive results.  There are several 
factors in this.  The heterogeneity of the patient group, many of whom may not have 
diastolic dysfunction, is prime amongst these.  The wide confidence intervals seen in the 
Andrew C McCulloch, 2009  Chapter 5, 248 
 
normal ranges for most of the radionuclide parameters of diastolic function, even within 
the relatively large group used to define normal resting ranges (section 3.5.1), is a serious 
limitation to their use.  Although the radiation dose from a radionuclide ventriculogram is 
modest, there is a drive towards minimising dose and substituting investigations that do not 
involve ionising radiation.  Stress echocardiography, therefore, may be an avenue for 
future research for the assessment of diastolic function with either physiological or 
pharmacological stress. 
Current tissue Doppler based indices of left ventricular filling pressures show only 
moderate degrees of correlation with invasive measurements, particularly where systolic 
function is preserved.  They are based upon focal measurements of mitral annular velocity 
as a surrogate for what is a global measurement.  Tissue Doppler is also limited by 
inaccuracies introduced by off-axis images.  Using the advancing field of speckle tracking 
to derive the same parameters as tissue Doppler may improve the correlation with invasive 
measurements.  More advanced techniques such as myocardial strain and strain rate 
imaging, particularly combined with stress, may be of use. 
Although radionuclide ventriculography provides a good estimate of left ventricular 
volume, it is a planar technique.  Activity from the posterior aspect of the heart is 
underrepresented due to attenuation artefact as it passes through the heart itself.  It is 
possible to calculate left ventricular volumes and ejection fraction from myocardial 
perfusion SPECT images.  As this is a tomographic technique, it should provide a more 
accurate estimate of left ventricular volume by delineating the endocardial border for the 
whole circumference of the ventricle.  However, this technique is reliant on adequate 
myocardial perfusion to define this endocardial border.  A sufficiently deep perfusion 
defect reduces the accuracy of border definition and, therefore, volume estimation.  In 
principle, it is possible to acquire blood pool ventriculography data using SPECT imaging.  
This has the advantage of not being susceptible to myocardial perfusion defects but loses 
one of the key benefits of planar RNVG, its lack of reliance on spatial resolution.  It is 
potentially more affected by problems with low count statistics and the necessary trade-off 
with temporal resolution than its planar counterpart.  However, the advent of solid state 
detectors and resolution recovery algorithms mean that many of these weaknesses are 
mitigate.  SPECT RNVG, therefore has the potential to be a useful research tool and the 
use of stress assessment can be explored further. 
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Appendix 1 – The Reproducibility of Systolic and 
Diastolic Function by RNVG – additional 
data 
1.1 Ejection Fraction 
Table Ap1-1 – LV ejection fraction Intra-study/Intra-observer Reproducibility – 5-S sub-
acquisition comparison (paired samples T test) 
Paired Differences – Sub-acquisitions 5 and S 
95% Confidence Interval of the 
Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig.  
(2-tailed) 
AMC -0.11 2.39 -0.70 0.48 0.71 24L 
AR -0.23 2.50 -0.85 0.38 0.45 
AMC 0.06 2.39 -0.53 0.65 0.84 
32L 
AR 0.004 2.60 -0.64 0.64 0.99 
AMC 0.05 2.38 -0.54 0.64 0.87 
24M 
AR -0.03 2.46 -0.64 0.57 0.92 
 
Table Ap1-2 – LV ejection fraction Intra-study/Inter-observer reproducibility – 24 frame 
variable width (paired samples T-test) 
Paired Differences – 24 Frame List Mode 
95% Confidence Interval of the 
Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig. 
(2-tailed) 
2 AMC-AR -1.70 3.36 -2.53 -0.88 <0.001 
3 AMC-AR -1.61 3.28 -2.42 -0.81 <0.001 
5 AMC-AR -1.64 3.21 -2.43 -0.86 <0.001 
S AMC-AR -1.77 3.20 -2.56 -0.98 <0.001 
A AMC-AR -1.68 3.21 -2.47 -0.89 <0.001 
2R AMC-AR -1.67 3.42 -2.52 -0.83 <0.001 
3R AMC-AR -1.79 3.45 -2.64 -0.94 <0.001 
5R AMC-AR -1.92 3.41 -2.76 -1.09 <0.001 
 
Table Ap1-3 – Intra-observer/Inter-study reproducibility of LV ejection fraction (24 frame 
variable width) (paired samples T test) 
Paired Differences – 24 Frame List Mode 
95% Confidence Interval of the 
Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig. 
(2-tailed) 
2-2R -0.87 5.18 -2.14 0.40 0.176 
3-3R -0.66 5.19 -1.93 0.62 0.308 AMC 
5-5R -0.27 4.71 -1.42 0.89 0.649 
2-2R -0.84 5.35 -2.16 0.47 0.206 
3-3R -0.83 5.50 -2.18 0.52 0.225 AR 
5-5R -0.55 4.98 -1.77 0.68 0.377 
Andrew C McCulloch, 2009  Appendix 1, 274 
 
Table Ap1-4 – Inter-observer/inter-study reproducibility of LV ejection fraction (paired 
samples T-test) 
Paired Differences 
95% Confidence Interval 
of the Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig.  
(2-tailed) 
AMC-AR – 2-2R -2.55 6.06 -4.04 -1.06 0.001 
AMC-AR – 3-3R -2.44 6.47 -4.03 -0.85 0.003 24L 
AMC-AR – 5-5R -2.19 5.89 -3.64 -0.74 0.004 
AMC-AR – 2-2R -2.46 5.94 -3.92 -1.0 0.001 
AMC-AR – 3-3R -2.30 6.13 -3.81 -0.79 0.003 32L 
AMC-AR – 5-5R -2.19 5.93 -3.65 -0.73 0.004 
AMC-AR – 2-2R -2.32 5.84 -3.75 -0.88 0.002 
AMC-AR – 3-3R -2.19 6.34 -3.75 -0.63 0.007 24M 
AMC-AR – 5-5R -2.12 5.78 -3.54 -0.70 0.004 
 
Table Ap1-5 – Inter-observer/inter-study reproducibility of LV ejection fraction (Pearson 
correlation coefficient) 
  24L 32L 24M 
2-2R 0.95 0.95 0.95 
3-3R 0.94 0.95 0.94 AMC-AR 
5-5R 0.95 0.95 0.95 
 
Table Ap1-6 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on left 
ventricular ejection fraction (paired samples T-test) 
Paired Differences 
95% Confidence Interval 
of the Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig.  
(2-tailed) 
AMC – 2-A 0.31 1.94 -0.17 0.79 0.197 
AMC – 3-A 0.21 1.36 -0.12 0.55 0.208 
AR – 2-A 0.33 2.01 -0.16 0.83 0.183 
24L 
AR – 3-A 0.14 1.43 -0.21 0.50 0.418 
AMC – 2-A 1.06 2.12 0.54 1.58 <0.001 
AMC – 3-A 0.63 1.62 0.23 1.03 0.002 
AMC – 5-A 0.42 1.12 0.14 0.69 0.004 
AR – 2-A 1.07 2.11 0.55 1.59 <0.001 
AR – 3-A 0.57 1.60 0.18 0.97 0.005 
32L 
AR – 5-A 0.38 1.14 0.10 0.65 0.009 
AMC – 2-A 0.56 2.23 0.02 1.11 0.044 
AMC – 3-A 0.26 1.59 -0.13 0.65 0.194 
AR – 2-A 0.50 2.20 -0.04 1.04 0.069 
24M 
AR – 3-A 0.20 1.46 -0.16 0.56 0.278 
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1.2 First Third Fractional Filling 
Table Ap1-7 – Left ventricular first third fractional filling Intra-study/Intra-observer 
reproducibility (paired samples T test) 
Paired Differences – Sub-acquisitions 5 and S 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
AMC -1.26 13.38 -4.55 2.03 0.447 24L 
AR 0.17 11.76 -2.72 3.07 0.904 
AMC -2.03 15.28 -5.79 1.72 0.284 
32L 
AR -2.05 13.15 -5.28 1.19 0.211 
AMC 0.09 13.53 -3.24 3.41 0.958 
24M 
AR 0.67 14.45 -2.88 4.22 0.708 
 
Table Ap1-8 – Left ventricular first third fractional filling intra-study/inter-observer 
reproducibility – Pearson correlation coefficient 
  24L 32L 24M 
2 AMC-AR 0.934 0.944 0.960 
3 AMC-AR 0.968 0.940 0.916 
5 AMC-AR 0.967 0.956 0.980 
S AMC-AR 0.983 0.961 0.928 
A AMC-AR 0.956 0.981 0.984 
2R AMC-AR 0.757 0.754 0.943 
3R AMC-AR 0.966 0.944 0.964 
5R AMC-AR 0.955 0.934 0.959 
 
Table Ap1-9 – Intra-study/Inter-observer reproducibility of left ventricular first third 
fractional filling (24 frame variable width) – Paired samples T-test 
Paired Differences – 24 Frame List Mode 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
2 AMC-AR -0.34 6.27 -1.89 1.20 0.657 
3 AMC-AR -0.24 4.47 -1.34 0.86 0.664 
5 AMC-AR -1.09 4.56 -2.21 0.03 0.056 
S AMC-AR 0.34 3.29 -0.47 1.15 0.399 
A AMC-AR -0.02 5.16 -1.29 1.24 0.970 
2R AMC-AR -0.06 11.20 -2.81 2.70 0.966 
3R AMC-AR 0.84 4.14 -0.18 1.86 0.104 
5R AMC-AR -0.23 5.09 -1.48 1.02 0.716 
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Table Ap1-10 – Intra-study/Inter-observer reproducibility of left ventricular first third 
fractional filling (32 frame variable width) – Paired samples T-test 
Paired Differences – 32 Frame List Mode 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
2 AMC-AR 1.24 5.97 -0.22 2.71 0.096 
3 AMC-AR -0.20 5.82 -1.63 1.24 0.786 
5 AMC-AR -0.006 5.27 -1.30 1.29 0.992 
S AMC-AR -0.02 5.27 -1.32 1.28 0.975 
A AMC-AR 0.25 3.58 -0.63 1.13 0.572 
2R AMC-AR -0.71 12.48 -3.78 2.35 0.644 
3R AMC-AR -0.02 5.87 -1.46 1.42 0.976 
5R AMC-AR 0.22 6.19 -1.30 1.74 0.774 
 
Table Ap1-11 – Intra-study/Inter-observer reproducibility of left ventricular first third 
fractional filling (24 frame fixed width) – Paired samples T-test 
Paired Differences – 24 Frame Fixed Width 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
2 AMC-AR -0.53 5.72 -1.94 0.87 0.452 
3 AMC-AR 0.27 7.48 -1.57 2.10 0.774 
5 AMC-AR -0.49 3.58 -1.37 0.39 0.271 
S AMC-AR 0.09 6.91 -1.60 1.79 0.912 
A AMC-AR 0.26 3.05 -0.49 1.01 0.497 
2R AMC-AR -0.63 5.73 -2.04 0.78 0.374 
3R AMC-AR 0.63 4.52 -0.48 1.74 0.260 
5R AMC-AR 0.40 4.83 -0.78 1.59 0.499 
 
Table Ap1-12 – Intra-observer/Inter-study reproducibility of left ventricular first third 
fractional filling (24 frame variable width) – Pearson correlation coefficient 
  24L 32L 24M 
2-2R 0.55 0.44 0.61 
3-3R 0.65 0.57 0.70 AMC 
5-5R 0.67 0.58 0.62 
2-2R 0.42 0.31 0.53 
3-3R 0.59 0.50 0.70 AR 
5-5R 0.67 0.57 0.64 
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Table Ap1-13 – Intra-observer/Inter-study reproducibility of left ventricular first third 
fractional filling (24 frame variable width) (paired samples T test) 
Paired Differences – 24 Frame List Mode 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
2-2R -2.28 16.15 -6.25 1.69 0.255 
3-3R -1.21 13.70 -4.58 2.15 0.474 
5-5R -0.07 14.04 -3.52 3.38 0.968 
AMC 
S-5R 1.19 12.21 -1.81 4.19 0.431 
2-2R -2.00 17.57 -6.32 2.32 0.359 
3-3R -0.13 15.35 -3.91 3.64 0.944 
5-5R 0.79 14.29 -2.72 4.30 0.654 
AR 
S-5R 0.62 12.83 -2.54 3.77 0.697 
 
Table Ap1-14 – Intra-observer/Inter-study reproducibility of left ventricular first third 
fractional filling (24 frame fixed width) (paired samples t test) 
Paired Differences – 24 Frame Fixed Width Mode 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
2-2R 0.53 16.63 -3.56 4.62 0.796 
3-3R 0.16 13.62 -3.19 3.51 0.923 
5-5R -0.74 15.05 -4.44 2.96 0.690 
AMC 
S-5R -0.83 14.01 -4.27 2.61 0.632 
2-2R 0.43 18.15 -4.03 4.90 0.847 
3-3R 0.53 13.89 -2.89 3.94 0.759 
5-5R 0.15 14.79 -3.49 3.79 0.935 
AR 
S-5R -0.52 14.14 -4.00 2.96 0.766 
 
Table Ap1-15 – Intra-observer/Inter-study reproducibility of left ventricular first third 
fractional filling (32 frame variable width) (paired samples T test) 
Paired Differences – 32 Frame List Mode 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
2-2R 1.49 19.20 -3.23 6.21 0.530 
3-3R -2.39 15.32 -6.16 1.38 0.210 
5-5R -0.24 15.28 -3.99 3.52 0.901 
AMC 
S-5R 1.80 15.49 -2.01 5.60 0.349 
2-2R -0.46 20.55 -5.51 4.59 0.856 
3-3R -2.22 17.35 -6.48 2.05 0.303 
5-5R -0.008 16.25 -4.00 3.99 0.996 
AR 
S-5R 2.04 15.71 -1.82 5.90 0.296 
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Table Ap1-16 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
left ventricular first third fractional filling (paired samples T-test) 
Paired Differences – 2 or 3 versus 10 minutes 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig 
(2-tailed) 
AMC – 2-A -0.23 10.84 -2.89 2.44 0.866 
AMC – 3-A -0.19 9.93 -2.63 2.25 0.876 
AR – 2-A 0.09 12.92 -3.08 3.27 0.953 
24L 
AR – 3-A 0.02 9.72 -2.37 2.42 0.983 
AMC – 2-A 2.36 12.67 -0.75 5.47 0.135 
AMC – 3-A -0.24 11.06 -2.96 2.48 0.861 
AR – 2-A 1.37 12.01 -1.58 4.32 0.358 
32L 
AR – 3-A 0.21 10.17 -2.29 2.71 0.869 
AMC – 2-A 0.45 11.33 -2.33 3.24 0.747 
AMC – 3-A -0.73 11.07 -3.45 1.99 0.595 
AR – 2-A 1.24 12.07 -1.73 4.21 0.407 
24M 
AR – 3-A -0.74 10.76 -3.38 1.91 0.580 
 
Table Ap1-17 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
left ventricular first third fractional filling – Pearson correlation coefficient 
  24L 32L 24M 
2-A 0.81 0.75 0.83 AMC 
3-A 0.83 0.80 0.80 
2-A 0.72 0.78 0.80 
AR 
3-A 0.85 0.83 0.82 
 
1.3 Peak Filling Rate (3 point regression) 
Table Ap1-18 – Left Ventricular  Peak Filling Rate Intra-study/Intra-observer Reproducibility 
– 5 and S sub-acquisition comparison (paired samples T test) 
Paired Differences – Sub-acquisitions 5 and S 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
AMC -4.01 26.67 -10.56 2.55 0.226 24L 
AR -3.96 28.83 -11.05 3.12 0.268 
AMC -8.07 41.26 -18.22 2.07 0.117 
32L 
AR -8.38 44.60 -19.35 2.58 0.132 
AMC -4.63 26.30 -11.10 1.83 0.157 
24M 
AR -4.98 29.22 -12.16 2.21 0.171 
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Figure Ap1-1 – Bland-Altman analysis of left ventricular Peak Filling Rate intra-study/intra-
observer reproducibility (24 frame list mode AMC 5-S acquisitions) 
 
 
Table Ap1-19 – LV Peak Filling Rate (3 point regression) Intra-study/Inter-observer 
Reproducibility – 24 frame variable width (paired samples T-test) 
Paired Differences – 24 Frame Variable Width 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
2 AMC-AR -5.59 13.90 -9.01 -2.17 0.002 
3 AMC-AR -5.20 12.62 -8.30 -2.10 0.001 
5 AMC-AR -5.92 12.99 -9.11 -2.73 <0.001 
S AMC-AR -5.88 16.02 -9.81 -1.94 0.004 
A AMC-AR -5.70 13.17 -8.94 -2.46 0.001 
2R AMC-AR -7.95 16.85 -12.09 -3.81 <0.001 
3R AMC-AR -8.03 15.83 -11.92 -4.14 <0.001 
5R AMC-AR -7.14 14.96 -10.82 -3.46 <0.001 
 
Figure Ap1-2 – Bland-Altman plot of Peak Filling Rate (3 point regression) – AMC-AR 24 
frame variable width 10 minute acquisition 
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Table Ap1-20 – Intra-observer/Inter-study LV Peak Filling Rate (3 point regression) 
reproducibility – Pearson correlation coefficient 
  24L 32L 24M 
2-2R 0.817 0.722 0.850 
3-3R 0.870 0.796 0.827 AMC 
5-5R 0.875 0.807 0.880 
2-2R 0.834 0.795 0.868 
3-3R 0.885 0.796 0.838 AR 
5-5R 0.891 0.803 0.891 
 
Table Ap1-21 – LV Peak Filling Rate (3 point regression) Intra-observer/Inter-study 
Reproducibility – 24 frame variable width (paired samples T-test) 
Paired Differences – 24 Frame Variable Width 
95% Confidence Interval of 
the Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig. 
(2-tailed) 
2-2R -1.95 41.03 -12.03 8.14 0.701 
3-3R 3.24 34.73 -5.30 11.77 0.452 AMC 
5-5R 1.10 33.15 -7.05 9.25 0.788 
2-2R -4.30 42.09 -14.65 6.04 0.409 
3-3R 0.41 34.54 -8.08 8.90 0.924 
 
AR 
5-5R -0.12 32.82 -8.19 7.95 0.977 
 
Table Ap1-22 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
LV Peak Filling Rate (3 point regression) – Pearson correlation coefficient 
  24L 32L 24M 
2-A 0.93 0.87 0.93 AMC 
3-A 0.96 0.91 0.95 
2-A 0.94 0.89 0.93 
AR 
3-A 0.96 0.90 0.95 
 
Table Ap1-23 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
LV Peak Filling Rate (3 point regression) (paired samples T-test) 
Paired Differences – 2 or 3 minutes vs 10 
95% Confidence Interval of 
the Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig.  
(2-tailed) 
AMC – 2-A 8.77 26.10 2.36 15.19 0.008 
AMC – 3-A 5.76 19.53 0.96 10.56 0.020 
AR – 2-A 8.66 25.51 2.39 14.93 0.008 
24L 
AR – 3-A 5.25 19.83 0.38 10.13 0.035 
AMC – 2-A 15.51 36.57 6.52 24.50 0.001 
AMC – 3-A 10.46 31.00 2.84 18.08 0.008 
AR – 2-A 15.88 36.26 6.97 24.79 0.001 
32L 
AR – 3-A 11.34 34.44 2.87 19.81 0.009 
AMC – 2-A 13.24 30.94 5.64 20.85 0.001 
AMC – 3-A 4.38 22.26 -1.09 9.86 0.114 
AR – 2-A 14.41 33.37 6.21 22.61 0.001 
24M 
AR – 3-A 4.32 23.52 -1.46 10.11 0.140 
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1.4 Time to Peak Filling 
Table Ap1-24 – LV Time to Peak Filling (RR) Intra-study/Intra-observer Reproducibility 
(paired samples T-test) 
Paired Differences – 5 and S sub-acquisitions 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
AMC 0.005 0.10 -0.012 0.029 0.702 24L 
AR 0.005 0.09 -0.018 0.027 0.689 
AMC 0.024 0.19 -0.023 0.071 0.313 
32L 
AR 0.025 0.18 -0.019 0.069 0.257 
AMC 0.003 0.13 -0.029 0.036 0.839 
24M 
AR -0.0004 0.14 -0.034 0.033 0.978 
 
Table Ap1-25 – LV Time to Peak Filling (RR) Intra-study/Inter-observer Pearson correlation 
coefficient 
  24L 32L 24M 
2 AMC-AR 0.94 0.84 0.95 
3 AMC-AR 0.93 0.95 0.96 
5 AMC-AR 0.95 0.86 0.93 
S AMC-AR 0.97 0.43 0.31 
A AMC-AR 0.79 0.94 0.88 
2R AMC-AR 0.87 0.81 0.87 
3R AMC-AR 0.83 0.80 0.83 
5R AMC-AR 0.86 0.90 0.87 
 
Table Ap1-26 – LV Time to Peak Filling (RR) Intra-study/Inter-observer Reproducibility - 24 
frame variable width (paired samples T-test) 
Paired Differences -24 Frame Variable Width 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
2 AMC-AR -0.003 0.037 -0.012 0.006 0.537 
3 AMC-AR 0.0009 0.036 -0.008 0.010 0.833 
5 AMC-AR 0.004 0.030 -0.003 0.012 0.228 
S AMC-AR 0.004 0.028 -0.003 0.011 0.213 
A AMC-AR 0.004 0.059 -0.010 0.019 0.592 
2R AMC-AR -0.008 0.062 -0.023 0.008 0.326 
3R AMC-AR -0.020 0.068 -0.036 -0.003 0.019 
5R AMC-AR -0.005 0.064 -0.021 0.011 0.551 
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Table Ap1-27 – Intra-observer/Inter-study LV Time to Peak Filling (RR) reproducibility - 
Pearson correlation coefficient 
  24L 32L 24M 
2-2R 0.35 0.28 0.43 
3-3R 0.42 0.39 0.36 AMC 
5-5R 0.42 0.39 0.25 
2-2R 0.24 0.14 0.31 
3-3R 0.34 0.34 0.46 AR 
5-5R 0.54 0.53 0.43 
 
Table Ap1-28 – LV Time to Peak Filling (RR) Intra-observer/Inter-study Reproducibility - 24 
frame variable width (paired samples T-test) 
Paired Differences – 24 Frame Variable Width 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig. (2-
tailed) 
2-2R 0.017 0.12 -0.012 0.046 0.254 
3-3R 0.008 0.11 -0.020 0.035 0.581 AMC 
5-5R -0.010 0.11 -0.038 0.018 0.468 
2-3R 0.012 0.14 -0.023 0.048 0.498 
3-3R -0.014 0.13 -0.045 0.018 0.390 AR 
5-5R -0.019 0.11 -0.046 0.008 0.155 
 
Table Ap1-29 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
LV Time to Peak Filling (RR) (paired samples T-test) 
Paired Differences – 2 or 3 minutes versus 10 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig. (2-
tailed) 
AMC – 2-A 0.013 0.10 -0.012 0.038 0.312 
AMC – 3-A 0.002 0.09 -0.021 0.024 0.888 
AR – 2-A 0.020 0.10 -0.005 0.044 0.112 
24L 
AR – 3-A 0.005 0.09 -0.018 0.028 0.693 
AMC – 2-A -0.008 0.13 -0.040 0.024 0.618 
AMC – 3-A 0.001 0.15 -0.037 0.039 0.955 
AR – 2-A -0.014 0.13 -0.047 0.018 0.383 
32L 
AR – 3-A 0.010 0.15 -0.026 0.047 0.574 
AMC – 2-A 0.017 0.12 -0.012 0.046 0.251 
AMC – 3-A 0.020 0.12 -0.010 0.048 0.173 
AR – 2-A 0.010 0.14 -0.023 0.044 0.542 
24M 
AR – 3-A 0.010 0.12 -0.020 0.040 0.502 
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Table Ap1-30 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
LV Time to Peak Filling (RR) – Pearson correlation coefficient 
  24L 32L 24M 
2-A 0.46 0.55 0.45 AMC 
3-A 0.54 0.39 0.51 
2-A 0.51 0.50 0.37 
AR 
3-A 0.48 0.48 0.51 
 
1.5 Peak Emptying Rate (RR) 
Table Ap1-31 – LV Peak Emptying Rate (RR) Intra-study/Intra-observer Reproducibility 
(paired samples T-test) 
Paired Differences – 5 and S sub-acquisitions 
95% Confidence Interval of the 
Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
AMC -3.14 21.63 -8.46 2.17 0.242 24L 
AR -2.79 23.46 -8.55 2.98 0.338 
AMC -5.36 29.22 -12.55 1.82 0.141 
32L 
AR -5.82 33.66 -14.10 2.45 0.165 
AMC -0.23 19.24 -4.96 4.50 0.924 
24M 
AR -0.34 20.38 -5.35 4.67 0.893 
 
 
Table Ap1-32 – LV Peak Emptying Rate (RR) Intra-study/Inter-observer Pearson correlation 
coefficient 
  24L 32L 24M 
2 AMC-AR 0.978 0.971 0.981 
3 AMC-AR 0.977 0.976 0.978 
5 AMC-AR 0.980 0.977 0.980 
S AMC-AR 0.976 0.970 0.977 
A AMC-AR 0.980 0.976 0.980 
2R AMC-AR 0.975 0.976 0.978 
3R AMC-AR 0.975 0.975 0.978 
5R AMC-AR 0.980 0.980 0.981 
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Table Ap1-33 – LV Peak Emptying Rate (RR) Intra-study/Inter-observer Reproducibility - 24 
frame variable width (paired samples T-test) 
Paired Differences – 24 Frame Variable Width 
95% Confidence Interval of the 
Difference 
 
Mean 
Std. 
Deviation Lower Upper 
Sig. 
(2-tailed) 
2 AMC-AR -9.01 18.20 -13.48 -4.53 <0.001 
3 AMC-AR -9.13 18.39 -13.66 -4.61 <0.001 
5 AMC-AR -9.41 16.88 -13.56 -5.26 <0.001 
S AMC-AR -9.05 17.82 -13.43 -4.67 <0.001 
A AMC-AR -9.63 16.38 -13.65 -5.60 <0.001 
2R AMC-AR -9.47 21.19 -14.68 -4.26 0.001 
3R AMC-AR -10.03 21.07 -15.21 -4.85 <0.001 
5R AMC-AR -10.13 19.22 -14.85 -5.40 <0.001 
 
Table Ap1-34 – Intra-observer/Inter-study LV Peak Emptying Rate (RR) reproducibility - 
Pearson correlation coefficient 
  24L 32L 24M 
2-2R 0.87 0.84 0.88 
3-3R 0.87 0.84 0.89 AMC 
5-5R 0.92 0.88 0.91 
2-2R 0.87 0.86 0.88 
3-3R 0.87 0.84 0.90 AR 
5-5R 0.92 0.88 0.91 
 
Table Ap1-35 – LV Peak Emptying Rate (RR) Intra-observer/Inter-study Reproducibility - 24 
frame variable width (paired samples T-test) 
Paired Differences – 24 Frame Variable Width 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig. 
(2-tailed) 
2-2R -11.34 41.00 -21.42 -1.27 0.028 
3-3R -11.77 41.71 -22.02 -1.51 0.025 AMC 
5-5R -8.25 33.56 -16.51 -0.004 0.050 
2-2R -11.81 44.84 -22.83 -0.79 0.036 
3-3R -12.66 46.12 -24.00 -1.32 0.029 AR 
5-5R -8.97 36.66 -17.98 0.04 0.051 
 
Table Ap1-36 – LV Peak Emptying Rate (RR) Intra-observer/Inter-study Reproducibility - 24 
frame fixed width (paired samples T-test) 
Paired Differences – 24 Frame Fixed Width 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
2-2R -9.98 40.19 -19.86 -0.10 0.048 
3-3R -11.12 38.17 -20.50 -1.73 0.021 AMC 
5-5R -9.19 34.43 -17.65 -0.72 0.034 
2-3R -11.56 43.76 -22.31 -0.80 0.036 
3-3R -12.21 39.35 -21.88 -2.54 0.014 AR 
5-5R -11.18 37.17 -20.32 -2.04 0.017 
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Table Ap1-37 – LV Peak Emptying Rate (RR) Intra-observer/Inter-study Reproducibility - 32 
frame variable width (paired samples T-test) 
Paired Differences – 32 Frame Variable Width 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
2-2R -22.76 52.87 -35.75 -9.76 0.001 
3-3R -22.78 53.49 -35.93 -9.63 0.001 AMC 
5-5R -16.25 44.23 -27.12 -5.37 0.004 
2-2R -23.43 54.56 -36.85 -10.02 0.001 
2-2R -23.78 57.04 -37.80 -9.75 0.001 AR 
3-3R -17.85 48.43 -29.75 -5.94 0.004 
 
Table Ap1-38 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
LV Peak Emptying Rate (RR)  – Pearson correlation coefficient 
  24L 32L 24M 
2-A 0.97 0.96 0.97 AMC 
3-A 0.98 0.97 0.98 
2-A 0.97 0.96 0.97 
AR 
3-A 0.98 0.96 0.98 
 
Table Ap1-39 – Effect of reducing acquisition time to 2 or 3 minutes versus 10 minutes on 
LV Peak Emptying Rate (RR) (paired samples T-test) 
Paired Differences – 2 or 3 versus 10 minutes 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
AMC – 2-A 9.22 17.07 5.02 13.41 <0.001 
AMC – 3-A 5.36 13.90 1.94 8.78 0.003 
AR – 2-A 8.60 18.27 4.11 13.09 <0.001 
24L 
AR – 3-A 4.87 16.07 0.92 8.82 0.016 
AMC – 2-A 21.30 24.07 15.38 27.22 <0.001 
AMC – 3-A 13.06 20.06 8.13 17.99 <0.001 
AR – 2-A 21.47 26.02 15.07 27.86 <0.001 
32L 
AR – 3-A 12.77 26.67 6.22 19.33 <0.001 
AMC – 2-A 11.46 19.61 6.64 16.28 <0.001 
AMC – 3-A 6.30 14.47 2.74 9.86 0.001 
AR – 2-A 10.76 20.94 5.61 15.91 <0.001 
24M 
AR – 3-A 6.10 16.25 2.11 10.10 0.003 
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Table Ap1-40 – Effect of reducing acquisition time to 2 or 3 minutes versus 5 minutes on LV 
Peak Emptying Rate (RR) (paired samples T-test) 
Paired Differences – 2 or 3 versus 5 minutes 
95% Confidence Interval of 
the Difference 
 
Mean Std. Deviation Lower Upper 
Sig.  
(2-tailed) 
AMC – 2-5 6.72 18.82 2.10 11.35 0.005 
AMC – 3-5 2.87 12.81 -0.28 6.02 0.074 
AR – 2-5 6.32 19.87 1.43 11.20 0.012 
24L 
AR – 3-5 2.59 13.62 -0.76 5.94 0.127 
AMC – 2-5 15.26 27.60 8.47 22.04 <0.001 
AMC – 3-5 7.01 19.02 2.34 11.69 0.004 
AR – 2-5 16.04 28.15 9.12 22.96 <0.001 
32L 
AR – 3-5 7.35 22.28 1.87 12.83 0.009 
AMC – 2-5 8.32 20.31 3.33 13.31 0.001 
AMC – 3-5 3.16 14.10 -0.30 6.63 0.073 
AR – 2-5 7.80 21.96 2.40 13.20 0.005 
24M 
AR – 3-5 3.14 14.67 -0.46 6.75 0.087 
 
